Browse by Title

Type here to filter the list

#
15+ years of ENCePP: what has been achieved, what’s next, and what’s in for ISPE

Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency ### 1655442###Lead Speaker###Pharmacoepidemiology/RWE Senior Specialist###RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency###
Lead Speaker: Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency
### she/her/hers @@@ K. Arnold Chan, MD, ScD (he/him/his) – TriNetX ### 1358385###Speaker###Senior Vice President, Insights & Evidence Generation###TriNetX###
Speaker: K. Arnold Chan, MD, ScD (he/him/his) – TriNetX
### he/him/his @@@ Helga Gardarsdottir, PharmD, PhD, FISPE (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands ### 1061395###Speaker###Professor RWD for decision making on medicines###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands###
Speaker: Helga Gardarsdottir, PharmD, PhD, FISPE (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Gianmario Candore, MSc – Bayer, Germany ### 1659477###Speaker###Partnership and Policy Senior Manager###Bayer, Germany###
Speaker: Gianmario Candore, MSc – Bayer, Germany
### @@@ Massoud Toussi – Cytel ### 2325298###Speaker######Cytel###
Speaker: Massoud Toussi – Cytel
### @@@ Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 1359276###Speaker###Assistant Professor###Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###
Speaker: Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
###
2024 ISPE Funded Manuscript Program Committee
2025 Scientific Program Committee
30-day risk of digoxin toxicity among older adults co-prescribed trimethoprim-sulfamethoxazole versus amoxicillin: A population-based cohort study

Flory Tsobo Muanda, MD, PhD – Western University ### 1994338###Presenting Author###Assistant Professor###Western University###
Presenting Author: Flory Tsobo Muanda, MD, PhD – Western University
### @@@ Fatemeh Ahmadi, PharmD, MSc – Westsern University ### 1994337###Co-Author###PhD student###Westsern University###
Co-Author: Fatemeh Ahmadi, PharmD, MSc – Westsern University
### @@@ Amit Garg, MD, PhD – Western University ### 1994339###Co-Author###Professor###Western University###
Co-Author: Amit Garg, MD, PhD – Western University
###
A
A Combined Machine Learning and Natural Language Processing Approach to Determine Metastatic Date Through Integrated Temporal Modeling

Vandana Priya – ConcertAI ### 2325649###Co-Author######ConcertAI###
Co-Author: Vandana Priya – ConcertAI
### @@@ Urvashi Bhattacharyya, PhD – ConcertAI ### 2325650###Co-Author###Lead Data Scientist###ConcertAI###
Co-Author: Urvashi Bhattacharyya, PhD – ConcertAI
### @@@ Sheenu Chandwani – ConcertAI ### 2325651###Co-Author######ConcertAI###
Co-Author: Sheenu Chandwani – ConcertAI
### @@@ Herman E. Ray, PhD – ConcertAI ### 2325652###Co-Author###Contractor###ConcertAI###
Co-Author: Herman E. Ray, PhD – ConcertAI
### @@@ Srikanth Tankala – ConcertAI ### 2325653###Co-Author######ConcertAI###
Co-Author: Srikanth Tankala – ConcertAI
### @@@ Jake Cohen – ConcertAI ### 2325654###Co-Author######ConcertAI###
Co-Author: Jake Cohen – ConcertAI
### @@@ Vivek Vaidya (he/him/his) – ConcertAI ### 2325655###Presenting Author###Executive Director - Predictive AI & Visual NLP###ConcertAI###
Presenting Author: Vivek Vaidya (he/him/his) – ConcertAI
### he/him/his
A comparison of self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases

Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine ### 1360173###Presenting Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Presenting Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
### @@@ Ivonne Martin – 2. Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands ### 2325487###Co-Author######2. Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands###
Co-Author: Ivonne Martin – 2. Department Data Science & Biostatistics, University Medical Centre Utrecht, the Netherlands
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###
Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1655571###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Co-Author: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hers @@@ Svetlana V. Belitser – 4. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands ### 1655669###Co-Author######4. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands###
Co-Author: Svetlana V. Belitser – 4. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
### @@@ Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. ### 1991140###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.###
Co-Author: Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.
### @@@ Elisa Correcher-Martinez – 5. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991142###Co-Author######5. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###
Co-Author: Elisa Correcher-Martinez – 5. Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Arantxa Urchueguía-Fornes, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health) ### 1991141###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)###
Co-Author: Arantxa Urchueguía-Fornes, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health)
### @@@ Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS) ### 1359445###Co-Author###Pharmacoepidemiologist###Spanish Agency of Medicines and Medical Devices (AEMPS)###
Co-Author: Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS)
### @@@ Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain ### 1655701###Co-Author######Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain###
Co-Author: Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Meritxell Pallejà-Millán – 8. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360561###Co-Author######8. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Meritxell Pallejà-Millán – 8. Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Elena Segundo, n/a – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991143###Co-Author######Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Elena Segundo, n/a – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain. ### 1657346###Co-Author###Medical Writer###Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.###
Co-Author: Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.
### @@@ Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht ### 1655741###Co-Author###Assistant Professor###Department of Data Science and Biostatistics, University Medical Center Utrecht###
Co-Author: Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Co-Author###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine###
Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine
###
A Methods Mischung

Eelko Hak, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2326059###Moderator######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Moderator: Eelko Hak, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Moderator###Associate Professor###University of North Carolina at Chapel Hill###
Moderator: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers
A Newly Developed Method for Assessing Exposure and Adherence to Free Dose Combinations: A Proof-of-Concept Using Antihypertensive Drugs in Danish Administrative and Healthcare Registers

Sidse Marie Neumann Nielsen – University of Copenhagen ### 2325396###Co-Author######University of Copenhagen###
Co-Author: Sidse Marie Neumann Nielsen – University of Copenhagen
### @@@ Maurizio Sessa, PharmD – Department of Drug Design and Pharmacology, University of Copenhagen ### 1062857###Presenting Author###Associate Professor###Department of Drug Design and Pharmacology, University of Copenhagen###
Presenting Author: Maurizio Sessa, PharmD – Department of Drug Design and Pharmacology, University of Copenhagen
###
A Novel Approach for Estimating Prevalence and Incidence for 100+ Health Conditions by Race/Ethnicity and County in the United States

Kate W. Gillespie, MPH PhD (she/her/hers) – Institute for Health Metrics and Evaluation (IHME) ### 1658529###Presenting Author###Assistant Director###Institute for Health Metrics and Evaluation (IHME)###
Presenting Author: Kate W. Gillespie, MPH PhD (she/her/hers) – Institute for Health Metrics and Evaluation (IHME)
### she/her/hers @@@ Assaf P. Oron, PhD (they/them/theirs) – University of Washington ### 2325719### Co-Author###Senior Analyst###University of Washington###
Co-Author: Assaf P. Oron, PhD (they/them/theirs) – University of Washington
### they/them/theirs @@@ Parkes Kendrick – University of Washington ### 2325720###Co-Author######University of Washington###
Co-Author: Parkes Kendrick – University of Washington
### @@@ Jiali Lei, MTM – Institute for Health Metrics and Evaluation, University of Washington ### 2325424###Co-Author###Analyst, Client Services###Institute for Health Metrics and Evaluation, University of Washington###
Co-Author: Jiali Lei, MTM – Institute for Health Metrics and Evaluation, University of Washington
### @@@ Charles Jonscher, PhD – University of Washington ### 2325721###Co-Author######University of Washington###
Co-Author: Charles Jonscher, PhD – University of Washington
### @@@ Greg A. Roth, MD – University of Washington ### 2325722###Co-Author######University of Washington###
Co-Author: Greg A. Roth, MD – University of Washington
### @@@ Eliseo J. Perez-Stable, MD – National Institutes of Health ### 2325723###Co-Author######National Institutes of Health###
Co-Author: Eliseo J. Perez-Stable, MD – National Institutes of Health
### @@@ George A. Mensah, MD – National Institutes of Health ### 2325724###Co-Author######National Institutes of Health###
Co-Author: George A. Mensah, MD – National Institutes of Health
### @@@ Ali Mokdad, PhD – University of Washington ### 2325725###Co-Author######University of Washington###
Co-Author: Ali Mokdad, PhD – University of Washington
### @@@ Laura Dwyer-Lindgren, PhD – University of Washington ### 2325726###Co-Author######University of Washington###
Co-Author: Laura Dwyer-Lindgren, PhD – University of Washington
###
A Novel High Dimensional Approach to Assess Treatment Heterogeneity in Claims Data: Sodium-glucose Cotransporter-2 inhibitors (SGLT2i) vs Glucagon-like Peptide-1 Receptor Agonists (GLP1RA) on Hospitalized Heart Failure Risk

Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill ### 1062647###Presenting Author###postdoc###University of North Carolina at Chapel Hill###
Presenting Author: Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill
### @@@ Virginia Pate, MS – University of North Carolina at Chapel Hill ### 1358426###Co-Author###Analyst###University of North Carolina at Chapel Hill###
Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 1991568###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Michael Kosorok – University of North Carolina Gillings School of Global Public Health Department of Biostatistics ### 1359686###Co-Author######University of North Carolina Gillings School of Global Public Health Department of Biostatistics###
Co-Author: Michael Kosorok – University of North Carolina Gillings School of Global Public Health Department of Biostatistics
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###
Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his
A scalable approach to assess the safety of novel systemic treatments for atopic dermatitis in clinical practice: First analysis cycle of the ADVANCES sequential monitoring system

Maria C. Schneeweiss, MD – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1360208###Presenting Author###Instructor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Presenting Author: Maria C. Schneeweiss, MD – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital ### 1302713###Co-Author###Professor###Brigham and Women's Hospital###
Co-Author: Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital
### @@@ Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital ### 1655514###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital###
Co-Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital
### @@@ Yinzhu Jin, MPH (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062667###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Yinzhu Jin, MPH (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Arash Mostaghimi, MD, MPA, MPH – Dept of Dermatology, Brigham and Women's Hospital, Harvard Medical School ### 1397912###Co-Author######Dept of Dermatology, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Arash Mostaghimi, MD, MPA, MPH – Dept of Dermatology, Brigham and Women's Hospital, Harvard Medical School
### @@@ Joseph Merola, MD – Dept of Dermatology, UT Southwestern ### 2325367###Co-Author######Dept of Dermatology, UT Southwestern###
Co-Author: Joseph Merola, MD – Dept of Dermatology, UT Southwestern
### @@@ Jonathan Silverberg, MD, PhD, MPH – Dept of Dermatology, George Washington University ### 1397913###Co-Author######Dept of Dermatology, George Washington University###
Co-Author: Jonathan Silverberg, MD, PhD, MPH – Dept of Dermatology, George Washington University
### @@@ David Rosmarin, MD – Dept of Dermatology, University of Indiana ### 2325368###Co-Author######Dept of Dermatology, University of Indiana###
Co-Author: David Rosmarin, MD – Dept of Dermatology, University of Indiana
### @@@ Robert Sidbury, MD, MPH – Division of Dermatology, Dept of Pediatrics, Seattle Children's Hospital ### 2325369###Co-Author######Division of Dermatology, Dept of Pediatrics, Seattle Children's Hospital###
Co-Author: Robert Sidbury, MD, MPH – Division of Dermatology, Dept of Pediatrics, Seattle Children's Hospital
### @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his
A Self-Controlled Case Series to Evaluate Risk of Ischemic Stroke Following Bivalent COVID-19 Vaccine Administration in a US Veteran Population

Kwan Hur, PhD – Veterans Health Administration ### 1657376###Co-Author###Biostatistician###Veterans Health Administration###
Co-Author: Kwan Hur, PhD – Veterans Health Administration
### @@@ Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration ### 1302728###Presenting Author###Investigator###Veterans Health Administration###
Presenting Author: Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration
### @@@ Bharat Thakkar, MS – Veterans Health Administration ### 1657536###Co-Author######Veterans Health Administration###
Co-Author: Bharat Thakkar, MS – Veterans Health Administration
### @@@ Lucy Pandey, MS – Veterans Health Administration ### 1657535###Co-Author######Veterans Health Administration###
Co-Author: Lucy Pandey, MS – Veterans Health Administration
### @@@ Walid Gellad, MD – VA Pittsburgh Healthcare System ### 1992664###Co-Author######VA Pittsburgh Healthcare System###
Co-Author: Walid Gellad, MD – VA Pittsburgh Healthcare System
### @@@ Peter Glassman, MBBS, MSc – Veterans Health Administration ### 1657543###Co-Author######Veterans Health Administration###
Co-Author: Peter Glassman, MBBS, MSc – Veterans Health Administration
### @@@ Chester B. Good, MD, MPH – Veterans Health Administration ### 1359135###Co-Author######Veterans Health Administration###
Co-Author: Chester B. Good, MD, MPH – Veterans Health Administration
### @@@ Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA ### 1659630###Co-Author###Director, Clinical Epidemiology Program###Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA###
Co-Author: Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA
### @@@ Donald R. Miller, ScD – Veterans Health Administration ### 1991692###Co-Author###Professor and Health Scientist###Veterans Health Administration###
Co-Author: Donald R. Miller, ScD – Veterans Health Administration
### @@@ Fran E. Cunningham, PharmD – Veterans Health Administration ### 1655509###Co-Author###Director, Center for Medication Safety###Veterans Health Administration###
Co-Author: Fran E. Cunningham, PharmD – Veterans Health Administration
###
A tree-based scan statistic for database studies with time-to-event outcomes

Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062580###Presenting Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Presenting Author: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Massimiliano Russo – The Ohio State University ### 2325679### Co-Author######The Ohio State University###
Co-Author: Massimiliano Russo – The Ohio State University
###
Accounting for Twins and Other Multiple Births in Perinatal Pharmacoepidemiological Studies Conducted Using Healthcare Administration Data

Jeremy P. Brown, MSc, PhD – Harvard T.H. Chan School of Public Health ### 1994052###Presenting Author###Postdoctoral Research Fellow###Harvard T.H. Chan School of Public Health###
Presenting Author: Jeremy P. Brown, MSc, PhD – Harvard T.H. Chan School of Public Health
### @@@ Jennifer J. Yland – Harvard T.H. Chan School of Public Health ### 2325201###Co-Author######Harvard T.H. Chan School of Public Health###
Co-Author: Jennifer J. Yland – Harvard T.H. Chan School of Public Health
### @@@ Paige Williams – Harvard T.H. Chan School of Public Health ### 2325202###Co-Author######Harvard T.H. Chan School of Public Health###
Co-Author: Paige Williams – Harvard T.H. Chan School of Public Health
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Co-Author###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
###
Acute Cardiovascular, Neurological and Metabolic Adverse Events Associated With The Use of Nirmatrelvir/ritonavir or Molnupiravir for COVID-19 Infection: a Nationwide Cohort Study in South Korea

Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302812###Presenting Author###Research Assistant Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea ### 1358469###Co-Author###PhD Student###School of Pharmacy, Sungkyunkwan University, Suwon, Korea###
Co-Author: Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea
### @@@ Gihwan Bae – Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea ### 2325577###Co-Author######Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea###
Co-Author: Gihwan Bae – Artificial Intelligence and Big-Data Convergence Center, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea
### @@@ Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea ### 1991610###Co-Author######Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea###
Co-Author: Jaehun Jung, MD, PhD – Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Ad26.COV2.S vaccine and thromboembolic risks among premenopausal women: Exploring variation by combined hormonal medication use

Melanie H. Jacobson, PhD, MPH (she/her/hers) – Johnson and Johnson Innovative Medicine ### 1993049###Presenting Author###Associate Director###Johnson and Johnson Innovative Medicine###
Presenting Author: Melanie H. Jacobson, PhD, MPH (she/her/hers) – Johnson and Johnson Innovative Medicine
### she/her/hers @@@ Joel N. Swerdel, PhD MS MPH (he/him/his) – Johnson and Johnson Innovative Medicine ### 1659127###Co-Author###Director###Johnson and Johnson Innovative Medicine###
Co-Author: Joel N. Swerdel, PhD MS MPH (he/him/his) – Johnson and Johnson Innovative Medicine
### he/him/his @@@ Azza Shoaibi, PhD, MPH – Johnson & Johnson ### 1360292###Co-Author###Director###Johnson & Johnson###
Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson
### @@@ Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine ### 1046837###Co-Author###Associate Director of Epidemiology###Johnson and Johnson Innovative Medicine###
Co-Author: Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine
### he/him/his @@@ Luis Humberto Anaya-Velarde, MD, MSc – Johnson & Johnson Innovative Medicine ### 1993409###Co-Author###Director, Medical Safety Officer###Johnson & Johnson Innovative Medicine###
Co-Author: Luis Humberto Anaya-Velarde, MD, MSc – Johnson & Johnson Innovative Medicine
### @@@ E. Claire Newbern, PhD, MPH – Johnson and Johnson Innovative Medicine ### 1991938###Co-Author###Director, Global Epidemiology###Johnson and Johnson Innovative Medicine###
Co-Author: E. Claire Newbern, PhD, MPH – Johnson and Johnson Innovative Medicine
###
Adaptive Approaches for Observational Studies: Methods for Pre-specifying Phased Diagnostics and Contingencies

Andrew R. Weckstein – Aetion Inc. ### 2325614###Presenting Author###PhD Student at Harvard University###Aetion Inc.###
Presenting Author: Andrew R. Weckstein – Aetion Inc.
### @@@ Vera Frajzyngier, PhD, MPH – Aetion ### 1991832###Co-Author###VP Scientific Research###Aetion###
Co-Author: Vera Frajzyngier, PhD, MPH – Aetion
### @@@ Sarah Vititoe, MPH – Aetion ### 2325435###Co-Author######Aetion###
Co-Author: Sarah Vititoe, MPH – Aetion
### @@@ Aidan Baglivo, BS – Aetion ### 1655637###Co-Author###Senior Analyst###Aetion###
Co-Author: Aidan Baglivo, BS – Aetion
### @@@ Elisha Beebe, BA – Aetion ### 1691611###Co-Author###Research Analyst###Aetion###
Co-Author: Elisha Beebe, BA – Aetion
### @@@ Priya Govil, BA – Aetion ### 1655431###Co-Author###Senior Analyst###Aetion###
Co-Author: Priya Govil, BA – Aetion
### @@@ Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA ### 1062817###Co-Author###Senior Advisor###Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA###
Co-Author: Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA
### @@@ Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration ### 1358505###Co-Author###Senior Epidemiologist###US Food and Drug Administration###
Co-Author: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration
### @@@ Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration ### 1358274###Co-Author######Office of Surveillance and Epidemiology, US Food and Drug Administration###
Co-Author: Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration
### @@@ Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration ### 1358504###Co-Author###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, U.S. Food and Drug Administration###
Co-Author: Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration
### @@@ Aloka Chakravarty, PhD, Mstat – Pfizer, Inc. ### 2325528###Co-Author###VP, Head of Enterprise RWE###Pfizer, Inc.###
Co-Author: Aloka Chakravarty, PhD, Mstat – Pfizer, Inc.
### @@@ Tamar Lasky, PhD (she/her/hers) – Retired ### 2325357###Co-Author###Retired###Retired###
Co-Author: Tamar Lasky, PhD (she/her/hers) – Retired
### she/her/hers @@@ Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1062756###Co-Author###VP/Head of Scientific Research + Analytics###Aetion, Inc.###
Co-Author: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1093999###Co-Author###Chief Science Officer###Aetion, Inc.###
Co-Author: Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers
Added Benefit and Waning Effectiveness of a Third-Dose mRNA COVID-19 Vaccine in Community-Dwelling Medicare Beneficiaries Aged ≥65 Years in Omicron Period

Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration ### 1659299###Co-Author###Mathematical Statistician###Center for Biologics Evaluation and Research, Food and Drug Administration###
Co-Author: Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration
### @@@ Kathryn Matuska, BA – Acumen, LLC ### 1659336###Co-Author###Policy Lead###Acumen, LLC###
Co-Author: Kathryn Matuska, BA – Acumen, LLC
### @@@ Rowan McEvoy, B.S. – Acumen, LLC ### 1991408###Presenting Author###Policy Lead###Acumen, LLC###
Presenting Author: Rowan McEvoy, B.S. – Acumen, LLC
### @@@ Hector S. Izurieta, MD, PhD – US Food and Drug Administration ### 1659297###Co-Author###Associate Director, OVRR/CBER###US Food and Drug Administration###
Co-Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration
### @@@ Jessica R. Hervol, MPH – Acumen, LLC ### 2325148###Co-Author######Acumen, LLC###
Co-Author: Jessica R. Hervol, MPH – Acumen, LLC
### @@@ Mikhail Menis, PharmD, MS (he/him/his) – Center for Biologics Evaluation and Research, Food and Drug Administration ### 1358507###Co-Author###Epidemiologist###Center for Biologics Evaluation and Research, Food and Drug Administration###
Co-Author: Mikhail Menis, PharmD, MS (he/him/his) – Center for Biologics Evaluation and Research, Food and Drug Administration
### he/him/his @@@ Arnstein Lindaas, MA – Acumen, LLC ### 1991272###Co-Author######Acumen, LLC###
Co-Author: Arnstein Lindaas, MA – Acumen, LLC
### @@@ Whitney Steele, PhD – Center for Biologics Evaluation and Research, U.S. Food and Drug Administration ### 1659334###Co-Author###Health Scientist###Center for Biologics Evaluation and Research, U.S. Food and Drug Administration###
Co-Author: Whitney Steele, PhD – Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Michael Wernecke, BA (he/him/his) – Acumen, LLC ### 1358529###Co-Author###Senior Research Manager###Acumen, LLC###
Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC
### he/him/his @@@ Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA ### 1358531###Co-Author######Centers for Medicare & Medicaid Services, Washington, DC, USA###
Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
###
Addressing RWE Transportability Concerns in Health Care Decision-Making. How to Do It Right?

Evie Merinopoulou, MSc – Cytel ### 2325637###Lead Speaker###Senior Director, Real-World Evidence###Cytel###
Lead Speaker: Evie Merinopoulou, MSc – Cytel
### @@@ Alind Gupta, PhD – Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto ### 1991513###Speaker###Adjunct Lecturer###Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto###
Speaker: Alind Gupta, PhD – Department of Epidemiology, Dalla Lana School of Public Health, University of Toronto
### @@@ Alessandria Strübing, MSPH – Daiichi Sankyo Europe ### 2325686###Speaker###Director Global Oncology, RWE Lead###Daiichi Sankyo Europe###
Speaker: Alessandria Strübing, MSPH – Daiichi Sankyo Europe
### @@@ Blythe Adamson, PhD, MPH – Flatiron Health ### 2325353###Speaker###Senior Principal Scientist###Flatiron Health###
Speaker: Blythe Adamson, PhD, MPH – Flatiron Health
### @@@ Stephen Duffield, PhD – National Institute of Health and Care Excellence (NICE) ### 1655608###Speaker###Associate Director for Real-World Evidence Methods###National Institute of Health and Care Excellence (NICE)###
Speaker: Stephen Duffield, PhD – National Institute of Health and Care Excellence (NICE)
###
ADHD Pharmacotherapy and Mortality in Individuals with ADHD: A Target Trial Emulation Study with Observational Data

Zheng Chang, PhD (he/him/his) – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1655403###Presenting Author###Principal researcher###Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Presenting Author: Zheng Chang, PhD (he/him/his) – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### he/him/his
Adherence to Medication

Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands ### 1658657###Lead Speaker###Associate Professor of Pharmacoepidemiology and Pharmaceutical Care Associate Professor of Pharmacoepidemiology###Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands###
Lead Speaker: Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands
### she/her/hers @@@ Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1062823###Speaker###Associate Professor###Brigham and Women's Hospital and Harvard Medical School###
Speaker: Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School
###
Adjusting number of cases, risk, risk difference and risk ratio estimated through an algorithm with unknown sensitivity: a contribution from the ConcePTION project

Giorgio Limoncella – University of Florence, Florence, Italy ### 1359790###Presenting Author###PhD Student###University of Florence, Florence, Italy###
Presenting Author: Giorgio Limoncella – University of Florence, Florence, Italy
### @@@ Leonardo Grilli, PhD – University of Florence ### 1994256###Co-Author###Full professor of statistics###University of Florence###
Co-Author: Leonardo Grilli, PhD – University of Florence
### @@@ Emanuela Dreassi – University of Florence ### 1994257###Co-Author###Full professor of Statistics###University of Florence###
Co-Author: Emanuela Dreassi – University of Florence
### @@@ Carla Rampichini, PhD – University of Florence ### 1994258###Co-Author###Full professor of Statistics###University of Florence###
Co-Author: Carla Rampichini, PhD – University of Florence
### @@@ Robert W. Platt, PhD (he/him/his) – McGill University ### 1358167###Co-Author###Professor###McGill University###
Co-Author: Robert W. Platt, PhD (he/him/his) – McGill University
### he/him/his @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers
Advanced Drug Utilization Research

Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands ### 1086986###Lead Speaker###PhD, FISPE###Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands###
Lead Speaker: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
### @@@ Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark ### 1358115###Lead Speaker###Assistant professor###University of Southern Denmark###
Lead Speaker: Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark
### @@@ Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands ### 1086972###Speaker###Professor###Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands###
Speaker: Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands
### @@@ Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1062862###Speaker###Assistant Professor###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Speaker: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2326851###Speaker###Professor###Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
###
Advanced Methods I: Let's GIT It Started: Transparency and Reproducibility Across the RWE Study Lifecycle with HARPER, GIT and the R Programming Language

Janick Weberpals, RPh, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1991181###Lead Speaker###Instructor in Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Lead Speaker: Janick Weberpals, RPh, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### he/him/his @@@ Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine ### 1360173###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###
Speaker: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
### @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###
Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062580###Speaker###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Speaker: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers
Advanced Methods II: Target Trial Emulation for Causal Inference in Practice

Vanessa Didelez, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 2325330###Lead Speaker###Professor of Statistics and Causal Inference###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Lead Speaker: Vanessa Didelez, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1397900###Speaker###Statistician, postdoctoral research fellow###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Claudia Börnhorst, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 2328477###Speaker###Senior Researcher###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Claudia Börnhorst, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###
Advancing Drug Safety Signal Management through Multimodal Approaches in Networking

Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1062943###Lead Speaker###Immediate Past Chair of the ISPE Student Council###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Lead Speaker: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Darmendra Ramcharran, PhD – GSK ### 1994710###Speaker###Sr Director, Safety & Quantitative Innovation###GSK###
Speaker: Darmendra Ramcharran, PhD – GSK
### @@@ Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Speaker###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Speaker: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Oskar Gauffin, MSc (he/him/his) – Uppsala Monitoring Centre ### 1358942###Speaker###Data Scientist###Uppsala Monitoring Centre###
Speaker: Oskar Gauffin, MSc (he/him/his) – Uppsala Monitoring Centre
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Speaker###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Speaker: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Speaker###Professor###University of Southern Denmark###
Speaker: Anton Pottegård, PhD, DMSc – University of Southern Denmark
### @@@ Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital ### 1062628###Speaker###Senior Pharmacist Educator###Keelung Chang Gung Memorial Hospital###
Speaker: Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital
### @@@ Weny Huang – Taiwan National Adverse Drug Reaction Reporting Center/ Taiwan Drug Relief Foundation ### 1360456###Speaker######Taiwan National Adverse Drug Reaction Reporting Center/ Taiwan Drug Relief Foundation###
Speaker: Weny Huang – Taiwan National Adverse Drug Reaction Reporting Center/ Taiwan Drug Relief Foundation
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Speaker###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Speaker: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Adverse pregnancy outcomes associated with in utero exposure to multiple sclerosis disease-modifying therapies in France: a nationwide cohort study

Morgane Swital, MSc – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM) ### 1993967###Presenting Author###PhD Candidate in Epidemiology###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)###
Presenting Author: Morgane Swital, MSc – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)
### @@@ Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360500###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM) ### 1993521###Co-Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###
Co-Author: Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM)
### @@@ Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360499###Co-Author###PhD, PharmD, MPH###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###
An evaluation of race and ethnicity-based representation among participants in phase III clinical trials for multiple myeloma

Tianyi Wang, PhD (she/her/hers) – Janssen Research & Development LLC. ### 2325119###Presenting Author###Associate Director, Global Epidemiology###Janssen Research & Development LLC.###
Presenting Author: Tianyi Wang, PhD (she/her/hers) – Janssen Research & Development LLC.
### she/her/hers @@@ Dinorah J. Villanueva, MS, MBA – Janssen Research & Development LLC. ### 2325137###Co-Author###Associate Director, DEICT Process Lead###Janssen Research & Development LLC.###
Co-Author: Dinorah J. Villanueva, MS, MBA – Janssen Research & Development LLC.
### @@@ Dina Gifkins – Janssen Research & Development, LLC ### 1658381###Co-Author###Senior Director, Global Epidemiology###Janssen Research & Development, LLC###
Co-Author: Dina Gifkins – Janssen Research & Development, LLC
###
An Introduction to Artificial Intelligence for Pharmacoepidemiologists

Harriet Dickinson, MPhil, PhD – Gilead ### 1991252###Lead Speaker###RWE Director###Gilead###
Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead
### @@@ Victoria Strauss, PhD – Boehringer Ingelheim ### 1992049###Speaker###Senior Principle TA methodology statistician###Boehringer Ingelheim###
Speaker: Victoria Strauss, PhD – Boehringer Ingelheim
### @@@ Joseph W. Zabinski, PhD – OM1, Inc. ### 1653785###Speaker###VP, AI###OM1, Inc.###
Speaker: Joseph W. Zabinski, PhD – OM1, Inc.
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Speaker###Associate Director of Epidemiology###IQVIA###
Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hers
Annual General Members Meeting & Awards Ceremony

Lisa G. Pont, PhD, FISPE – University of Technology Sydney ### 1655255###Speaker###Professor of Pharmacy###University of Technology Sydney###
Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
### @@@ Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals ### 1360272###Speaker###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Speaker: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers
Antibiotic Exposure and Inactivated Influenza Vaccine Effectiveness

Daniel B. Horton, MD, MSCE (he/him/his) – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1063295###Presenting Author###Associate Professor of Pediatrics and Epidemiology###Rutgers Center for Pharmacoepidemiology and Treatment Science###
Presenting Author: Daniel B. Horton, MD, MSCE (he/him/his) – Rutgers Center for Pharmacoepidemiology and Treatment Science
### he/him/his @@@ Abner Nyandege, PhD – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1359571###Co-Author######Rutgers Center for Pharmacoepidemiology and Treatment Science###
Co-Author: Abner Nyandege, PhD – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Edward Nonnenmache – Bayshore Analytics and Integrated Solutions LLC ### 2325432###Co-Author######Bayshore Analytics and Integrated Solutions LLC###
Co-Author: Edward Nonnenmache – Bayshore Analytics and Integrated Solutions LLC
### @@@ Jason A. Roy, PhD – Rutgers School of Public Health ### 1360415###Co-Author###Professor of Biostatistics and Epidemiology###Rutgers School of Public Health###
Co-Author: Jason A. Roy, PhD – Rutgers School of Public Health
### @@@ Kirk Benack – Montefiore Medical Center ### 2325433###Co-Author######Montefiore Medical Center###
Co-Author: Kirk Benack – Montefiore Medical Center
### @@@ Saira Jan, MS, Pharm.D. – Horizon Blue Cross Blue Shield of New Jersey ### 1359574###Co-Author###Vice President and Chief Pharmacy Officer###Horizon Blue Cross Blue Shield of New Jersey###
Co-Author: Saira Jan, MS, Pharm.D. – Horizon Blue Cross Blue Shield of New Jersey
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Co-Author###Professor of Medicine and Epidemiology###Rutgers University###
Co-Author: Soko Setoguchi, MD, DrPH – Rutgers University
### @@@ Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research ### 1046831###Co-Author###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research###
Co-Author: Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research
### he/him/his @@@ Brian L. Strom, MD, MPH (he/him/his) – Rutgers, State University of New Jersey ### 1302723###Co-Author###Chancellor, Biomedical and Health Sciences###Rutgers, State University of New Jersey###
Co-Author: Brian L. Strom, MD, MPH (he/him/his) – Rutgers, State University of New Jersey
### he/him/his
Antidepressant Adherence Patterns and Hospitalization Risk Among Type 2 Diabetic Adults — An Application of Group-Based Trajectory Modeling

Yueh-Yi Chiang, BSPharm (she/her/hers) – University of Maryland School of Pharmacy ### 1991614###Presenting Author###PhD Candidate###University of Maryland School of Pharmacy###
Presenting Author: Yueh-Yi Chiang, BSPharm (she/her/hers) – University of Maryland School of Pharmacy
### she/her/hers @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy###
Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy
###
Antipsychotic abuse and dependence: A 10-year review of reports to the European Pharmacovigilance System

João Paulo Fernandes – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 2325550###Presenting Author######Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###
Presenting Author: João Paulo Fernandes – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
### @@@ Pedro Benjamim – MD Clinical Pharmacology Unit, Santa Maria Local Health Unit, Lisbon,Portugal ### 2325658###Co-Author######MD Clinical Pharmacology Unit, Santa Maria Local Health Unit, Lisbon,Portugal###
Co-Author: Pedro Benjamim – MD Clinical Pharmacology Unit, Santa Maria Local Health Unit, Lisbon,Portugal
### @@@ Márcia Silva – INFARMED, I.P. - Autoridade Nacional do Medicamento e Produtos de Saúde, Lisboa, Portugal ### 2325659###Co-Author######INFARMED, I.P. - Autoridade Nacional do Medicamento e Produtos de Saúde, Lisboa, Portugal###
Co-Author: Márcia Silva – INFARMED, I.P. - Autoridade Nacional do Medicamento e Produtos de Saúde, Lisboa, Portugal
### @@@ Bruno Sepodes, PharmD, MSc, PhD, MPH – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 1655923###Co-Author###Full Professor###Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###
Co-Author: Bruno Sepodes, PharmD, MSc, PhD, MPH – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
### @@@ Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 1359276###Co-Author###Assistant Professor###Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###
Co-Author: Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
###
Antipsychotics dose patterns in people with severe mental illness: a population-based study using primary care data

Juan Carlos JC Bazo-Alvarez, MSc – University College London ### 1062671###Presenting Author######University College London###
Presenting Author: Juan Carlos JC Bazo-Alvarez, MSc – University College London
### @@@ Irene Petersen, PhD – University College London ### 1658084###Co-Author######University College London###
Co-Author: Irene Petersen, PhD – University College London
###
Applications of trajectory methods in medication adherence research: A decade in review and a look ahead

Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1062823###Lead Speaker###Associate Professor###Brigham and Women's Hospital and Harvard Medical School###
Lead Speaker: Julie C. Lauffenburger, PharmD, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Jessica M. Franklin, PhD (she/her/hers) – Optum ### 1359343###Speaker###Principal Consultant###Optum###
Speaker: Jessica M. Franklin, PhD (she/her/hers) – Optum
### she/her/hers @@@ Cécile Payet – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 2325505###Speaker######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###
Speaker: Cécile Payet – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Marissa J. Seamans, PhD – University of California Los Angeles ### 1359410###Speaker###Assistant Professor###University of California Los Angeles###
Speaker: Marissa J. Seamans, PhD – University of California Los Angeles
### @@@ Chao Cai, PhD (she/her/hers) – University of South Carolina ### 1994283###Speaker###Assistant Professor###University of South Carolina###
Speaker: Chao Cai, PhD (she/her/hers) – University of South Carolina
### she/her/hers @@@ Ellen (Feng-Hua) Loh, PhD – Touro University ### 1445421###Speaker###Assistant Professor###Touro University###
Speaker: Ellen (Feng-Hua) Loh, PhD – Touro University
###
Applied Sensitivity Analyses

Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Lead Speaker###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Lead Speaker: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1062756###Speaker###VP/Head of Scientific Research + Analytics###Aetion, Inc.###
Speaker: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers
Applying the self-controlled case series to analyse safety endpoints in single-arm, open label extension studies: A case study of Belimumab for the treatment of systemic lupus erythematosus and risk of infection

Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine ### 1360173###Presenting Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Presenting Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
### @@@ Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK ### 1991261###Co-Author###Vice President###Analysis Group, Inc., London, UK###
Co-Author: Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK
### she/her/hers @@@ Kieran J. Rothnie, PhD – GSK ### 1062865###Co-Author###Director Epidemiology###GSK###
Co-Author: Kieran J. Rothnie, PhD – GSK
### @@@ Stephen Evans – London School of Hygiene and Tropical Medicine ### 2328409###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Stephen Evans – London School of Hygiene and Tropical Medicine
### @@@ Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine###
Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine
###
Are You My Mother? A Validation of Clinical Practice Research Datalink (CPRD) Aurum Mother Baby Link

Catherine Vasilakis-Scaramozza, PhD (she/her/hers) – BCDSP ### 1358130###Presenting Author###Epidemiologist###BCDSP###
Presenting Author: Catherine Vasilakis-Scaramozza, PhD (she/her/hers) – BCDSP
### she/her/hers @@@ Rebecca Persson, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program ### 1657756###Co-Author###Epidemiologist###Boston Collaborative Drug Surveillance Program###
Co-Author: Rebecca Persson, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program
### she/her/hers @@@ George Kafatos, MSc PhD CStat – Amgen ### 1657757###Co-Author###Observational Research Director###Amgen###
Co-Author: George Kafatos, MSc PhD CStat – Amgen
### @@@ David E. Neasham, PhD – Amgen Ltd ### 1657758###Co-Author###Senior Manager###Amgen Ltd###
Co-Author: David E. Neasham, PhD – Amgen Ltd
### @@@ Katrina Wilcox Hagberg, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program ### 1062956###Co-Author###Senior Epidemiologist###Boston Collaborative Drug Surveillance Program###
Co-Author: Katrina Wilcox Hagberg, MPH (she/her/hers) – Boston Collaborative Drug Surveillance Program
### she/her/hers @@@ Susan Jick, DSc – Boston Collaborative Drug Surveillance Program ### 1358051###Co-Author###DIrector###Boston Collaborative Drug Surveillance Program###
Co-Author: Susan Jick, DSc – Boston Collaborative Drug Surveillance Program
###
Assessing COVID-19 Vaccine Effectiveness

Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania ### 1359970###Moderator###Associate Professor of Medicine and Epidemiology###University of Pennsylvania###
Moderator: Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania
### he/him/his @@@ Hilda Duran, MPH, MD, MSc (she/her/hers) – La Salle University ### 2406737###Moderator###Scientist###La Salle University###
Moderator: Hilda Duran, MPH, MD, MSc (she/her/hers) – La Salle University
### she/her/hers
Assessing the impact of data diversity on background incidence rates of adverse events of special interest: the component strategy from the COVID-19 Vaccine Monitoring project

Giuseppe Roberto, PhD, PharmD – ARS Toscana, Florence ### 1359195###Co-Author###PharmD, PhD###ARS Toscana, Florence###
Co-Author: Giuseppe Roberto, PhD, PharmD – ARS Toscana, Florence
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###
Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht ### 1655741###Co-Author###Assistant Professor###Department of Data Science and Biostatistics, University Medical Center Utrecht###
Co-Author: Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht
### @@@ Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands ### 1991418###Co-Author###PhD candidate###Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands###
Co-Author: Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands
### @@@ Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain ### 1655701###Co-Author######Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain###
Co-Author: Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
### @@@ Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS) ### 1359445###Co-Author###Pharmacoepidemiologist###Spanish Agency of Medicines and Medical Devices (AEMPS)###
Co-Author: Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS)
### @@@ Olga Paoletti – ARS Toscana ### 1359270###Co-Author###Researcher###ARS Toscana###
Co-Author: Olga Paoletti – ARS Toscana
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. ### 1991140###Co-Author######Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.###
Co-Author: Juan José Carreras, PhD, PharmD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.
### @@@ Ainara Mira, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain. ### 1360557###Co-Author###Senior biostatistician###Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.###
Co-Author: Ainara Mira, PhD – Vaccine Research Department, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO - Public Health), Avenida Cataluña, 21, 46020 Valencia, Spain.
### @@@ Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain. ### 1657346###Co-Author###Medical Writer###Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.###
Co-Author: Fabio Riefolo, PhD – Teamit Institute, Partnership, Barcelona Health Hub, Barcelona, Spain.
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Co-Author###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Presenting Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Presenting Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers
Assessing treatment effectiveness when no appropriate comparator exists: low-density lipoprotein cholesterol lowering therapy (LLT) for the prevention of aortic stenosis (AS) as a case example

Dana J. Murdock, MPH, PhD – Regeneron Pharmaceuticals, Inc. ### 1658103###Co-Author###Assistant Director, Epidemiology ###Regeneron Pharmaceuticals, Inc.###
Co-Author: Dana J. Murdock, MPH, PhD – Regeneron Pharmaceuticals, Inc.
### @@@ Li Wang – Regeneron Pharmaceuticals, Inc. ### 2325582###Co-Author######Regeneron Pharmaceuticals, Inc.###
Co-Author: Li Wang – Regeneron Pharmaceuticals, Inc.
### @@@ Robert Sanchez – Regeneron Pharmaceuticals, Inc. ### 1992243###Co-Author######Regeneron Pharmaceuticals, Inc.###
Co-Author: Robert Sanchez – Regeneron Pharmaceuticals, Inc.
### @@@ Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals ### 1360272###Co-Author###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Co-Author: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Kusha Mohammadi – Regeneron Pharmaceuticals, Inc. ### 2325583###Co-Author######Regeneron Pharmaceuticals, Inc.###
Co-Author: Kusha Mohammadi – Regeneron Pharmaceuticals, Inc.
### @@@ Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc. ### 1360060###Co-Author######Regeneron Pharmaceuticals, Inc.###
Co-Author: Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc.
### @@@ Sergio Fazio – Regeneron Pharmaceuticals, Inc. ### 2325584###Co-Author######Regeneron Pharmaceuticals, Inc.###
Co-Author: Sergio Fazio – Regeneron Pharmaceuticals, Inc.
### @@@ Jessica J. Jalbert, PhD (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1062874###Presenting Author###Executive Director###Regeneron Pharmaceuticals, Inc.###
Presenting Author: Jessica J. Jalbert, PhD (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers
Assessment of laboratory data quality in real-world data

Xinyue Liu, PhD – Epidemiology, Merck & Co., Inc. ### 2326298###Presenting Author###Senior Principal Scientist###Epidemiology, Merck & Co., Inc.###
Presenting Author: Xinyue Liu, PhD – Epidemiology, Merck & Co., Inc.
### @@@ Tianchen Lyu – Health Outcomes & Biomedical informatics, University of Florida ### 2330965###Co-Author######Health Outcomes & Biomedical informatics, University of Florida###
Co-Author: Tianchen Lyu – Health Outcomes & Biomedical informatics, University of Florida
### @@@ Xing He – Health Outcomes & Biomedical informatics, University of Florida ### 2330966###Co-Author######Health Outcomes & Biomedical informatics, University of Florida###
Co-Author: Xing He – Health Outcomes & Biomedical informatics, University of Florida
### @@@ Lihai Song – Biostatistics and Research Decision Sciences, Merck & Co., Inc. ### 2330967###Co-Author######Biostatistics and Research Decision Sciences, Merck & Co., Inc.###
Co-Author: Lihai Song – Biostatistics and Research Decision Sciences, Merck & Co., Inc.
### @@@ Edward Bortnichak – Epidemiology, Merck & Co. Inc. ### 2330968###Co-Author######Epidemiology, Merck & Co. Inc.###
Co-Author: Edward Bortnichak – Epidemiology, Merck & Co. Inc.
### @@@ Jiang Bian, PhD – College of Medicine, University of Florida ### 1658680###Co-Author###Professor, Health Outcomes & Biomedical Informatics###College of Medicine, University of Florida###
Co-Author: Jiang Bian, PhD – College of Medicine, University of Florida
###
Assessment of non-cardiac congenital malformations and in utero exposure to modafinil/armodafinil in the Sentinel Distributed Database

Catherine Callahan, PhD, MA (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration ### 2325627###Presenting Author###Senior Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration###
Presenting Author: Catherine Callahan, PhD, MA (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration
### she/her/hers @@@ Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325162###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Kimberly Barrett – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325635###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Kimberly Barrett – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Derek Campbell – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325636###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Derek Campbell – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Kira Leishear, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration ### 1655537###Co-Author###Lead Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration###
Co-Author: Kira Leishear, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, United States Food and Drug Administration
### @@@ Carrie Ceresa – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration ### 2325638###Co-Author######Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration###
Co-Author: Carrie Ceresa – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration
### @@@ Miriam Dinatale – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration ### 2325639###Co-Author######Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration###
Co-Author: Miriam Dinatale – Office of New Drugs, Center for Drug Evaluation and Research, United States Food and Drug Administration
###
Assessment of Potential Adverse Events Following the 2022–2023 Seasonal Influenza Vaccines Among U.S. Adults Aged 65 Years and Older

Xiangyu (Chianti) Shi, MS – Acumen LLC ### 1991273###Co-Author######Acumen LLC###
Co-Author: Xiangyu (Chianti) Shi, MS – Acumen LLC
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Presenting Author###Epidemiologist###US FDA###
Presenting Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Michelle Ondari, MSPH – Acumen LLC ### 1991411###Co-Author######Acumen LLC###
Co-Author: Michelle Ondari, MSPH – Acumen LLC
### @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###
Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Pablo Freyria Duenas, MA – Acumen LLC ### 2325114###Co-Author######Acumen LLC###
Co-Author: Pablo Freyria Duenas, MA – Acumen LLC
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###
Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC ### 2325538###Co-Author###Senior Policy Assoicate###Acumen, LLC###
Co-Author: Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC
### @@@ Sylvia Cho, PhD – US FDA ### 2325116###Co-Author######US FDA###
Co-Author: Sylvia Cho, PhD – US FDA
### @@@ Laurie Feinberg, MD – Acumen LLC ### 2325117###Co-Author######Acumen LLC###
Co-Author: Laurie Feinberg, MD – Acumen LLC
### @@@ Mao I. Hu, BS – Acumen LLC ### 1655532###Co-Author###Policy Researcher###Acumen LLC###
Co-Author: Mao I. Hu, BS – Acumen LLC
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA ### 1358531###Co-Author######Centers for Medicare & Medicaid Services, Washington, DC, USA###
Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###
Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###
Association between Denosumab and Risk of Cardiovascular Events in Patient with Osteoporosis: A Target Trial Emulation Study with Clone-Censor-Weight Approach

Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University ### 1991536###Presenting Author###Research fellow###National Cheng Kung University###
Presenting Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Huei-Kai Huang, MD PhD (he/him/his) – Department of Family Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan ### 2330061###Co-Author###Attending physician###Department of Family Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan###
Co-Author: Huei-Kai Huang, MD PhD (he/him/his) – Department of Family Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
### he/him/his @@@ Peter Ping-Sung Liu, MS – Center for Healthy Longevity, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan. ### 2328367###Co-Author######Center for Healthy Longevity, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.###
Co-Author: Peter Ping-Sung Liu, MS – Center for Healthy Longevity, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
### @@@ Tzu-Chi Liao, MS – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. ### 2327341###Co-Author######School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.###
Co-Author: Tzu-Chi Liao, MS – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
### @@@ Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital ### 1062628###Co-Author###Senior Pharmacist Educator###Keelung Chang Gung Memorial Hospital###
Co-Author: Shih-Chieh Shao, PhD – Keelung Chang Gung Memorial Hospital
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Association Between Fine Particulate Matter Exposure During Breast Cancer Treatment And Mortality Among Older Women in the United States

Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1063041###Presenting Author###Instructor of Medicine###Rutgers Center for Pharmacoepidemiology and Treatment Science###
Presenting Author: Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Rachel C. Nethery, PhD – Harvard T.H. Chan School of Public Health ### 1359788###Co-Author###Assistant Professor of Biostatistics###Harvard T.H. Chan School of Public Health###
Co-Author: Rachel C. Nethery, PhD – Harvard T.H. Chan School of Public Health
### @@@ Melanie Rua, PharmD, MPH – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1991270###Co-Author######Rutgers Center for Pharmacoepidemiology and Treatment Science###
Co-Author: Melanie Rua, PharmD, MPH – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Hari Iyer, PhD – Rutgers Cancer Institute of New Jersey ### 2325641###Co-Author######Rutgers Cancer Institute of New Jersey###
Co-Author: Hari Iyer, PhD – Rutgers Cancer Institute of New Jersey
### @@@ Elisa Bandera, MD, PhD – Rutgers Cancer Institute of New Jersey ### 2325384###Co-Author######Rutgers Cancer Institute of New Jersey###
Co-Author: Elisa Bandera, MD, PhD – Rutgers Cancer Institute of New Jersey
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Co-Author###Professor of Medicine and Epidemiology###Rutgers University###
Co-Author: Soko Setoguchi, MD, DrPH – Rutgers University
###
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Risk of Depression in U.S. Older Adults with Type 2 Diabetes

Ying Lu – University of Florida ### 1994192###Co-Author######University of Florida###
Co-Author: Ying Lu – University of Florida
### @@@ Huilin Tang, MS – University of Florida ### 1658671###Presenting Author###Predoctoral Fellowship###University of Florida###
Presenting Author: Huilin Tang, MS – University of Florida
### @@@ William T Donahoo, MD – University of Florida ### 1360407###Co-Author######University of Florida###
Co-Author: William T Donahoo, MD – University of Florida
### @@@ Jiang Bian, PhD – College of Medicine, University of Florida ### 1658680###Co-Author###Professor, Health Outcomes & Biomedical Informatics###College of Medicine, University of Florida###
Co-Author: Jiang Bian, PhD – College of Medicine, University of Florida
### @@@ Jingchuan Guo, MD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida ### 1357944###Co-Author###Assistant Professor###Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida###
Co-Author: Jingchuan Guo, MD, PhD – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
###
Association between macrolide exposure in early pregnancy and major congenital malformations: a large French population-based study during 2010-20 period

Anh Tran, BPharm, MSc (she/her/hers) – EPI-PHARE ### 1993512###Presenting Author###PhD Candidate###EPI-PHARE###
Presenting Author: Anh Tran, BPharm, MSc (she/her/hers) – EPI-PHARE
### she/her/hers @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Jeanne SIBIUDE – IAME, INSERM ### 1993519###Co-Author######IAME, INSERM###
Co-Author: Jeanne SIBIUDE – IAME, INSERM
### @@@ Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM) ### 1993521###Co-Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###
Co-Author: Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM)
### @@@ Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360500###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Lise Marty, PhD – EPI-PHARE (ANSM/CNAM) ### 2325312###Co-Author###Biostatistician###EPI-PHARE (ANSM/CNAM)###
Co-Author: Lise Marty, PhD – EPI-PHARE (ANSM/CNAM)
### @@@ Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358499###Co-Author###deputy director###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Xavier Duval – IAME, INSERM ### 1993515###Co-Author######IAME, INSERM###
Co-Author: Xavier Duval – IAME, INSERM
### @@@ Sarah Tubiana – IAME, INSERM ### 1993514###Co-Author######IAME, INSERM###
Co-Author: Sarah Tubiana – IAME, INSERM
###
Association between Metformin Use and Psychiatric Disorders in Patients with Diabetes

Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Presenting Author###PhD student###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University ### 1991536###Co-Author###Research fellow###National Cheng Kung University###
Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Association between Preoperative Use of Selective Serotonin Reuptake Inhibitor Treatments and Post-hepatectomy Liver Failure after Liver Surgery: a Nationwide Cohort Study on the French Health Data System (SNDS)

Cécile Payet – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 2325505###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###
Co-Author: Cécile Payet – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Xavier Muller – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France ### 2325506###Co-Author######Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France###
Co-Author: Xavier Muller – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Health Data Department, Lyon, France ### 1991160###Presenting Author###Deputy head of the health data department of the Hospices Civils de Lyon###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Health Data Department, Lyon, France###
Presenting Author: Marie Viprey, PharmD, PhD – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Health Data Department, Lyon, France
### @@@ Aurélie Moskal, PhD (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ### 1991154###Co-Author###Health Data Analyst###Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France###
Co-Author: Aurélie Moskal, PhD (she/her/hers) – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France
### she/her/hers @@@ Stéphanie POLAZZI – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 2325507###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###
Co-Author: Stéphanie POLAZZI – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Bruno CHARPIAT – Pharmacy Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France ### 2325508###Co-Author######Pharmacy Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France###
Co-Author: Bruno CHARPIAT – Pharmacy Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France
### @@@ Jean-Yves MABRUT – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France ### 2325509###Co-Author######Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France###
Co-Author: Jean-Yves MABRUT – Department of General Surgery and Liver Transplantation, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
### @@@ Antoine DUCLOS – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France ### 2325510###Co-Author######Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France###
Co-Author: Antoine DUCLOS – Research on Healthcare Performance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon, France ; Hospices Civils de Lyon, Service des Données de Santé, Lyon, France
### @@@ Mickaël LESURTEL – Department of HPB surgery and liver transplantation, AP-HP, Beaujon Hospital, DMU DIGEST, University of Paris Cité, Paris, France. ### 2325511###Co-Author######Department of HPB surgery and liver transplantation, AP-HP, Beaujon Hospital, DMU DIGEST, University of Paris Cité, Paris, France.###
Co-Author: Mickaël LESURTEL – Department of HPB surgery and liver transplantation, AP-HP, Beaujon Hospital, DMU DIGEST, University of Paris Cité, Paris, France.
###
Association of fluoroquinolones with the risk of spontaneous pneumothorax

Anne Bénard-Laribière – Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France ### 1062911###Co-Author######Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France###
Co-Author: Anne Bénard-Laribière – Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France
### @@@ Elodie Pambrun – Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France ### 1360544###Co-Author######Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France###
Co-Author: Elodie Pambrun – Univ. Bordeaux, INSERM, BPH, team AHeaD, U1219, F-33000 Bordeaux, France
### @@@ Serge Kouzan – Pulmonary Department, Centre Regional Hospital, Chambery, France ### 2325391###Co-Author######Pulmonary Department, Centre Regional Hospital, Chambery, France###
Co-Author: Serge Kouzan – Pulmonary Department, Centre Regional Hospital, Chambery, France
### @@@ Jean-Luc Faillie – Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; INSERM, Université de Montpellier, Institut Desbrest d’Épidémiologie et de Santé Publique, Montpellier, France ### 1358928###Co-Author######Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; INSERM, Université de Montpellier, Institut Desbrest d’Épidémiologie et de Santé Publique, Montpellier, France###
Co-Author: Jean-Luc Faillie – Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier; INSERM, Université de Montpellier, Institut Desbrest d’Épidémiologie et de Santé Publique, Montpellier, France
### @@@ Julien Bezin – Univ. Bordeaux, INSERM, BPH, U1219, équipe AHeaD, Bordeaux (France); CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, Bordeaux (France) ### 1358001###Co-Author######Univ. Bordeaux, INSERM, BPH, U1219, équipe AHeaD, Bordeaux (France); CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, Bordeaux (France)###
Co-Author: Julien Bezin – Univ. Bordeaux, INSERM, BPH, U1219, équipe AHeaD, Bordeaux (France); CHU de Bordeaux, Pôle de santé publique, Service de pharmacologie médicale, Bordeaux (France)
### @@@ Antoine Pariente, MD, PhD – INSERM team AHeaD - Pharmacoepi & Beyond, Univ Bordeaux ### 1358005###Presenting Author###Professor of Pharmacology - Head of Public Health Department###INSERM team AHeaD - Pharmacoepi & Beyond, Univ Bordeaux###
Presenting Author: Antoine Pariente, MD, PhD – INSERM team AHeaD - Pharmacoepi & Beyond, Univ Bordeaux
###
Association of Non-Steroidal Anti-Inflammatory Drug Use during Pregnancy and Miscarriage: A Norwegian Registry Linkage Study

Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway ### 1062980###Presenting Author###Assistant Professor in Pharmacoepidemiology###Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway###
Presenting Author: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
### @@@ Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Hilde M. Engjom, PhD – Norwegian Institute of Public Health ### 1659158###Co-Author###Specialist consultant and postdoctoral researcher###Norwegian Institute of Public Health###
Co-Author: Hilde M. Engjom, PhD – Norwegian Institute of Public Health
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers
Association of Suicide Attempts with Gabapentinoid treatment

Siu Chung Andrew Yuen, MPharm (he/him/his) – UCL School of Pharmacy ### 2330956###Presenting Author###PhD student###UCL School of Pharmacy###
Presenting Author: Siu Chung Andrew Yuen, MPharm (he/him/his) – UCL School of Pharmacy
### he/him/his @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
### @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Co-Author###Lecturer/Assistant Professor###UCL School of Pharmacy###
Co-Author: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/his
Associations of serum lipid traits with fracture and osteoporosis: A prospective cohort study from the UK Biobank

Xi Xiong, Msc – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1993246###Presenting Author###PhD student###Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Presenting Author: Xi Xiong, Msc – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ David Lui – Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 2325370###Co-Author######Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: David Lui – Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1991171###Co-Author###PhD Researcher###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
### he/him/his @@@ Ziyi Zhou – School of Health and Wellbeing, University of Glasgow ### 2325371###Co-Author######School of Health and Wellbeing, University of Glasgow###
Co-Author: Ziyi Zhou – School of Health and Wellbeing, University of Glasgow
### @@@ Chao Xu – School of Health and Wellbeing, University of Glasgow ### 2325372###Co-Author######School of Health and Wellbeing, University of Glasgow###
Co-Author: Chao Xu – School of Health and Wellbeing, University of Glasgow
### @@@ Paul Welsh – School of Cardiovascular and Metabolic Health, University of Glasgow ### 2325373###Co-Author######School of Cardiovascular and Metabolic Health, University of Glasgow###
Co-Author: Paul Welsh – School of Cardiovascular and Metabolic Health, University of Glasgow
### @@@ Naveed Sattar – School of Cardiovascular and Metabolic Health, University of Glasgow ### 2325374###Co-Author######School of Cardiovascular and Metabolic Health, University of Glasgow###
Co-Author: Naveed Sattar – School of Cardiovascular and Metabolic Health, University of Glasgow
### @@@ Carlos Celis-Morales – School of Health and Wellbeing, University of Glasgow ### 2325375###Co-Author######School of Health and Wellbeing, University of Glasgow###
Co-Author: Carlos Celis-Morales – School of Health and Wellbeing, University of Glasgow
### @@@ Jill Pell – School of Health and Wellbeing, University of Glasgow ### 2325376###Co-Author######School of Health and Wellbeing, University of Glasgow###
Co-Author: Jill Pell – School of Health and Wellbeing, University of Glasgow
### @@@ Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358232###Co-Author###Professor###Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### he/him/his @@@ Carlos K. Wong – Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358585###Co-Author######Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Carlos K. Wong – Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ Frederick Ho – School of Health and Wellbeing, University of Glasgow ### 2325377###Co-Author######School of Health and Wellbeing, University of Glasgow###
Co-Author: Frederick Ho – School of Health and Wellbeing, University of Glasgow
###
Avoidable Bias in Real-World Evidence Studies on Treatment Effects: How to Detect and Prevent It

Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Lead Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and ### 1360380###Speaker###Associate Professor of Medicine###Brigham and Women's Hospital and###
Speaker: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers @@@ Jessica M. Franklin, PhD (she/her/hers) – Optum ### 1359343###Speaker###Principal Consultant###Optum###
Speaker: Jessica M. Franklin, PhD (she/her/hers) – Optum
### she/her/hers @@@ Samy Suissa, PhD, FRSC, FCAHS – McGill University ### 1302854###Speaker###Distinguished James McGill Professor###McGill University###
Speaker: Samy Suissa, PhD, FRSC, FCAHS – McGill University
### @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###
Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
###
B
Back to the Source: a Review of the Current State of Social Determinants of Health in European and US Real World Data Sources

Isha Mehta, MPH – Regeneron Pharmaceuticals ### 2325355###Lead Speaker###Sr. Manager, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Lead Speaker: Isha Mehta, MPH – Regeneron Pharmaceuticals
### @@@ Andrea F. Marcus, PhD, MPH (she/her/hers) – Regeneron Pharmaceuticals ### 1063148###Speaker###Senior Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Speaker: Andrea F. Marcus, PhD, MPH (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Syd Phillips, MPH – Transom Development ### 2325356###Speaker######Transom Development###
Speaker: Syd Phillips, MPH – Transom Development
### @@@ Enriqueta Vallejo-Yagüe, PhD, Pharm – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland ### 2325322###Speaker###Advanced Postdoc and Team Lead###Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland###
Speaker: Enriqueta Vallejo-Yagüe, PhD, Pharm – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
### @@@ Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands ### 1062870###Speaker###PhD Researcher###PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands###
Speaker: Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
### he/him/his @@@ Tamar Lasky, PhD (she/her/hers) – Retired ### 2325357###Speaker###Retired###Retired###
Speaker: Tamar Lasky, PhD (she/her/hers) – Retired
### she/her/hers @@@ Eileen Dareng, MD, PhD – Astra Zeneca ### 2325328###Speaker###Director Safety Epidemiology###Astra Zeneca###
Speaker: Eileen Dareng, MD, PhD – Astra Zeneca
### @@@ Denise Umuhire – European Medicines Agency ### 1994155###Speaker######European Medicines Agency###
Speaker: Denise Umuhire – European Medicines Agency
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656### Co-Author###Head of Real-World Evidence###European Medicines Agency###
Co-Author: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Elizabeth Russell, PhD, MSc – Merck & Co., Inc ### 2325358### Co-Author###Principle Scientist###Merck & Co., Inc###
Co-Author: Elizabeth Russell, PhD, MSc – Merck & Co., Inc
###
Benchmarking Large Language Model Performance on Natural Language Processing Tasks for Pharmacoepidemiology

Hui Feng, PhD (she/her/hers) – IQVIA ### 2325214###Presenting Author###Senior AI Scientist###IQVIA###
Presenting Author: Hui Feng, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Francesco Ronzano – IQVIA ### 2325220###Co-Author######IQVIA###
Co-Author: Francesco Ronzano – IQVIA
### @@@ Jude LaFleur – IQVIA ### 2325217###Co-Author######IQVIA###
Co-Author: Jude LaFleur – IQVIA
### @@@ Matthew L. Garber, n/a – IQVIA ### 2325218###Co-Author###Senior AI Engineer###IQVIA###
Co-Author: Matthew L. Garber, n/a – IQVIA
### @@@ Rodrigo de Oliveira, PhD – IQVIA ### 2325219###Co-Author###Senior AI Engineer###IQVIA###
Co-Author: Rodrigo de Oliveira, PhD – IQVIA
### @@@ Katharine Roth – IQVIA ### 2325234###Co-Author######IQVIA###
Co-Author: Katharine Roth – IQVIA
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Co-Author###Associate Director of Epidemiology###IQVIA###
Co-Author: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hers @@@ Jay Nanavati – IQVIA ### 2325215###Co-Author######IQVIA###
Co-Author: Jay Nanavati – IQVIA
### @@@ Khaldoun Zine El Abidine, M.A.Sc. – IQVIA ### 2325216###Co-Author###Senior Director of Technology###IQVIA###
Co-Author: Khaldoun Zine El Abidine, M.A.Sc. – IQVIA
###
Beyond Borders: Health Disparities in the US and Europe

Lina Titievsky, PhD MPH – GSK ### 1358168###Moderator###Senior Director and Head of Hepatology Epidemiology###GSK###
Moderator: Lina Titievsky, PhD MPH – GSK
### @@@ Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands ### 1062870###Moderator###PhD Researcher###PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands###
Moderator: Taichi Ochi, MSc LLM (he/him/his) – PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
### he/him/his
Bleeding risk associated with non-steroidal anti-inflammatory drug use in patients with venous thromboembolism: a nationwide cohort study

Søren Riis Petersen, BSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 2325554###Presenting Author###Medical student / Research fellow###The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Presenting Author: Søren Riis Petersen, BSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Kasper Bonnesen, MD, PhD (he/him/his) – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1991650###Co-Author###Postdoc###The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Kasper Bonnesen, MD, PhD (he/him/his) – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### he/him/his @@@ Lars Pedersen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1358234###Co-Author###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Lars Pedersen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Erik Lerkevang Grove, MD, PhD – Department of Cardiology, Aarhus University Hospital ### 2325556###Co-Author######Department of Cardiology, Aarhus University Hospital###
Co-Author: Erik Lerkevang Grove, MD, PhD – Department of Cardiology, Aarhus University Hospital
### @@@ Morten Schmidt, MD, PhD, DMSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1360426###Co-Author######The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Morten Schmidt, MD, PhD, DMSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###
Brain-penetrant calcium channel blockers for psychiatric use: revisiting the evidence for benefit

David M. Kern, PhD, MS (he/him/his) – Johnson & Johnson ### 1062834###Presenting Author###Sr. Director, Epidemiology###Johnson & Johnson###
Presenting Author: David M. Kern, PhD, MS (he/him/his) – Johnson & Johnson
### he/him/his @@@ Justin Bohn, ScD – Johnson & Johnson ### 1991161###Co-Author###Associate Director, Epidemiology###Johnson & Johnson###
Co-Author: Justin Bohn, ScD – Johnson & Johnson
### @@@ Michael Maher – Johnson & Johnson ### 2325320###Co-Author######Johnson & Johnson###
Co-Author: Michael Maher – Johnson & Johnson
### @@@ Amin Yakubu – Johnson & Johnson ### 2325321###Co-Author######Johnson & Johnson###
Co-Author: Amin Yakubu – Johnson & Johnson
### @@@ Dmytro Dymshyts – Johnson & Johnson ### 1994088###Co-Author######Johnson & Johnson###
Co-Author: Dmytro Dymshyts – Johnson & Johnson
### @@@ Azza Shoaibi, PhD, MPH – Johnson & Johnson ### 1360292###Co-Author###Director###Johnson & Johnson###
Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson
###
Break
Break/Exhibits/Posters
Break/Exhibits/Posters
Break/Exhibits/Posters
Break/Exhibits/Posters
Break/Exhibits/Posters
Breaking Bias Barriers: Quantitative Bias Analysis for Rigorous Real-World Evidence

Grace Hsu, MSc – Cytel ### 2325354###Presenting Author###Director of Real World Evidence###Cytel###
Presenting Author: Grace Hsu, MSc – Cytel
###
Bringing athletes back to sport safely: Data-driven ramp-up intervention from wearable data linked with EHR in the NFL

Mackenzie Herzog, PhD, MPH – IQVIA ### 2330847###Presenting Author###Director, Epidemiology###IQVIA###
Presenting Author: Mackenzie Herzog, PhD, MPH – IQVIA
### @@@ Kristin Shiue, PhD, MPH – IQVIA ### 2331015###Co-Author######IQVIA###
Co-Author: Kristin Shiue, PhD, MPH – IQVIA
### @@@ Rebecca Lee, PhD, MPH – IQVIA ### 2331016###Co-Author######IQVIA###
Co-Author: Rebecca Lee, PhD, MPH – IQVIA
### @@@ Leigh Weiss, PT, DPT, MS, ATC – New York Giants ### 2331018###Co-Author######New York Giants###
Co-Author: Leigh Weiss, PT, DPT, MS, ATC – New York Giants
### @@@ Tyler Williams, MS, ATC – Minnesota Vikings ### 2331019###Co-Author######Minnesota Vikings###
Co-Author: Tyler Williams, MS, ATC – Minnesota Vikings
### @@@ Allen Sills, MD, FACS – NFL ### 2330855###Co-Author######NFL###
Co-Author: Allen Sills, MD, FACS – NFL
### @@@ Christina D. Mack, PhD, FISPE – IQVIA ### 2326929###Co-Author###Chief Scientific Officer###IQVIA###
Co-Author: Christina D. Mack, PhD, FISPE – IQVIA
###
Building global consensus on definitions for drug safety studies in pregnancy to improve harmonized evaluation of real-world data

Anne Broe, MD PhD (she/her/hers) – IQVIA, London, UK ### 2325222###Lead Speaker###Senior Epidemiologist###IQVIA, London, UK###
Lead Speaker: Anne Broe, MD PhD (she/her/hers) – IQVIA, London, UK
### she/her/hers @@@ Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1360167###Speaker###Deputy Director for Safety###Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Speaker: Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Sydney K. Willis, PhD – IQVIA ### 1723609###Speaker###Epidemiologist###IQVIA###
Speaker: Sydney K. Willis, PhD – IQVIA
### @@@ Eileen Dareng, MD, PhD – Astra Zeneca ### 2325328###Speaker###Director Safety Epidemiology###Astra Zeneca###
Speaker: Eileen Dareng, MD, PhD – Astra Zeneca
### @@@ Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway ### 1062980###Speaker###Assistant Professor in Pharmacoepidemiology###Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway###
Speaker: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
###
C
Can We De-risk the Risk? Drug Exposure in Older Adults

Kaley N. Hayes, PharmD, PhD – Brown University ### 1062830###Moderator###Assistant Professor###Brown University###
Moderator: Kaley N. Hayes, PharmD, PhD – Brown University
### @@@ Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2326851###Moderator###Professor###Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Moderator: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
###
Cardiovascular Treatments and Outcomes

Jonathan L. Slaughter, MD, MPH – Nationwide Children's Hospital and The Ohio State University ### 1062665###Moderator###Professor###Nationwide Children's Hospital and The Ohio State University###
Moderator: Jonathan L. Slaughter, MD, MPH – Nationwide Children's Hospital and The Ohio State University
### @@@ Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia ### 1358335###Moderator###Professor###Quality Use of Medicines and Pharmacy Research Centre, University of South Australia###
Moderator: Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
###
Case Series Analysis of Thromboembolic Events (Arterial and Venous) in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study

Miranda Davies – Drug Safety Research Unit, Southampton, UK ### 1062916###Co-Author###Chief Medical Officer###Drug Safety Research Unit, Southampton, UK###
Co-Author: Miranda Davies – Drug Safety Research Unit, Southampton, UK
### @@@ Sandeep Dhanda – Drug Safety Research Unit ### 1359019###Co-Author###Senior Clinical Research Fellow###Drug Safety Research Unit###
Co-Author: Sandeep Dhanda – Drug Safety Research Unit
### @@@ Alison Evans, PhD – Drug Safety Research Unit ### 1062893###Co-Author###Senior Research Fellow###Drug Safety Research Unit###
Co-Author: Alison Evans, PhD – Drug Safety Research Unit
### @@@ Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit ### 1359017###Presenting Author###Head of Epidemiology and Research###Drug Safety Research Unit###
Presenting Author: Debabrata Roy, PhD (he/him/his) – Drug Safety Research Unit
### he/him/his @@@ Saad Shakir, MB ChB LRCP&S – Drug Safety Research Unit, Southampton, UK ### 1358988###Co-Author###Director - Drug Safety Research Unit###Drug Safety Research Unit, Southampton, UK###
Co-Author: Saad Shakir, MB ChB LRCP&S – Drug Safety Research Unit, Southampton, UK
###
Catalyzing International Harmonization of Real World Evidence Standards

Maryam Nafie – Duke-Margolis Institute for Health Policy ### 2325688###Co-Author######Duke-Margolis Institute for Health Policy###
Co-Author: Maryam Nafie – Duke-Margolis Institute for Health Policy
### @@@ Rachele Hendricks-Sturrup, DHSc (she/her/hers) – Duke-Margolis Institute for Health Policy ### 2325620###Presenting Author###Research Director###Duke-Margolis Institute for Health Policy###
Presenting Author: Rachele Hendricks-Sturrup, DHSc (she/her/hers) – Duke-Margolis Institute for Health Policy
### she/her/hers @@@ Valerie Parker, MS – Duke-Margolis Institute for Health Policy ### 2325693###Co-Author######Duke-Margolis Institute for Health Policy###
Co-Author: Valerie Parker, MS – Duke-Margolis Institute for Health Policy
###
Changes in Neutropenia Outcomes after the 2019 Clozapine Risk Evaluation and Mitigation Strategy Update

Ting-Ying Huang, PhD – Komodo Health ### 2325701###Presenting Author###Director, Research Consulting###Komodo Health###
Presenting Author: Ting-Ying Huang, PhD – Komodo Health
### @@@ Jana Chang, MPH – Komodo Health ### 2325707###Co-Author######Komodo Health###
Co-Author: Jana Chang, MPH – Komodo Health
### @@@ Kenneth Taylor, PhD, DPT – Komodo Health ### 2325708###Co-Author######Komodo Health###
Co-Author: Kenneth Taylor, PhD, DPT – Komodo Health
### @@@ Yuqin Wei, MS – Komodo Health ### 2325700###Co-Author######Komodo Health###
Co-Author: Yuqin Wei, MS – Komodo Health
###
Changes in psychotropic medication prescribing for children and adolescents in France following the COVID-19 pandemic

Zaba Valtuille, MSc (she/her/hers) – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France ### 2325624###Presenting Author###Biostatistician###Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France###
Presenting Author: Zaba Valtuille, MSc (she/her/hers) – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France
### she/her/hers @@@ Eric Aquaviva, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325625###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Eric Aquaviva, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Vincent Trebossen, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325626###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Vincent Trebossen, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Naim Ouldali, MD, PhD – Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325628###Co-Author######Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Naim Ouldali, MD, PhD – Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Aurelie Bourmaud, MD, PhD – Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France ### 2325629###Co-Author######Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France###
Co-Author: Aurelie Bourmaud, MD, PhD – Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France
### @@@ Stephane Sclison – IQVIA – Consulting Services & Analytics Department ### 2325630###Co-Author######IQVIA – Consulting Services & Analytics Department###
Co-Author: Stephane Sclison – IQVIA – Consulting Services & Analytics Department
### @@@ Alexandre Gomez – IQVIA – Consulting Services & Analytics Department ### 2325631###Co-Author######IQVIA – Consulting Services & Analytics Department###
Co-Author: Alexandre Gomez – IQVIA – Consulting Services & Analytics Department
### @@@ Alexis Revet, MD, PhD – Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France ### 2325632###Co-Author######Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France###
Co-Author: Alexis Revet, MD, PhD – Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France
### @@@ Hugo Peyre, MD, PhD – Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France ### 2325633###Co-Author######Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France###
Co-Author: Hugo Peyre, MD, PhD – Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France
### @@@ Richard Delorme, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325634###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Richard Delorme, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Florentia Kaguelidou, MD, PhD – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France ### 1093556###Co-Author######Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France###
Co-Author: Florentia Kaguelidou, MD, PhD – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France
###
Characteristics of Glucagon-like peptide-1 (GLP-1) receptor agonists users without a diabetes diagnosis recorded in the Swedish National Diabetes Register

Laura Pazzagli, PhD – Clinical Epidemiology Division, Karolinska Institutet ### 1358376###Presenting Author###Research Specialist###Clinical Epidemiology Division, Karolinska Institutet###
Presenting Author: Laura Pazzagli, PhD – Clinical Epidemiology Division, Karolinska Institutet
### @@@ Ylva Trolle Lagerros, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet ### 2325190###Co-Author######Clinical Epidemiology Division, Karolinska Institutet###
Co-Author: Ylva Trolle Lagerros, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet
###
Characteristics, Trajectories, and Medication Use of Patients in Temporary Stays in Denmark

Hanin Harbi, MScPharm – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark ### 1993309###Presenting Author###PhD student###Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark###
Presenting Author: Hanin Harbi, MScPharm – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark
### @@@ Carina Lundby – Odense University Hospital ### 1062629###Co-Author######Odense University Hospital###
Co-Author: Carina Lundby – Odense University Hospital
### @@@ Peter Bjødstrup Jensen – University of Southern Denmark ### 1397868###Co-Author######University of Southern Denmark###
Co-Author: Peter Bjødstrup Jensen – University of Southern Denmark
### @@@ Søren Post Larsen – REAGENS ### 1659370###Co-Author######REAGENS###
Co-Author: Søren Post Larsen – REAGENS
### @@@ Linda Grouleff Rørbæk – Komponent ### 2325268###Co-Author######Komponent###
Co-Author: Linda Grouleff Rørbæk – Komponent
### @@@ Lene Vestergaard Ravn-Nielsen – Odense University Hospital ### 2325269###Co-Author######Odense University Hospital###
Co-Author: Lene Vestergaard Ravn-Nielsen – Odense University Hospital
### @@@ Jesper Ryg – Odense University Hospital ### 1659371###Co-Author######Odense University Hospital###
Co-Author: Jesper Ryg – Odense University Hospital
### @@@ Kasper Edwards – Technical University of Denmark ### 2325270###Co-Author######Technical University of Denmark###
Co-Author: Kasper Edwards – Technical University of Denmark
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Co-Author###Professor###University of Southern Denmark###
Co-Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
Characterizing perinatal treatment patterns and outcomes in rheumatologic disease: A retrospective cohort study in a US health insurance claims database

Melanie H. Jacobson, PhD, MPH (she/her/hers) – Johnson and Johnson Innovative Medicine ### 1993049###Presenting Author###Associate Director###Johnson and Johnson Innovative Medicine###
Presenting Author: Melanie H. Jacobson, PhD, MPH (she/her/hers) – Johnson and Johnson Innovative Medicine
### she/her/hers @@@ Rupa Makadia, PhD – Global Epidemiology, Johnson & Johnson Innovative Medicine ### 1360290###Co-Author###Director###Global Epidemiology, Johnson & Johnson Innovative Medicine###
Co-Author: Rupa Makadia, PhD – Global Epidemiology, Johnson & Johnson Innovative Medicine
### @@@ Nathan E. Hall, MS – Johnson & Johnson ### 2325260###Co-Author###Manager, Observational Health Data Analytics###Johnson & Johnson###
Co-Author: Nathan E. Hall, MS – Johnson & Johnson
### @@@ Jill Hardin – Johnson & Johnson ### 2325261###Co-Author######Johnson & Johnson###
Co-Author: Jill Hardin – Johnson & Johnson
### @@@ Sicong Huang, MD, MS – Janssen Research & Development, LLC ### 2325262###Co-Author######Janssen Research & Development, LLC###
Co-Author: Sicong Huang, MD, MS – Janssen Research & Development, LLC
### @@@ Anna Ostropolets, MD, PhD – Johnson and Johnson Innovative Medicine ### 2325257###Co-Author######Johnson and Johnson Innovative Medicine###
Co-Author: Anna Ostropolets, MD, PhD – Johnson and Johnson Innovative Medicine
### @@@ Ran Sun – Johnson & Johnson Innovative Medicine ### 2325263###Co-Author######Johnson & Johnson Innovative Medicine###
Co-Author: Ran Sun – Johnson & Johnson Innovative Medicine
### @@@ Rebecca Zaha – Johnson and Johnson Innovative Medicine ### 2325264###Co-Author######Johnson and Johnson Innovative Medicine###
Co-Author: Rebecca Zaha – Johnson and Johnson Innovative Medicine
### @@@ Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA ### 1993399###Co-Author###Associate Director###Johnson & Johnson, Titusville, New Jersey, USA###
Co-Author: Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA
### she/her/hers
Claims-Based Frailty Trajectories During Adjuvant Chemotherapy Predict Long-Term Mortality in Older Women with Stage I-III Breast Cancer

Emilie D. Duchesneau, PhD, MSPH (she/her/hers) – Department of Epidemiology and Prevention, Wake Forest School of Medicine ### 2325307###Presenting Author###Assistant Professor###Department of Epidemiology and Prevention, Wake Forest School of Medicine###
Presenting Author: Emilie D. Duchesneau, PhD, MSPH (she/her/hers) – Department of Epidemiology and Prevention, Wake Forest School of Medicine
### she/her/hers @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###
Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Qoua L. Her, PharmD, MSPharm, MSc – University of North Carolina at Chapel Hill ### 1659732###Co-Author###Graduate Student###University of North Carolina at Chapel Hill###
Co-Author: Qoua L. Her, PharmD, MSPharm, MSc – University of North Carolina at Chapel Hill
### @@@ Zhang Zhang – Department of Health Policy and Management, University of North Carolina at Chapel Hill ### 2325308###Co-Author###PhD Candidate###Department of Health Policy and Management, University of North Carolina at Chapel Hill###
Co-Author: Zhang Zhang – Department of Health Policy and Management, University of North Carolina at Chapel Hill
### @@@ Alan C. Kinlaw, PhD – Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill ### 1358525###Co-Author###Assistant Professor###Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill###
Co-Author: Alan C. Kinlaw, PhD – Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill
### @@@ Zoey Song, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA ### 2325256###Co-Author######Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA###
Co-Author: Zoey Song, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
### @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Co-Author###Associate Professor###University of North Carolina at Chapel Hill###
Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Jennifer L. Lund, MSPH, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1062592###Co-Author###Associate Professor, Department of Epidemiology###University of North Carolina at Chapel Hill###
Co-Author: Jennifer L. Lund, MSPH, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers
Clone-censor-weight to evaluate the effect of timing of treatment initiation in individuals with new-onset diabetes eligible for treatment

Sia Kromann Nicolaisen – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark. ### 2327588###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark.###
Co-Author: Sia Kromann Nicolaisen – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark.
### @@@ Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1063102###Presenting Author###Professor and Consultant Physician###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Presenting Author: Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Lars Pedersen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1358234###Co-Author###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Lars Pedersen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###
Coffee with Exhibitors
Coffee with Exhibitors
Coffee with Exhibitors
Committee Meetings
Committee Meetings
Comparative Analysis of High Dimensional Propensity Scoring and Dimensionality Reduction in Cohort Studies

Sudhir Venkatesan, PhD, MPH – BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca ### 1658797###Presenting Author###Director###BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca###
Presenting Author: Sudhir Venkatesan, PhD, MPH – BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca
### @@@ Jonatan Nåtman – BPM Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden ### 2325238###Co-Author######BPM Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden###
Co-Author: Jonatan Nåtman – BPM Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden
### @@@ Eva Lesén – AstraZeneca ### 2325239###Co-Author###Director, CVRM Evidence Strategy###AstraZeneca###
Co-Author: Eva Lesén – AstraZeneca
### @@@ Stefan Franzén, PhD (he/him/his) – BPM Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden ### 2325240###Co-Author###Director###BPM Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden###
Co-Author: Stefan Franzén, PhD (he/him/his) – BPM Evidence Statistics, BioPharmaceutical Medical, AstraZeneca, Gothenburg, Sweden
### he/him/his @@@ Sima Shahsavari – Late CVRM Biometrics, Astrazeneca, Gothenburg, Sweden ### 2325241###Co-Author###Associate Director, Data Science###Late CVRM Biometrics, Astrazeneca, Gothenburg, Sweden###
Co-Author: Sima Shahsavari – Late CVRM Biometrics, Astrazeneca, Gothenburg, Sweden
### @@@ Mario Ouwens, PhD – BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca ### 1358658###Co-Author######BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca###
Co-Author: Mario Ouwens, PhD – BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca
###
Comparative bleeding risks among NOAC users for nonvalvular atrial fibrillation aged <65 years in the Sentinel System

Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA ### 1062817###Presenting Author###Senior Advisor###Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA###
Presenting Author: Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA
### @@@ Andrew L. Simon, MS – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ### 1993468###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA###
Co-Author: Andrew L. Simon, MS – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
### @@@ Joy Kolonoski – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA ### 2325521###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA###
Co-Author: Joy Kolonoski – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
### @@@ David J. Graham, MD, MPH – US Food and Drug Administration ### 1655356###Co-Author###Associate director###US Food and Drug Administration###
Co-Author: David J. Graham, MD, MPH – US Food and Drug Administration
### @@@ Rongmei zhang, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US FDA ### 1359044###Co-Author###Senior Mathematical statistician###Office of Biostatistics, Center for Drug Evaluation and Research, US FDA###
Co-Author: Rongmei zhang, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US FDA
### @@@ John G. Connolly – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA ### 2325236###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA###
Co-Author: John G. Connolly – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA
###
Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study

Arvid Engström, MD – Clinical Epidemiology Division ### 1655989###Co-Author###PhD student###Clinical Epidemiology Division###
Co-Author: Arvid Engström, MD – Clinical Epidemiology Division
### @@@ Jonas Söderling – Clinical Epidemiology Division, Karolinska Institutet ### 2325698###Co-Author######Clinical Epidemiology Division, Karolinska Institutet###
Co-Author: Jonas Söderling – Clinical Epidemiology Division, Karolinska Institutet
### @@@ Anders Hviid – Statens Serum Institut ### 1655991###Co-Author######Statens Serum Institut###
Co-Author: Anders Hviid – Statens Serum Institut
### @@@ Björn Eliasson – Sahlgrenska University Hospital ### 1655992###Co-Author######Sahlgrenska University Hospital###
Co-Author: Björn Eliasson – Sahlgrenska University Hospital
### @@@ Soffia Gudbjörnsdottir – University of Gothenburg ### 1655993###Co-Author######University of Gothenburg###
Co-Author: Soffia Gudbjörnsdottir – University of Gothenburg
### @@@ Viktor Wintzell, PhD – Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden ### 1062598###Co-Author###Research coordinator###Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Viktor Wintzell, PhD – Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
### @@@ Kristian Hveem – Norwegian University of Science and Technology ### 1655994###Co-Author######Norwegian University of Science and Technology###
Co-Author: Kristian Hveem – Norwegian University of Science and Technology
### @@@ Christian Jonasson – Norwegian University of Science and Technology ### 1655995###Co-Author######Norwegian University of Science and Technology###
Co-Author: Christian Jonasson – Norwegian University of Science and Technology
### @@@ Mads Melbye – Danish Cancer Institute ### 2325205###Co-Author######Danish Cancer Institute###
Co-Author: Mads Melbye – Danish Cancer Institute
### @@@ Björn Pasternak, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet ### 1655252###Presenting Author###Principal Researcher###Clinical Epidemiology Division, Karolinska Institutet###
Presenting Author: Björn Pasternak, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet
### @@@ Peter Ueda – Karolinska Institutet ### 2325206###Co-Author######Karolinska Institutet###
Co-Author: Peter Ueda – Karolinska Institutet
###
Comparative effectiveness and cardiovascular safety of enzalutamide versus abiraterone amongst older U.S. men diagnosed with metastatic castration-resistant prostate cancer

Charles E. Gaber, PhD, MPH (he/him/his) – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA ### 2325462###Presenting Author###Assistant Professor###Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA###
Presenting Author: Charles E. Gaber, PhD, MPH (he/him/his) – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA
### he/him/his @@@ Ebere Okpara, BPharm – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA ### 2325683###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA###
Co-Author: Ebere Okpara, BPharm – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA
### @@@ Abdullah I. Abdelaziz, BPharm, MS – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA ### 1659353###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA###
Co-Author: Abdullah I. Abdelaziz, BPharm, MS – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA
### @@@ Jyotirmoy Sarker, MPharm, MBA, MBiotech – University of Illinois Chicago, Department of Pharmacy Systems, Outcomes and Policy ### 1659792###Co-Author###Research Assistant, PhD Candidate###University of Illinois Chicago, Department of Pharmacy Systems, Outcomes and Policy###
Co-Author: Jyotirmoy Sarker, MPharm, MBA, MBiotech – University of Illinois Chicago, Department of Pharmacy Systems, Outcomes and Policy
### @@@ Kent A. Hanson, PharmD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA ### 2325684###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA###
Co-Author: Kent A. Hanson, PharmD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA
### @@@ Lubna Hassan, PharmD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA ### 2325685###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA###
Co-Author: Lubna Hassan, PharmD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA
### @@@ Fang-Ju Lin, PhD, MS – 1 Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA ### 2325697###Co-Author######1 Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA###
Co-Author: Fang-Ju Lin, PhD, MS – 1 Department of Pharmacy Systems, Outcomes and Policy, University of Illinois-Chicago College of Pharmacy, Chicago, IL, USA
### @@@ Todd A. Lee, PharmD, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago ### 1657993###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago###
Co-Author: Todd A. Lee, PharmD, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago
### @@@ Natalie Reizine, MD – Division of Hematology & Oncology, Department of Medicine, University of Illinois-Chicago College of Medicine, Chicago, IL, USA ### 2325699###Co-Author######Division of Hematology & Oncology, Department of Medicine, University of Illinois-Chicago College of Medicine, Chicago, IL, USA###
Co-Author: Natalie Reizine, MD – Division of Hematology & Oncology, Department of Medicine, University of Illinois-Chicago College of Medicine, Chicago, IL, USA
###
Comparative effectiveness and safety of different hydroxychloroquine doses for patients with systemic lupus erythematosus: nationwide analysis using target trial emulation framework

Brian Meng-Hsun Li, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 2325378###Presenting Author###PhD student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Presenting Author: Brian Meng-Hsun Li, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Meng-Yu Weng, MD, PhD – Division of Allergy, Immunology and Rheumatology, National Cheng-Kung University Medical Center ### 2325255###Co-Author###Attending Rheumatologist and Assistant Professor###Division of Allergy, Immunology and Rheumatology, National Cheng-Kung University Medical Center###
Co-Author: Meng-Yu Weng, MD, PhD – Division of Allergy, Immunology and Rheumatology, National Cheng-Kung University Medical Center
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Comparative effectiveness and safety of dual antiplatelet therapy with ticagrelor vs. clopidogrel in older adults with acute coronary syndrome: A population-based study using the target trial framework.

Carole Anna Marxer, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet ### 2325189###Presenting Author###Postdoctoral Fellow###Department of Medical Epidemiology and Biostatistics, Karolinska Institutet###
Presenting Author: Carole Anna Marxer, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
### @@@ Paul Hjemdahl – Department Medicine Solna, Clinical Epidemiology/Clinical Pharmacology, Karolinska Institutet and Karolinska University Hospital ### 2325642###Co-Author######Department Medicine Solna, Clinical Epidemiology/Clinical Pharmacology, Karolinska Institutet and Karolinska University Hospital###
Co-Author: Paul Hjemdahl – Department Medicine Solna, Clinical Epidemiology/Clinical Pharmacology, Karolinska Institutet and Karolinska University Hospital
### @@@ Tomas Jernberg – Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet ### 2325643###Co-Author######Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet###
Co-Author: Tomas Jernberg – Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet
### @@@ Juan J. Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet ### 1397864###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet###
Co-Author: Juan J. Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
### @@@ Edouard L. Fu – Leiden University Medical Center ### 2325333###Co-Author######Leiden University Medical Center###
Co-Author: Edouard L. Fu – Leiden University Medical Center
###
Comparative effectiveness and safety of extended treatment vs. discontinuation of oral anticoagulants in patients with venous thromboembolism

Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
### @@@ Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA ### 1360618###Co-Author###Professor of Medicine, Harvard Medical School###Massachusetts General Hospital, Boston, MA###
Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1991377###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
###
Comparative Effectiveness of Second-line ADHD Medications Using Real World Data: Emulation of a Target Trial

Le Zhang, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1658856###Presenting Author###Postdoctoral researcher###Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Presenting Author: Le Zhang, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Nanbo Zhu – Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden ### 2325131###Co-Author######Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Nanbo Zhu – Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
### @@@ Ralf Kuja-Halkola – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 2325129###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Ralf Kuja-Halkola – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Brian M. D’Onofrio, PhD – Department of Psychological and Brain Sciences, Indiana University, Bloomington, USA ### 1655402###Co-Author###Professor###Department of Psychological and Brain Sciences, Indiana University, Bloomington, USA###
Co-Author: Brian M. D’Onofrio, PhD – Department of Psychological and Brain Sciences, Indiana University, Bloomington, USA
### @@@ Isabell Brikell – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 2325130###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Isabell Brikell – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Paul Lichtenstein – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1655960###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Paul Lichtenstein – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Henrik Larsson – School of Medical Sciences, Örebro University, Örebro, Sweden ### 2325398###Co-Author######School of Medical Sciences, Örebro University, Örebro, Sweden###
Co-Author: Henrik Larsson – School of Medical Sciences, Örebro University, Örebro, Sweden
### @@@ Zheng Chang, PhD (he/him/his) – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1655403###Co-Author###Principal researcher###Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Zheng Chang, PhD (he/him/his) – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### he/him/his
Comparative Rates of Traumatic Physical Injury Among Concurrent Users of Opioid Analgesics and Skeletal Muscle Relaxants: Cohort Studies Using United States Medicaid Data

Cheng Chen, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA ### 2325645###Co-Author###Epidemiologist Reviewer###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA###
Co-Author: Cheng Chen, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
### @@@ Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania ### 1359957###Co-Author###Professor of Epidemiology###Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania###
Co-Author: Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania
### @@@ Colleen M. Brensinger – University of Pennsylvania ### 2325121###Co-Author######University of Pennsylvania###
Co-Author: Colleen M. Brensinger – University of Pennsylvania
### @@@ Todd A. Miano, PharmD, PhD – University of Pennsylvania ### 1357966###Co-Author###Assistant Professor of Epidemiology###University of Pennsylvania###
Co-Author: Todd A. Miano, PharmD, PhD – University of Pennsylvania
### @@@ Warren B. Bilker, PhD – University of Pennsylvania ### 1357965###Co-Author######University of Pennsylvania###
Co-Author: Warren B. Bilker, PhD – University of Pennsylvania
### @@@ Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute ### 1062553###Co-Author###Senior Scientific Investigator###Kaiser Permanente Washington Health Research Institute###
Co-Author: Sascha Dublin, MD, PhD – Kaiser Permanente Washington Health Research Institute
### @@@ Sophie P. Chung – AthenaHealth, Inc ### 2325122###Co-Author######AthenaHealth, Inc###
Co-Author: Sophie P. Chung – AthenaHealth, Inc
### @@@ John R Horn – University of Washington ### 2325123###Co-Author######University of Washington###
Co-Author: John R Horn – University of Washington
### @@@ Anika Tiwari – University of Pennsylvania ### 2325124###Co-Author######University of Pennsylvania###
Co-Author: Anika Tiwari – University of Pennsylvania
### @@@ Charles E. Leonard, PharmD, MSCE, FISPE (he/him/his) – University of Pennsylvania ### 1096939###Presenting Author###Associate Professor of Epidemiology###University of Pennsylvania###
Presenting Author: Charles E. Leonard, PharmD, MSCE, FISPE (he/him/his) – University of Pennsylvania
### he/him/his
Comparative Risk of Epilepsy Among Antihypertensive Medications: An Emulated Target Trial

Xuerong Wen – University of Rhode Island ### 2326696###Co-Author###Associate professor###University of Rhode Island###
Co-Author: Xuerong Wen – University of Rhode Island
### @@@ Marianne N. Otoo, MPharm (she/her/hers) – Department of Pharmacy Practice & Clinical Research, College of Pharmacy, University of Rhode Island ### 2328235###Presenting Author###PhD Candidate###Department of Pharmacy Practice & Clinical Research, College of Pharmacy, University of Rhode Island###
Presenting Author: Marianne N. Otoo, MPharm (she/her/hers) – Department of Pharmacy Practice & Clinical Research, College of Pharmacy, University of Rhode Island
### she/her/hers @@@ Todd Brothers – College of Pharmacy, University of Rhode Island ### 2328236###Co-Author######College of Pharmacy, University of Rhode Island###
Co-Author: Todd Brothers – College of Pharmacy, University of Rhode Island
### @@@ Nicole Asal – College of Pharmacy, University of Rhode Island ### 2330998###Co-Author######College of Pharmacy, University of Rhode Island###
Co-Author: Nicole Asal – College of Pharmacy, University of Rhode Island
### @@@ Kristina Ward – College of Pharmacy, University of Rhode Island ### 2328237###Co-Author######College of Pharmacy, University of Rhode Island###
Co-Author: Kristina Ward – College of Pharmacy, University of Rhode Island
###
Comparative Risks of Fractures and Mortality in Patients with Osteoarthritis initiating Tramadol versus Other Opioids

Sushama Kattinakere Sreedhara, MBBS, MSPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1360619###Co-Author###Research Scientist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Sushama Kattinakere Sreedhara, MBBS, MSPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Nazleen F. Khan, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1063044###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Nazleen F. Khan, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Jeffrey Katz – Department of Orthopedic Surgery and Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655920###Co-Author######Department of Orthopedic Surgery and Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Jeffrey Katz – Department of Orthopedic Surgery and Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Su Been Lee – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1658753###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Su Been Lee – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Presenting Author: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
###
Comparative safety of biologic and targeted-synthetic DMARDs in patients with rheumatoid arthritis: a multi-database real-world cohort study

Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Presenting Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Presenting Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Yinzhu Jin, MPH (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062667### Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Yinzhu Jin, MPH (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Jun Liu – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1659307###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Jun Liu – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###
Comparative safety of short-acting opioid dose escalation versus long-acting opioid regimen in nursing homes

Heeyoon Jung, MS – Population Health Sciences Program, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School ### 2325288###Co-Author######Population Health Sciences Program, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School###
Co-Author: Heeyoon Jung, MS – Population Health Sciences Program, Morningside Graduate School of Biomedical Sciences, UMass Chan Medical School
### @@@ Anthony Nunes, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School ### 1063175###Presenting Author###Assistant Professor###Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School###
Presenting Author: Anthony Nunes, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School
### @@@ Yiyang Yuan, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School ### 1993100###Co-Author######Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School###
Co-Author: Yiyang Yuan, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School
### @@@ Jonggyu Baek, PhD – Division of Biostatistics and Health Services Research, Department of Population and Quantitative Health Sciences, UMass Chan Medical School ### 1360210###Co-Author###Assistant Professor###Division of Biostatistics and Health Services Research, Department of Population and Quantitative Health Sciences, UMass Chan Medical School###
Co-Author: Jonggyu Baek, PhD – Division of Biostatistics and Health Services Research, Department of Population and Quantitative Health Sciences, UMass Chan Medical School
### @@@ Shao-Hsien Liu, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School ### 1993099###Co-Author###Assistant Professor###Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School###
Co-Author: Shao-Hsien Liu, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School
### @@@ Jayne Pawasauskas, PharmD – Department of Pharmacy practice, College of Pharmacy, University of Rhode Island actice, Coll ### 1359532###Co-Author######Department of Pharmacy practice, College of Pharmacy, University of Rhode Island actice, Coll###
Co-Author: Jayne Pawasauskas, PharmD – Department of Pharmacy practice, College of Pharmacy, University of Rhode Island actice, Coll
### @@@ Anne Hume, PharmD – Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island ### 1360211###Co-Author###Professor of Pharmacy###Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island###
Co-Author: Anne Hume, PharmD – Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island
### @@@ Kate Lapane, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School ### 1358791###Co-Author###Consultant###Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School###
Co-Author: Kate Lapane, PhD – Division of Epidemiology, Department of Population and Quantitative Health Sciences, UMass Chan Medical School
###
Comparative Study of Zero/Low Versus Conventional Fluoroscopy Workflows for Ablation of Paroxysmal Atrial Fibrillation in Routine Clinical Practice

Shumin Zhang, MD, ScD – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson ### 2330643###Presenting Author###Senior Director Regulatory RWE & Epidemiology###MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson###
Presenting Author: Shumin Zhang, MD, ScD – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson
### @@@ Guy Cafri – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson ### 2331010###Co-Author######MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson###
Co-Author: Guy Cafri – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson
### @@@ Midhuna Vijayakumar – Mu Sigma Business Solutions LLC ### 2331011###Co-Author######Mu Sigma Business Solutions LLC###
Co-Author: Midhuna Vijayakumar – Mu Sigma Business Solutions LLC
### @@@ Brian John Sanchez – Biosense Webster, Inc., part of Johnson & Johnson MedTech ### 2331012###Co-Author######Biosense Webster, Inc., part of Johnson & Johnson MedTech###
Co-Author: Brian John Sanchez – Biosense Webster, Inc., part of Johnson & Johnson MedTech
### @@@ Phuong Park – Biosense Webster, Inc., part of Johnson & Johnson MedTech ### 2331013###Co-Author######Biosense Webster, Inc., part of Johnson & Johnson MedTech###
Co-Author: Phuong Park – Biosense Webster, Inc., part of Johnson & Johnson MedTech
### @@@ LeeMing Boo – Biosense Webster, Inc., part of Johnson & Johnson MedTech ### 2331014###Co-Author######Biosense Webster, Inc., part of Johnson & Johnson MedTech###
Co-Author: LeeMing Boo – Biosense Webster, Inc., part of Johnson & Johnson MedTech
### @@@ Paul Coplan – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson ### 2326930###Co-Author######MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson###
Co-Author: Paul Coplan – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson
###
Comparing causal estimands from a sequential nested trial emulation with a treatment decision design to a conventional single point randomized trial: A simulation study

Chase D. Latour (she/her/hers) – University of North Carolina at Chapel Hill ### 1062974###Co-Author###PhD Candidate###University of North Carolina at Chapel Hill###
Co-Author: Chase D. Latour (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Catherine Wiener, MS – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1991528###Presenting Author###PhD Student###Department of Epidemiology, University of North Carolina at Chapel Hill###
Presenting Author: Catherine Wiener, MS – Department of Epidemiology, University of North Carolina at Chapel Hill
### @@@ Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals ### 1991788###Co-Author###Associate Director of Pharmacoepidemiology###Regeneron Pharmaceuticals###
Co-Author: Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals
### @@@ Kathleen Hurwitz – Target RWE ### 2330989###Co-Author######Target RWE###
Co-Author: Kathleen Hurwitz – Target RWE
### @@@ M. Alan Brookhart, PhD – Target RWE ### 1991706###Co-Author###Professor###Target RWE###
Co-Author: M. Alan Brookhart, PhD – Target RWE
###
Comparing Healthcare Utilization and Cost in Empagliflozin vs GLP-1RA Initiators with Type 2 Diabetes without Established Cardiovascular Disease

Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1655331###Presenting Author###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Helen Tesfaye – Brigham and Women's Hospital ### 2326385###Co-Author######Brigham and Women's Hospital###
Co-Author: Helen Tesfaye – Brigham and Women's Hospital
### @@@ Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School ### 1991353###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
### @@@ Deborah J. Wexler, MD, MSc – Massachusetts General Hospital ### 1360566###Co-Author######Massachusetts General Hospital###
Co-Author: Deborah J. Wexler, MD, MSc – Massachusetts General Hospital
### @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Robert Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 2325366###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Robert Glynn, PhD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Christina shay – Boehringer Ingelheim ### 2326386###Co-Author######Boehringer Ingelheim###
Co-Author: Christina shay – Boehringer Ingelheim
### @@@ niklas Schmedt – Boehringer Ingelheim ### 2326387###Co-Author######Boehringer Ingelheim###
Co-Author: niklas Schmedt – Boehringer Ingelheim
### @@@ lisette koeneman – Boehringer Ingelheim ### 2326388###Co-Author######Boehringer Ingelheim###
Co-Author: lisette koeneman – Boehringer Ingelheim
### @@@ Julie M. Paik, MD, ScD – Brigham and Women's Hospital ### 1655332###Co-Author######Brigham and Women's Hospital###
Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital
### @@@ Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and ### 1360380###Co-Author###Associate Professor of Medicine###Brigham and Women's Hospital and###
Co-Author: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers
Comparing OMOP and ConcePTION common data models in CPRD GOLD: direct oral anticoagulants versus vitamin k antagonists on the risk of bleeding and cardiovascular outcomes

Nicholas Hunt, MSc (he/him/his) – Utrecht University / Erasmus Medical Centre Rotterdam ### 2325299###Presenting Author###PhD Candidate / Epidemiologist###Utrecht University / Erasmus Medical Centre Rotterdam###
Presenting Author: Nicholas Hunt, MSc (he/him/his) – Utrecht University / Erasmus Medical Centre Rotterdam
### he/him/his @@@ Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Marloes Bazelier, PhD – Utrecht University ### 1358894###Co-Author######Utrecht University###
Co-Author: Marloes Bazelier, PhD – Utrecht University
### @@@ Helga Gardarsdottir, PharmD, PhD, FISPE (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands ### 1061395###Co-Author###Professor RWD for decision making on medicines###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands###
Co-Author: Helga Gardarsdottir, PharmD, PhD, FISPE (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers @@@ Nicola L. Barclay, PhD – University of Oxford ### 1992262###Co-Author###Postdoctoral Research Assistant in Health Data Sciences / Epidemiology###University of Oxford###
Co-Author: Nicola L. Barclay, PhD – University of Oxford
### @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Co-Author###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Co-Author###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
###
Comparing Safety and Effectiveness of Pfizer BA.4-5 and Sanofi bivalent COVID-19 Vaccines Used in the Spring 2023 Booster Programme in England: a Target Trial Emulation Study Using the OpenSAFELY Platform

William Hulme, MSc PhD (he/him/his) – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 1360178###Presenting Author###Statistical Epidemiologist###Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Presenting Author: William Hulme, MSc PhD (he/him/his) – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### he/him/his @@@ Colm Andrews – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 2325281###Co-Author######Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Co-Author: Colm Andrews – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### @@@ Em Prestige – London School of Hygiene and Tropical Medicine ### 2325283###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Em Prestige – London School of Hygiene and Tropical Medicine
### @@@ Edward Parker – London School of Hygiene and Tropical Medicine ### 2325526###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Edward Parker – London School of Hygiene and Tropical Medicine
### @@@ Venexia M. Walker, PhD – University of Bristol ### 1900247###Co-Author###Research Fellow in Medical Statistics and Health Data Science###University of Bristol###
Co-Author: Venexia M. Walker, PhD – University of Bristol
### @@@ Christopher Wood – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 2325525###Co-Author###Clinical Informatician###Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Co-Author: Christopher Wood – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### @@@ Becky Smith – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 2325527###Co-Author######Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Co-Author: Becky Smith – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### @@@ Andrea Schaffer – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 2325530###Co-Author######Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Co-Author: Andrea Schaffer – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### @@@ Alex Walker – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 1360174###Co-Author######Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Co-Author: Alex Walker – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### @@@ Helen Curtis – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 1360180###Co-Author######Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Co-Author: Helen Curtis – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### @@@ Brian MacKenna – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford ### 1360171###Co-Author######Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford###
Co-Author: Brian MacKenna – Bennett Institute of Applied Data Science, Nuffield Dept of Primary Care Health Sciences, University of Oxford
### @@@ Amir Mehrkar – University of Oxford ### 1360181###Co-Author######University of Oxford###
Co-Author: Amir Mehrkar – University of Oxford
### @@@ Ben Goldacre – University of Oxford ### 1360189###Co-Author######University of Oxford###
Co-Author: Ben Goldacre – University of Oxford
### @@@ Miguel A. Hernán – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet ### 1360646###Co-Author######CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet###
Co-Author: Miguel A. Hernán – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet
### @@@ Jonathan Sterne, MSc PhD (he/him/his) – University of Bristol ### 2325178###Co-Author###Professor of Medical Statistics and Epidemiology###University of Bristol###
Co-Author: Jonathan Sterne, MSc PhD (he/him/his) – University of Bristol
### he/him/his
Comparing the performance of probabilistic and rule-based phenotype algorithms for angioedema to the experience observed in randomized clinical trials.

Joel N. Swerdel, PhD MS MPH (he/him/his) – Johnson and Johnson Innovative Medicine ### 1659127###Presenting Author###Director###Johnson and Johnson Innovative Medicine###
Presenting Author: Joel N. Swerdel, PhD MS MPH (he/him/his) – Johnson and Johnson Innovative Medicine
### he/him/his @@@ Judy Racoosin – US FDA ### 2325249###Co-Author######US FDA###
Co-Author: Judy Racoosin – US FDA
### @@@ Gowtham Rao – Johnson and Johnson Innovative Medicine ### 1360293###Co-Author######Johnson and Johnson Innovative Medicine###
Co-Author: Gowtham Rao – Johnson and Johnson Innovative Medicine
### @@@ Martijn Schuemie – Johnson and Johnson Innovative Medicine ### 1993413###Co-Author######Johnson and Johnson Innovative Medicine###
Co-Author: Martijn Schuemie – Johnson and Johnson Innovative Medicine
### @@@ Patrick B. Ryan, PhD – Johnson and Johnson Innovative Medicine ### 1661016###Co-Author######Johnson and Johnson Innovative Medicine###
Co-Author: Patrick B. Ryan, PhD – Johnson and Johnson Innovative Medicine
###
Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System

Mayura Shinde, DrPH – Harvard Pilgrim Health Care Institute ### 2325160###Presenting Author###Research Scientist###Harvard Pilgrim Health Care Institute###
Presenting Author: Mayura Shinde, DrPH – Harvard Pilgrim Health Care Institute
### @@@ Austin Cosgrove – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325161###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Austin Cosgrove – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Maria E. Kempner – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325164###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Maria E. Kempner – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325162###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Jennifer G. Lyons – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Jolene Mosley – Department of Population Medicine, Harvard Pilgrim HealthCare Institute, Boston, MA ### 2325547###Co-Author######Department of Population Medicine, Harvard Pilgrim HealthCare Institute, Boston, MA###
Co-Author: Jolene Mosley – Department of Population Medicine, Harvard Pilgrim HealthCare Institute, Boston, MA
### @@@ Andrew Petrone – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachuetts, USA ### 2325548###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachuetts, USA###
Co-Author: Andrew Petrone – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachuetts, USA
### @@@ Elizabeth Messenger-Jones – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325163###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Elizabeth Messenger-Jones – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Maria Lewis – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325549###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Maria Lewis – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Yueqin Zhao, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD ### 1359918###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD###
Co-Author: Yueqin Zhao, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
### @@@ Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1360167###Co-Author###Deputy Director for Safety###Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Co-Author: Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1991185###Co-Author###Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Co-Author: José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325127###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Wei Hua, MSc, MHS, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1358275###Co-Author###Deputy Division Director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Co-Author: Wei Hua, MSc, MHS, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
###
Comparison of switching to direct oral anticoagulants and continuous low-molecular-weight heparin in the treatment of cancer-associated venous thromboembolism in Taiwan

Wei Kang, MSc – The University of Hong Kong ### 1358561###Presenting Author###PhD student###The University of Hong Kong###
Presenting Author: Wei Kang, MSc – The University of Hong Kong
### @@@ Chin-Yao Shen, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1063185###Co-Author###Ph.D Candidate###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Chin-Yao Shen, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994356###Co-Author###Research Associate###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Vincent KC Yan, BPharm – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1658570###Co-Author###PhD candidate###Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Vincent KC Yan, BPharm – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ Yue Wei, MPH – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong ### 1658509###Co-Author###Student###Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong###
Co-Author: Yue Wei, MPH – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong
### @@@ Tung Hiu Li, MPhil – Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR ### 1991122###Co-Author###Student###Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR###
Co-Author: Tung Hiu Li, MPhil – Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR
### @@@ Caige Huang – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong ### 2325580###Co-Author###Student###Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong###
Co-Author: Caige Huang – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358232###Co-Author###Professor###Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### he/him/his @@@ Esther W Chan, PhD – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358455###Co-Author###Professor###Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Esther W Chan, PhD – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
###
Comparison of Treatment and Outcomes for Inflammatory Bowel Disease Unclassified versus Ulcerative Colitis and Crohn’s Disease

Nuvall Cherian, MD – University of Pennsylvania ### 2330957###Co-Author###Instructor###University of Pennsylvania###
Co-Author: Nuvall Cherian, MD – University of Pennsylvania
### @@@ James D. Lewis, MD, MSCE (he/him/his) – University of Pennsylvania ### 2330958###Presenting Author###Professor of Medicine and Epidemiology###University of Pennsylvania###
Presenting Author: James D. Lewis, MD, MSCE (he/him/his) – University of Pennsylvania
### he/him/his
Concomitant use of low-dose methotrexate and trimethoprim-sulfamethoxazole and the 30-day risk of all-cause mortality among older adults: A population-based cohort study

Hasti Sadeghi – Western University ### 2325380###Co-Author######Western University###
Co-Author: Hasti Sadeghi – Western University
### @@@ Fatemeh Ahmadi, PharmD, MSc – Westsern University ### 1994337###Co-Author###PhD student###Westsern University###
Co-Author: Fatemeh Ahmadi, PharmD, MSc – Westsern University
### @@@ Flory Tsobo Muanda, MD, PhD – Western University ### 1994338###Presenting Author###Assistant Professor###Western University###
Presenting Author: Flory Tsobo Muanda, MD, PhD – Western University
###
Confounding control in high-throughput studies – principles and applications

Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Lead Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Lead Speaker: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers @@@ Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Speaker###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Speaker: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Justin Bohn, ScD – Johnson & Johnson ### 1991161###Speaker###Associate Director, Epidemiology###Johnson & Johnson###
Speaker: Justin Bohn, ScD – Johnson & Johnson
### @@@ Todd A. Miano, PharmD, PhD – University of Pennsylvania ### 1357966###Speaker###Assistant Professor of Epidemiology###University of Pennsylvania###
Speaker: Todd A. Miano, PharmD, PhD – University of Pennsylvania
### @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Speaker###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Speaker: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson ### 1046821###Speaker###Vice President and Global Head of Epidemiology###Johnson & Johnson###
Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson
###
Conjunctivitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States

Jessica M. Franklin, PhD (she/her/hers) – Optum ### 1359343###Presenting Author###Principal Consultant###Optum###
Presenting Author: Jessica M. Franklin, PhD (she/her/hers) – Optum
### she/her/hers @@@ Andrea F. Marcus, PhD, MPH (she/her/hers) – Regeneron Pharmaceuticals ### 1063148###Co-Author###Senior Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Co-Author: Andrea F. Marcus, PhD, MPH (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Ihtisham Sultan, Ph.D – Regeneron ### 1658223###Co-Author######Regeneron###
Co-Author: Ihtisham Sultan, Ph.D – Regeneron
### @@@ Ashley Howell – Regeneron ### 2325258###Co-Author######Regeneron###
Co-Author: Ashley Howell – Regeneron
### @@@ Sarah-Jo Sinnott, MPharm, PhD – Sanofi ### 1093405###Co-Author###Director, Pharmacoepidemiology###Sanofi###
Co-Author: Sarah-Jo Sinnott, MPharm, PhD – Sanofi
### @@@ Jeannette Green – Regeneron ### 2325275###Co-Author######Regeneron###
Co-Author: Jeannette Green – Regeneron
### @@@ Stephen M. Ezzy, MS – Optum ### 1359003###Co-Author###Epidemiology Analyst IV###Optum###
Co-Author: Stephen M. Ezzy, MS – Optum
### @@@ Robert Gately – Optum ### 1358810###Co-Author######Optum###
Co-Author: Robert Gately – Optum
### @@@ Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron ### 1991877###Co-Author###VP, Head of Pharmacoepidemiology###Regeneron###
Co-Author: Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron
### she/her/hers @@@ Florence Wang, ScD – Optum ### 1063158###Co-Author###VP of Epidemiology###Optum###
Co-Author: Florence Wang, ScD – Optum
###
Considerations for Negative Control Outcome Analyses in Vaccine Effectiveness Studies: Post-Hoc Analyses from an Adult Vaccine Effectiveness Study conducted within the FDA BEST Initiative

Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1991129###Presenting Author###Epidemiologist###Optum Epidemiology###
Presenting Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health ### 1655293###Co-Author###Lead Director -Epidemiology, Safety Surveillance & Collaboration###CVS Health###
Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health
### she/her/hers @@@ J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions ### 1062745###Co-Author###Director, Epidemiology###RTI Health Solutions###
Co-Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Jie Deng – Optum Epidemiology ### 1991126###Co-Author######Optum Epidemiology###
Co-Author: Jie Deng – Optum Epidemiology
### @@@ Jonathan Deshazo, PhD, MPH – CVS Health ### 2325150###Co-Author######CVS Health###
Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health
### @@@ Morgan M. Richey, Ph.D, MPH – RTI International ### 2325231###Co-Author###Research Pharmacoepidemiologist###RTI International###
Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International
### @@@ Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology ### 1358090###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology
### @@@ Ron J. Parambi, MBBS, MPH – Optum ### 1991121###Co-Author###Senior Epidemiology Analyst###Optum###
Co-Author: Ron J. Parambi, MBBS, MPH – Optum
### @@@ Michael Miller, n/a – Optum Life Sciences ### 1659009###Co-Author###Epidemiological Data AAnalyst###Optum Life Sciences###
Co-Author: Michael Miller, n/a – Optum Life Sciences
### @@@ Jennifer Song, MA, MURP – United Health Group ### 1360471###Co-Author###Senior Epidemiology Analyst###United Health Group###
Co-Author: Jennifer Song, MA, MURP – United Health Group
### @@@ Wafa Tarazi, PhD, MHPA – Optum Serve ### 1991285###Co-Author###Senior Consultant/ Epidemiologist###Optum Serve###
Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve
### @@@ Lisa B. Weatherby – Optum Epidemiology ### 1991128###Co-Author######Optum Epidemiology###
Co-Author: Lisa B. Weatherby – Optum Epidemiology
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute ### 1659086###Co-Author###Senior Research Scientist###Harvard Pilgrim Health Care Institute###
Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###
Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###
Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
### @@@ Grace W. Yang – OptumServe ### 1659346###Co-Author######OptumServe###
Co-Author: Grace W. Yang – OptumServe
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health ### 1046832###Co-Author###Adjunct Faculty###Harvard T.H. Chan School of Public Health###
Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
###
Considerations for Your Cardiovascular Study Design

Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet ### 1932107###Moderator###Postdoctoral Researcher###CAUSALab at IMM, Karolinska Institutet###
Moderator: Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet
### she/her/hers @@@ Ghadeer Dawwas, PhD – University of Pennsylvania ### 1360505###Moderator###Posdoctoral Research Fellow ###University of Pennsylvania###
Moderator: Ghadeer Dawwas, PhD – University of Pennsylvania
###
Council Meetings
COVID-19: Now and Later

Nicolas H. Thurin, PharmD, PhD – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux ### 1062878###Moderator###Special consultant###Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux###
Moderator: Nicolas H. Thurin, PharmD, PhD – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux
### @@@ Dorothee B. Bartels, PhD – HeDa-Advisors ### 1088158###Moderator###HealthData-Advisors###HeDa-Advisors###
Moderator: Dorothee B. Bartels, PhD – HeDa-Advisors
###
COVID-19 outcomes and vaccinations in Swedish solid organ transplant recipients 2020-2021: A nationwide multi-register comparative cohort study

John Søfteland, PhD – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden ### 2325151###Co-Author###Researcher###The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: John Søfteland, PhD – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659121###Co-Author###Assoc. Prof.###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Jesper Magnusson – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden ### 2325152###Co-Author######The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: Jesper Magnusson – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Vanda Friman, PhD – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 2325153###Co-Author###Assoc. Prof.###Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Vanda Friman, PhD – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Magnus Gisslén, PhD – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358955###Co-Author###Professor###Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Magnus Gisslén, PhD – Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Marie Felldin – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden ### 2325154###Co-Author######The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: Marie Felldin – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Andreas Schult – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden ### 2325155###Co-Author######The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: Andreas Schult – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Kristjan Karason, MD, PhD – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden ### 2325156###Co-Author###Senior Cardiologist###The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: Kristjan Karason, MD, PhD – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Seema Baid-Agrawal – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden ### 2325158###Co-Author######The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: Seema Baid-Agrawal – The Transplant Institute, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Carin Wallquist – Department of Nephrology, Skåne University Hospital, Malmö, Sweden ### 2325159###Co-Author######Department of Nephrology, Skåne University Hospital, Malmö, Sweden###
Co-Author: Carin Wallquist – Department of Nephrology, Skåne University Hospital, Malmö, Sweden
### @@@ Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358933###Presenting Author###Professor of Register Epidemiology###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Presenting Author: Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
###
COVID-19: Part V

Montse Soriano Gabarro, MD, MSC, FISPE (she/her/hers) – Bayer AG, Berlin, Germany ### 2328251###Moderator###Head Partnerships and IEG Office###Bayer AG, Berlin, Germany###
Moderator: Montse Soriano Gabarro, MD, MSC, FISPE (she/her/hers) – Bayer AG, Berlin, Germany
### she/her/hers @@@ Fariba Ahmadizar, PharmD, MSc, PhD (she/her/hers) – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 2326427###Moderator###Assistant Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Moderator: Fariba Ahmadizar, PharmD, MSc, PhD (she/her/hers) – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### she/her/hers
CV Risk Post-Vaccine Exposure

Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Moderator###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Moderator: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Cindy Ke Zhou, PhD – Moderna, Inc. ### 1993398###Moderator###Director, Global Safety Epidemiology ###Moderna, Inc.###
Moderator: Cindy Ke Zhou, PhD – Moderna, Inc.
###
D
DARWIN EU® - Age-specific burden of RSV-related disease in Europe

Johnmary T. Arinze, MD, PhD – Department of Medical Informatics, Erasmus Medical Center ### 2328989###Co-Author###Epidemiologist###Department of Medical Informatics, Erasmus Medical Center###
Co-Author: Johnmary T. Arinze, MD, PhD – Department of Medical Informatics, Erasmus Medical Center
### @@@ Miguel Mayer, MD, PhD, MPH, MSc – UPF ### 1994170###Co-Author###Scientific coordinator###UPF###
Co-Author: Miguel Mayer, MD, PhD, MPH, MSc – UPF
### @@@ Guillaume Verdy – Centre Hospitalier Universitaire Bordeaux, France ### 2325486###Co-Author######Centre Hospitalier Universitaire Bordeaux, France###
Co-Author: Guillaume Verdy – Centre Hospitalier Universitaire Bordeaux, France
### @@@ Maarten van Kessel – Department of Medical Informatics, Erasmus Medical Center ### 2330991###Co-Author######Department of Medical Informatics, Erasmus Medical Center###
Co-Author: Maarten van Kessel – Department of Medical Informatics, Erasmus Medical Center
### @@@ Juan-Manuel Ramírez-Anguita – Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain ### 2326187###Co-Author######Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain###
Co-Author: Juan-Manuel Ramírez-Anguita – Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
### @@@ Angela Leis, PhD PsyM – Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain ### 2328099###Co-Author###Senior rearcher###Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain###
Co-Author: Angela Leis, PhD PsyM – Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
### @@@ Romain Griffier, MD – Centre Hospitalier Universitaire Bordeaux, France ### 1994172###Co-Author######Centre Hospitalier Universitaire Bordeaux, France###
Co-Author: Romain Griffier, MD – Centre Hospitalier Universitaire Bordeaux, France
### @@@ Marek Oja – Institute of Computer Science, University of Tartu, Tartu, Estonia ### 2325339###Co-Author######Institute of Computer Science, University of Tartu, Tartu, Estonia###
Co-Author: Marek Oja – Institute of Computer Science, University of Tartu, Tartu, Estonia
### @@@ Raivo Kolde – Institute of Computer Science, University of Tartu, Tartu, Estonia ### 2325337###Co-Author######Institute of Computer Science, University of Tartu, Tartu, Estonia###
Co-Author: Raivo Kolde – Institute of Computer Science, University of Tartu, Tartu, Estonia
### @@@ Antonella Delmestri, PhD (she/her/hers) – University of Oxford ### 1358614###Co-Author###Lead Health Data Scientist###University of Oxford###
Co-Author: Antonella Delmestri, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 2325409###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ James Brash, PhD – IQVIA ### 1657415###Co-Author###Data Scientist###IQVIA###
Co-Author: James Brash, PhD – IQVIA
### @@@ Dina Vojinovic, MD, PhD – IQVIA ### 1991398###Co-Author###Epidemiologist###IQVIA###
Co-Author: Dina Vojinovic, MD, PhD – IQVIA
### @@@ Hanne Ballegooijen – IQVIA ### 2328455###Co-Author######IQVIA###
Co-Author: Hanne Ballegooijen – IQVIA
### @@@ Sarah Seager, MS – IQVIA ### 1657425###Co-Author###Senior Director, Analytics & AI###IQVIA###
Co-Author: Sarah Seager, MS – IQVIA
### @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Co-Author###Assistant Professor###Erasmus MC and IDIAPJGol###
Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
### @@@ Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC ### 1092267###Presenting Author###Associate Professor###Department of Medical Informatics, Erasmus MC###
Presenting Author: Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC
### she/her/hers
DARWIN EU® - Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis

Dina Vojinovic, MD, PhD – IQVIA ### 1991398###Presenting Author###Epidemiologist###IQVIA###
Presenting Author: Dina Vojinovic, MD, PhD – IQVIA
### @@@ Johnmary T. Arinze, MD, PhD – Department of Medical Informatics, Erasmus Medical Center ### 2328989###Co-Author###Epidemiologist###Department of Medical Informatics, Erasmus Medical Center###
Co-Author: Johnmary T. Arinze, MD, PhD – Department of Medical Informatics, Erasmus Medical Center
### @@@ Antonella Delmestri, PhD (she/her/hers) – University of Oxford ### 1358614###Co-Author###Lead Health Data Scientist###University of Oxford###
Co-Author: Antonella Delmestri, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ James Brash, PhD – IQVIA ### 1657415###Co-Author###Data Scientist###IQVIA###
Co-Author: James Brash, PhD – IQVIA
### @@@ Sarah Seager, MS – IQVIA ### 1657425###Co-Author###Senior Director, Analytics & AI###IQVIA###
Co-Author: Sarah Seager, MS – IQVIA
### @@@ Guillaume Verdy – Centre Hospitalier Universitaire Bordeaux, France ### 2325486###Co-Author######Centre Hospitalier Universitaire Bordeaux, France###
Co-Author: Guillaume Verdy – Centre Hospitalier Universitaire Bordeaux, France
### @@@ Núria Mercadé-Besora, MS – University of Oxford ### 2325516###Co-Author###Rsearch Assistant in Health Data Sciences###University of Oxford###
Co-Author: Núria Mercadé-Besora, MS – University of Oxford
### @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Co-Author###Assistant Professor###Erasmus MC and IDIAPJGol###
Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
### @@@ Mees Mosseveld – Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands ### 2325408###Co-Author######Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands###
Co-Author: Mees Mosseveld – Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
### @@@ Miguel Mayer, MD, PhD, MPH, MSc – UPF ### 1994170###Co-Author###Scientific coordinator###UPF###
Co-Author: Miguel Mayer, MD, PhD, MPH, MSc – UPF
### @@@ Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC ### 1092267###Co-Author###Associate Professor###Department of Medical Informatics, Erasmus MC###
Co-Author: Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC
### she/her/hers
DARWIN EU® - Risk of Thromboembolic Events Associated With COVID-19 During the Omicron Period, and SARS-CoV-2 Vaccination

Martí Català, PhD (he/him/his) – University of Oxford ### 1659148###Presenting Author###Senior Data Scientist###University of Oxford###
Presenting Author: Martí Català, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Co-Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###
Co-Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC ### 1092267###Co-Author###Associate Professor###Department of Medical Informatics, Erasmus MC###
Co-Author: Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC
### she/her/hers @@@ Mees Mosseveld – Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands ### 2325408###Co-Author######Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands###
Co-Author: Mees Mosseveld – Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
### @@@ James Brash, PhD – IQVIA ### 1657415###Co-Author###Data Scientist###IQVIA###
Co-Author: James Brash, PhD – IQVIA
### @@@ Sarah Seager, MS – IQVIA ### 1657425###Co-Author###Senior Director, Analytics & AI###IQVIA###
Co-Author: Sarah Seager, MS – IQVIA
### @@@ Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 2325409###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Núria Mercadé-Besora, MS – University of Oxford ### 2325516###Co-Author###Rsearch Assistant in Health Data Sciences###University of Oxford###
Co-Author: Núria Mercadé-Besora, MS – University of Oxford
### @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Co-Author###Assistant Professor###Erasmus MC and IDIAPJGol###
Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
### @@@ Marek Oja – Institute of Computer Science, University of Tartu, Tartu, Estonia ### 2325339###Co-Author######Institute of Computer Science, University of Tartu, Tartu, Estonia###
Co-Author: Marek Oja – Institute of Computer Science, University of Tartu, Tartu, Estonia
### @@@ Edward Burn, PhD – University of Oxford ### 1358374###Co-Author###Senior Researcher in Epidemiology and Health Economics###University of Oxford###
Co-Author: Edward Burn, PhD – University of Oxford
### @@@ Albert Prats-Uribe, MD, MPH, FFPH, DPhil – University of Oxford ### 1360474###Co-Author###Senior Clinical Researcher in Public Health and Epidemiology###University of Oxford###
Co-Author: Albert Prats-Uribe, MD, MPH, FFPH, DPhil – University of Oxford
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Co-Author###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Raivo Kolde – Institute of Computer Science, University of Tartu, Tartu, Estonia ### 2325337###Co-Author######Institute of Computer Science, University of Tartu, Tartu, Estonia###
Co-Author: Raivo Kolde – Institute of Computer Science, University of Tartu, Tartu, Estonia
### @@@ Xintong Li, DPhil – University of Oxford ### 1656003###Co-Author###Postdoctoral data scientist###University of Oxford###
Co-Author: Xintong Li, DPhil – University of Oxford
###
DARWIN EU® - Trends of prescription opioid use in Europe

Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford ### 1358612###Presenting Author###Postdoctoral Researcher###University of Oxford###
Presenting Author: Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford
### he/him/his @@@ Mike Du, DPhil – Nuffield Department of Orthopaedics, Centre for Statistics in Medicine , Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK ### 1659557###Co-Author###Student###Nuffield Department of Orthopaedics, Centre for Statistics in Medicine , Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK###
Co-Author: Mike Du, DPhil – Nuffield Department of Orthopaedics, Centre for Statistics in Medicine , Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
### @@@ Yuchen Guo, PhD – University of Oxford ### 1360088###Co-Author###Postdoctoral researcher###University of Oxford###
Co-Author: Yuchen Guo, PhD – University of Oxford
### @@@ Cesar Barboza – Department of Medical Informatics, Erasmus Medical Center, Rotterdam, the Netherlands ### 2325335###Co-Author######Department of Medical Informatics, Erasmus Medical Center, Rotterdam, the Netherlands###
Co-Author: Cesar Barboza – Department of Medical Informatics, Erasmus Medical Center, Rotterdam, the Netherlands
### @@@ James Brash, PhD – IQVIA ### 1657415###Co-Author###Data Scientist###IQVIA###
Co-Author: James Brash, PhD – IQVIA
### @@@ Antonella Delmestri, PhD (she/her/hers) – University of Oxford ### 1358614###Co-Author###Lead Health Data Scientist###University of Oxford###
Co-Author: Antonella Delmestri, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Co-Author###Assistant Professor###Erasmus MC and IDIAPJGol###
Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
### @@@ Romain Griffier, MD – Centre Hospitalier Universitaire Bordeaux, France ### 1994172###Co-Author######Centre Hospitalier Universitaire Bordeaux, France###
Co-Author: Romain Griffier, MD – Centre Hospitalier Universitaire Bordeaux, France
### @@@ Raivo Kolde – Institute of Computer Science, University of Tartu, Tartu, Estonia ### 2325337###Co-Author######Institute of Computer Science, University of Tartu, Tartu, Estonia###
Co-Author: Raivo Kolde – Institute of Computer Science, University of Tartu, Tartu, Estonia
### @@@ Wai Yi Man, MSc – University of Oxford ### 2325135###Co-Author###Database Programmer###University of Oxford###
Co-Author: Wai Yi Man, MSc – University of Oxford
### @@@ Núria Mercadé-Besora, MS – University of Oxford ### 2325516###Co-Author###Rsearch Assistant in Health Data Sciences###University of Oxford###
Co-Author: Núria Mercadé-Besora, MS – University of Oxford
### @@@ Marek Oja – Institute of Computer Science, University of Tartu, Tartu, Estonia ### 2325339###Co-Author######Institute of Computer Science, University of Tartu, Tartu, Estonia###
Co-Author: Marek Oja – Institute of Computer Science, University of Tartu, Tartu, Estonia
### @@@ Sarah Seager, MS – IQVIA ### 1657425###Co-Author###Senior Director, Analytics & AI###IQVIA###
Co-Author: Sarah Seager, MS – IQVIA
### @@@ Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC ### 1092267###Co-Author###Associate Professor###Department of Medical Informatics, Erasmus MC###
Co-Author: Katia MC Verhamme, MD, PhD (she/her/hers) – Department of Medical Informatics, Erasmus MC
### she/her/hers @@@ Dina Vojinovic, MD, PhD – IQVIA ### 1991398###Co-Author###Epidemiologist###IQVIA###
Co-Author: Dina Vojinovic, MD, PhD – IQVIA
### @@@ Edward Burn, PhD – University of Oxford ### 1358374###Co-Author###Senior Researcher in Epidemiology and Health Economics###University of Oxford###
Co-Author: Edward Burn, PhD – University of Oxford
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Co-Author###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Martí Català, PhD (he/him/his) – University of Oxford ### 1659148###Co-Author###Senior Data Scientist###University of Oxford###
Co-Author: Martí Català, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Co-Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###
Co-Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers
Data Mining for Drug-Drug Interactions and More

Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Lead Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson ### 1046821###Speaker###Vice President and Global Head of Epidemiology###Johnson & Johnson###
Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson
### @@@ Macarius M. Donneyong, MPH, PhD – The Ohio State University ### 1062698###Speaker###Associate Professor###The Ohio State University###
Speaker: Macarius M. Donneyong, MPH, PhD – The Ohio State University
### @@@ Todd A. Miano, PharmD, PhD – University of Pennsylvania ### 1357966###Speaker###Assistant Professor of Epidemiology###University of Pennsylvania###
Speaker: Todd A. Miano, PharmD, PhD – University of Pennsylvania
###
Dementia Associated With Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Study

Bin Hong – Sungkyunkwan University ### 1660197###Presenting Author###PhD Candidate###Sungkyunkwan University###
Presenting Author: Bin Hong – Sungkyunkwan University
### @@@ Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 2325186###Co-Author###Postdoctoral fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1991617###Co-Author###PhD student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Woo Jung Kim – 3Department of Psychiatry, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea ### 2325585###Co-Author######3Department of Psychiatry, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea###
Co-Author: Woo Jung Kim – 3Department of Psychiatry, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea
### @@@ Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991609###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###
Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Depression among women with reproductive system disorders

Mette Bliddal, PhD (she/her/hers) – Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark ### 1062809###Presenting Author###Associate professor###Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark###
Presenting Author: Mette Bliddal, PhD (she/her/hers) – Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
### she/her/hers @@@ Rikke Wesselhoeft, MD – Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark ### 1062690###Co-Author###Associate Professor###Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark###
Co-Author: Rikke Wesselhoeft, MD – Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark
### @@@ Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark ### 1358115###Co-Author###Assistant professor###University of Southern Denmark###
Co-Author: Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark
### @@@ Magdalena Janecka – Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA ### 2325223###Co-Author######Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA###
Co-Author: Magdalena Janecka – Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA
### @@@ Nina Zaks – Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA ### 2325224###Co-Author######Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA###
Co-Author: Nina Zaks – Department of Child and Adolescent Psychiatry, New York University Grossman School of Medicine, New York, NY, USA
### @@@ Lone Kjeld Petersen – Department of Obstetrics and Gynecology, University Hospital Odense, Denmark ### 2325225###Co-Author######Department of Obstetrics and Gynecology, University Hospital Odense, Denmark###
Co-Author: Lone Kjeld Petersen – Department of Obstetrics and Gynecology, University Hospital Odense, Denmark
### @@@ Sofie D. Egsgaard, MSPH (she/her/hers) – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1991402###Co-Author###PhD-Student###Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Sofie D. Egsgaard, MSPH (she/her/hers) – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### she/her/hers @@@ Peter Bjødstrup Jensen – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 2325221###Co-Author######Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Peter Bjødstrup Jensen – Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### @@@ Trine Munk-Olsen – Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark ### 1993914###Co-Author###Professor###Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark###
Co-Author: Trine Munk-Olsen – Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark
###
Developing a de-novo mortality model for relapsed and refractory multiple myeloma: emulation of subjective life expectancy criteria from a clinical trial in real-world data

Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals ### 1991788### Co-Author###Associate Director of Pharmacoepidemiology###Regeneron Pharmaceuticals###
Co-Author: Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals
### @@@ Paul Spin – Eversana ### 2325728###Co-Author######Eversana###
Co-Author: Paul Spin – Eversana
### @@@ Di Wang – Eversana ### 2325729###Co-Author######Eversana###
Co-Author: Di Wang – Eversana
### @@@ Qiufei Ma – Regeneron Pharmaceuticals ### 2325730###Co-Author######Regeneron Pharmaceuticals###
Co-Author: Qiufei Ma – Regeneron Pharmaceuticals
### @@@ Glenn S. Kroog – Regeneron Pharmaceuticals ### 2325731###Co-Author######Regeneron Pharmaceuticals###
Co-Author: Glenn S. Kroog – Regeneron Pharmaceuticals
### @@@ Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals ### 1360408###Presenting Author###Sr. Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Presenting Author: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals
### he/him/his
Developing a Roadmap for Foundational Training Courses in Pharmacoepidemiology: A Core Competencies-Based Approach

Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA ### 1358307###Lead Speaker###Professor###University of Kentucky, College of Pharmacy, Lexington, KY, USA###
Lead Speaker: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA
### she/her/hers @@@ Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Speaker###Associate Professor###McGill University###
Speaker: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/his @@@ Chioma S. Ejekam, MD, MPH, MS.c, MWACP, FMCPH- ACEDHARS (she/her/hers) – University of Lagos ### 1993970###Speaker###Consultant, Member of Faculty(Adjunct) ###University of Lagos###
Speaker: Chioma S. Ejekam, MD, MPH, MS.c, MWACP, FMCPH- ACEDHARS (she/her/hers) – University of Lagos
### she/her/hers @@@ Amie Goodin, PhD, MPP – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States ### 1659995###Speaker###Assistant Professor###Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States###
Speaker: Amie Goodin, PhD, MPP – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Speaker###Professor###University of Southern Denmark###
Speaker: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
Development and Application of an Index to Adjust for Concomitant Hepatotoxic Medication Exposure in Hepatic Safety Studies

Jessie Torgersen, MD, MHS, MSCE (she/her/hers) – University of Pennsylvania Perelman School of Medicine ### 1991579###Presenting Author###Assistant Professor of Medicine###University of Pennsylvania Perelman School of Medicine###
Presenting Author: Jessie Torgersen, MD, MHS, MSCE (she/her/hers) – University of Pennsylvania Perelman School of Medicine
### she/her/hers @@@ Craig W. Newcomb, MS – Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA ### 1991581###Co-Author######Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA###
Co-Author: Craig W. Newcomb, MS – Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
### @@@ Dena M. Carbonari, MS – Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA ### 1655454###Co-Author######Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA###
Co-Author: Dena M. Carbonari, MS – Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Center for Real-World Effectiveness and Safety of Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
### @@@ Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania ### 1359957###Co-Author###Professor of Epidemiology###Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania###
Co-Author: Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics, University of Pennsylvania
### @@@ Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine ### 1062599###Co-Author###Associate Professor###London School of Hygiene and Tropical Medicine / Yale School of Medicine###
Co-Author: Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine
### @@@ Janet P. Tate, ScD – VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA ### 1359969###Co-Author###Associate Professor###VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA###
Co-Author: Janet P. Tate, ScD – VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA
### @@@ Jason A. Roy, PhD – Rutgers School of Public Health ### 1360415###Co-Author###Professor of Biostatistics and Epidemiology###Rutgers School of Public Health###
Co-Author: Jason A. Roy, PhD – Rutgers School of Public Health
### @@@ Tamar H. Taddei, MD – VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA ### 1991586###Co-Author######VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA###
Co-Author: Tamar H. Taddei, MD – VA Connecticut Healthcare System, US Department of Veterans Affairs, West Haven, CT, USA
### @@@ Amy C. Justice, MD, PhD – Yale School of Medicine ### 1360015###Co-Author######Yale School of Medicine###
Co-Author: Amy C. Justice, MD, PhD – Yale School of Medicine
### @@@ Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania ### 1359970###Co-Author###Associate Professor of Medicine and Epidemiology###University of Pennsylvania###
Co-Author: Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania
### he/him/his
Development of the Reporting recommendations Intended for pharmaceutical risk Minimization Evaluation Studies-Standards for Reporting of Implementation Studies Extension (RIMES-SE)

Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific ### 1088147###Presenting Author###Senior Director###Evidera. Inc., PPD, a part of Thermo Fisher Scientific###
Presenting Author: Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific
### @@@ Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago ### 1046822###Co-Author###Professor and Dean###Loyola University of Chicago###
Co-Author: Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago
### @@@ Nallely Mora – Parkinson School of Health Sciences and Public Health, Loyola U Chicago ### 2325518###Co-Author######Parkinson School of Health Sciences and Public Health, Loyola U Chicago###
Co-Author: Nallely Mora – Parkinson School of Health Sciences and Public Health, Loyola U Chicago
### @@@ Viviana Nguyen – Evidera, Inc/PPD a part of Thermo Fisher Scientific ### 2325519###Co-Author######Evidera, Inc/PPD a part of Thermo Fisher Scientific###
Co-Author: Viviana Nguyen – Evidera, Inc/PPD a part of Thermo Fisher Scientific
### @@@ Hilary Pinnock – Usher Institute, Edinburgh, Scotland ### 2325520###Co-Author######Usher Institute, Edinburgh, Scotland###
Co-Author: Hilary Pinnock – Usher Institute, Edinburgh, Scotland
### @@@ Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Co-Author: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers
Diabetes Drugs Are Good for the Heart

Hemalkumar B. Mehta, MS, PhD (he/him/his) – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health ### 1093588###Moderator###Associate Professor###Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health###
Moderator: Hemalkumar B. Mehta, MS, PhD (he/him/his) – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
### he/him/his @@@ Alexandra Z. Sosinsky, ScM (she/her/hers) – Genesis Research Group ### 1084113###Moderator###Director, Pharmacoepidemiology & Safety###Genesis Research Group###
Moderator: Alexandra Z. Sosinsky, ScM (she/her/hers) – Genesis Research Group
### she/her/hers
Difference in the Risk of Fall and Related Injuries among First-line Treatments in Older Adults with Depression: A Target Trial Emulation with Cloning-Censoring-Weighting Approach

Grace Hsin-Min Wang, PharmD, MS (she/her/hers) – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States ### 1358156###Presenting Author###PhD student###Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States###
Presenting Author: Grace Hsin-Min Wang, PharmD, MS (she/her/hers) – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States
### she/her/hers @@@ Wei-Hsuan Lo-Ciganic – Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA ### 2325140###Co-Author######Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA###
Co-Author: Wei-Hsuan Lo-Ciganic – Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
### @@@ Amie Goodin, PhD, MPP – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States ### 1659995###Co-Author###Assistant Professor###Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States###
Co-Author: Amie Goodin, PhD, MPP – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States
### @@@ Rachel Reise – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States ### 1658316###Co-Author######Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States###
Co-Author: Rachel Reise – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States
### @@@ Ronald Shorr – North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL, United States ### 2325139###Co-Author######North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL, United States###
Co-Author: Ronald Shorr – North Florida/South Georgia Veterans Health System Geriatric Research Education and Clinical Center, Gainesville, FL, United States
### @@@ Hsin-Min Wang – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, Florida, United States ### 1655475###Co-Author######Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, Florida, United States###
Co-Author: Hsin-Min Wang – Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy, Gainesville, Florida, United States
###
Discontinuation of antipsychotic medications in older adults following hospitalization and risks of adverse clinical outcomes

Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325401###Presenting Author###Research fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Presenting Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ James Wilkins – McLean Hospital ### 2325404###Co-Author######McLean Hospital###
Co-Author: James Wilkins – McLean Hospital
### @@@ Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School ### 1991353###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###
Disease Pattern, Serotype Distribution and Healthcare Resources Utilisation of Antimicrobial Resistance in Patients with Pneumococcal Infection in Hong Kong – A Population-based Study

Jack Chi Him Lau, MPH (he/him/his) – The University of Hong Kong ### 2329998###Presenting Author###Resaerch student###The University of Hong Kong###
Presenting Author: Jack Chi Him Lau, MPH (he/him/his) – The University of Hong Kong
### he/him/his @@@ Keith Wai-ki Cheung – The University of Hong Kong ### 2330065###Co-Author######The University of Hong Kong###
Co-Author: Keith Wai-ki Cheung – The University of Hong Kong
### @@@ Kim Shijian Lao, PhD – Global Medical and Scientific Affairs, MSD, Hong Kong, China ### 2330066###Co-Author######Global Medical and Scientific Affairs, MSD, Hong Kong, China###
Co-Author: Kim Shijian Lao, PhD – Global Medical and Scientific Affairs, MSD, Hong Kong, China
### @@@ Celine SL Chui, PhD – School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 2325999###Co-Author###Assistant Professor###School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Celine SL Chui, PhD – School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong
###
Don't Be Biased!

Marie Linder, PhD (she/her/hers) – Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden ### 2327033###Moderator###Senior statistician###Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden###
Moderator: Marie Linder, PhD (she/her/hers) – Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
### she/her/hers @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Moderator###Co-founder and President###Aetion###
Moderator: Jeremy A. Rassen, ScD, FISPE – Aetion
###
Dr. Karl Lauterbach the German Minister of Health: Opportunities for Pharmacoepidemiology and the new healthcare data access law in Germany
Drug target Mendelian Randomisation vs propensity score weighting for causal inference: estimating vaccine-induced antibody effect on COVID-19 outcomes

Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford ### 1358612###Presenting Author###Postdoctoral Researcher###University of Oxford###
Presenting Author: Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford
### he/him/his @@@ Marta Alcalde Herraiz – University of Oxford ### 1991479###Co-Author###Research Assistant in Health Data Sciences and Pharmacogenomics###University of Oxford###
Co-Author: Marta Alcalde Herraiz – University of Oxford
### @@@ Danielle Newby, PhD – University of Oxford ### 1991362###Co-Author###Senior Postdoctoral Researcher in Real World Evidence###University of Oxford###
Co-Author: Danielle Newby, PhD – University of Oxford
### @@@ Stephen Burgess – MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom ### 2325397###Co-Author######MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom###
Co-Author: Stephen Burgess – MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Co-Author###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his
Drug-Drug Interactions and their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study

John E. Hughes, MPharm – School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland ### 2325237###Presenting Author###PhD Candidate###School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland###
Presenting Author: John E. Hughes, MPharm – School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland
### @@@ Kathleen E. Bennett, PhD – Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland. ### 1090570###Co-Author###Professor of Biostatistics###Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland.###
Co-Author: Kathleen E. Bennett, PhD – Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
### @@@ Caitriona Cahir, PhD – Data Science Centre, School of Population Health, RCSI University of Medicine and Health Science ### 1062673###Co-Author######Data Science Centre, School of Population Health, RCSI University of Medicine and Health Science###
Co-Author: Caitriona Cahir, PhD – Data Science Centre, School of Population Health, RCSI University of Medicine and Health Science
###
Drugs and Alcohol Disorders

Ursula Kirchmayer, MPH (she/her/hers) – Department of Epidemiology, ASL Roma1, SSR Lazio, Rome, Italy ### 2327919###Moderator###Senior Researcher###Department of Epidemiology, ASL Roma1, SSR Lazio, Rome, Italy###
Moderator: Ursula Kirchmayer, MPH (she/her/hers) – Department of Epidemiology, ASL Roma1, SSR Lazio, Rome, Italy
### she/her/hers @@@ Janet K. Sluggett, PhD, BPharm(Hons), GDip ClinEpid, FANZCAP, FSHP (she/her/hers) – University of South Australia ### 2326857###Moderator###Associate Professor in Pharmacy and Pharmacoepidemiology###University of South Australia###
Moderator: Janet K. Sluggett, PhD, BPharm(Hons), GDip ClinEpid, FANZCAP, FSHP (she/her/hers) – University of South Australia
### she/her/hers
E
Effect Modification by Hydroxychloroquine on the Nephrolithiasis Preventive Effect of SGLT2 Inhibitors

Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1062943###Presenting Author###Immediate Past Chair of the ISPE Student Council###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Chan-Jung Liu – National Cheng Kung University Hospital ### 2325300###Co-Author######National Cheng Kung University Hospital###
Co-Author: Chan-Jung Liu – National Cheng Kung University Hospital
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System

Hugo Jourdain, PhD (he/him/his) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 2326724###Presenting Author###Pharmacoepidemiologist - Statistician###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Presenting Author: Hugo Jourdain, PhD (he/him/his) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### he/him/his @@@ Léa Hoisnard – EpiDerme ### 2327348###Co-Author######EpiDerme###
Co-Author: Léa Hoisnard – EpiDerme
### @@@ Emilie Sbidian – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France ### 2326731###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France###
Co-Author: Emilie Sbidian – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###
Effectiveness and Safety of Oral Anticoagulants among patients with Atrial Fibrillation and Advanced Kidney Disease

Qiaoxi Chen, phD – Brigham and Women's Hospital ### 2325400###Co-Author###Postdoctoral Research Fellow###Brigham and Women's Hospital###
Co-Author: Qiaoxi Chen, phD – Brigham and Women's Hospital
### @@@ Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA ### 1360618###Co-Author###Professor of Medicine, Harvard Medical School###Massachusetts General Hospital, Boston, MA###
Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA
### @@@ Edouard L. Fu – Leiden University Medical Center ### 2325333###Co-Author######Leiden University Medical Center###
Co-Author: Edouard L. Fu – Leiden University Medical Center
### @@@ Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325401###Co-Author###Research fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital ### 2325379###Presenting Author###Research Fellow###Brigham and Women's Hospital###
Presenting Author: Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital
### @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###
Effectiveness and Safety of the MVA-BN vaccine against Mpox in at-risk individuals in the United States (USMVAc)

Soowoo Back, MPH – Aetion, Inc ### 2325674###Co-Author###Senior Scientist###Aetion, Inc###
Co-Author: Soowoo Back, MPH – Aetion, Inc
### @@@ Bethany Knox, MPH – Aetion, Inc ### 2325675###Co-Author###Scientist###Aetion, Inc###
Co-Author: Bethany Knox, MPH – Aetion, Inc
### @@@ Luca Giraldi, PhD, MS – European Medicines Agency (EMA) ### 1991503###Co-Author######European Medicines Agency (EMA)###
Co-Author: Luca Giraldi, PhD, MS – European Medicines Agency (EMA)
### @@@ Ciara D. Coakley, MSc – Aetion Germany GmbH ### 1991949###Co-Author###Senior Scientific Analyst###Aetion Germany GmbH###
Co-Author: Ciara D. Coakley, MSc – Aetion Germany GmbH
### @@@ Nicolas Deltour, MSc – Aetion Germany GmbH ### 2325676###Co-Author###Vice President, RWE Strategy###Aetion Germany GmbH###
Co-Author: Nicolas Deltour, MSc – Aetion Germany GmbH
### @@@ Emmanuelle Jacquot, MD – Aixial ### 2325677###Co-Author######Aixial###
Co-Author: Emmanuelle Jacquot, MD – Aixial
### @@@ Hanaya Raad, MPH – Oracle ### 2325678###Co-Author###Project Manager, Real World Evidence###Oracle###
Co-Author: Hanaya Raad, MPH – Oracle
### @@@ Lorna Leal, MD, PhD – European Medicines Agency (EMA) ### 1991504###Co-Author###Scientific Specialist###European Medicines Agency (EMA)###
Co-Author: Lorna Leal, MD, PhD – European Medicines Agency (EMA)
### @@@ Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency ### 1655442###Co-Author###Pharmacoepidemiology/RWE Senior Specialist###RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency###
Co-Author: Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency
### she/her/hers @@@ Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1062756###Presenting Author###VP/Head of Scientific Research + Analytics###Aetion, Inc.###
Presenting Author: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers
Effectiveness of COVID-19 vaccines administered during pregnancy in Spain and Norway

Núria Mercadé-Besora, MS – University of Oxford ### 2325516###Presenting Author###Rsearch Assistant in Health Data Sciences###University of Oxford###
Presenting Author: Núria Mercadé-Besora, MS – University of Oxford
### @@@ Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1655801###Co-Author###Postdoctoral Fellow###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325297###Co-Author######Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Berta Raventós, PhD – Erasmus Medical Center ### 1992204###Co-Author###Postdoctoral researcher###Erasmus Medical Center###
Co-Author: Berta Raventós, PhD – Erasmus Medical Center
### @@@ Theresa Burkard, PhD (she/her/hers) – University of Oxford ### 1993259###Co-Author###Postdoctoral Data Scientist###University of Oxford###
Co-Author: Theresa Burkard, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Edward Burn, PhD – University of Oxford ### 1358374###Co-Author###Senior Researcher in Epidemiology and Health Economics###University of Oxford###
Co-Author: Edward Burn, PhD – University of Oxford
### @@@ Martí Català, PhD (he/him/his) – University of Oxford ### 1659148###Co-Author###Senior Data Scientist###University of Oxford###
Co-Author: Martí Català, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 2325409###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Laura Pérez-Crespo, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Co-Author###Assistant Professor###Erasmus MC and IDIAPJGol###
Co-Author: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
###
Effectiveness of metformin in preventing asthma exacerbations: a self-controlled case series and inverse propensity score weighting analysis

Bohee Lee, PharmD, PhD (she/her/hers) – Imperial College London ### 2325342###Presenting Author###Research Associate###Imperial College London###
Presenting Author: Bohee Lee, PharmD, PhD (she/her/hers) – Imperial College London
### she/her/hers @@@ Ernie Wong, PhD – Imperial College London ### 2325343###Co-Author######Imperial College London###
Co-Author: Ernie Wong, PhD – Imperial College London
### @@@ Tricia Tan, PhD – Imperial College London ### 2325344###Co-Author######Imperial College London###
Co-Author: Tricia Tan, PhD – Imperial College London
### @@@ Chloe Bloom, PhD – Imperial College London ### 2325345###Co-Author######Imperial College London###
Co-Author: Chloe Bloom, PhD – Imperial College London
###
Effectiveness of recombinant herpes zoster vaccine by immune status and prior receipt of live zoster vaccine in Medicare enrollees, 2018-2019

Jonathan Fix, PhD, MSPH (he/him/his) – Novavax ### 2325182###Presenting Author###Associate Director, Safety Epidemiology and Benefit Risk###Novavax###
Presenting Author: Jonathan Fix, PhD, MSPH (he/him/his) – Novavax
### he/him/his @@@ Nadja A. Vielot, PhD, MSPH (she/her/hers) – University of North Carolina at Chapel Hill ### 2325179### Co-Author###Assistant Professor###University of North Carolina at Chapel Hill###
Co-Author: Nadja A. Vielot, PhD, MSPH (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Co-Author###Associate Professor###University of North Carolina at Chapel Hill###
Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###
Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ David Weber – University of North Carolina at Chapel Hill ### 2325181###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: David Weber – University of North Carolina at Chapel Hill
### @@@ Sylvia Becker-Dreps – University of North Carolina at Chapel Hill ### 2325180###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: Sylvia Becker-Dreps – University of North Carolina at Chapel Hill
### @@@ Jennifer L. Lund, MSPH, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1062592###Co-Author###Associate Professor, Department of Epidemiology###University of North Carolina at Chapel Hill###
Co-Author: Jennifer L. Lund, MSPH, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers
Effectiveness Over Time of a Complete Primary Series of the Original, Monovalent COVID-19 Vaccines Among Adults Aged 18-64 Years in the United States

J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions ### 1062745###Presenting Author###Director, Epidemiology###RTI Health Solutions###
Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology ### 1991129###Co-Author###Epidemiologist###Optum Epidemiology###
Co-Author: Lauren S. Peetluk, PhD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###
Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Yixin Jiao – Acumen, LLC ### 1991146###Co-Author######Acumen, LLC###
Co-Author: Yixin Jiao – Acumen, LLC
### @@@ Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health ### 1655293###Co-Author###Lead Director -Epidemiology, Safety Surveillance & Collaboration###CVS Health###
Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health
### she/her/hers @@@ Jie Deng – Optum Epidemiology ### 1991126###Co-Author######Optum Epidemiology###
Co-Author: Jie Deng – Optum Epidemiology
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Co-Author###Epidemiologist###US FDA###
Co-Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology ### 1358090###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Rachel P. Ogilvie, PhD, MPH – Optum Epidemiology
### @@@ Ron J. Parambi, MBBS, MPH – Optum ### 1991121###Co-Author###Senior Epidemiology Analyst###Optum###
Co-Author: Ron J. Parambi, MBBS, MPH – Optum
### @@@ Michael Miller, n/a – Optum Life Sciences ### 1659009###Co-Author###Epidemiological Data AAnalyst###Optum Life Sciences###
Co-Author: Michael Miller, n/a – Optum Life Sciences
### @@@ Jennifer Song, MA, MURP – United Health Group ### 1360471###Co-Author###Senior Epidemiology Analyst###United Health Group###
Co-Author: Jennifer Song, MA, MURP – United Health Group
### @@@ Lisa B. Weatherby – Optum Epidemiology ### 1991128###Co-Author######Optum Epidemiology###
Co-Author: Lisa B. Weatherby – Optum Epidemiology
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute ### 1659086###Co-Author###Senior Research Scientist###Harvard Pilgrim Health Care Institute###
Co-Author: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers @@@ An-Chi Lo – Acumen, LLC ### 1358511###Co-Author######Acumen, LLC###
Co-Author: An-Chi Lo – Acumen, LLC
### @@@ Jessica R. Hervol, MPH – Acumen, LLC ### 2325148###Co-Author######Acumen, LLC###
Co-Author: Jessica R. Hervol, MPH – Acumen, LLC
### @@@ Michael Wernecke, BA (he/him/his) – Acumen, LLC ### 1358529###Co-Author###Senior Research Manager###Acumen, LLC###
Co-Author: Michael Wernecke, BA (he/him/his) – Acumen, LLC
### he/him/his @@@ Sylvia Cho, PhD – US FDA ### 2325116###Co-Author######US FDA###
Co-Author: Sylvia Cho, PhD – US FDA
### @@@ Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration ### 1358856###Co-Author###Associate Director for Science###US Food and Drug Administration###
Co-Author: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
### she/her/hers @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###
Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Christine L. Bui, MPH – RTI-HS ### 2325149###Co-Author###Director, Epidemiology###RTI-HS###
Co-Author: Christine L. Bui, MPH – RTI-HS
### @@@ Alexandra Stone, PhD, MSc – Optum Serve ### 1991303###Co-Author###Managing Consultant###Optum Serve###
Co-Author: Alexandra Stone, PhD, MSc – Optum Serve
### @@@ Wafa Tarazi, PhD, MHPA – Optum Serve ### 1991285###Co-Author###Senior Consultant/ Epidemiologist###Optum Serve###
Co-Author: Wafa Tarazi, PhD, MHPA – Optum Serve
### @@@ Jonathan Deshazo, PhD, MPH – CVS Health ### 2325150###Co-Author######CVS Health###
Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health ### 1046832###Co-Author###Adjunct Faculty###Harvard T.H. Chan School of Public Health###
Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###
Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Grace W. Yang – OptumServe ### 1659346###Co-Author######OptumServe###
Co-Author: Grace W. Yang – OptumServe
### @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###
Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###
Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###
EmBRACEing Collaborations for Benefit-Risk Decision Making

Priya Bahri, PhD – European Medicines Agency (EMA) ### 1061402###Moderator###Senior Lead###European Medicines Agency (EMA)###
Moderator: Priya Bahri, PhD – European Medicines Agency (EMA)
### @@@ Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals ### 1360272###Moderator###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Moderator: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers
Emulating 6 Cardiovascular Outcome Trials of Antihyperglycemics in Patients with Type 2 Diabetes: A Multinational Analysis Based on 3 Asian Real-World Databases

Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1991617###Presenting Author###PhD student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Sohee Park, PharmD, PhD (she/her/hers) – Aston Pharmacy School ### 2327663###Co-Author###Lecturer###Aston Pharmacy School###
Co-Author: Sohee Park, PharmD, PhD (she/her/hers) – Aston Pharmacy School
### she/her/hers @@@ Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea ### 1358469###Co-Author###PhD Student###School of Pharmacy, Sungkyunkwan University, Suwon, Korea###
Co-Author: Ahhyung Choi, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, Korea
### @@@ Han Eol Jeong, MPH, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 2329936###Co-Author######School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Han Eol Jeong, MPH, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Brian Meng-Hsun Li, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 2325378###Co-Author###PhD student###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Brian Meng-Hsun Li, MClinPharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994356###Co-Author###Research Associate###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1062943###Co-Author###Immediate Past Chair of the ISPE Student Council###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Philip C.M. Au, MPhil – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong ### 2331006###Co-Author######Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong###
Co-Author: Philip C.M. Au, MPhil – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong, Hong Kong
### @@@ Ching Lung Cheung, PhD – Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 2330869###Co-Author######Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Ching Lung Cheung, PhD – Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Co-Author###Lecturer/Assistant Professor###UCL School of Pharmacy###
Co-Author: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/his @@@ Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong ### 1358232###Co-Author###Professor###Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong###
Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
### he/him/his @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Emulating a target trial for assessing the comparative effectiveness of a newly marketed medication: the example of angiotensin-neprilysin inhibitor in patients with heart failure

Géric Maura, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1660115###Presenting Author###PharmD/PhD###Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Presenting Author: Géric Maura, PhD – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Pierre-Olivier Blotière – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden ### 1660114###Co-Author###PhD###Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Pierre-Olivier Blotière – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
### @@@ Edouard L. Fu – Leiden University Medical Center ### 2325333###Co-Author######Leiden University Medical Center###
Co-Author: Edouard L. Fu – Leiden University Medical Center
### @@@ Juan J. Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet ### 1397864###Co-Author######Department of Medical Epidemiology and Biostatistics, Karolinska Institutet###
Co-Author: Juan J. Carrero – Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
###
Emulating a target trial to avoid immortal time-bias in the estimation of PCSK9 inhibitor effects post myocardial infarction: Methodological opportunities and challenges

Thomas Cars – Sence Research BV ### 2325143###Presenting Author######Sence Research BV###
Presenting Author: Thomas Cars – Sence Research BV
### @@@ Stefan Gustafsson – Sence Research BV ### 2325144###Co-Author######Sence Research BV###
Co-Author: Stefan Gustafsson – Sence Research BV
### @@@ Queenie Chan, MEng, MSc, PhD – Center for Observational Research, Amgen Ltd ### 2325141###Co-Author###Observational Research Senior Manager###Center for Observational Research, Amgen Ltd###
Co-Author: Queenie Chan, MEng, MSc, PhD – Center for Observational Research, Amgen Ltd
### @@@ Nafeesa Dhalwani – Center for Observational Research, Amgen Inc ### 2325142###Co-Author######Center for Observational Research, Amgen Inc###
Co-Author: Nafeesa Dhalwani – Center for Observational Research, Amgen Inc
### @@@ Shia T. Kent, PhD – Center for Observational Research, Amgen Inc ### 1991702###Co-Author###Observational Research Senior Manager###Center for Observational Research, Amgen Inc###
Co-Author: Shia T. Kent, PhD – Center for Observational Research, Amgen Inc
### @@@ Johan Sundstrom – Department of Medical Sciences, Uppsala University ### 2325484###Co-Author######Department of Medical Sciences, Uppsala University###
Co-Author: Johan Sundstrom – Department of Medical Sciences, Uppsala University
### @@@ Emil Hagstrom – Uppsala Clinical Research Center ### 2325145###Co-Author######Uppsala Clinical Research Center###
Co-Author: Emil Hagstrom – Uppsala Clinical Research Center
### @@@ M. Alan Brookhart, PhD – Target RWE ### 1991706###Co-Author###Professor###Target RWE###
Co-Author: M. Alan Brookhart, PhD – Target RWE
###
Emulating a Target Trial to Estimate the Causal Effect of Antiseizure Medication on Birthweight

Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Presenting Author###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Presenting Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1397900###Co-Author###Statistician, postdoctoral research fellow###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062658###Co-Author###Prof. Dr. sc. hum.###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
###
Enhancing Drug Safety Review with Advanced Artificial Intelligence: A Pilot Study on Large Language Model-Assisted Literature Screening

Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration ### 1063144###Presenting Author###Lead Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration###
Presenting Author: Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Dan Li – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration ### 2325425###Co-Author###Bioinformatician###Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration###
Co-Author: Dan Li – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration
### @@@ Leihong Wu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration ### 2325426###Co-Author###Bioinformatician###Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration###
Co-Author: Leihong Wu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration
### @@@ Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration ### 1359919###Co-Author###Deputy Super Office Director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration###
Co-Author: Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Joshua Xu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration ### 2325427###Co-Author###Supervisory Computer Scientist###Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration###
Co-Author: Joshua Xu – Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration
###
Epidemiologic Modeling of US Cholesterol Treatment And Cardiovascular Outcomes Based On US And European Guidelines

G. Caleb Alexander, MD – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ### 1093469###Presenting Author###Professor of Epidemiology and Medicine###Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD###
Presenting Author: G. Caleb Alexander, MD – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
### @@@ Jill Curran – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland ### 2325468###Co-Author######Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland###
Co-Author: Jill Curran – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
### @@@ Alejandro Victores – Merck & Co., Inc., Rahway, New Jersey, US ### 2325565###Co-Author######Merck & Co., Inc., Rahway, New Jersey, US###
Co-Author: Alejandro Victores – Merck & Co., Inc., Rahway, New Jersey, US
### @@@ Hemalkumar B. Mehta, MS, PhD (he/him/his) – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health ### 1093588###Co-Author###Associate Professor###Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health###
Co-Author: Hemalkumar B. Mehta, MS, PhD (he/him/his) – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health
### he/him/his @@@ Shanshan Lin, ScM – Johns Hopkins University, School of Medicine, Division of General Internal of Medicine ### 1992291###Co-Author###Research data analyst###Johns Hopkins University, School of Medicine, Division of General Internal of Medicine###
Co-Author: Shanshan Lin, ScM – Johns Hopkins University, School of Medicine, Division of General Internal of Medicine
### @@@ Xuya Xiao, MHS (she/her/hers) – Johns Hopkins Bloomberg School of Public Health ### 1991149###Co-Author###Research analyst###Johns Hopkins Bloomberg School of Public Health###
Co-Author: Xuya Xiao, MHS (she/her/hers) – Johns Hopkins Bloomberg School of Public Health
### she/her/hers @@@ Erin D. Michos – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland ### 2325566###Co-Author######Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland###
Co-Author: Erin D. Michos – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland
### @@@ Jeromie Ballreich – Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland ### 1359926###Co-Author###Assistant Scientist###Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland###
Co-Author: Jeromie Ballreich – Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
### @@@ Lori D. Bash – Merck & Co., Inc., Rahway, New Jersey, US ### 2325567###Co-Author######Merck & Co., Inc., Rahway, New Jersey, US###
Co-Author: Lori D. Bash – Merck & Co., Inc., Rahway, New Jersey, US
### @@@ Jason Exter – Merck & Co., Inc., Rahway, New Jersey, US ### 2325568###Co-Author######Merck & Co., Inc., Rahway, New Jersey, US###
Co-Author: Jason Exter – Merck & Co., Inc., Rahway, New Jersey, US
### @@@ Seth S. Martin – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland ### 2325569###Co-Author######Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland###
Co-Author: Seth S. Martin – Division of Cardiology, Johns Hopkins Medicine, Baltimore, Maryland
### @@@ Kathryn Foti – Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama ### 2325570###Co-Author######Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama###
Co-Author: Kathryn Foti – Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama
###
Epidemiology and RWE of Medical Devices, Diagnostics, and MedTech

Mary E. Ritchey, PhD, FISPE – CERobs Consulting ### 1994002###Lead Speaker###Chief Scientific Officer###CERobs Consulting###
Lead Speaker: Mary E. Ritchey, PhD, FISPE – CERobs Consulting
### @@@ Paul Coplan – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson ### 2326930###Speaker######MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson###
Speaker: Paul Coplan – MedTech Epidemiology & Real-World Data Sciences, Johnson & Johnson
### @@@ Mackenzie Herzog, PhD, MPH – IQVIA ### 2330847###Speaker###Director, Epidemiology###IQVIA###
Speaker: Mackenzie Herzog, PhD, MPH – IQVIA
### @@@ Stephen S. Johnston, PhD – Johnson and Johnson ### 1657997###Speaker###Senior Director###Johnson and Johnson###
Speaker: Stephen S. Johnston, PhD – Johnson and Johnson
### @@@ David Maislin – Biomedical Statistical Consulting ### 1761991###Speaker###Managing Partner###Biomedical Statistical Consulting###
Speaker: David Maislin – Biomedical Statistical Consulting
### @@@ Lisa Weiss, PhD – Healthcare Innovation & Technology Lab ### 1088159###Speaker######Healthcare Innovation & Technology Lab###
Speaker: Lisa Weiss, PhD – Healthcare Innovation & Technology Lab
###
Establishing a validation framework of claims-based treatment discontinuation definitions using natural language processing and electronic health records

Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325401###Presenting Author###Research fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Presenting Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325347###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
### @@@ Jun Liu – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1659307###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Jun Liu – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###
Estimating the Effects of Chronic Medications: Questions to Ask and Tools to Help Answer Them

Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Lead Speaker###Associate Professor###University of North Carolina at Chapel Hill###
Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Andrew WJ Toler, MS – Axle Informatics ### 2325715###Speaker###Assistant Director, Real World Evidence###Axle Informatics###
Speaker: Andrew WJ Toler, MS – Axle Informatics
###
Estimating the Prevalence of Immunoglobulin A Nephropathy (IgAN) in the European Union: A Weighted Average Estimation Approach Utilizing Diagnostic Procedure Frequency in a Rare Disease Setting

Jocelyn Buisker, MSc – Novartis Pharma AG, Basel, Switzerland ### 2330986###Presenting Author###Associate Director Epidemiologist###Novartis Pharma AG, Basel, Switzerland###
Presenting Author: Jocelyn Buisker, MSc – Novartis Pharma AG, Basel, Switzerland
### @@@ Sigrid Behr, PhD – Novartis Pharma AG ### 2330987###Co-Author######Novartis Pharma AG###
Co-Author: Sigrid Behr, PhD – Novartis Pharma AG
###
Estimating the risk of transient ischemic attacks and non-hemorrhagic stroke following Spikevax bivalent compared to influenza vaccination in the US

Christopher Bush, MPH (he/him/his) – Aetion, Inc. ### 1655850###Presenting Author###Associate Director###Aetion, Inc.###
Presenting Author: Christopher Bush, MPH (he/him/his) – Aetion, Inc.
### he/him/his @@@ Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1991443###Co-Author###Senior Scientist###Aetion, Inc.###
Co-Author: Neloufar Rahai, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ John Kroner – Aetion, Inc. ### 2325311###Co-Author######Aetion, Inc.###
Co-Author: John Kroner – Aetion, Inc.
### @@@ Brian Conroy – Aetion, Inc. ### 2325310###Co-Author######Aetion, Inc.###
Co-Author: Brian Conroy – Aetion, Inc.
### @@@ Katherine E. Mues, PhD, MPH – Aetion, Inc. ### 1655854###Co-Author###Vice President###Aetion, Inc.###
Co-Author: Katherine E. Mues, PhD, MPH – Aetion, Inc.
### @@@ Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc. ### 1655853###Co-Author###Director, Global Safety Epidemiologist###Moderna, Inc.###
Co-Author: Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Lei Zhu – Moderna, Inc. ### 1993192###Co-Author######Moderna, Inc.###
Co-Author: Lei Zhu – Moderna, Inc.
### @@@ Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###
Co-Author: Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hers
Evaluating concordance in results from database studies and randomized trials after aligning distribution of key risk factors for the outcome of interest

Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1655331###Presenting Author###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and ### 1360380###Co-Author###Associate Professor of Medicine###Brigham and Women's Hospital and###
Co-Author: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers
Evaluating the Differential Risk of Rheumatoid Arthritis-Associated Interstitial Lung Disease with Biological and Targeted Synthetic DMARDs: A Nationwide Cohort Study in Taiwan

Chin-Yao Shen, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1063185###Presenting Author###Ph.D Candidate###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Chin-Yao Shen, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University ### 1991536###Co-Author###Research fellow###National Cheng Kung University###
Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Co-Author###PhD student###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Evaluating the Impact of Data Standardization on Administrative Healthcare Data Among Patients with COVID-19 Diagnosed in Outpatient Settings

Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1062756###Presenting Author###VP/Head of Scientific Research + Analytics###Aetion, Inc.###
Presenting Author: Elizabeth M. Garry, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Aidan Baglivo, BS – Aetion ### 1655637###Co-Author###Senior Analyst###Aetion###
Co-Author: Aidan Baglivo, BS – Aetion
### @@@ Priya Govil, BA – Aetion ### 1655431###Co-Author###Senior Analyst###Aetion###
Co-Author: Priya Govil, BA – Aetion
### @@@ Jennifer L. Duryea, MPH – Replica Analytics ### 2325660###Co-Author###Lead Product Manager###Replica Analytics###
Co-Author: Jennifer L. Duryea, MPH – Replica Analytics
### @@@ Ayad K. Ali, RPh, PhD, FACE – Aetion, Inc ### 1657558###Co-Author###Principal Pharmacoepidemiologist###Aetion, Inc###
Co-Author: Ayad K. Ali, RPh, PhD, FACE – Aetion, Inc
### @@@ Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration ### 1358274###Co-Author######Office of Surveillance and Epidemiology, US Food and Drug Administration###
Co-Author: Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration
### @@@ Tamar Lasky, PhD (she/her/hers) – Retired ### 2325357###Co-Author###Retired###Retired###
Co-Author: Tamar Lasky, PhD (she/her/hers) – Retired
### she/her/hers @@@ Aloka Chakravarty, PhD, Mstat – Pfizer, Inc. ### 2325528###Co-Author###VP, Head of Enterprise RWE###Pfizer, Inc.###
Co-Author: Aloka Chakravarty, PhD, Mstat – Pfizer, Inc.
### @@@ Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA ### 1062817###Co-Author###Senior Advisor###Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA###
Co-Author: Marie C. Bradley, PhD, MPharm, MSc.PH – Real World Evidence Analytics, Office of Medical Policy, CDER, US FDA
###
Evaluation of data quality in multi-database pharmacoepidemiologic studies: current practices and future trends

Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1659959###Lead Speaker###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Lead Speaker: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Speaker###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Speaker: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991500###Speaker###Scientific Programmer & PhD Student###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###
Speaker: Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### she/her/hers @@@ Daniel R. Morales, PhD – European Medicines Agency ### 1062632###Speaker###pharmacoepidemiologist###European Medicines Agency###
Speaker: Daniel R. Morales, PhD – European Medicines Agency
### @@@ Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration ### 1358504###Speaker###Associate Director of Pharmacoepidemiology###Oncology Center of Excellence, U.S. Food and Drug Administration###
Speaker: Donna R. Rivera, PharmD, MSc – Oncology Center of Excellence, U.S. Food and Drug Administration
### @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Speaker###Lecturer/Assistant Professor###UCL School of Pharmacy###
Speaker: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/his @@@ Jeffrey Brown, PhD – TriNetX ### 1655343###Speaker###Chief Scientific Officer###TriNetX###
Speaker: Jeffrey Brown, PhD – TriNetX
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Speaker###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Speaker: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands ### 1991418###Speaker###PhD candidate###Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands###
Speaker: Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands
### @@@ Constanza L. L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991498###Speaker###Assistant Professor###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###
Speaker: Constanza L. L. Andaur Navarro, PhD – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Speaker###Professor###University of Southern Denmark###
Speaker: Anton Pottegård, PhD, DMSc – University of Southern Denmark
### @@@ Robert W. Platt, PhD (he/him/his) – McGill University ### 1358167###Speaker###Professor###McGill University###
Speaker: Robert W. Platt, PhD (he/him/his) – McGill University
### he/him/his
Evaluation of Febrile Seizure Risk Following Ancestral Monovalent COVID-19 mRNA Vaccination Among U.S. Children Aged 2-5 Years

Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Presenting Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Presenting Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Elizabeth R. Smith – Acumen, LLC ### 1659094###Co-Author######Acumen, LLC###
Co-Author: Elizabeth R. Smith – Acumen, LLC
### @@@ Zhiruo Wan, MS – Acumen LLC ### 1993607###Co-Author###Data and Policy Analyst IV###Acumen LLC###
Co-Author: Zhiruo Wan, MS – Acumen LLC
### @@@ Kandace L. Amend, PhD – Optum Epidemiology ### 1063027###Co-Author###Senior Epidemiologist###Optum Epidemiology###
Co-Author: Kandace L. Amend, PhD – Optum Epidemiology
### @@@ Alex Secora, PhD – IQVIA ### 1991253###Co-Author###Asociate Director of Epidemiology###IQVIA###
Co-Author: Alex Secora, PhD – IQVIA
### @@@ Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health ### 1655293###Co-Author###Lead Director -Epidemiology, Safety Surveillance & Collaboration###CVS Health###
Co-Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health
### she/her/hers @@@ Kamran Kazemi – Acumen, LLC ### 2325466###Co-Author######Acumen, LLC###
Co-Author: Kamran Kazemi – Acumen, LLC
### @@@ Jennifer Song, MA, MURP – United Health Group ### 1360471###Co-Author###Senior Epidemiology Analyst###United Health Group###
Co-Author: Jennifer Song, MA, MURP – United Health Group
### @@@ Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc ### 2325147###Co-Author###Senior Research Scientist###Carelon Research, Inc###
Co-Author: Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc
### she/her/hers @@@ Jonathan Deshazo, PhD, MPH – CVS Health ### 2325150###Co-Author######CVS Health###
Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health
### @@@ John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health ### 1046832###Co-Author###Adjunct Faculty###Harvard T.H. Chan School of Public Health###
Co-Author: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health
### @@@ Nandini Selvam, PhD, MPH – IQVIA ### 2325467###Co-Author###VP & GM###IQVIA###
Co-Author: Nandini Selvam, PhD, MPH – IQVIA
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###
Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
### @@@ Mao I. Hu, BS – Acumen LLC ### 1655532###Co-Author###Policy Researcher###Acumen LLC###
Co-Author: Mao I. Hu, BS – Acumen LLC
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
###
Events on Day Zero of Follow-Up: Considerations for Cohort Studies of Adverse Events After COVID-19 Diagnosis

J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions ### 1062745###Presenting Author###Director, Epidemiology###RTI Health Solutions###
Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Morgan M. Richey, Ph.D, MPH – RTI International ### 2325231###Co-Author###Research Pharmacoepidemiologist###RTI International###
Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International
### @@@ Arnstein Lindaas, MA – Acumen, LLC ### 1991272###Co-Author######Acumen, LLC###
Co-Author: Arnstein Lindaas, MA – Acumen, LLC
### @@@ Stella G. Muthuri, PhD – IBM Consulting ### 1660980###Co-Author###Epidemiologist###IBM Consulting###
Co-Author: Stella G. Muthuri, PhD – IBM Consulting
### @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###
Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Co-Author###Epidemiologist###US FDA###
Co-Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Christine L. Bui, MPH – RTI-HS ### 2325149###Co-Author###Director, Epidemiology###RTI-HS###
Co-Author: Christine L. Bui, MPH – RTI-HS
### @@@ Mollie McKillop – IBM Consulting ### 2325193###Co-Author######IBM Consulting###
Co-Author: Mollie McKillop – IBM Consulting
### @@@ Lisa Kowarski, MPH – IBM Consulting ### 1658849###Co-Author######IBM Consulting###
Co-Author: Lisa Kowarski, MPH – IBM Consulting
### @@@ Hai Lyu – Acumen., LLC ### 2325541###Co-Author###Policy Associate###Acumen., LLC###
Co-Author: Hai Lyu – Acumen., LLC
### @@@ Angela Cheng, MPH – Acumen LLC ### 2325195###Co-Author######Acumen LLC###
Co-Author: Angela Cheng, MPH – Acumen LLC
### @@@ Zhiruo Wan, MS – Acumen LLC ### 1993607###Co-Author###Data and Policy Analyst IV###Acumen LLC###
Co-Author: Zhiruo Wan, MS – Acumen LLC
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###
Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Alison Tse Kawai, ScD, ScM – RTI Health Solutions ### 1095195###Co-Author###Director, Epidemiology###RTI Health Solutions###
Co-Author: Alison Tse Kawai, ScD, ScM – RTI Health Solutions
### @@@ Jeffrey B. Beers, MD – IBM Consulting ### 1658850###Co-Author###Clinical SME###IBM Consulting###
Co-Author: Jeffrey B. Beers, MD – IBM Consulting
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ Timothy Burrell, MD, MBA – IBM Consulting ### 1658852###Co-Author###Associate Partner###IBM Consulting###
Co-Author: Timothy Burrell, MD, MBA – IBM Consulting
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###
Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###
Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###
Evolution of Contraceptive Use in France From 2012 To 2022

Lorraine PONCET, PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM) ### 2327685###Presenting Author###Epidemiologist###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)###
Presenting Author: Lorraine PONCET, PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)
### @@@ Noémie Roland, PhD – EPI-PHARE ### 2327346###Co-Author###Epidemiologist###EPI-PHARE###
Co-Author: Noémie Roland, PhD – EPI-PHARE
### @@@ Romain Fortuna – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM) ### 2327686###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)###
Co-Author: Romain Fortuna – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358499###Co-Author###deputy director###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###
Exhibits
Exhibits/Poster Session A
Exhibits/Poster Session B
Exhibits/Posters
Exhibits/Posters
Exhibits/Posters
Extending randomized trial estimates to different target populations: An application to a nested trial comparing anticoagulant regimens for percutaneous coronary intervention

Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet ### 1932107###Presenting Author###Postdoctoral Researcher###CAUSALab at IMM, Karolinska Institutet###
Presenting Author: Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet
### she/her/hers @@@ Issa J. J. Dahabreh – CAUSALab, Harvard T.H. Chan School of Public Health ### 1658425###Co-Author######CAUSALab, Harvard T.H. Chan School of Public Health###
Co-Author: Issa J. J. Dahabreh – CAUSALab, Harvard T.H. Chan School of Public Health
### @@@ David Erlinge – Lund University ### 2325259###Co-Author######Lund University###
Co-Author: David Erlinge – Lund University
### @@@ Stefan James – Uppsala Clinical Research Center ### 1658428###Co-Author######Uppsala Clinical Research Center###
Co-Author: Stefan James – Uppsala Clinical Research Center
### @@@ Ole Fröbert – Department of Medical Sciences ### 1658426###Co-Author######Department of Medical Sciences###
Co-Author: Ole Fröbert – Department of Medical Sciences
### @@@ Anita Berglund, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet ### 1658431###Co-Author###Ass Professor###CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet###
Co-Author: Anita Berglund, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet
### @@@ Miguel A. Hernán – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet ### 1360646###Co-Author######CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet###
Co-Author: Miguel A. Hernán – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet
### @@@ Anthony A. Matthews, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet ### 1658424###Co-Author######CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet###
Co-Author: Anthony A. Matthews, PhD – CAUSALab, Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet
### @@@ Rebecca Rylance – Department of Cardiology, Clinical Sciences, Lund University ### 2325504###Co-Author######Department of Cardiology, Clinical Sciences, Lund University###
Co-Author: Rebecca Rylance – Department of Cardiology, Clinical Sciences, Lund University
###
F
Feasibility of Prospective Real-World Studies to Fulfill Regulatory Commitments and Requirements in Oncology within the United States (US)

Eric S. Meadows, PhD – Flatiron Health ### 2328124###Presenting Author###Scientific Engagement###Flatiron Health###
Presenting Author: Eric S. Meadows, PhD – Flatiron Health
### @@@ Matthew W. Reynolds, PhD, FISPE – Azimuth Research Group ### 1659421### Co-Author###Senior Vice President, Scientific Affairs###Azimuth Research Group###
Co-Author: Matthew W. Reynolds, PhD, FISPE – Azimuth Research Group
### @@@ Angela Chen, PharmD – Flatiron Health ### 2328125###Co-Author######Flatiron Health###
Co-Author: Angela Chen, PharmD – Flatiron Health
### @@@ Jenna M. Collins, MPH – Flatiron Health ### 2328127###Co-Author######Flatiron Health###
Co-Author: Jenna M. Collins, MPH – Flatiron Health
### @@@ Majd T. Ghanim, MD, MSCR – Flatiron Health ### 2328128###Co-Author###Medical Director###Flatiron Health###
Co-Author: Majd T. Ghanim, MD, MSCR – Flatiron Health
### @@@ Ivy Altomare, MD – Flatiron Health ### 2328129###Co-Author######Flatiron Health###
Co-Author: Ivy Altomare, MD – Flatiron Health
### @@@ Craig A. Serra, MS, MBA – Flatiron Health ### 2328130###Co-Author###Head, Clinical Research Scientific and Technical Engagement###Flatiron Health###
Co-Author: Craig A. Serra, MS, MBA – Flatiron Health
### @@@ Nicole Liaw, PharmD, MBA – Flatiron Health ### 2328131###Co-Author######Flatiron Health###
Co-Author: Nicole Liaw, PharmD, MBA – Flatiron Health
###
Feasible computation of propensity score and outcome regression models with the Highly Adaptive Lasso

Georg Hahn, PhD – Brigham and Women's Hospital and Harvard Medical School ### 2325657###Presenting Author###Lead investigator###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Georg Hahn, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers
Finding the (many) missing cases of chronic disease using linkage: an illustration from arthritis research

Belay Birlie Yimer, PhD – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom ### 1655409###Co-Author###Research Associate ###Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom###
Co-Author: Belay Birlie Yimer, PhD – Centre for Epidemiology Versus Arthritis, Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom
### @@@ Jenny Humphreys, MD, PHD – Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom ### 1991117###Co-Author######Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom###
Co-Author: Jenny Humphreys, MD, PHD – Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom
### @@@ Meghna Jani, MBCHB, PhD, MRCP, MSc – University of Manchester ### 1062944###Co-Author###NIHR Advanced Fellow/ Senior Clinical Lecturer###University of Manchester###
Co-Author: Meghna Jani, MBCHB, PhD, MRCP, MSc – University of Manchester
### @@@ John McBeth, PhD – Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom ### 2325586###Co-Author######Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom###
Co-Author: John McBeth, PhD – Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom
### @@@ William G. Dixon, MD PhD – University of Manchester ### 1062521###Presenting Author###Professor of Digital Epidemiology###University of Manchester###
Presenting Author: William G. Dixon, MD PhD – University of Manchester
###
First-trimester antibiotic treatments for urinary tract infections and risk of congenital malformations

Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1063282###Presenting Author###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Kelly Fung, MS – Brigham and Women's Hospital and Harvard Medical School ### 2325301###Co-Author###Research Specialist###Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Kelly Fung, MS – Brigham and Women's Hospital and Harvard Medical School
### @@@ Brian T. Bateman, MD, MSc – Stanford University ### 1088175###Co-Author######Stanford University###
Co-Author: Brian T. Bateman, MD, MSc – Stanford University
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Co-Author###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Chih-Wan Grace Lin, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 2325302###Co-Author###Postdoctoral Research Fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Chih-Wan Grace Lin, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Kathryn J. Gray, MD PhD – University of Washington ### 2325303###Co-Author###Associate Professor###University of Washington###
Co-Author: Kathryn J. Gray, MD PhD – University of Washington
### @@@ Malavika Prabhu – Massachusetts General Hospital ### 2325304###Co-Author######Massachusetts General Hospital###
Co-Author: Malavika Prabhu – Massachusetts General Hospital
### @@@ Andrea Ciaranello – Massachusetts General Hospital ### 2325305###Co-Author######Massachusetts General Hospital###
Co-Author: Andrea Ciaranello – Massachusetts General Hospital
### @@@ Laura Riley – Weill Cornell Medicine ### 2325306###Co-Author######Weill Cornell Medicine###
Co-Author: Laura Riley – Weill Cornell Medicine
### @@@ Helen Mogun – Brigham and Women's Hospital ### 2325282###Co-Author######Brigham and Women's Hospital###
Co-Author: Helen Mogun – Brigham and Women's Hospital
### @@@ Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School ### 1991353###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
### @@@ Gauri Bhatkhande, MPH – Brigham and Women's Hospital ### 1991339###Co-Author######Brigham and Women's Hospital###
Co-Author: Gauri Bhatkhande, MPH – Brigham and Women's Hospital
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
###
Flatiron - Are you ready for the future? How game-changing technology can unlock the next generation of RWE
Foundations in Causal Inference

Geetha Iyer – Harvard T.H. Chan School of Public Health ### 1655925###Lead Speaker######Harvard T.H. Chan School of Public Health###
Lead Speaker: Geetha Iyer – Harvard T.H. Chan School of Public Health
### @@@ Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson ### 1046821###Speaker###Vice President and Global Head of Epidemiology###Johnson & Johnson###
Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson
###
Framework for the application of Pharmacoepidemiology and Real-World Data analysis in Safety Signal Assessments

Suzanne N. Landi, MPH, PhD – GlaxoSmithKline ### 1063181###Presenting Author###Director, Immunology Epidemiology###GlaxoSmithKline###
Presenting Author: Suzanne N. Landi, MPH, PhD – GlaxoSmithKline
### @@@ O'Mareen Spence, PhD – GSK ### 2330959### Co-Author######GSK###
Co-Author: O'Mareen Spence, PhD – GSK
### @@@ Heather Ecklund, MPH – GSK ### 2330960###Co-Author######GSK###
Co-Author: Heather Ecklund, MPH – GSK
### @@@ Cailey Smith, ScM – GSK ### 2330961###Co-Author######GSK###
Co-Author: Cailey Smith, ScM – GSK
### @@@ Kieran J. Rothnie, PhD – GSK ### 1062865###Co-Author###Director Epidemiology###GSK###
Co-Author: Kieran J. Rothnie, PhD – GSK
### @@@ Rachel Cohen, MPH – GSK ### 2330962###Co-Author######GSK###
Co-Author: Rachel Cohen, MPH – GSK
### @@@ Diana Martins, MSc – GSK ### 2330963###Co-Author######GSK###
Co-Author: Diana Martins, MSc – GSK
### @@@ Keele Wurst, PhD – GSK ### 2330447###Co-Author######GSK###
Co-Author: Keele Wurst, PhD – GSK
###
From a Pill to the Planet: Addressing Healthcare Sustainability through Pharmacoepidemiologic Research

Johanna Villén, MSc – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, Sweden ### 1991120###Lead Speaker###PhD student###Pharmacoepidemiology, Department of Pharmacy, Uppsala University, Sweden###
Lead Speaker: Johanna Villén, MSc – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, Sweden
### @@@ Björn Wettermark, MscPharm, PhD (he/him/his) – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden ### 1358174###Speaker###Professor###Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden###
Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden
### he/him/his @@@ Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands ### 1086972###Speaker###Professor###Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands###
Speaker: Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands
### @@@ GERD MAACK, PhD – German Environment Agency ### 2325581###Speaker###Senior Scienctist###German Environment Agency###
Speaker: GERD MAACK, PhD – German Environment Agency
### @@@ Elisabetta Poluzzi, PhD – Department of Medical and Surgical Sciences - University of Bologna ### 1659721###Speaker###Professor of Pharmacology###Department of Medical and Surgical Sciences - University of Bologna###
Speaker: Elisabetta Poluzzi, PhD – Department of Medical and Surgical Sciences - University of Bologna
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Speaker###Professor of Medicine and Epidemiology###Rutgers University###
Speaker: Soko Setoguchi, MD, DrPH – Rutgers University
###
From Data to Diagnosis: Methods and Applications in Cancer Pharmacoepidemiology

Sebastian Jugl, MS, RPh (he/him/his) – University of Florida ### 1063291###Moderator###PhD Student###University of Florida###
Moderator: Sebastian Jugl, MS, RPh (he/him/his) – University of Florida
### he/him/his @@@ Matthew W. Reynolds, PhD, FISPE – Azimuth Research Group ### 1659421###Moderator###Senior Vice President, Scientific Affairs###Azimuth Research Group###
Moderator: Matthew W. Reynolds, PhD, FISPE – Azimuth Research Group
###
From Theory to Practice: The Impact of the NICE Real-World Evidence Framework in Health Technology Assessment

Natalie Tikhonovsky – Lane Clark & Peacock LLP ### 2330948###Co-Author######Lane Clark & Peacock LLP###
Co-Author: Natalie Tikhonovsky – Lane Clark & Peacock LLP
### @@@ Nishit Dhanji – Lane Clark & Peacock LLP ### 2330949###Co-Author######Lane Clark & Peacock LLP###
Co-Author: Nishit Dhanji – Lane Clark & Peacock LLP
### @@@ Benjamin D. Bray, MD MBChB (he/him/his) – LCP ### 2329420###Presenting Author###Evidence Generation Lead###LCP###
Presenting Author: Benjamin D. Bray, MD MBChB (he/him/his) – LCP
### he/him/his @@@ Sreeram Ramagopalan – Lane Clark & Peacock LLP ### 2330950###Co-Author######Lane Clark & Peacock LLP###
Co-Author: Sreeram Ramagopalan – Lane Clark & Peacock LLP
###
G
Glucagon-like Peptide 1 Receptor Agonist Use and Risk of Thyroid Cancer: Scandinavian Cohort Study

Björn Pasternak, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet ### 1655252###Presenting Author###Principal Researcher###Clinical Epidemiology Division, Karolinska Institutet###
Presenting Author: Björn Pasternak, MD, PhD – Clinical Epidemiology Division, Karolinska Institutet
### @@@ Viktor Wintzell, PhD – Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden ### 1062598###Co-Author###Research coordinator###Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Viktor Wintzell, PhD – Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
### @@@ Anders Hviid – Statens Serum Institut ### 1655991###Co-Author######Statens Serum Institut###
Co-Author: Anders Hviid – Statens Serum Institut
### @@@ Björn Eliasson – Sahlgrenska University Hospital ### 1655992###Co-Author######Sahlgrenska University Hospital###
Co-Author: Björn Eliasson – Sahlgrenska University Hospital
### @@@ Soffia Gudbjörnsdottir – University of Gothenburg ### 1655993###Co-Author######University of Gothenburg###
Co-Author: Soffia Gudbjörnsdottir – University of Gothenburg
### @@@ Christian Jonasson – Norwegian University of Science and Technology ### 1655995###Co-Author######Norwegian University of Science and Technology###
Co-Author: Christian Jonasson – Norwegian University of Science and Technology
### @@@ Kristian Hveem – Norwegian University of Science and Technology ### 1655994###Co-Author######Norwegian University of Science and Technology###
Co-Author: Kristian Hveem – Norwegian University of Science and Technology
### @@@ Henrik Svanström – Statens Serum Institut ### 2325204###Co-Author######Statens Serum Institut###
Co-Author: Henrik Svanström – Statens Serum Institut
### @@@ Mads Melbye – Danish Cancer Institute ### 2325205###Co-Author######Danish Cancer Institute###
Co-Author: Mads Melbye – Danish Cancer Institute
### @@@ Peter Ueda – Karolinska Institutet ### 2325206###Co-Author######Karolinska Institutet###
Co-Author: Peter Ueda – Karolinska Institutet
###
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study in Canada, Denmark, Norway, Sweden, South Korea and Taiwan

Sarah M. Baxter, MPharm, PhD (she/her/hers) – Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom ### 2325492###Presenting Author###Postdoctoral Research Fellow###Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom###
Presenting Author: Sarah M. Baxter, MPharm, PhD (she/her/hers) – Centre for Public Health, Queen's University Belfast, Belfast, United Kingdom
### she/her/hers @@@ Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1062545###Co-Author###Postdoctoral researcher###Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### he/him/his @@@ Jacob Harbo Andersen – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1360423###Co-Author######Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Jacob Harbo Andersen – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### @@@ Thomas Heiberg Brix – Department of Endocrinology, Odense University Hospital, Odense, Denmark ### 2325493###Co-Author######Department of Endocrinology, Odense University Hospital, Odense, Denmark###
Co-Author: Thomas Heiberg Brix – Department of Endocrinology, Odense University Hospital, Odense, Denmark
### @@@ Laszlo Hegedüs – Department of Endocrinology, Odense University Hospital, Odense, Denmark ### 2325494###Co-Author######Department of Endocrinology, Odense University Hospital, Odense, Denmark###
Co-Author: Laszlo Hegedüs – Department of Endocrinology, Odense University Hospital, Odense, Denmark
### @@@ Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1062943###Co-Author###Immediate Past Chair of the ISPE Student Council###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Chris Tzu-Ting Su – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 2325495###Co-Author######School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Chris Tzu-Ting Su – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994356###Co-Author###Research Associate###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Zoe Chi-Jui Chang – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 2325498###Co-Author######School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Zoe Chi-Jui Chang – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Swaleh Hussain – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1991884###Co-Author######Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Swaleh Hussain – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Cherry Chu, MSc – Women's College Hospital Research Institute, Toronto, Toronto, Ontario, Canada ### 1659107###Co-Author######Women's College Hospital Research Institute, Toronto, Toronto, Ontario, Canada###
Co-Author: Cherry Chu, MSc – Women's College Hospital Research Institute, Toronto, Toronto, Ontario, Canada
### @@@ Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1359899###Co-Author###Scientist###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Tony Antoniou – Li Ka Shing Knowledge Institute, St. Michael’s Hospital ### 1660981###Co-Author###Scientist###Li Ka Shing Knowledge Institute, St. Michael’s Hospital###
Co-Author: Tony Antoniou – Li Ka Shing Knowledge Institute, St. Michael’s Hospital
### @@@ Antoine Eskander – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 2325500###Co-Author######Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Antoine Eskander – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Zachary Bouck – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 2325501###Co-Author######Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Zachary Bouck – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1062862###Co-Author###Assistant Professor###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 2325186###Co-Author###Postdoctoral fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Eun-Young Choi, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1655650###Co-Author###PhD student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Eun-Young Choi, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Karin Modig, MSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden ### 1994660###Co-Author######Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Karin Modig, MSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
### @@@ Mats Talbäck, BSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden ### 2325502###Co-Author######Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Mats Talbäck, BSc, PhD – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
### @@@ Rickard Ljung, MD, PhD, MPH – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden ### 2325503###Co-Author######Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden###
Co-Author: Rickard Ljung, MD, PhD, MPH – Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
### @@@ Hanne L. Løvdal Gulseth – Norwegian Institute of Public Health ### 1360123###Co-Author######Norwegian Institute of Public Health###
Co-Author: Hanne L. Løvdal Gulseth – Norwegian Institute of Public Health
### @@@ Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1358431###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### @@@ Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland ### 1093536###Co-Author###Senior Lecturer###Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland###
Co-Author: Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Co-Author###Professor###University of Southern Denmark###
Co-Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
GP consultations for menstrual disorders after COVID-19 vaccination – a self-controlled cohort study based on routine healthcare data from the Netherlands

Rana Jajou, PhD – Netherlands Pharmacovigilance Centre Lareb ### 2325410###Co-Author###Epidemiologist###Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Rana Jajou, PhD – Netherlands Pharmacovigilance Centre Lareb
### @@@ Thomas Lieber – Netherlands Pharmacovigilance Centre Lareb ### 2325411###Co-Author######Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Thomas Lieber – Netherlands Pharmacovigilance Centre Lareb
### @@@ Eugene P. Van Puijenbroek, MD, PhD (he/him/his) – Netherlands Pharmacovigilance Centre Lareb ### 1657307###Co-Author###senior advisor###Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Eugene P. Van Puijenbroek, MD, PhD (he/him/his) – Netherlands Pharmacovigilance Centre Lareb
### he/him/his @@@ Erik Mulder – Netherlands Pharmacovigilance Centre Lareb ### 2325412###Co-Author######Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Erik Mulder – Netherlands Pharmacovigilance Centre Lareb
### @@@ Jetty A. Overbeek, PhD – PHARMO Institute for Drug Outcomes Research ### 1062554###Co-Author###Head of PHARMO Research###PHARMO Institute for Drug Outcomes Research###
Co-Author: Jetty A. Overbeek, PhD – PHARMO Institute for Drug Outcomes Research
### @@@ Karin Hek – Netherlands institute for health services research (NIVEL) ### 1660077###Co-Author######Netherlands institute for health services research (NIVEL)###
Co-Author: Karin Hek – Netherlands institute for health services research (NIVEL)
### @@@ Florence P.A.M van Hunsel, PharmD, PhD – Netherlands Pharmacovigilance Centre Lareb ### 1062617###Presenting Author###Lead Safety Innovation###Netherlands Pharmacovigilance Centre Lareb###
Presenting Author: Florence P.A.M van Hunsel, PharmD, PhD – Netherlands Pharmacovigilance Centre Lareb
### @@@ Agnes Kant – Netherlands Pharmacovigilance Centre Lareb ### 1657352###Co-Author######Netherlands Pharmacovigilance Centre Lareb###
Co-Author: Agnes Kant – Netherlands Pharmacovigilance Centre Lareb
###
Growing Old Gracefully

Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences ### 1658378###Moderator###Senior Lecturer###School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences###
Moderator: Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences
### he/him/his @@@ Joan Forns, PhD – RTI Health Solutions ### 1062754###Moderator######RTI Health Solutions###
Moderator: Joan Forns, PhD – RTI Health Solutions
###
H
Harms of Incretin-based Therapies for Diabetes Treatment

Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC ### 2328663###Moderator###Founder & CEO###CERobs Consulting, LLC###
Moderator: Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC
### she/her/hers @@@ Chintan Dave, PharmD, PhD – Rutgers University ### 1655382###Moderator###Assistant Professor of Pharmacy and Epidemiology###Rutgers University###
Moderator: Chintan Dave, PharmD, PhD – Rutgers University
###
Head-to-head Comparison of Dapagliflozin vs Empagliflozin: Cardiovascular and Safety Events

Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and ### 1360380###Presenting Author###Associate Professor of Medicine###Brigham and Women's Hospital and###
Presenting Author: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers @@@ HoJin Shin, BPharm, PhD – Brigham and Women's Hospital ### 1062644### Co-Author###Postdoctoral Research Fellow###Brigham and Women's Hospital###
Co-Author: HoJin Shin, BPharm, PhD – Brigham and Women's Hospital
### @@@ Julie M. Paik, MD, ScD – Brigham and Women's Hospital ### 1655332###Co-Author######Brigham and Women's Hospital###
Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital
### @@@ Brendan M. Everett, MD, MPH – Brigham and Women’s Hospital ### 1360564###Co-Author######Brigham and Women’s Hospital###
Co-Author: Brendan M. Everett, MD, MPH – Brigham and Women’s Hospital
### @@@ Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital ### 1302713###Co-Author###Professor###Brigham and Women's Hospital###
Co-Author: Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital
### @@@ Deborah J. Wexler, MD, MSc – Massachusetts General Hospital ### 1360566###Co-Author######Massachusetts General Hospital###
Co-Author: Deborah J. Wexler, MD, MSc – Massachusetts General Hospital
###
Healthy Live Births Should be Considered as Competing Events in Studies of Medication Use During Pregnancy

Chase D. Latour (she/her/hers) – University of North Carolina at Chapel Hill ### 1062974###Presenting Author###PhD Candidate###University of North Carolina at Chapel Hill###
Presenting Author: Chase D. Latour (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Mark Klose – University of North Carolina at Chapel Hill ### 2325407###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: Mark Klose – University of North Carolina at Chapel Hill
### @@@ Jessie Edwards, PhD MSPH – University of North Carolina at Chapel Hill ### 1358533###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: Jessie Edwards, PhD MSPH – University of North Carolina at Chapel Hill
### @@@ Zoey Song, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA ### 2325256###Co-Author######Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA###
Co-Author: Zoey Song, MPH – Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
### @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Co-Author###Associate Professor###University of North Carolina at Chapel Hill###
Co-Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Mollie E. Wood, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC ### 1659932###Co-Author###Assistant Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC###
Co-Author: Mollie E. Wood, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC
###
Hey! Please Control Yourself!

Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1655571###Moderator###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Moderator: Sophie H. Bots, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hers @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Moderator###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Moderator: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
High Throughput Signal Identification of Drug Use in Pregnancy for Detection of Adverse Infant Outcomes

Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Presenting Author###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Presenting Author: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Megan Wiley – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325529###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Megan Wiley – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ David V. Cole – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325560###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: David V. Cole – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Inna Dashevsky – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325561###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Inna Dashevsky – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Celeste LY Ewig, PharmD – University of Florida ### 1657495###Co-Author###Graduate Assistant###University of Florida###
Co-Author: Celeste LY Ewig, PharmD – University of Florida
### @@@ Katherine Haffenreffer – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325563###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Katherine Haffenreffer – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Earl J. Morris, IV, PharmD, MPH, PhD (he/him/his) – University of Florida ### 1063338###Co-Author###Research Assistant Professor###University of Florida###
Co-Author: Earl J. Morris, IV, PharmD, MPH, PhD (he/him/his) – University of Florida
### he/him/his @@@ Elizabeth Siranosian – University of North Carolina ### 2325573###Co-Author######University of North Carolina###
Co-Author: Elizabeth Siranosian – University of North Carolina
### @@@ Nicole E. E. Smolinski, PharmD – University of Florida ### 1358688###Co-Author###Graduate Student###University of Florida###
Co-Author: Nicole E. E. Smolinski, PharmD – University of Florida
### @@@ Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325434###Co-Author###Research Scientist###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy ### 1358834###Co-Author###Graduate Student###University of Florida, Department of Pharmaceutical Outcomes & Policy###
Co-Author: Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy
### @@@ Yehua Wang, MSPH (he/him/his) – University of Florida, College of Pharmacy, Gainesville, FL, USA ### 1659868###Co-Author###Graduate Student###University of Florida, College of Pharmacy, Gainesville, FL, USA###
Co-Author: Yehua Wang, MSPH (he/him/his) – University of Florida, College of Pharmacy, Gainesville, FL, USA
### he/him/his @@@ Audrey Wolfe – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325564###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Audrey Wolfe – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Elizabeth A. Suarez, PhD – Rutgers Institute for Health ### 1991274###Co-Author###Instructor###Rutgers Institute for Health###
Co-Author: Elizabeth A. Suarez, PhD – Rutgers Institute for Health
### @@@ Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc ### 2325147###Co-Author###Senior Research Scientist###Carelon Research, Inc###
Co-Author: Lauren E. Parlett, PhD (she/her/hers) – Carelon Research, Inc
### she/her/hers @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###
Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
### @@@ Margaret Adgent, MSPH, PhD – Department of Health Policy, Vanderbilt University Medical Center ### 1063010###Co-Author###Research Associate Professor###Department of Health Policy, Vanderbilt University Medical Center###
Co-Author: Margaret Adgent, MSPH, PhD – Department of Health Policy, Vanderbilt University Medical Center
### @@@ Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine ### 1991648###Co-Author######Department of Genetic Medicine, Johns Hopkins School of Medicine###
Co-Author: Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine
### @@@ Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Co-Author: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers
High-Dimensional Multiple Imputation (HDMI) For Partially Observed Confounders Including Natural Language Processing-Derived Auxiliary Covariates

Janick Weberpals, RPh, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1991181###Presenting Author###Instructor in Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Presenting Author: Janick Weberpals, RPh, PhD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### he/him/his @@@ Pamela A. Shaw – Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA ### 1991182###Co-Author######Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA###
Co-Author: Pamela A. Shaw – Biostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Joseph M. Plasek – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325346###Co-Author######Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Joseph M. Plasek – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Li Zhou – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1658668###Co-Author######Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Li Zhou – Division of General Internal Medicine and Primary Care, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325347###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Thomas DeRamus – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325348###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Thomas DeRamus – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Co-Author###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Co-Author: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1991183###Co-Author###Associate Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Co-Author: Bradley G. Hammill, DrPH (he/him/his) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### he/him/his @@@ Hana Lee, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1655520###Co-Author######Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###
Co-Author: Hana Lee, PhD – Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325127###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ John G. Connolly – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA ### 2325236###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA###
Co-Author: John G. Connolly – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Kimberly J. Dandreo – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA ### 2325349###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA###
Co-Author: Kimberly J. Dandreo – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA
### @@@ Fang Tian – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1659617###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###
Co-Author: Fang Tian – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration ### 1358274###Co-Author######Office of Surveillance and Epidemiology, US Food and Drug Administration###
Co-Author: Wei Liu, PhD, MSc – Office of Surveillance and Epidemiology, US Food and Drug Administration
### @@@ Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA ### 1062564###Co-Author###Associate Director RWE###Office of Surveillance and Epidemiology, CDER, US FDA###
Co-Author: Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA
### she/her/hers @@@ José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1991185###Co-Author###Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Co-Author: José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Co-Author###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
###
Hospitalization Risk among Early Adopters of Respiratory Syncytial Virus Vaccines: A Machine Learning Approach

Michael J. Munsell, PhD – Panalgo ### 1661018###Presenting Author###Director of Research###Panalgo###
Presenting Author: Michael J. Munsell, PhD – Panalgo
### @@@ Mark Friedman, MD – Panalgo ### 1358265###Co-Author######Panalgo###
Co-Author: Mark Friedman, MD – Panalgo
### @@@ Joseph Menzin, PhD – Panalgo ### 1063316###Co-Author######Panalgo###
Co-Author: Joseph Menzin, PhD – Panalgo
### @@@ Tiffany S. Siu Woodworth, MPH, MBA – Panalgo ### 1062696###Co-Author######Panalgo###
Co-Author: Tiffany S. Siu Woodworth, MPH, MBA – Panalgo
###
Hot Topic Session: Should confounding control be based on subject-matter knowledge, or driven by the data? A ‎debate

Alejandro Arana – RTI Health Solutions ### 2326326###Speaker######RTI Health Solutions###
Speaker: Alejandro Arana – RTI Health Solutions
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Speaker###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Speaker: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Yuchen Guo, PhD – University of Oxford ### 1360088###Speaker###Postdoctoral researcher###University of Oxford###
Speaker: Yuchen Guo, PhD – University of Oxford
### @@@ Patrick B. Ryan, PhD – Johnson and Johnson Innovative Medicine ### 1661016###Speaker######Johnson and Johnson Innovative Medicine###
Speaker: Patrick B. Ryan, PhD – Johnson and Johnson Innovative Medicine
### @@@ Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain ### 1046827###Moderator###Senior Director###RTI Health Solutions, Barcelona, Spain###
Moderator: Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Moderator###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Moderator: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his
How can Pharmacoepidemiology research contribute to tackle the Public Health threat of Antimicrobial Resistance? A global approach

Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands ### 1086972###Lead Speaker###Professor###Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands###
Lead Speaker: Katja Taxis, PhD – Pharmaco-Therapy, -Epidemiology and -Economics, Faculty of Science & Engineering, University of Groningen, The Netherlands
### @@@ Chloé Corrie Hans Smit, PharmD – University of Technology Sydney ### 1658456###Speaker###PhD researcher###University of Technology Sydney###
Speaker: Chloé Corrie Hans Smit, PharmD – University of Technology Sydney
### @@@ Maarten Lambert, MA (he/him/his) – University of Groningen ### 1657490###Speaker###PhD Candidate###University of Groningen###
Speaker: Maarten Lambert, MA (he/him/his) – University of Groningen
### he/him/his @@@ Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University ### 1093644###Speaker###Associate professor###Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University###
Speaker: Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University
### she/her/hers @@@ Luciane Cruz Lopes, ScD, MSc – Pharmaceutical Science Graduate Course. University of Sorocaba, Sao Paulo, Brazil ### 1659927###Speaker###Full professor and senior researcher###Pharmaceutical Science Graduate Course. University of Sorocaba, Sao Paulo, Brazil###
Speaker: Luciane Cruz Lopes, ScD, MSc – Pharmaceutical Science Graduate Course. University of Sorocaba, Sao Paulo, Brazil
### @@@ Ria Benkő, Dr. (she/her/hers) – Institute of Clinical Pharmacy, University of Szeged ### 1993178###Speaker###Associate Professor###Institute of Clinical Pharmacy, University of Szeged###
Speaker: Ria Benkő, Dr. (she/her/hers) – Institute of Clinical Pharmacy, University of Szeged
### she/her/hers @@@ Lisa G. Pont, PhD, FISPE – University of Technology Sydney ### 1655255###Speaker###Professor of Pharmacy###University of Technology Sydney###
Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
###
How to Design a Real-World Study of Biologics, Including Biosimilars

Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA ### 1046829###Lead Speaker###Vice President and Global Head of Epidemiology & Database Studies###IQVIA###
Lead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc. ### 1088313###Speaker###Executive Director of Observational Research###Amgen, Inc.###
Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
### she/her/hers @@@ Thijs J. Giezen, PhD – Spaarne Gasthuis ### 1088311###Speaker###Hospital Pharmacist###Spaarne Gasthuis###
Speaker: Thijs J. Giezen, PhD – Spaarne Gasthuis
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Speaker###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###
Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
###
Hypereosinophilia following initiation of glucagon-like peptide 1 receptor agonists: a sequence symmetry analysis using the Danish health registries

Martin Torp Rahbek, MD (he/him/his) – University of Southern Denmark ### 1991403###Presenting Author###PhD student###University of Southern Denmark###
Presenting Author: Martin Torp Rahbek, MD (he/him/his) – University of Southern Denmark
### he/him/his @@@ Søren Andreas Just – Odense University Hospital ### 2325198###Co-Author######Odense University Hospital###
Co-Author: Søren Andreas Just – Odense University Hospital
### @@@ Kasper Bruun Kristensen – Odense University Hospital ### 2325199###Co-Author######Odense University Hospital###
Co-Author: Kasper Bruun Kristensen – Odense University Hospital
### @@@ Hussam Mahmoud Sheta – University of Southern Denmark ### 2325200###Co-Author######University of Southern Denmark###
Co-Author: Hussam Mahmoud Sheta – University of Southern Denmark
### @@@ Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark ### 1062967###Co-Author###Professor of clinical pharmacology###University of Southern Denmark###
Co-Author: Jesper Hallas, MD, PhD, FISPE (he/him/his) – University of Southern Denmark
### he/him/his @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Co-Author###Professor###University of Southern Denmark###
Co-Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
### @@@ Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1062545###Co-Author###Postdoctoral researcher###Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### he/him/his
Hypothetical target trial to compare the effectiveness of atezolizumab, pembrolizumab and nivolumab in second line treatment of advanced non-small cell lung cancer

Euloge Clovis Kenne Pagui, PhD – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Norway ### 2325242###Presenting Author###Researcher###1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Norway###
Presenting Author: Euloge Clovis Kenne Pagui, PhD – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo, Norway
### @@@ Simon Boge Brant – NordicRWE AS, Oslo, Norway ### 2325243###Co-Author###Statistitian###NordicRWE AS, Oslo, Norway###
Co-Author: Simon Boge Brant – NordicRWE AS, Oslo, Norway
### @@@ Kristian Svendsen, PhD – NordicRWE AS, Oslo, Norway ### 2325244###Co-Author###Associate professor in pharmacoepidemiology###NordicRWE AS, Oslo, Norway###
Co-Author: Kristian Svendsen, PhD – NordicRWE AS, Oslo, Norway
### @@@ Arnoldo Frigessi – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo ### 2325245###Co-Author###Full professor###1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo###
Co-Author: Arnoldo Frigessi – 1) Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, University of Oslo
### @@@ Åslaug Helland – Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo ### 2325246###Co-Author###Professor, group leader###Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo###
Co-Author: Åslaug Helland – Division of Cancer Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo
### @@@ Steinar Ø Thoresen, MD PhD Professor emeritus – NordicRWE AS, Oslo, Norway ### 2325247###Co-Author###Medical Director###NordicRWE AS, Oslo, Norway###
Co-Author: Steinar Ø Thoresen, MD PhD Professor emeritus – NordicRWE AS, Oslo, Norway
### @@@ Christian Jonasson – Norwegian University of Science and Technology ### 1655995###Co-Author######Norwegian University of Science and Technology###
Co-Author: Christian Jonasson – Norwegian University of Science and Technology
###
I
Identification of patient groups at high risk of fluoroquinolone-associated potentially life-threatening adverse events in German routine care: a population-based cohort study

Julia Wicherski, MSc (she/her/hers) – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology ### 2325588###Presenting Author###PhD candidate###Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology###
Presenting Author: Julia Wicherski, MSc (she/her/hers) – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology
### she/her/hers @@@ Jonas Peltner – German Center for Neurodegenerative Diseases (DZNE), Pharmacoepidemiology in Neurodegenerative Disorders ### 2325177###Co-Author###Research associate###German Center for Neurodegenerative Diseases (DZNE), Pharmacoepidemiology in Neurodegenerative Disorders###
Co-Author: Jonas Peltner – German Center for Neurodegenerative Diseases (DZNE), Pharmacoepidemiology in Neurodegenerative Disorders
### @@@ Cornelia Becker – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology ### 2325589###Co-Author######Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology###
Co-Author: Cornelia Becker – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology
### @@@ Katrin Schüssel – Scientific Institute of the AOK (WIdO) ### 2325590###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Katrin Schüssel – Scientific Institute of the AOK (WIdO)
### @@@ Gabriela Brückner – Scientific Institute of the AOK (WIdO) ### 2325591###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Gabriela Brückner – Scientific Institute of the AOK (WIdO)
### @@@ Andreas Schlotmann – Scientific Institute of the AOK (WIdO) ### 2325593###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Andreas Schlotmann – Scientific Institute of the AOK (WIdO)
### @@@ Helmut Schröder – Scientific Institute of the AOK (WIdO) ### 2325594###Co-Author######Scientific Institute of the AOK (WIdO)###
Co-Author: Helmut Schröder – Scientific Institute of the AOK (WIdO)
### @@@ Winfried Kern – Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg ### 2325595###Co-Author######Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg###
Co-Author: Winfried Kern – Division of Infectious Diseases, Department of Medicine II, Medical Center-University of Freiburg
### @@@ Birgitta Weltermann – Institute of General Practice and Family Medicine, University of Bonn ### 2325596###Co-Author######Institute of General Practice and Family Medicine, University of Bonn###
Co-Author: Birgitta Weltermann – Institute of General Practice and Family Medicine, University of Bonn
### @@@ Britta Haenisch – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology ### 2325437###Co-Author######Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology###
Co-Author: Britta Haenisch – Federal Institute for Drugs and Medical Devices (BfArM), Pharmacoepidemiology
###
Identifying adverse drug events in clinical notes of Intensive Care patients: the need for a gold standard corpus to enable automation via Natural Language Processing

Rachel M. Murphy, MPharm MSc (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325470###Presenting Author###PhD Student###Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Presenting Author: Rachel M. Murphy, MPharm MSc (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### she/her/hers @@@ Dave A. Dongelmans – Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325471###Co-Author######Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Dave A. Dongelmans – Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Nicolette F. de Keizer – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325472###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Nicolette F. de Keizer – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Rosa J. Jongeneel – Amsterdam University Medical Centers ### 2325473###Co-Author######Amsterdam University Medical Centers###
Co-Author: Rosa J. Jongeneel – Amsterdam University Medical Centers
### @@@ Christiaan H. Koster – Department of Anesthesiology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands ### 2325474###Co-Author######Department of Anesthesiology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands###
Co-Author: Christiaan H. Koster – Department of Anesthesiology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
### @@@ Kitty J. Jager – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325475###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Kitty J. Jager – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Ameen Abu-Hanna – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325476###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Ameen Abu-Hanna – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Iacer Calixto – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325477###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Iacer Calixto – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Joanna E. Klopotowska, PharmD, PhD (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325203###Co-Author###Assistant Professor, Principal Investigator###Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Joanna E. Klopotowska, PharmD, PhD (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### she/her/hers
Identifying Novel Endpoints in Rare Disease Studies Using Real-World Evidence: A Regulatory Science Perspective

Julien E. Heidt, MS – IQVIA ### 2325212###Presenting Author###Senior Consultant Epidemiologist, Regulatory Science and Study Innovation###IQVIA###
Presenting Author: Julien E. Heidt, MS – IQVIA
### @@@ Reid D'Amico, PhD – IQVIA ### 2325480###Co-Author###Principal###IQVIA###
Co-Author: Reid D'Amico, PhD – IQVIA
### @@@ Christina D. Mack, PhD, FISPE – IQVIA ### 2326929###Co-Author###Chief Scientific Officer###IQVIA###
Co-Author: Christina D. Mack, PhD, FISPE – IQVIA
###
Identifying Subgroups Associated with Switching Patterns of Asthma Treatment: A Real-World Drug Utilization Study Using the Parametric G-Formula.

Irene Mommers, MSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2328415###Presenting Author###PhD student###PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Presenting Author: Irene Mommers, MSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Job F M van Boven, PharmD, PhD – University Medical Center Groningen ### 2330951###Co-Author###Associate Professor###University Medical Center Groningen###
Co-Author: Job F M van Boven, PharmD, PhD – University Medical Center Groningen
### @@@ Jens H.J. Bos, BSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2327265###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Jens H.J. Bos, BSc – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Sumaira Mubarik, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2327269###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Sumaira Mubarik, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Eelko Hak, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2326059###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Eelko Hak, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
### @@@ Maarten J. Bijlsma, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands ### 2327295###Co-Author######PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands###
Co-Author: Maarten J. Bijlsma, PhD – PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands
###
Immortal bias from different lengths of grace period in a clone-censor-weight design: a simulation study.

Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994356###Presenting Author###Research Associate###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### he/him/his @@@ Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University ### 1991536###Co-Author###Research fellow###National Cheng Kung University###
Co-Author: Albert Tzu-Ming Chuang, PharmD – National Cheng Kung University
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Immune-Related Adverse Events of Anti-PD-(L)1 Immunotherapy With and Without Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Evidence Study

Ping Shao, M.B.B.S, MS – Regeneron ### 1991789###Presenting Author###Associate Director###Regeneron###
Presenting Author: Ping Shao, M.B.B.S, MS – Regeneron
### @@@ Alexi N. Archambault, PhD, MPH – Regeneron ### 1658114###Co-Author###Assoc Dir Pharmacoepidemiology###Regeneron###
Co-Author: Alexi N. Archambault, PhD, MPH – Regeneron
### @@@ Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals ### 1360408###Co-Author###Sr. Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Co-Author: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals
### he/him/his @@@ Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron ### 1991877###Co-Author###VP, Head of Pharmacoepidemiology###Regeneron###
Co-Author: Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron
### she/her/hers @@@ Julius Asubonteng, PhD – Regeneron ### 1991791###Co-Author###Director###Regeneron###
Co-Author: Julius Asubonteng, PhD – Regeneron
### @@@ Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc. ### 1360060###Co-Author######Regeneron Pharmaceuticals, Inc.###
Co-Author: Gregory P. Geba, MD, DrPH – Regeneron Pharmaceuticals, Inc.
### @@@ Asha B. Pillai, MD – Regeneron ### 2325210###Co-Author###Chair, Hematology, Hematologic Malignancies, and Transplantation###Regeneron###
Co-Author: Asha B. Pillai, MD – Regeneron
###
Impact of data source diversity on the distribution of key variables in pregnancy cohorts based on the ConcePTION pregnancy algorithm leveraging a random forest imputation model

Anna Girardi, PharmD, PhD – ARS Toscana ### 1659698###Presenting Author###Collaborator###ARS Toscana###
Presenting Author: Anna Girardi, PharmD, PhD – ARS Toscana
### @@@ Giorgio Limoncella – University of Florence, Florence, Italy ### 1359790###Co-Author###PhD Student###University of Florence, Florence, Italy###
Co-Author: Giorgio Limoncella – University of Florence, Florence, Italy
### @@@ Giulia Hyeraci, PharmD – ARS Toscana ### 1359614###Co-Author###Pharmacoepidemiology consultant###ARS Toscana###
Co-Author: Giulia Hyeraci, PharmD – ARS Toscana
### @@@ Giuseppe Roberto, PhD, PharmD – ARS Toscana, Florence ### 1359195###Co-Author###PharmD, PhD###ARS Toscana, Florence###
Co-Author: Giuseppe Roberto, PhD, PharmD – ARS Toscana, Florence
### @@@ Claudia C. Bartolini – ARS Toscana ### 1063227###Co-Author###Researcher###ARS Toscana###
Co-Author: Claudia C. Bartolini – ARS Toscana
### @@@ Olga Paoletti – ARS Toscana ### 1359270###Co-Author###Researcher###ARS Toscana###
Co-Author: Olga Paoletti – ARS Toscana
### @@@ Davide Messina – ARS Toscana, Florence, Italy ### 1359791###Co-Author###Programmer###ARS Toscana, Florence, Italy###
Co-Author: Davide Messina – ARS Toscana, Florence, Italy
### @@@ Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360560###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Felipe Villalobos, MD, PhD – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1991144###Co-Author######Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###
Co-Author: Carlo Alberto Bissacco – Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Jesse M. van den Berg, MD (he/him/his) – PHARMO Institute for Drug Outcomes Research ### 1991361###Co-Author###PhD student###PHARMO Institute for Drug Outcomes Research###
Co-Author: Jesse M. van den Berg, MD (he/him/his) – PHARMO Institute for Drug Outcomes Research
### he/him/his @@@ Eline Houben, PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands ### 1658871###Co-Author###Senior Research Manager###PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands###
Co-Author: Eline Houben, PhD – PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands
### @@@ Katia Santacà, PhD – University of Verona ### 2325272###Co-Author###Postdoctoral Fellow###University of Verona###
Co-Author: Katia Santacà, PhD – University of Verona
### @@@ Valentina Ientile – Italian National Institute for Nuclear Physics ### 2325640###Co-Author######Italian National Institute for Nuclear Physics###
Co-Author: Valentina Ientile – Italian National Institute for Nuclear Physics
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Co-Author###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###
Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Gianluca Trifirò, MD, FISPE – Università di Verona ### 1302766###Co-Author###Full Professor of Pharmacology###Università di Verona###
Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona
### @@@ Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands ### 1991500###Co-Author###Scientific Programmer & PhD Student###Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands###
Co-Author: Vjola Hoxhaj, PharmD, MSc (she/her/hers) – Julius Center for Health Science and Primary Care, University Medical Center Utrecht, the Netherlands
### she/her/hers @@@ Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht ### 1655741###Co-Author###Assistant Professor###Department of Data Science and Biostatistics, University Medical Center Utrecht###
Co-Author: Carlos E. Durán, MD, PhD – Department of Data Science and Biostatistics, University Medical Center Utrecht
### @@@ Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands ### 1991418###Co-Author###PhD candidate###Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands###
Co-Author: Judit Riera-Arnau, MD – Department of Data Science and Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, Netherlands
### @@@ Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain ### 1655701###Co-Author######Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain###
Co-Author: Patricia Garcia – Division of Pharmacoepidemiology and Pharmacovigilance, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain
### @@@ Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS) ### 1359445###Co-Author###Pharmacoepidemiologist###Spanish Agency of Medicines and Medical Devices (AEMPS)###
Co-Author: Mar Martín-Pérez, PharmD, PhD – Spanish Agency of Medicines and Medical Devices (AEMPS)
### @@@ Consuelo Huerta-Alvarez, MD, MPH, PhD – Complutense University of Madrid ### 1655572###Co-Author######Complutense University of Madrid###
Co-Author: Consuelo Huerta-Alvarez, MD, MPH, PhD – Complutense University of Madrid
### @@@ Ana Llorente-Garcia – Spanish Agency of Medicines and Medical Devices(AEMPS) ### 1359446###Co-Author######Spanish Agency of Medicines and Medical Devices(AEMPS)###
Co-Author: Ana Llorente-Garcia – Spanish Agency of Medicines and Medical Devices(AEMPS)
### @@@ Francisco Sánchez-Sáez, PhD – FISABIO ### 2325273###Co-Author###Researcher###FISABIO###
Co-Author: Francisco Sánchez-Sáez, PhD – FISABIO
### @@@ Gabriel Sanfélix-Gimeno, PharmD, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region ### 2325274###Co-Author######Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region###
Co-Author: Gabriel Sanfélix-Gimeno, PharmD, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region
### @@@ Clara L. Rodríguez-Bernal, DDS, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain ### 2325165###Co-Author###Lead of perinatal pharmacoepidemiology research###Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain###
Co-Author: Clara L. Rodríguez-Bernal, DDS, PhD – Health Services Research and Pharmacoepidemiology Unit, Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain
### @@@ Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France ### 1358268###Co-Author###Head of Statistics and Data management###Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France###
Co-Author: Régis Lassalle, MSc – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France
### @@@ Jérémy Jové – BPE ### 1358369###Co-Author###Statistician###BPE###
Co-Author: Jérémy Jové – BPE
### @@@ Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France ### 1658844###Co-Author###Statistician###Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France###
Co-Author: Marie-Agnès Bernard – Bordeaux PharmacoEpi, INSERM CIC-P1401, Université de Bordeaux, Bordeaux, France
### @@@ Nicolas H. Thurin, PharmD, PhD – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux ### 1062878###Co-Author###Special consultant###Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux###
Co-Author: Nicolas H. Thurin, PharmD, PhD – Bordeaux PharmacoEpi, INSERM CIC-P 1401, Université de Bordeaux
### @@@ Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 1359730###Co-Author###professor###Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Sue Jordan, MB.BCh., PhD. PGCE (FE), – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Daniel Thayer – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 1658933###Co-Author######Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Daniel Thayer – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Hywel T. Evans, PhD – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 2325276###Co-Author###Research Officer###Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Hywel T. Evans, PhD – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Alex Coldea – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK ### 2325278###Co-Author######Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK###
Co-Author: Alex Coldea – Faculty of Medicine, Health and Life Science, Swansea University, Wales, UK
### @@@ Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University ### 1900338###Co-Author###Specialist in health statistics and biometrics###Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University###
Co-Author: Marco Manfrini – Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University
### @@@ Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway ### 1062980###Co-Author###Assistant Professor in Pharmacoepidemiology###Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway###
Co-Author: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
### @@@ Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325297###Co-Author######Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Co-Author###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Michele Tari – Caserta Local Health Unit, Caserta ### 1302883###Co-Author###Pharmacist###Caserta Local Health Unit, Caserta###
Co-Author: Michele Tari – Caserta Local Health Unit, Caserta
### @@@ Romin Pajouheshnia, PhD – RTI Health Solutions ### 2325267###Co-Author###Research Epidemiologist###RTI Health Solutions###
Co-Author: Romin Pajouheshnia, PhD – RTI Health Solutions
### @@@ Ana Sofia Afonso – Eli Lilly & Company ### 2325183###Co-Author######Eli Lilly & Company###
Co-Author: Ana Sofia Afonso – Eli Lilly & Company
### @@@ Maryline Le Noan-Lainé – Eli Lilly, Global Patient Safety, Cork Ireland ### 2325184###Co-Author######Eli Lilly, Global Patient Safety, Cork Ireland###
Co-Author: Maryline Le Noan-Lainé – Eli Lilly, Global Patient Safety, Cork Ireland
### @@@ Ditte Mølgaard-Nielsen, PhD – Novo Nordisk ### 1992023###Co-Author######Novo Nordisk###
Co-Author: Ditte Mølgaard-Nielsen, PhD – Novo Nordisk
### @@@ Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK ### 1991261###Co-Author###Vice President###Analysis Group, Inc., London, UK###
Co-Author: Marianne Cunnington, PhD (she/her/hers) – Analysis Group, Inc., London, UK
### she/her/hers @@@ Caitlin N. Dodd, PhD (she/her/hers) – Panalgo ### 1659256###Co-Author###Associate Director, Analytic Services###Panalgo###
Co-Author: Caitlin N. Dodd, PhD (she/her/hers) – Panalgo
### she/her/hers @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers
Impact of initial opioid prescription on risk of incident opioid use disorder among patients newly diagnosed with musculoskeletal pain

Allison Perry, PhD – Norstella ### 2325421###Presenting Author###Director, RWD Engagement Management###Norstella###
Presenting Author: Allison Perry, PhD – Norstella
### @@@ Michael J. Munsell, PhD – Panalgo ### 1661018###Co-Author###Director of Research###Panalgo###
Co-Author: Michael J. Munsell, PhD – Panalgo
### @@@ Sydnie Stackland, MS – Panalgo ### 2325422###Co-Author######Panalgo###
Co-Author: Sydnie Stackland, MS – Panalgo
### @@@ Chelsea Dutra, MPH – Panalgo ### 2325423###Co-Author######Panalgo###
Co-Author: Chelsea Dutra, MPH – Panalgo
### @@@ Magdalena Cerdá, DrPH ### 2429545###Co-Author#########
Co-Author: Magdalena Cerdá, DrPH
###
Impact of Kentucky Medicaid Prior Authorization Removal on Dispensing and Continuity of Buprenorphine for the Treatment of Opioid Use Disorder

Dustin K. Miracle, PharmD, MS – University of Kentucky College of Pharmacy ### 1658813###Presenting Author###Graduate Research Assistant###University of Kentucky College of Pharmacy###
Presenting Author: Dustin K. Miracle, PharmD, MS – University of Kentucky College of Pharmacy
### @@@ Lindsey R. Hammerslag, PhD – University of Kentucky ### 1655863###Co-Author###Assistant Research Professor###University of Kentucky###
Co-Author: Lindsey R. Hammerslag, PhD – University of Kentucky
### @@@ Svetla Slavova, PhD – University of Kentucky ### 1359478###Co-Author###Professor###University of Kentucky###
Co-Author: Svetla Slavova, PhD – University of Kentucky
### @@@ Michelle Lofwall, MD, DFAPA, DFASAM – University of Kentucky ### 1360578###Co-Author###Professor###University of Kentucky###
Co-Author: Michelle Lofwall, MD, DFAPA, DFASAM – University of Kentucky
### @@@ Jeffery Talbert, PhD – University of Kentucky College of Medicine ### 1360576###Co-Author###Professor###University of Kentucky College of Medicine###
Co-Author: Jeffery Talbert, PhD – University of Kentucky College of Medicine
### @@@ Sharon L. Walsh, PhD – University of Kentucky ### 1360577###Co-Author###Professor###University of Kentucky###
Co-Author: Sharon L. Walsh, PhD – University of Kentucky
### @@@ Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy ### 1656010###Co-Author###Professor###University of Kentucky College of Pharmacy###
Co-Author: Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy
###
Impact of Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Diseases and Antibiotic Prescribing in the United Kingdom

Lydia E. Gamey – School of Pharmacy, Queen's University Belfast ### 2325418###Presenting Author###Doctoral Student###School of Pharmacy, Queen's University Belfast###
Presenting Author: Lydia E. Gamey – School of Pharmacy, Queen's University Belfast
### @@@ Carmel Hughes – School of Pharmacy, Queen's University Belfast ### 2325419###Co-Author######School of Pharmacy, Queen's University Belfast###
Co-Author: Carmel Hughes – School of Pharmacy, Queen's University Belfast
### @@@ Wallis Lau, PhD – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom. ### 1063024###Co-Author######Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.###
Co-Author: Wallis Lau, PhD – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.
### @@@ Boqing Chen, MSc (he/him/his) – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom. ### 1993239###Co-Author###PhD student###Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.###
Co-Author: Boqing Chen, MSc (he/him/his) – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.
### he/him/his @@@ Konstantinos Karampatsas – Centre for Neonatal and Paediatric Infection, St. George’s University of London ### 2325420###Co-Author######Centre for Neonatal and Paediatric Infection, St. George’s University of London###
Co-Author: Konstantinos Karampatsas – Centre for Neonatal and Paediatric Infection, St. George’s University of London
### @@@ Yingfen Hsia – School of Pharmacy, Queen's University Belfast ### 1655894###Co-Author######School of Pharmacy, Queen's University Belfast###
Co-Author: Yingfen Hsia – School of Pharmacy, Queen's University Belfast
###
Impact of Risk Evaluation and Mitigation Strategies on Teratogenic Medications Among Publicly and Privately Insured Reproductive-Age Women

Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1063282###Presenting Author###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital ### 1655514###Co-Author###Research Specialist###Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital###
Co-Author: Priyanka Anand, MBBS, MPH – Division of Pharmacoepidemiology and Pharmacoeconomics, Dept of Medicine, Brigham and Women's Hospital
### @@@ Ameet Sarpatwari, PhD, JD (he/him/his) – Brigham and Women's Hospital / Harvard Medical School ### 1360165###Co-Author###Assistant Professor of Medicine###Brigham and Women's Hospital / Harvard Medical School###
Co-Author: Ameet Sarpatwari, PhD, JD (he/him/his) – Brigham and Women's Hospital / Harvard Medical School
### he/him/his @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Co-Author###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Mufaddal Mahesri, MD, MPH (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1655868###Co-Author###Research Scientist###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Mufaddal Mahesri, MD, MPH (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School ### 1991353###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
### @@@ Heidi Zakoul, BA – Brigham and Women's Hospital - Division of Pharmacoepidemiology ### 1991320###Co-Author######Brigham and Women's Hospital - Division of Pharmacoepidemiology###
Co-Author: Heidi Zakoul, BA – Brigham and Women's Hospital - Division of Pharmacoepidemiology
### @@@ Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1397958###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###
Co-Author: Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
### @@@ Helen Mogun – Brigham and Women's Hospital ### 2325282###Co-Author######Brigham and Women's Hospital###
Co-Author: Helen Mogun – Brigham and Women's Hospital
### @@@ Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration ### 1360117###Co-Author###Associate Director for Research and Strategic Initiatives###US Food and Drug Administration###
Co-Author: Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration
### @@@ Cynthia LaCivita, PharmD – US Food and Drug Administration ### 1993690###Co-Author###Director Division of RIsk Managment###US Food and Drug Administration###
Co-Author: Cynthia LaCivita, PharmD – US Food and Drug Administration
### @@@ Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration ### 1062973###Co-Author###Epidemiologist###U.S. Food and Drug Administration###
Co-Author: Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration
### @@@ Claudia B. Manzo, PharmD – FDA ### 2325284###Co-Author###Office Director###FDA###
Co-Author: Claudia B. Manzo, PharmD – FDA
### @@@ Gerald J. Dal Pan, MD, MHS – US Food and Drug Administration ### 1046835###Co-Author###Medical epidemiologist###US Food and Drug Administration###
Co-Author: Gerald J. Dal Pan, MD, MHS – US Food and Drug Administration
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
###
Impact of the US Food and Drug Administration Warning for Increased Risk of Aortic Aneurysms or Dissections on Fluoroquinolone Prescribing Trends

John G. Rizk, BSPharm, MSc – University of Maryland, Baltimore ### 2325441###Presenting Author###PhD Candidate###University of Maryland, Baltimore###
Presenting Author: John G. Rizk, BSPharm, MSc – University of Maryland, Baltimore
### @@@ Julia F. Slejko, PhD – University of Maryland School of Pharmacy ### 1402426###Co-Author###Associate Professor###University of Maryland School of Pharmacy###
Co-Author: Julia F. Slejko, PhD – University of Maryland School of Pharmacy
### @@@ Emily Heil, PharmD, MS – University of Maryland, Baltimore ### 2325532###Co-Author###Professor###University of Maryland, Baltimore###
Co-Author: Emily Heil, PharmD, MS – University of Maryland, Baltimore
### @@@ Dominique Seo – University of Maryland, Baltimore ### 2325533###Co-Author######University of Maryland, Baltimore###
Co-Author: Dominique Seo – University of Maryland, Baltimore
### @@@ Danya M. Qato, PhD, PharmD, MPH – University of Maryland, Baltimore ### 1655816###Co-Author###Associate Professor###University of Maryland, Baltimore###
Co-Author: Danya M. Qato, PhD, PharmD, MPH – University of Maryland, Baltimore
###
Impacts of Dobbs Decision and COVID-19 on Abortion-related Trends within TriNetX Electronic Medical Record Data

Sara A. Ephross – Syneos Health ### 2329294###Presenting Author######Syneos Health###
Presenting Author: Sara A. Ephross – Syneos Health
### @@@ Nicole Carneal-Frazer, PhD – Syneos Health ### 2330592###Co-Author###Associate Director, Epidemiology###Syneos Health###
Co-Author: Nicole Carneal-Frazer, PhD – Syneos Health
### @@@ Jacquelyne Brauneis – Syneos Health ### 2330595###Co-Author######Syneos Health###
Co-Author: Jacquelyne Brauneis – Syneos Health
### @@@ Jessica D. Albano – Syneos Health ### 2330593###Co-Author######Syneos Health###
Co-Author: Jessica D. Albano – Syneos Health
###
Improvements of Machine Learning Predictions of Overall Survival After Multiple Imputations for Features Regardless of Their Missing Degrees

HOA LE, MD, PhD (he/him/his) – Daiichi Sankyo ### 1993775###Presenting Author###Director###Daiichi Sankyo###
Presenting Author: HOA LE, MD, PhD (he/him/his) – Daiichi Sankyo
### he/him/his @@@ Yoko Tanaka, PhD – Daiichi Sankyo ### 1993853###Co-Author######Daiichi Sankyo###
Co-Author: Yoko Tanaka, PhD – Daiichi Sankyo
### @@@ Stas Zakharkin – Daiichi Sankyo ### 2325644###Co-Author######Daiichi Sankyo###
Co-Author: Stas Zakharkin – Daiichi Sankyo
###
Incidence and Survival of Pregnancy Associated Breast Cancer: A Contribution from the IMI ConcePTION Project Piloted in Finland and Norway

Maarit K. Leinonen, MD, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland ### 1358190###Presenting Author###Associate professor###Knowledge Brokers, Finnish Institute for Health and Welfare; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland###
Presenting Author: Maarit K. Leinonen, MD, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare; Teratology Information Service, Emergency Medicine and Services, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
### @@@ Visa Martikainen – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1359729###Co-Author###Data manager, statistician###Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###
Co-Author: Visa Martikainen – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
### @@@ Cori Campbell, DPhil – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 2325296###Co-Author###Assistant Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Cori Campbell, DPhil – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325297###Co-Author######Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Saeed Hayati – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA ### 1993399###Co-Author###Associate Director###Johnson & Johnson, Titusville, New Jersey, USA###
Co-Author: Alexis Krumme, ScD (she/her/hers) – Johnson & Johnson, Titusville, New Jersey, USA
### she/her/hers @@@ Joan K. Morris – Population Health Research Institute, St George’s, University of London, UK ### 1900343###Co-Author###Professor###Population Health Research Institute, St George’s, University of London, UK###
Co-Author: Joan K. Morris – Population Health Research Institute, St George’s, University of London, UK
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Mika Gissler, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland ### 1360036###Co-Author###Professor###Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland###
Co-Author: Mika Gissler, PhD – Knowledge Brokers, Finnish Institute for Health and Welfare, Helsinki, Finland
###
Incorporating real-world data and mathematical modelling to estimate the undiagnosed Chronic hepatitis C population

William W.L. Wong, PhD – School of Pharmacy, University of Waterloo ### 1661008###Presenting Author###Associate Professor###School of Pharmacy, University of Waterloo###
Presenting Author: William W.L. Wong, PhD – School of Pharmacy, University of Waterloo
### @@@ Zeny feng – Department of Mathematics and Statistics, University of Guelph ### 2325233###Co-Author######Department of Mathematics and Statistics, University of Guelph###
Co-Author: Zeny feng – Department of Mathematics and Statistics, University of Guelph
###
Increasing retention in a large-scale, remote wearable device study: learnings from the COVID-RED trial

Duco Veen, PhD – Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands ### 2330980###Co-Author######Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands###
Co-Author: Duco Veen, PhD – Department of Methodology and Statistics, Utrecht University, Utrecht, the Netherlands
### @@@ Marianna Mitratza, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. ### 2330981###Co-Author######Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.###
Co-Author: Marianna Mitratza, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
### @@@ Timo B. Brakenhoff, PhD – Julius Clinical ### 2330982###Co-Author######Julius Clinical###
Co-Author: Timo B. Brakenhoff, PhD – Julius Clinical
### @@@ Brianna M. Goodale, PhD – Julius Clinical ### 2325903###Co-Author###Head of Data Science###Julius Clinical###
Co-Author: Brianna M. Goodale, PhD – Julius Clinical
### @@@ Laura C. Zwiers, MPhil – Julius Clinical ### 2325902###Presenting Author###Scientific Officer, PhD Candidate###Julius Clinical###
Presenting Author: Laura C. Zwiers, MPhil – Julius Clinical
### @@@ Paul Klaver – Julius Clinical ### 2330983###Co-Author######Julius Clinical###
Co-Author: Paul Klaver – Julius Clinical
### @@@ Kay Y. Hage – Julius Clinical ### 2330984###Co-Author######Julius Clinical###
Co-Author: Kay Y. Hage – Julius Clinical
### @@@ George S. Downward, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. ### 2330985###Co-Author######Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.###
Co-Author: George S. Downward, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
### @@@ Diederick E. Grobbee, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands ### 1993358###Co-Author###Professor of Clinical Epidemiology###Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands###
Co-Author: Diederick E. Grobbee, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
###
Influence of mRNA Covid-19 Vaccine Dosing Interval on the Risk of Myocarditis

Stéphane Le Vu – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1655649###Presenting Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Presenting Author: Stéphane Le Vu – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Marion Bertrand – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1359610###Co-Author###MSc###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Marion Bertrand – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Laura Semenzato, MSc (she/her/hers) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360498###Co-Author###Statistician - PhD candidate in Pharmacoepidemiology###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Laura Semenzato, MSc (she/her/hers) – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### she/her/hers @@@ Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360145###Co-Author###Epidemiologist###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Marie-Joelle Jabagi, PharmD PhD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360499###Co-Author###PhD, PharmD, MPH###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérémie Botton, PhD, PharmD, MPH – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360500###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358499###Co-Author###deputy director###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358633###Co-Author###Phamacoepidemiology professor###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Mahmoud Zureik, Phamacoepidemiology professor – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###
Inhaler Utilization Patterns among Medicare Beneficiaries (2008-2020): Towards Sustainable Prescribing Practices in the US

Ashwaghosha Parthasarathi, MBBS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research ### 2325687###Co-Author######Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research###
Co-Author: Ashwaghosha Parthasarathi, MBBS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research
### @@@ Catherine Chen – Department of Medicine, Rutgers Robert Wood Johnson Medical School ### 2325690###Co-Author######Department of Medicine, Rutgers Robert Wood Johnson Medical School###
Co-Author: Catherine Chen – Department of Medicine, Rutgers Robert Wood Johnson Medical School
### @@@ Poonam Gandhi, MS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research ### 1359859###Co-Author###Research Project Manager###Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research###
Co-Author: Poonam Gandhi, MS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research
### @@@ Mary Bridgeman – Rutgers University Ernest Mario School of Pharmacy ### 2325696###Co-Author######Rutgers University Ernest Mario School of Pharmacy###
Co-Author: Mary Bridgeman – Rutgers University Ernest Mario School of Pharmacy
### @@@ Amy Li – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research ### 2325702###Co-Author######Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research###
Co-Author: Amy Li – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research
### @@@ Isao Iwata – Penn Medicine Princeton Health ### 2325703###Co-Author######Penn Medicine Princeton Health###
Co-Author: Isao Iwata – Penn Medicine Princeton Health
### @@@ Padukudru Anand Mahesh – Department of Respiratory Medicine, JSS Medical College ### 2325704###Co-Author######Department of Respiratory Medicine, JSS Medical College###
Co-Author: Padukudru Anand Mahesh – Department of Respiratory Medicine, JSS Medical College
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Presenting Author###Professor of Medicine and Epidemiology###Rutgers University###
Presenting Author: Soko Setoguchi, MD, DrPH – Rutgers University
###
Initiating Antidepressant Treatment in Pregnancy: Timing, Intensity, and Influential Maternal and Familial Factors

Alexis Carson, MPH – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 2325271###Presenting Author###PhD Candidate###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Presenting Author: Alexis Carson, MPH – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1655801###Co-Author###Postdoctoral Fellow###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
###
Initiation of SGLT2i vs GLP1-RA and the Risk of Chronic Kidney Disease in Persons with Type 2 Diabetes Mellitus

Simon K. Jensen, MD, PhD (he/him/his) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1655428###Presenting Author###Epidemiologist###Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Presenting Author: Simon K. Jensen, MD, PhD (he/him/his) – Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### he/him/his @@@ Uffe Heide-Jørgensen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1655336###Co-Author###Statistician###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Uffe Heide-Jørgensen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Ina T. Andersen, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 2325250###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Ina T. Andersen, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1063102###Co-Author###Professor and Consultant Physician###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Christian Fynbo Christiansen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062563###Co-Author###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Christian Fynbo Christiansen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###
Innovative Self-controlled Risk Interval Analysis of Effectiveness of COVID-19 mRNA Booster Vaccination in the Veterans Health Administration, Omicron Predominant Period

Caroline Korves, ScD – White River Junction Veterans Affairs Medical Center ### 1991421###Co-Author###Epidemiologist###White River Junction Veterans Affairs Medical Center###
Co-Author: Caroline Korves, ScD – White River Junction Veterans Affairs Medical Center
### @@@ Martin Kulldorff, PhD – Acumen, LLC ### 1658760###Co-Author######Acumen, LLC###
Co-Author: Martin Kulldorff, PhD – Acumen, LLC
### @@@ Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center ### 1991423###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Abirami S. Balajee, MPH – White River Junction Veterans Affairs Medical Center
### @@@ Jeremy Smith, MPH – White River Junction Veterans Affairs Medical Center ### 1991425###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Jeremy Smith, MPH – White River Junction Veterans Affairs Medical Center
### @@@ Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center ### 1991424###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Gabrielle M. Zwain, BA – White River Junction Veterans Affairs Medical Center
### @@@ David J. Graham, MD, MPH – US Food and Drug Administration ### 1655356###Co-Author###Associate director###US Food and Drug Administration###
Co-Author: David J. Graham, MD, MPH – US Food and Drug Administration
### @@@ Jurandir Dalle Lucca, MD, PhD – White River Junction Veterans Affairs Medical Center ### 2325405###Co-Author######White River Junction Veterans Affairs Medical Center###
Co-Author: Jurandir Dalle Lucca, MD, PhD – White River Junction Veterans Affairs Medical Center
### @@@ Hector S. Izurieta, MD, PhD – US Food and Drug Administration ### 1659297###Presenting Author###Associate Director, OVRR/CBER###US Food and Drug Administration###
Presenting Author: Hector S. Izurieta, MD, PhD – US Food and Drug Administration
###
Intermediate Pharmacoepidemiology: Approaches to Unmeasured Confounders

Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Lead Speaker###Associate Professor###University of North Carolina at Chapel Hill###
Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Speaker###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Speaker: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Mugdha Gokhale, PhD – Pfizer ### 1088166###Speaker###Director, Value & Evidence###Pfizer###
Speaker: Mugdha Gokhale, PhD – Pfizer
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Speaker###Professor###University of North Carolina at Chapel Hill###
Speaker: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet ### 1932107###Speaker###Postdoctoral Researcher###CAUSALab at IMM, Karolinska Institutet###
Speaker: Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet
### she/her/hers
Intermediate/Advanced Topics in Vaccine Safety and Effectiveness

Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc. ### 2327781###Lead Speaker###Director, Global Safety Epidemiology###Moderna, Inc.###
Lead Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute ### 1659086###Lead Speaker###Senior Research Scientist###Harvard Pilgrim Health Care Institute###
Lead Speaker: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Henok Tadesse Ayele, PhD – Merck & Co., Inc. ### 1062670###Speaker###Principal Scientist###Merck & Co., Inc.###
Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.
### @@@ Kaatje Bollaerts, PhD – P95 Epidemiology & Pharmacovigilance ### 2329038###Speaker###Epidemiology Business Head###P95 Epidemiology & Pharmacovigilance###
Speaker: Kaatje Bollaerts, PhD – P95 Epidemiology & Pharmacovigilance
### @@@ Robert T. Chen, MA, MD, FISPE (he/him/his) – Brighton Collaboration ### 1088150###Speaker###Scientific Director###Brighton Collaboration###
Speaker: Robert T. Chen, MA, MD, FISPE (he/him/his) – Brighton Collaboration
### he/him/his @@@ Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc. ### 1655853###Speaker###Director, Global Safety Epidemiologist###Moderna, Inc.###
Speaker: Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Hector S. Izurieta, MD, PhD – US Food and Drug Administration ### 1659297###Speaker###Associate Director, OVRR/CBER###US Food and Drug Administration###
Speaker: Hector S. Izurieta, MD, PhD – US Food and Drug Administration
### @@@ Katherine E. Mues, PhD, MPH – Aetion, Inc. ### 1655854###Speaker###Vice President###Aetion, Inc.###
Speaker: Katherine E. Mues, PhD, MPH – Aetion, Inc.
###
Introduction to Drug Utilization Research

Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands ### 1086986###Lead Speaker###PhD, FISPE###Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands###
Lead Speaker: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
### @@@ Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark ### 1358115###Lead Speaker###Assistant professor###University of Southern Denmark###
Lead Speaker: Lotte Rasmussen, MScPharm, PhD – University of Southern Denmark
### @@@ Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2326851###Speaker###Professor###Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Speaker: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Lisa G. Pont, PhD, FISPE – University of Technology Sydney ### 1655255###Speaker###Professor of Pharmacy###University of Technology Sydney###
Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
### @@@ Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University ### 1093644###Speaker###Associate professor###Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University###
Speaker: Indre Treciokiene, Dr. (she/her/hers) – Pharmacy and Pharmacology Center, Faculty of Medicine, Vilnius University
### she/her/hers @@@ Björn Wettermark, MscPharm, PhD (he/him/his) – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden ### 1358174###Speaker###Professor###Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden###
Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Pharmacoepidemiology, Department of Pharmacy, Uppsala University, 752 36 Uppsala, Sweden
### he/him/his
Intussusception Risk after Rotavirus Vaccination in Korean Infants

Haerin Cho, MA – Ewha Womans University ### 1660195###Presenting Author###PhD student###Ewha Womans University###
Presenting Author: Haerin Cho, MA – Ewha Womans University
### @@@ Na-Young Jeong, PhD – Ewha Womans University ### 1062838###Co-Author###Postdoctoral researcher###Ewha Womans University###
Co-Author: Na-Young Jeong, PhD – Ewha Womans University
### @@@ Hee-Jin Kim, MA – Ewha Womans University ### 1063354###Co-Author###PhD student###Ewha Womans University###
Co-Author: Hee-Jin Kim, MA – Ewha Womans University
### @@@ Nam-Kyong Choi – Ewha Womans University ### 1660178###Co-Author######Ewha Womans University###
Co-Author: Nam-Kyong Choi – Ewha Womans University
###
Investigating the association between Incretin-based therapies and thyroid cancer incidence using United States Medicare data 2007-2019

Clement Acheampong, B.Pharm, MPH – University of North Carolina at Chapel Hill ### 2325331###Presenting Author###PhD Student###University of North Carolina at Chapel Hill###
Presenting Author: Clement Acheampong, B.Pharm, MPH – University of North Carolina at Chapel Hill
### @@@ John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 1991568###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Klara R. Klein, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 2329810###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: Klara R. Klein, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Lawrence T. Kim, MD – University of North Carolina ### 2329811###Co-Author###Professor###University of North Carolina###
Co-Author: Lawrence T. Kim, MD – University of North Carolina
### @@@ Joshua Evron, MD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 2329812###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: Joshua Evron, MD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Anna Kahkoska, MD, PhD – University of North Carolina at Chapel Hill ### 2329813###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: Anna Kahkoska, MD, PhD – University of North Carolina at Chapel Hill
### @@@ Caroline A. Thompson, PhD – University of North Carolina at Chapel Hill ### 2329814###Co-Author######University of North Carolina at Chapel Hill###
Co-Author: Caroline A. Thompson, PhD – University of North Carolina at Chapel Hill
### @@@ Virginia Pate, MS – University of North Carolina at Chapel Hill ### 1358426###Co-Author###Analyst###University of North Carolina at Chapel Hill###
Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill
### @@@ Peter Leese – NC TraCS Institute, School of Medicine, University of North Carolina at Chapel Hill ### 2329815###Co-Author###Director, Data Science Lab###NC TraCS Institute, School of Medicine, University of North Carolina at Chapel Hill###
Co-Author: Peter Leese – NC TraCS Institute, School of Medicine, University of North Carolina at Chapel Hill
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###
Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his
Is gabapentin used as an alternative for opioids? Characterizing gabapentin initiation in Medicare beneficiaries

GYeon Oh, PhD – University of Kentucky, Department of Epidemiology and Environmental Health ### 2330996###Presenting Author###Postdoctoral Scholar###University of Kentucky, Department of Epidemiology and Environmental Health###
Presenting Author: GYeon Oh, PhD – University of Kentucky, Department of Epidemiology and Environmental Health
### @@@ Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA ### 1358307###Co-Author###Professor###University of Kentucky, College of Pharmacy, Lexington, KY, USA###
Co-Author: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA
### she/her/hers @@@ Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy ### 1656010###Co-Author###Professor###University of Kentucky College of Pharmacy###
Co-Author: Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy
### @@@ Erin L. Abner, PhD – University of Kentucky, Department of Epidemiology and Environmental Health ### 2330997###Co-Author######University of Kentucky, Department of Epidemiology and Environmental Health###
Co-Author: Erin L. Abner, PhD – University of Kentucky, Department of Epidemiology and Environmental Health
###
Is low socioeconomic position associated with mortality among mechanically ventilated patients in Denmark?

Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine ### 2325327###Presenting Author###Principal Research Scientist###Harvard Pilgrim Health Care Institute, Dept. of Population Medicine###
Presenting Author: Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine
### @@@ Erzsébet Horváth-Puhó – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1655233###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Erzsébet Horváth-Puhó – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Lise S. Skovgaard Svingel – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1655268###Co-Author######Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Lise S. Skovgaard Svingel – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
### @@@ Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark ### 1359288###Co-Author###Professor & Chair###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark###
Co-Author: Henrik Toft Sørensen, MD, PhD, DMSc, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark
###
ISPE Board of Directors' Lunch & Meeting
ISPE Board of Directors' Meeting
L
Lactation Room
Lactation Room
Lactation Room
Lactation Room
Lactation Room
Leftover of amoxicillin suspension after use by children in the Netherlands

Milad Sadreghaemy, PharmD – Utrecht University ### 2325694###Presenting Author###Researcher###Utrecht University###
Presenting Author: Milad Sadreghaemy, PharmD – Utrecht University
### @@@ Magdalena Gamba – Utrecht University ### 2325695###Co-Author######Utrecht University###
Co-Author: Magdalena Gamba – Utrecht University
### @@@ Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1063247###Co-Author###Assistant Professor Clinical Therapeutics###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Toine Egberts – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands ### 1302793###Co-Author######Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands###
Co-Author: Toine Egberts – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands
###
Leveraging human genetics to inform the effect of blood pressure lowering drugs on adverse pregnancy outcomes

Maria Carolina Borges – University of Bristol ### 2325597###Presenting Author######University of Bristol###
Presenting Author: Maria Carolina Borges – University of Bristol
### @@@ Qian Yang – University of Bristol ### 2325598###Co-Author######University of Bristol###
Co-Author: Qian Yang – University of Bristol
### @@@ Nancy McBride – University of Bristol ### 2325599###Co-Author######University of Bristol###
Co-Author: Nancy McBride – University of Bristol
### @@@ Marwa Al Arab – University of Bristol ### 2325600###Co-Author######University of Bristol###
Co-Author: Marwa Al Arab – University of Bristol
### @@@ Christy Burden, MBChB, BSc, MD, MRCOG – University of Bristol ### 1900248###Co-Author###Associate Professor in Obstetrics###University of Bristol###
Co-Author: Christy Burden, MBChB, BSc, MD, MRCOG – University of Bristol
### @@@ Kate Birchenall – University of Bristol ### 2325602###Co-Author######University of Bristol###
Co-Author: Kate Birchenall – University of Bristol
### @@@ Ana Luiza Soares – University of Bristol ### 2325603###Co-Author######University of Bristol###
Co-Author: Ana Luiza Soares – University of Bristol
### @@@ Tom Bond – University of Bristol ### 2325604###Co-Author######University of Bristol###
Co-Author: Tom Bond – University of Bristol
### @@@ Maria C. Magnus – Norwegian Institute of Public Health ### 1993433###Co-Author######Norwegian Institute of Public Health###
Co-Author: Maria C. Magnus – Norwegian Institute of Public Health
### @@@ Deborah Lawlor – University of Bristol ### 2325605###Co-Author######University of Bristol###
Co-Author: Deborah Lawlor – University of Bristol
###
Lightning Session 1

Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA ### 1046829###Moderator###Vice President and Global Head of Epidemiology & Database Studies###IQVIA###
Moderator: Jaclyn L. Bosco, PhD, MPH. FISPE (she/her/hers) – IQVIA
### she/her/hers @@@ Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine ### 1046837###Moderator###Associate Director of Epidemiology###Johnson and Johnson Innovative Medicine###
Moderator: Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine
### he/him/his @@@ Lisa G. Pont, PhD, FISPE – University of Technology Sydney ### 1655255###Moderator###Professor of Pharmacy###University of Technology Sydney###
Moderator: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
### @@@ Kristin Palmsten, ScD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1062579###Moderator###Senior Research Investigator###Pregnancy and Child Health Research Center, HealthPartners Institute###
Moderator: Kristin Palmsten, ScD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute
### she/her/hers
Lightning Session 2

Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research ### 1046831###Moderator###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research###
Moderator: Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research
### he/him/his @@@ Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine ### 1062599###Moderator###Associate Professor###London School of Hygiene and Tropical Medicine / Yale School of Medicine###
Moderator: Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine
### @@@ Michael Steinbuch, MS, PhD, FISPE – Procter & Gamble ### 2406745###Moderator###Global Head of Postmarket Product Vigilance###Procter & Gamble###
Moderator: Michael Steinbuch, MS, PhD, FISPE – Procter & Gamble
### @@@ Mary E. Ritchey, PhD, FISPE – CERobs Consulting ### 1994002###Moderator###Chief Scientific Officer###CERobs Consulting###
Moderator: Mary E. Ritchey, PhD, FISPE – CERobs Consulting
###
Lightning Session 3

Sandra Lopez Leon, MD PhD – Novartis Pharma ### 2326687###Moderator###Director Pharmacoepidemiologist###Novartis Pharma###
Moderator: Sandra Lopez Leon, MD PhD – Novartis Pharma
### @@@ Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute ### 1061396###Moderator###Sn VP Regulatory RWE/Epidemiology & Biostatistics###Research Triangle Institute###
Moderator: Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute
### @@@ Kourtney J. Davis, PhD (she/her/hers) – Janssen R&D, LLC ### 1360502###Moderator###Vice President, Global Epidemiology###Janssen R&D, LLC###
Moderator: Kourtney J. Davis, PhD (she/her/hers) – Janssen R&D, LLC
### she/her/hers @@@ Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA ### 1358307###Moderator###Professor###University of Kentucky, College of Pharmacy, Lexington, KY, USA###
Moderator: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA
### she/her/hers
Longitudinal Treatment Pathways Following Opioid Use Disorder Diagnosis Among Commercially-Insured Beneficiaries in the U.S.

John G. Rizk, BSPharm, MSc – University of Maryland, Baltimore ### 2325441###Presenting Author###PhD Candidate###University of Maryland, Baltimore###
Presenting Author: John G. Rizk, BSPharm, MSc – University of Maryland, Baltimore
### @@@ Uzma Pathan, BPharm, MPharm, MS – University of Maryland, Baltimore ### 2325438###Co-Author###PhD student###University of Maryland, Baltimore###
Co-Author: Uzma Pathan, BPharm, MPharm, MS – University of Maryland, Baltimore
### @@@ Jannat Saini, PharmD, MPH – University of Maryland, Baltimore ### 1655815###Co-Author######University of Maryland, Baltimore###
Co-Author: Jannat Saini, PharmD, MPH – University of Maryland, Baltimore
### @@@ Bethany DiPaula, PharmD, BCPP, FASHP – University of Maryland, Baltimore ### 2325439###Co-Author###Professor###University of Maryland, Baltimore###
Co-Author: Bethany DiPaula, PharmD, BCPP, FASHP – University of Maryland, Baltimore
### @@@ Megan Ehret, PharmD – University of Maryland, Baltimore ### 2325440###Co-Author######University of Maryland, Baltimore###
Co-Author: Megan Ehret, PharmD – University of Maryland, Baltimore
### @@@ Abree Johnson, MS, MBA – University of Maryland Baltimore ### 2325442###Co-Author###Director, Pharmaceutical Research Computing###University of Maryland Baltimore###
Co-Author: Abree Johnson, MS, MBA – University of Maryland Baltimore
### @@@ Danya M. Qato, PhD, PharmD, MPH – University of Maryland, Baltimore ### 1655816###Co-Author###Associate Professor###University of Maryland, Baltimore###
Co-Author: Danya M. Qato, PhD, PharmD, MPH – University of Maryland, Baltimore
###
Long-term Use of Benzodiazepines for Insomnia in Primary Healthcare Facilities in Beijing, China

Mengyuan Fu, PhD – International Research Center for Medicinal Administration, Peking University ### 2330451###Presenting Author###Postdoctoral fellow###International Research Center for Medicinal Administration, Peking University###
Presenting Author: Mengyuan Fu, PhD – International Research Center for Medicinal Administration, Peking University
### @@@ Joseph S. Ross, MD – Department of Medicine, Yale School of Medicine ### 2330452###Co-Author######Department of Medicine, Yale School of Medicine###
Co-Author: Joseph S. Ross, MD – Department of Medicine, Yale School of Medicine
### @@@ Luwen Shi – Peking University Health Science Center ### 2326013###Co-Author######Peking University Health Science Center###
Co-Author: Luwen Shi – Peking University Health Science Center
### @@@ Xiaodong Guan – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University ### 2326014###Co-Author######Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University###
Co-Author: Xiaodong Guan – Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University
###
Lunch
Lunch
Lunch
Lunch on Your Own
Lunch on Your Own
M
Major Congenital Malformations After First-Trimester Exposure to Smoking Cessation Pharmacotherapies: A Population-based Study in Australia, New Zealand, Norway and Sweden

Duong T. Tran, PhD – National Drug and Alcohol Research Centre ### 1994094###Presenting Author###Research Fellow###National Drug and Alcohol Research Centre###
Presenting Author: Duong T. Tran, PhD – National Drug and Alcohol Research Centre
### @@@ Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health ### 1360547###Co-Author###Senior researcher###Norwegian Institute of Public Health###
Co-Author: Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health
### she/her/hers @@@ Sarah Donald – University of Otago ### 1994093###Co-Author######University of Otago###
Co-Author: Sarah Donald – University of Otago
### @@@ Annelies L. Robijn, PhD MSc BSc – National Drug and Alcohol Research Centre ### 1994097###Co-Author###Research Fellow###National Drug and Alcohol Research Centre###
Co-Author: Annelies L. Robijn, PhD MSc BSc – National Drug and Alcohol Research Centre
### @@@ Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. ### 1062759###Co-Author###Assistant Professor###Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.###
Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
### @@@ Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1063219###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Co-Author: Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### she/her/hers @@@ Lianne Parkin, MB ChB, PhD – University of Otago ### 1994096###Co-Author######University of Otago###
Co-Author: Lianne Parkin, MB ChB, PhD – University of Otago
### @@@ Sallie-Anne Pearson, PhD – UNSW Sydney ### 1358403###Co-Author###Professor of Health Systems###UNSW Sydney###
Co-Author: Sallie-Anne Pearson, PhD – UNSW Sydney
### @@@ Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. ### 1358377###Co-Author###Associate professor###Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.###
Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
### @@@ Helga Zoega – Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia. ### 1358124###Co-Author###Associate professor/professor###Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.###
Co-Author: Helga Zoega – Medicines Intelligence Research Program, School of Population Health, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.
### @@@ Nicholas Zwar – Bond University ### 1994098###Co-Author######Bond University###
Co-Author: Nicholas Zwar – Bond University
### @@@ Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre ### 1358233###Co-Author###Senior Research Fellow###National Drug and Alcohol Research Centre###
Co-Author: Alys Havard, PhD (she/her/hers) – National Drug and Alcohol Research Centre
### she/her/hers
Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy: An Observational Database Study

Geetika Kalloo, PhD (she/her/hers) – Carelon Research ### 2325522###Presenting Author###Associate Research Director###Carelon Research###
Presenting Author: Geetika Kalloo, PhD (she/her/hers) – Carelon Research
### she/her/hers @@@ Maria Guzman – Carelon Research ### 2325523###Co-Author######Carelon Research###
Co-Author: Maria Guzman – Carelon Research
### @@@ Christopher L. Crowe – Carelon Research ### 2325524###Co-Author######Carelon Research###
Co-Author: Christopher L. Crowe – Carelon Research
### @@@ Stephan Lanes – Carelon Research ### 2325146###Co-Author######Carelon Research###
Co-Author: Stephan Lanes – Carelon Research
### @@@ Bahar C. Coley – Carelon Research ### 2325309###Co-Author######Carelon Research###
Co-Author: Bahar C. Coley – Carelon Research
### @@@ David Martin, MD, MPH – Moderna, Inc. ### 1360465###Co-Author###Vice President, Clinical Safety and Risk Management###Moderna, Inc.###
Co-Author: David Martin, MD, MPH – Moderna, Inc.
### @@@ Lei Zhu – Moderna, Inc. ### 1993192###Co-Author######Moderna, Inc.###
Co-Author: Lei Zhu – Moderna, Inc.
### @@@ Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc. ### 1655853###Co-Author###Director, Global Safety Epidemiologist###Moderna, Inc.###
Co-Author: Priyadarshani Dharia, PhD, MD, MPH (she/her/hers) – Moderna, Inc.
### she/her/hers @@@ Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc. ### 1655290###Co-Author###Sr. Director, Global Safety Epidemiologist###Moderna, Inc.###
Co-Author: Daina B. Esposito, MPH, PhD (she/her/hers) – Moderna, Inc.
### she/her/hers
Media Coverage of COVID-19 Vaccine Risks in Australia During 2021: Risk Communication During a Rapidly Evolving Situation

Ashleigh Hooimeyer – The University of Sydney ### 1655938###Presenting Author###PhD Candidate###The University of Sydney###
Presenting Author: Ashleigh Hooimeyer – The University of Sydney
### @@@ Eliza McEwin – The University of Sydney ### 1655937###Co-Author######The University of Sydney###
Co-Author: Eliza McEwin – The University of Sydney
### @@@ Annim Mohammad – The University of Sydney ### 1655940###Co-Author###Research Associate###The University of Sydney###
Co-Author: Annim Mohammad – The University of Sydney
### @@@ Zhicheng Wang, PhD – The University of Sydney ### 2325712###Co-Author######The University of Sydney###
Co-Author: Zhicheng Wang, PhD – The University of Sydney
### @@@ Kellia Chiu, PhD – University of Toronto ### 2325717###Co-Author######University of Toronto###
Co-Author: Kellia Chiu, PhD – University of Toronto
### @@@ Sally McDonald – The University of Sydney ### 2325718###Co-Author######The University of Sydney###
Co-Author: Sally McDonald – The University of Sydney
### @@@ Barbara Mintzes, PhD (she/her/hers) – The University of Sydney ### 1360156###Co-Author###Professor of Evidence-based Pharmaceutical Policy###The University of Sydney###
Co-Author: Barbara Mintzes, PhD (she/her/hers) – The University of Sydney
### she/her/hers
Medications to treat insomnia in children and adolescents (2016-2023) in France: a time series analysis of trends

Zaba Valtuille, MSc (she/her/hers) – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France ### 2325624###Co-Author###Biostatistician###Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France###
Co-Author: Zaba Valtuille, MSc (she/her/hers) – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France
### she/her/hers @@@ Eric Aquaviva, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325625###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Eric Aquaviva, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Vincent Trebossen, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325626###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Vincent Trebossen, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Naim Ouldali, MD, PhD – Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325628###Co-Author######Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Naim Ouldali, MD, PhD – Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Aurelie Bourmaud, MD, PhD – Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France ### 2325629###Co-Author######Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France###
Co-Author: Aurelie Bourmaud, MD, PhD – Clinical Epidemiology Unit, INSERM CIC1426, Robert Debré University Hospital, APHP.Nord, Paris Cité University- Paris, France
### @@@ Stephane Sclison – IQVIA – Consulting Services & Analytics Department ### 2325630###Co-Author######IQVIA – Consulting Services & Analytics Department###
Co-Author: Stephane Sclison – IQVIA – Consulting Services & Analytics Department
### @@@ Alexandre Gomez – IQVIA – Consulting Services & Analytics Department ### 2325631###Co-Author######IQVIA – Consulting Services & Analytics Department###
Co-Author: Alexandre Gomez – IQVIA – Consulting Services & Analytics Department
### @@@ Alexis Revet, MD, PhD – Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France ### 2325632###Co-Author######Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France###
Co-Author: Alexis Revet, MD, PhD – Department of Child and Adolescent Psychiatry, Toulouse University Hospital, Toulouse, France
### @@@ Hugo Peyre, MD, PhD – Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France ### 2325633###Co-Author######Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France###
Co-Author: Hugo Peyre, MD, PhD – Autism Reference Centre of Languedoc-Roussillon CRA-LR, Excellence Centre for Autism and Neurodevelopmental disorders CeAND, Montpellier University Hospital, MUSE University, France
### @@@ Richard Delorme, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France ### 2325634###Co-Author######Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France###
Co-Author: Richard Delorme, MD, PhD – Department of Child and Adolescent Psychiatry, Robert Debré University Hospital, APHP.Nord, Paris Cité University, Paris, France
### @@@ Florentia Kaguelidou, MD, PhD – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France ### 1093556###Presenting Author######Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France###
Presenting Author: Florentia Kaguelidou, MD, PhD – Center of Clinical Investigations, Inserm CIC1426, Robert Debré University Hospital, APHP.Nord, Paris, France
###
Mental Health: Treatment Comparative Effectiveness, Dose, Discontinuation, Use and Trends

Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA ### 1358831###Moderator###Assistant Professor###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA###
Moderator: Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA
### @@@ Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy ### 1358158###Moderator###Lecturer/Assistant Professor###UCL School of Pharmacy###
Moderator: Kenneth KC Man, PhD, CStat, FRSPH (he/him/his) – UCL School of Pharmacy
### he/him/his
Methodological advances in regulatory Real World Evidence generation systems: Perspectives from Sentinel and DARWIN-EU

Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Lead Speaker###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Lead Speaker: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration ### 1359919###Speaker###Deputy Super Office Director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration###
Speaker: Robert Ball, MD, MPH, ScM – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real-World Evidence###European Medicines Agency###
Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1046819###Speaker###Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Speaker: Sebastian Schneeweiss, MD, ScD (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### he/him/his @@@ Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol ### 1358413###Speaker###Assistant Professor###Erasmus MC and IDIAPJGol###
Speaker: Talita Duarte-Salles, PhD – Erasmus MC and IDIAPJGol
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Speaker###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Speaker: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his
Methodological guidance for real world evidence to assess the effects of deprescribing

Kaley N. Hayes, PharmD, PhD – Brown University ### 1062830###Lead Speaker###Assistant Professor###Brown University###
Lead Speaker: Kaley N. Hayes, PharmD, PhD – Brown University
### @@@ Joshua David Niznik, PharmD, PhD (he/him/his) – University of North Carolina ### 1655386###Speaker###Assistant Professor###University of North Carolina###
Speaker: Joshua David Niznik, PharmD, PhD (he/him/his) – University of North Carolina
### he/him/his @@@ Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA ### 1358307###Speaker###Professor###University of Kentucky, College of Pharmacy, Lexington, KY, USA###
Speaker: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA
### she/her/hers @@@ Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences ### 1658378###Speaker###Senior Lecturer###School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences###
Speaker: Frank Moriarty, MPharm PhD MPSI (he/him/his) – School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences
### he/him/his @@@ Clare M. Johnson-Applin, PharmD, MS (she/her/hers) – University of Kentucky College of Pharmacy ### 2325385###Speaker###PhD Student###University of Kentucky College of Pharmacy###
Speaker: Clare M. Johnson-Applin, PharmD, MS (she/her/hers) – University of Kentucky College of Pharmacy
### she/her/hers @@@ Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health ### 1302736###Speaker###Associate Professor###Brown University School of Public Health###
Speaker: Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health
### he/him/his
Methodology for Identifying Single-drug Involved Poisoning Deaths: Application to Gabapentin-involved Drug Poisoning Death Surveillance

Svetla Slavova, PhD – University of Kentucky ### 1359478###Presenting Author###Professor###University of Kentucky###
Presenting Author: Svetla Slavova, PhD – University of Kentucky
### @@@ Sarah Hargrove, M.S. – University of Kentucky ### 2330970###Co-Author###Program Manager of KY Drug Overdose Fatality Surveillance System###University of Kentucky###
Co-Author: Sarah Hargrove, M.S. – University of Kentucky
### @@@ Holly Hedegaard, MD, MSPH – Epidemiology Consulting, LLC ### 2330971###Co-Author###Medical Director###Epidemiology Consulting, LLC###
Co-Author: Holly Hedegaard, MD, MSPH – Epidemiology Consulting, LLC
### @@@ Douglas Oyler, PharmD – University of Kentucky ### 2330972###Co-Author###Assistant Professor###University of Kentucky###
Co-Author: Douglas Oyler, PharmD – University of Kentucky
### @@@ Bruce A. Goldberger, Ph.D. – University of Kentucky ### 2330973###Co-Author###Consultant###University of Kentucky###
Co-Author: Bruce A. Goldberger, Ph.D. – University of Kentucky
### @@@ Peter Akpunonu, MD – University of Kentucky ### 2330974###Co-Author###Associate Professor###University of Kentucky###
Co-Author: Peter Akpunonu, MD – University of Kentucky
### @@@ Krassimir Slavov, MS – University of Kentucky ### 2330975###Co-Author######University of Kentucky###
Co-Author: Krassimir Slavov, MS – University of Kentucky
### @@@ Nabarum Dasgupta, PhD – University of North Carolina ### 2330976###Co-Author######University of North Carolina###
Co-Author: Nabarum Dasgupta, PhD – University of North Carolina
### @@@ Dana Quesinberry, JD, DrPH – University of Kentucky, College of Public Health ### 2330977###Co-Author###Assistant Professor, Associate Director of Kentucky Injury Prevention and Research Center###University of Kentucky, College of Public Health###
Co-Author: Dana Quesinberry, JD, DrPH – University of Kentucky, College of Public Health
### @@@ Lara Daniels, MPH – KIPRC, University of Kentucky ### 2330978###Co-Author###Epidemiologist###KIPRC, University of Kentucky###
Co-Author: Lara Daniels, MPH – KIPRC, University of Kentucky
### @@@ William Ralston, MD – Kentucky State Medical Examiner's Office ### 2330979###Co-Author###Chief Medical Examiner###Kentucky State Medical Examiner's Office###
Co-Author: William Ralston, MD – Kentucky State Medical Examiner's Office
### @@@ Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy ### 1656010###Co-Author###Professor###University of Kentucky College of Pharmacy###
Co-Author: Patricia R. Freeman, RPh, PhD, FAPhA, FNAP – University of Kentucky College of Pharmacy
###
Methods and New Approaches in Pragmatic Trials

Priscilla Velentgas, PhD (she/her/hers) – Merck ### 2015422###Lead Speaker###Senior Director###Merck###
Lead Speaker: Priscilla Velentgas, PhD (she/her/hers) – Merck
### she/her/hers @@@ Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC ### 2328663###Speaker###Founder & CEO###CERobs Consulting, LLC###
Speaker: Cynthia J. Girman, DrPH, FISPE (she/her/hers) – CERobs Consulting, LLC
### she/her/hers @@@ Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine ### 2325327###Speaker###Principal Research Scientist###Harvard Pilgrim Health Care Institute, Dept. of Population Medicine###
Speaker: Noelle M. Cocoros, DSc, MPH – Harvard Pilgrim Health Care Institute, Dept. of Population Medicine
### @@@ Sebastian Weis ### 2455588###Speaker#########
Speaker: Sebastian Weis
###
Modern Pregnancy Pharmacoepidemiology: Methodological Challenges and Solutions in Study Design

Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain ### 1046827###Lead Speaker###Senior Director###RTI Health Solutions, Barcelona, Spain###
Lead Speaker: Andrea V. Margulis, MD, ScD, FISPE – RTI Health Solutions, Barcelona, Spain
### @@@ Brian T. Bateman, MD, MSc – Stanford University ### 1088175###Speaker######Stanford University###
Speaker: Brian T. Bateman, MD, MSc – Stanford University
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Speaker###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Speaker: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Speaker###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Speaker: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1360167###Speaker###Deputy Director for Safety###Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Speaker: Leyla Sahin, MD – Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
###
Mood Meds Mix: A Balancing Act

Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1093628###Moderator###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Moderator: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal ### 1359276###Moderator###Assistant Professor###Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal###
Moderator: Carla Torre, PharmD, MSc, PhD – Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisbon, Portugal
###
Move Over, PS!

Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Moderator###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Moderator: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ G. Niklas Norén, PhD – Uppsala Monitoring Centre ### 2329935###Moderator###Chief Science Officer###Uppsala Monitoring Centre###
Moderator: G. Niklas Norén, PhD – Uppsala Monitoring Centre
###
Multitrajectories of polypharmacy composition patterns and their impacts on clinical outcomes among older people: a longitudinal cohort study

Liang-Yi Lin, MS (she/her/hers) – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan ### 2325291###Presenting Author###Research assistance###Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan###
Presenting Author: Liang-Yi Lin, MS (she/her/hers) – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
### she/her/hers @@@ Shih-Tsung Huang, PharmD, PhD – Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan ### 1093541###Co-Author###Project Assistant Professor###Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan###
Co-Author: Shih-Tsung Huang, PharmD, PhD – Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan
### @@@ Liang-Kung Chen, MD,PhD – Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan ### 1358740###Co-Author######Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan###
Co-Author: Liang-Kung Chen, MD,PhD – Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan
### @@@ Fei-Yuan Hsiao, PhD – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan ### 1358452###Co-Author######Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan###
Co-Author: Fei-Yuan Hsiao, PhD – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
###
N
National Trends in Benzodiazepine Prescribing by Provider Type in Children and Adults, 2013-2022

Naomi Cruz (she/her/hers) – Rutgers School of Public Health ### 2325132###Presenting Author###PhD Candidate###Rutgers School of Public Health###
Presenting Author: Naomi Cruz (she/her/hers) – Rutgers School of Public Health
### she/her/hers @@@ Hillary Samples – Center for Pharmacoepidemiology and Treatment Science, Rutgers University ### 2325133###Co-Author######Center for Pharmacoepidemiology and Treatment Science, Rutgers University###
Co-Author: Hillary Samples – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
### @@@ Stephen Crystal, Ph.D. – Center for Health Services Research, Rutgers University ### 1358692###Co-Author###Board of Governors Professor###Center for Health Services Research, Rutgers University###
Co-Author: Stephen Crystal, Ph.D. – Center for Health Services Research, Rutgers University
### @@@ Fangzhou Xie – Rutgers University ### 2325134###Co-Author######Rutgers University###
Co-Author: Fangzhou Xie – Rutgers University
### @@@ Mark Olfson – New York State Psychiatric Institute, Columbia University ### 1358690###Co-Author######New York State Psychiatric Institute, Columbia University###
Co-Author: Mark Olfson – New York State Psychiatric Institute, Columbia University
### @@@ Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA ### 1358831###Co-Author###Assistant Professor###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA###
Co-Author: Greta A. Bushnell, PhD, MSPH – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy, and Aging Research, Rutgers University, New Brunswick, NJ, USA
###
Natural Language Processing in Pharmacoepidemiology: Lessons from the Multi-source Observational Safety study for Advanced Information Classification using NLP (MOSAIC-NLP)

Dena H. Jaffe, MSc PhD (she/her/hers) – Oracle Health ### 2364850###Presenting Author###Real-World Data Strategist###Oracle Health###
Presenting Author: Dena H. Jaffe, MSc PhD (she/her/hers) – Oracle Health
### she/her/hers @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Elise Berliner – Oracle ### 2364852###Co-Author######Oracle###
Co-Author: Elise Berliner – Oracle
### @@@ Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration ### 2326839###Co-Author###Lead Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration###
Co-Author: Sarah K. Dutcher, PhD, MS – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
###
Navigating the Cancer Landscape Using Innovative Pharmacoepidemiologic Methods

Oluwadamilola Onasanya, MD, MPH, PhD Candidate – University of Maryland, Baltimore/Carelon Research ### 1659417###Moderator###PhD Candidate/Senior Researcher, Safety and Epidemiology###University of Maryland, Baltimore/Carelon Research###
Moderator: Oluwadamilola Onasanya, MD, MPH, PhD Candidate – University of Maryland, Baltimore/Carelon Research
### @@@ Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland ### 1093536###Moderator###Senior Lecturer###Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland###
Moderator: Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland
###
New Frontiers For Pharmacoepidemiology: Cutting Edge Approaches to Data Collection and Integration

Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC ### 1046833###Lead Speaker###Chief Scientific Officer, IQVIA Real-World Solutions, Retired###Dreyer Strategies LLC###
Lead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
### she/her/hers @@@ Mackenzie Herzog, PhD, MPH – IQVIA ### 2330847###Speaker###Director, Epidemiology###IQVIA###
Speaker: Mackenzie Herzog, PhD, MPH – IQVIA
### @@@ William G. Dixon, MD PhD – University of Manchester ### 1062521###Speaker###Professor of Digital Epidemiology###University of Manchester###
Speaker: William G. Dixon, MD PhD – University of Manchester
### @@@ Kristen A. Hahn, MPH, PhD (she/her/hers) – PicnicHealth ### 1721252###Speaker###Head of RWE Research###PicnicHealth###
Speaker: Kristen A. Hahn, MPH, PhD (she/her/hers) – PicnicHealth
### she/her/hers
New Member & Early-Stage Investigator Lunch
Novel Individualized Therapeutics: Challenges and Opportunities for the Use of Real-World Evidence in Rare Diseases

Timothy Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital ### 2325125###Lead Speaker###Instructor in Medicine###Brigham and Women's Hospital###
Lead Speaker: Timothy Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital
### he/him/his @@@ Julien E. Heidt, MS – IQVIA ### 2325212###Speaker###Senior Consultant Epidemiologist, Regulatory Science and Study Innovation###IQVIA###
Speaker: Julien E. Heidt, MS – IQVIA
### @@@ Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA ### 1062564###Speaker###Associate Director RWE###Office of Surveillance and Epidemiology, CDER, US FDA###
Speaker: Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA
### she/her/hers @@@ Daniel Rosenberg, PhD – Johnson & Johnson ### 1993532###Speaker###Cross-Therapy Area Leader, Global Epidemiology###Johnson & Johnson###
Speaker: Daniel Rosenberg, PhD – Johnson & Johnson
### @@@ Tara MacCannell, PhD MSc – Vertex Pharmaceuticals ### 2325213###Speaker###Global Head of RWE, Executive Director###Vertex Pharmaceuticals###
Speaker: Tara MacCannell, PhD MSc – Vertex Pharmaceuticals
### @@@ Delphine Saragoussi, MD, MScPH – Evidera, a business unit of PPD, part of Thermo Fisher Scientific ### 1359687###Speaker###Executive DIrector Epidemiology and Scientific Affairs###Evidera, a business unit of PPD, part of Thermo Fisher Scientific###
Speaker: Delphine Saragoussi, MD, MScPH – Evidera, a business unit of PPD, part of Thermo Fisher Scientific
###
O
OM1 - Noise vs. Value: Novel Approaches to Addressing Data Gaps in Real-World Data Sources
On Optimizing Outcomes for Older Adults

Catherine Rogers Murray, MPH (she/her/hers) – Exponent, Inc. ### 1658596###Moderator###Managing Scientist###Exponent, Inc.###
Moderator: Catherine Rogers Murray, MPH (she/her/hers) – Exponent, Inc.
### she/her/hers @@@ Emilie D. Duchesneau, PhD, MSPH (she/her/hers) – Department of Epidemiology and Prevention, Wake Forest School of Medicine ### 2325307###Moderator###Assistant Professor###Department of Epidemiology and Prevention, Wake Forest School of Medicine###
Moderator: Emilie D. Duchesneau, PhD, MSPH (she/her/hers) – Department of Epidemiology and Prevention, Wake Forest School of Medicine
### she/her/hers
Opioid Odyssey

Tanja Mueller, PhD, MPH, FHEA (she/her/hers) – University of Strathclyde ### 1723573###Moderator###Lecturer###University of Strathclyde###
Moderator: Tanja Mueller, PhD, MPH, FHEA (she/her/hers) – University of Strathclyde
### she/her/hers @@@ Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1655344###Moderator###Assistant Professor###University of North Carolina at Chapel Hill###
Moderator: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his
Oracle Life Sciences + ZEG Berlin - How the Use of Retrospective Real-World Data [Claims and HER] Can Identify Potential Safety Events
Oracle Life Sciences + ZEG Berlin - How the Use of Retrospective Real-World Data [Claims and HER] Can Identify Potential Safety Events
Orchestrating the Data Symphony: Harmoniously Combining Diverse Datasets in External Control Arm Studies in Oncology

Olivier Humblet, ScD (he/him/his) – Regeneron Pharmaceuticals ### 2325381###Lead Speaker###Director###Regeneron Pharmaceuticals###
Lead Speaker: Olivier Humblet, ScD (he/him/his) – Regeneron Pharmaceuticals
### he/him/his @@@ Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc. ### 1093999###Speaker###Chief Science Officer###Aetion, Inc.###
Speaker: Nicolle M. Gatto, PhD, MPH (she/her/hers) – Aetion, Inc.
### she/her/hers @@@ Patrice Verpillat, MD, MPH, PhD – European Medicines Agency ### 1409656###Speaker###Head of Real-World Evidence###European Medicines Agency###
Speaker: Patrice Verpillat, MD, MPH, PhD – European Medicines Agency
### @@@ Uwe Siebert, MPH, MSc, ScD (he/him/his) – UMIT TIROL - University for Health Sciences and Technology ### 2325382###Speaker###Chair, Dept. of Public Health, Health Services Research and Health Technology Assessment###UMIT TIROL - University for Health Sciences and Technology###
Speaker: Uwe Siebert, MPH, MSc, ScD (he/him/his) – UMIT TIROL - University for Health Sciences and Technology
### he/him/his @@@ Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals ### 1360408###Speaker###Sr. Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Speaker: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals
### he/him/his
Oseltamivir and Risk of Serious Neuropsychiatric Events

James W. Antoon, MD, PhD, MPH – Vanderbilt University Medical Center ### 1655239###Presenting Author###Assistant Professor of Pediatrics###Vanderbilt University Medical Center###
Presenting Author: James W. Antoon, MD, PhD, MPH – Vanderbilt University Medical Center
### @@@ Derek J. williams, MD, MPH – Vanderbilt University Medical Center ### 1658421###Co-Author###Associate Professor###Vanderbilt University Medical Center###
Co-Author: Derek J. williams, MD, MPH – Vanderbilt University Medical Center
### @@@ Jean Bruce – Department of Health Policy, Vanderbilt University Medical Center ### 1993063###Co-Author###Database Administrator###Department of Health Policy, Vanderbilt University Medical Center###
Co-Author: Jean Bruce – Department of Health Policy, Vanderbilt University Medical Center
### @@@ Mert Sekmen – VUMC Division of Pediatric Hospital Medicine ### 1993064###Co-Author######VUMC Division of Pediatric Hospital Medicine###
Co-Author: Mert Sekmen – VUMC Division of Pediatric Hospital Medicine
### @@@ Yuwei Zhu, MD, MS – Vanderbilt University Medical Center ### 1993065###Co-Author###Senior Associate in Biostatistics###Vanderbilt University Medical Center###
Co-Author: Yuwei Zhu, MD, MS – Vanderbilt University Medical Center
### @@@ Carlos G. Grijalva, MD MPH FIDSA – Department of Health Policy, Vanderbilt University Medical Center ### 1063183###Co-Author###Professor, Health Policy###Department of Health Policy, Vanderbilt University Medical Center###
Co-Author: Carlos G. Grijalva, MD MPH FIDSA – Department of Health Policy, Vanderbilt University Medical Center
###
P
Parameterization of beta distributions for bias parameters of binary exposure misclassification in probabilistic bias analysis

Qi Zhang, MSPH (she/her/hers) – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA ### 2325128###Presenting Author###PhD candidate###Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA###
Presenting Author: Qi Zhang, MSPH (she/her/hers) – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA
### she/her/hers @@@ Richard F. MacLehose – Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN ### 1659935###Co-Author######Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN###
Co-Author: Richard F. MacLehose – Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN
### @@@ Lindsay J. Collin – Department of Population Health Sciences, Huntsman Cancer Institute University of Utah, Salt Lake City, UT ### 1360139###Co-Author######Department of Population Health Sciences, Huntsman Cancer Institute University of Utah, Salt Lake City, UT###
Co-Author: Lindsay J. Collin – Department of Population Health Sciences, Huntsman Cancer Institute University of Utah, Salt Lake City, UT
### @@@ Thomas P. Ahern – Departments of Surgery of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT ### 1655809###Co-Author######Departments of Surgery of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT###
Co-Author: Thomas P. Ahern – Departments of Surgery of Biochemistry, Larner College of Medicine, University of Vermont, Burlington, VT
### @@@ Timothy L. Lash, DSc – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA ### 1358745###Co-Author###Professor and Chair###Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA###
Co-Author: Timothy L. Lash, DSc – Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA
###
Partitioning Variation in Prescribing of Statins as a Percentage of Total Prescribed Medications for the Cardiovascular System: A Spatiotemporal Ecologic Study in England (2015-2019)

Nicholas Bakewell, MSc (he/him/his) – Institute of Health Policy, Management and Evaluation ### 1992486###Presenting Author###PhD Student###Institute of Health Policy, Management and Evaluation###
Presenting Author: Nicholas Bakewell, MSc (he/him/his) – Institute of Health Policy, Management and Evaluation
### he/him/his
Pattern and Barriers of Benzodiazepine Discontinuation Among Older Adults Following Hospitalization

Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325401###Presenting Author###Research fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Presenting Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ James Wilkins – McLean Hospital ### 2325404###Co-Author######McLean Hospital###
Co-Author: James Wilkins – McLean Hospital
### @@@ Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital ### 2325379###Co-Author###Research Fellow###Brigham and Women's Hospital###
Co-Author: Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital
### @@@ Qiaoxi Chen, phD – Brigham and Women's Hospital ### 2325400###Co-Author###Postdoctoral Research Fellow###Brigham and Women's Hospital###
Co-Author: Qiaoxi Chen, phD – Brigham and Women's Hospital
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###
Pattern of use of biological drugs in pediatric patients with immune-mediated inflammatory diseases through the Italian VALORE distributed database network

Chiara Bellitto, MS (she/her/hers) – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330032###Presenting Author###Post-graduate student###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Presenting Author: Chiara Bellitto, MS (she/her/hers) – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### she/her/hers @@@ Federica Soardo – University of Verona, Verona ### 2330992###Co-Author######University of Verona, Verona###
Co-Author: Federica Soardo – University of Verona, Verona
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Co-Author###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###
Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330030###Co-Author###Post-doc fellowship###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330034###Co-Author######Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Clèment Mathieu – University of Verona, Verona ### 2330199###Co-Author######University of Verona, Verona###
Co-Author: Clèment Mathieu – University of Verona, Verona
### @@@ Massimo Carollo – University of Verona, Verona ### 2330200###Co-Author######University of Verona, Verona###
Co-Author: Massimo Carollo – University of Verona, Verona
### @@@ Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330031###Co-Author###Researcher###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy ### 2330035###Co-Author######Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy###
Co-Author: Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy
### @@@ Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy ### 2330036###Co-Author######Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy###
Co-Author: Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy
### @@@ Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia ### 2330037###Co-Author######Centro Regionale Farmacovigilanza Regione Puglia###
Co-Author: Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia
### @@@ Paolo Stella – Apulian Regional Health Department, Bari, Italy ### 2330038###Co-Author######Apulian Regional Health Department, Bari, Italy###
Co-Author: Paolo Stella – Apulian Regional Health Department, Bari, Italy
### @@@ Anna Cavazzana – Azienda Zero, Regione Veneto, Italy ### 2330039###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Anna Cavazzana – Azienda Zero, Regione Veneto, Italy
### @@@ Angela Scapin – Azienda Zero, Regione Veneto, Italy ### 2330040###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Angela Scapin – Azienda Zero, Regione Veneto, Italy
### @@@ Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy ### 2330041###Co-Author######Department of Epidemiology, Lazio Regional Health Service, Rome, Italy###
Co-Author: Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy
### @@@ Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service ### 2329370###Co-Author######Department of Epidemiology ASL Roma 1, Lazio Regional Health Service###
Co-Author: Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service
### @@@ Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330042###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330043###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330044###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330045###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330046###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330047###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Rita Francesca Scarpelli – Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy ### 2330201###Co-Author######Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy###
Co-Author: Rita Francesca Scarpelli – Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy
### @@@ Giovambattista De Sarro – University “Magna Graciae” of Catanzaro, Catanzaro, Italy ### 2330202###Co-Author######University “Magna Graciae” of Catanzaro, Catanzaro, Italy###
Co-Author: Giovambattista De Sarro – University “Magna Graciae” of Catanzaro, Catanzaro, Italy
### @@@ Marco Tuccori, PharmD, PhD – Unit of Adverse Drug Reactions Monitoring. University Hospital of Pisa; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy ### 2327640###Co-Author######Unit of Adverse Drug Reactions Monitoring. University Hospital of Pisa; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy###
Co-Author: Marco Tuccori, PharmD, PhD – Unit of Adverse Drug Reactions Monitoring. University Hospital of Pisa; Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Co-Author###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Co-Author: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Giorgio Costa – APSS Trento ### 2330198###Co-Author######APSS Trento###
Co-Author: Giorgio Costa – APSS Trento
### @@@ Silvana Anna Maria Urru – APSS Trento ### 2330210###Co-Author######APSS Trento###
Co-Author: Silvana Anna Maria Urru – APSS Trento
### @@@ Annalisa Campomori – APSS Trento ### 2330211###Co-Author######APSS Trento###
Co-Author: Annalisa Campomori – APSS Trento
### @@@ Stefania Spila Alegiani – Italian National Institute of Health ### 2329364###Co-Author######Italian National Institute of Health###
Co-Author: Stefania Spila Alegiani – Italian National Institute of Health
### @@@ Marco Massari – Italian National Institute of Health ### 2329371###Co-Author######Italian National Institute of Health###
Co-Author: Marco Massari – Italian National Institute of Health
### @@@ Alessandra Allotta – Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy ### 2330203###Co-Author######Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy###
Co-Author: Alessandra Allotta – Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy
### @@@ Sebastiano Addario Pollina – Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy ### 2330204###Co-Author######Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy###
Co-Author: Sebastiano Addario Pollina – Epidemiologic Observatory of the Sicily Regional Health Service, Palermo, Italy
### @@@ Roberto Da Cas – Italian National Institute of Health ### 2329368###Co-Author######Italian National Institute of Health###
Co-Author: Roberto Da Cas – Italian National Institute of Health
### @@@ Giampaolo Bucaneve – Umbria Regional Centre of Pharmacovigilance, Perugia, Italy ### 2330205###Co-Author######Umbria Regional Centre of Pharmacovigilance, Perugia, Italy###
Co-Author: Giampaolo Bucaneve – Umbria Regional Centre of Pharmacovigilance, Perugia, Italy
### @@@ Antea Maria Pia Mangano – Agenzia regionale sanitaria della regione Marche, Ancona, Italy ### 2330206###Co-Author######Agenzia regionale sanitaria della regione Marche, Ancona, Italy###
Co-Author: Antea Maria Pia Mangano – Agenzia regionale sanitaria della regione Marche, Ancona, Italy
### @@@ Francesco Balducci – Agenzia regionale sanitaria della regione Marche, Ancona, Italy ### 2330207###Co-Author######Agenzia regionale sanitaria della regione Marche, Ancona, Italy###
Co-Author: Francesco Balducci – Agenzia regionale sanitaria della regione Marche, Ancona, Italy
### @@@ Carla Sorrentino – Ufficio Monitoraggio Spesa Farmaci e Dispositivi Medici, Regione Abruzzo, Pescara, Italy ### 2330208###Co-Author######Ufficio Monitoraggio Spesa Farmaci e Dispositivi Medici, Regione Abruzzo, Pescara, Italy###
Co-Author: Carla Sorrentino – Ufficio Monitoraggio Spesa Farmaci e Dispositivi Medici, Regione Abruzzo, Pescara, Italy
### @@@ Ilenia Senesi – Abruzzo Regional Centre of Pharmacovigilance, Perugia, Italy ### 2330209###Co-Author######Abruzzo Regional Centre of Pharmacovigilance, Perugia, Italy###
Co-Author: Ilenia Senesi – Abruzzo Regional Centre of Pharmacovigilance, Perugia, Italy
### @@@ Gianluca Trifirò, MD, FISPE – Università di Verona ### 1302766###Co-Author###Full Professor of Pharmacology###Università di Verona###
Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona
###
Patterns of fall-risk increasing drugs (FRIDs) use and associations with falls in residential aged care: A group-based multi-trajectory analysis of an 8-year longitudinal cohort study

Nasir Wabe – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University ### 2325447###Presenting Author###Senior Research Fellow ###Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University###
Presenting Author: Nasir Wabe – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University
### @@@ Guogui Huang – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University ### 2325448###Co-Author######Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University###
Co-Author: Guogui Huang – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University
### @@@ Sandun Silva – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University ### 2325449###Co-Author######Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University###
Co-Author: Sandun Silva – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University
### @@@ Amy Nguyen – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University AND St Vincent’s Clinical School, University of New South Wales Medicine, UNSW Sydney, Sydney, Australia ### 2325450###Co-Author######Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University AND St Vincent’s Clinical School, University of New South Wales Medicine, UNSW Sydney, Sydney, Australia###
Co-Author: Amy Nguyen – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University AND St Vincent’s Clinical School, University of New South Wales Medicine, UNSW Sydney, Sydney, Australia
### @@@ Karla Seaman – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University ### 2325451###Co-Author######Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University###
Co-Author: Karla Seaman – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University
### @@@ Magdalena Z. Raban, BPharm, MIPH, PhD (she/her/hers) – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University ### 2325452###Co-Author###Associate Professor###Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University###
Co-Author: Magdalena Z. Raban, BPharm, MIPH, PhD (she/her/hers) – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University
### she/her/hers @@@ Peter Gates – National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia ### 2325453###Co-Author######National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia###
Co-Author: Peter Gates – National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
### @@@ Richard Day – St Vincent’s Clinical School, University of New South Wales Medicine, UNSW Sydney, Sydney, Australia ### 2325454###Co-Author######St Vincent’s Clinical School, University of New South Wales Medicine, UNSW Sydney, Sydney, Australia###
Co-Author: Richard Day – St Vincent’s Clinical School, University of New South Wales Medicine, UNSW Sydney, Sydney, Australia
### @@@ Jacqueline Close – Neuroscience Research Australia, UNSW Sydney, Sydney, Australia AND School of Clinical Medicine, UNSW Sydney, Sydney, Australia ### 2325455###Co-Author######Neuroscience Research Australia, UNSW Sydney, Sydney, Australia AND School of Clinical Medicine, UNSW Sydney, Sydney, Australia###
Co-Author: Jacqueline Close – Neuroscience Research Australia, UNSW Sydney, Sydney, Australia AND School of Clinical Medicine, UNSW Sydney, Sydney, Australia
### @@@ Stephen Lord – Neuroscience Research Australia, UNSW Sydney, Sydney, Australia AND School of Population Health, UNSW Sydney, Sydney, Australia ### 2325456###Co-Author######Neuroscience Research Australia, UNSW Sydney, Sydney, Australia AND School of Population Health, UNSW Sydney, Sydney, Australia###
Co-Author: Stephen Lord – Neuroscience Research Australia, UNSW Sydney, Sydney, Australia AND School of Population Health, UNSW Sydney, Sydney, Australia
### @@@ Johanna Westbrook – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University ### 2325457###Co-Author######Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University###
Co-Author: Johanna Westbrook – Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Macquarie University
###
Patterns of Symptomatic Therapies Utilized in Alzheimer's Disease and Related Dementias

Huiwen Deng, PharmD, MPH (she/her/hers) – Department of Pharmacy, Systems, Outcomes, and Policy, College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA ### 1658078###Presenting Author###PhD Candidate###Department of Pharmacy, Systems, Outcomes, and Policy, College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA ###
Presenting Author: Huiwen Deng, PharmD, MPH (she/her/hers) – Department of Pharmacy, Systems, Outcomes, and Policy, College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA
### she/her/hers @@@ Todd A. Lee, PharmD, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago ### 1657993###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago###
Co-Author: Todd A. Lee, PharmD, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago
### @@@ Charles E. Gaber, PhD, MPH (he/him/his) – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA ### 2325462###Co-Author###Assistant Professor###Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA###
Co-Author: Charles E. Gaber, PhD, MPH (he/him/his) – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA
### he/him/his @@@ Kibum Kim, BPharm, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago ### 2325463###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago###
Co-Author: Kibum Kim, BPharm, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago
### @@@ Stephanie Y. Crawford, PhD, MPH – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA ### 2325464###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA###
Co-Author: Stephanie Y. Crawford, PhD, MPH – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USA
### @@@ Elizabeth A. Bayliss, MD, MSPH – Institute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO, USA; Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO, USA ### 1360509###Co-Author###Senior Scientific Investigator###Institute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO, USA; Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO, USA###
Co-Author: Elizabeth A. Bayliss, MD, MSPH – Institute for Health Research, Kaiser Permanente Colorado, Central Support Services, 16601 East Centretech Parkway, Aurora, CO, USA; Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO, USA
### @@@ Sonal Singh, MD, MPH, FACP – Department of Family Medicine and Community Health, UMass Chan Medical School, Worcester MA, USA ### 1093621###Co-Author###Associate Professor###Department of Family Medicine and Community Health, UMass Chan Medical School, Worcester MA, USA###
Co-Author: Sonal Singh, MD, MPH, FACP – Department of Family Medicine and Community Health, UMass Chan Medical School, Worcester MA, USA
### @@@ Jessica Gerald Young, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 2325465###Co-Author######Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA###
Co-Author: Jessica Gerald Young, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
### @@@ Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA ### 2325127###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA###
Co-Author: Darren Toh, ScD – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA
### @@@ Xiaojuan Li, PhD, MSPH (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 1655388###Co-Author###Assistant Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA###
Co-Author: Xiaojuan Li, PhD, MSPH (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA
### she/her/hers
PDS Editorial Board
Pediatric Pharmacoepi: Drugs and Bugs Among Us!

Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Moderator###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Moderator: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers @@@ Timothy Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital ### 2325125###Moderator###Instructor in Medicine###Brigham and Women's Hospital###
Moderator: Timothy Savage, MD, MPH, MSc (he/him/his) – Brigham and Women's Hospital
### he/him/his
Pediatric Pharmacoepidemiology

Jenny Sun, PhD – Pfizer, Inc. ### 1657990###Lead Speaker###Epidemiologist, Safety Surveillance Research###Pfizer, Inc.###
Lead Speaker: Jenny Sun, PhD – Pfizer, Inc.
### @@@ Daniel B. Horton, MD, MSCE (he/him/his) – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1063295###Speaker###Associate Professor of Pediatrics and Epidemiology###Rutgers Center for Pharmacoepidemiology and Treatment Science###
Speaker: Daniel B. Horton, MD, MSCE (he/him/his) – Rutgers Center for Pharmacoepidemiology and Treatment Science
### he/him/his @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Speaker###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###
Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Jonathan L. Slaughter, MD, MPH – Nationwide Children's Hospital and The Ohio State University ### 1062665###Speaker###Professor###Nationwide Children's Hospital and The Ohio State University###
Speaker: Jonathan L. Slaughter, MD, MPH – Nationwide Children's Hospital and The Ohio State University
###
Performance of Entropy Balancing & Covariate Balancing Propensity Score Methods for Controlling Confounding under Challenging Real-World Conditions in Observational Studies: Simulation Study in the CorEvitas Psoriasis Registry

Michael Singleton, PhD – CorEvitas, part of Thermo Fisher Scientific ### 2325428###Presenting Author###Lead Biostatistician###CorEvitas, part of Thermo Fisher Scientific###
Presenting Author: Michael Singleton, PhD – CorEvitas, part of Thermo Fisher Scientific
### @@@ Oksana Pugach, PhD – CorEvitas, LLC ### 1655418###Co-Author###Associate Director Query Coordination in Biostatistics###CorEvitas, LLC###
Co-Author: Oksana Pugach, PhD – CorEvitas, LLC
### @@@ Melissa Eliot, PhD – CorEvitas, LLC ### 2325429###Co-Author######CorEvitas, LLC###
Co-Author: Melissa Eliot, PhD – CorEvitas, LLC
### @@@ Robert R. McLean, DSc, MPH – CorEvitas, LLC ### 2325430###Co-Author######CorEvitas, LLC###
Co-Author: Robert R. McLean, DSc, MPH – CorEvitas, LLC
### @@@ Adam Sima, PhD – CorEvitas, LLC ### 2325431###Co-Author######CorEvitas, LLC###
Co-Author: Adam Sima, PhD – CorEvitas, LLC
### @@@ Heather J. Litman, PhD – CorEvitas, LLC ### 1655423###Co-Author###Vice President of Biostatistics###CorEvitas, LLC###
Co-Author: Heather J. Litman, PhD – CorEvitas, LLC
###
Performance of the Self-Controlled Case Series with active comparators for signal detection in the Clinical Practice Research Datalink (CPRD): a case study on antibiotics

Astrid Coste, MSc – London School of Hygiene and Tropical Medicine ### 1659277###Presenting Author###PhD Student###London School of Hygiene and Tropical Medicine###
Presenting Author: Astrid Coste, MSc – London School of Hygiene and Tropical Medicine
### @@@ Angel Wong – London School of Hygiene and Tropical Medicine ### 1062549###Co-Author###BSc PhD###London School of Hygiene and Tropical Medicine###
Co-Author: Angel Wong – London School of Hygiene and Tropical Medicine
### @@@ François Haguinet, MS – GSK ### 1062964###Co-Author###Associate Director, Safety and Quantitative Innovation###GSK###
Co-Author: François Haguinet, MS – GSK
### @@@ Andrew Bate, PhD – GSK ### 1088314###Co-Author###VP & Head, Safety Innovation & Analytics, Global Safety###GSK###
Co-Author: Andrew Bate, PhD – GSK
### @@@ Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine###
Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine
###
Periconceptional Oral Contraceptive Use and the Risk of Spontaneous Abortion: Results From the PRIDE Study.

Michael Ceulemans, PharmD, PhD – Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium ### 2326115###Co-Author######Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium###
Co-Author: Michael Ceulemans, PharmD, PhD – Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
### @@@ Lieve Tuitjer – IQ Health, Radboud university medical center, the Netherlands ### 2327687###Co-Author######IQ Health, Radboud university medical center, the Netherlands###
Co-Author: Lieve Tuitjer – IQ Health, Radboud university medical center, the Netherlands
### @@@ Nel Roeleveld – IQ Health, Radboud university medical center, the Netherlands ### 2327688###Co-Author######IQ Health, Radboud university medical center, the Netherlands###
Co-Author: Nel Roeleveld – IQ Health, Radboud university medical center, the Netherlands
### @@@ Marc Spaanderman – Department of Obstetrics & Gynecology, Radboud university medical center, the Netherlands ### 2327689###Co-Author######Department of Obstetrics & Gynecology, Radboud university medical center, the Netherlands###
Co-Author: Marc Spaanderman – Department of Obstetrics & Gynecology, Radboud university medical center, the Netherlands
### @@@ Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway ### 1062980###Presenting Author###Assistant Professor in Pharmacoepidemiology###Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway###
Presenting Author: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
###
Pharmacoepidemiologic Approaches to Studying Drug-Drug Interactions

Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Lead Speaker###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Todd A. Miano, PharmD, PhD – University of Pennsylvania ### 1357966###Speaker###Assistant Professor of Epidemiology###University of Pennsylvania###
Speaker: Todd A. Miano, PharmD, PhD – University of Pennsylvania
### @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany ### 2328243###Speaker###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany###
Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany
### he/him/his
Pharmacogenetic CYP2D6 variability, phenoconversion and treatment outcomes: A Danish population-based cohort study of 6,798 individuals initiating atomoxetine treatment

Christiane Gasse, PhD, Dip Epid (McGill) – Aarhus University Hospital Psychiatry ### 1063206###Presenting Author###Associate professor###Aarhus University Hospital Psychiatry###
Presenting Author: Christiane Gasse, PhD, Dip Epid (McGill) – Aarhus University Hospital Psychiatry
### @@@ Kazi Ishtiak-Ahmed – Department of Affective Disorders, Aarhus University Hospital Psychiatry, Aarhus, Denmark ### 1063090###Co-Author###Research Statistics (Postdoc researcher)###Department of Affective Disorders, Aarhus University Hospital Psychiatry, Aarhus, Denmark###
Co-Author: Kazi Ishtiak-Ahmed – Department of Affective Disorders, Aarhus University Hospital Psychiatry, Aarhus, Denmark
### @@@ Janne Pia Thistrup – Aarhus University ### 2325680###Co-Author######Aarhus University###
Co-Author: Janne Pia Thistrup – Aarhus University
### @@@ Loa Clausen – Aarhus University Hospital ### 2325681###Co-Author######Aarhus University Hospital###
Co-Author: Loa Clausen – Aarhus University Hospital
### @@@ Per Hove Thomsen – Aarhus University Hospital Psychiatry ### 2325682###Co-Author######Aarhus University Hospital Psychiatry###
Co-Author: Per Hove Thomsen – Aarhus University Hospital Psychiatry
###
Pharmacogenomics, Precision Medicine and Oncology

Amalia M. Issa, PhD, MPH, FISPE ### 1046825###Lead Speaker#########
Lead Speaker: Amalia M. Issa, PhD, MPH, FISPE
### @@@ Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine ### 1086987###Lead Speaker###Associate Dean###University of Missouri School of Medicine###
Lead Speaker: Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine
### @@@ Geoffrey Liu, MSc, MD (he/him/his) – Princess Margaret Cancer Centre, University Health Network, Toronto, Canada ### 1088039###Speaker###Professor###Princess Margaret Cancer Centre, University Health Network, Toronto, Canada###
Speaker: Geoffrey Liu, MSc, MD (he/him/his) – Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
### he/him/his
Pharmacovigilance and Signal Detection

Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Lead Speaker###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Lead Speaker: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Monica A. Muñoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 2326354###Lead Speaker###Division Director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration###
Lead Speaker: Monica A. Muñoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### she/her/hers @@@ G. Niklas Norén, PhD – Uppsala Monitoring Centre ### 2329935###Speaker###Chief Science Officer###Uppsala Monitoring Centre###
Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre
### @@@ Jens-Ulrich Stegmann ### 2344879###Speaker#########
Speaker: Jens-Ulrich Stegmann
###
Phosphodiesterase-5 inhibition and Alzheimer disease risk: A Mendelian randomization study

Marta Alcalde Herraiz – University of Oxford ### 1991479###Presenting Author###Research Assistant in Health Data Sciences and Pharmacogenomics###University of Oxford###
Presenting Author: Marta Alcalde Herraiz – University of Oxford
### @@@ Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford ### 1358612###Co-Author###Postdoctoral Researcher###University of Oxford###
Co-Author: Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford
### he/him/his @@@ Benjamin Woolf – University of Bristol ### 2325392###Co-Author######University of Bristol###
Co-Author: Benjamin Woolf – University of Bristol
### @@@ James Yarmolinsky – University of Bristol ### 2325393###Co-Author######University of Bristol###
Co-Author: James Yarmolinsky – University of Bristol
### @@@ Ioanna Tzoulaki – Imperial College London ### 2325394###Co-Author######Imperial College London###
Co-Author: Ioanna Tzoulaki – Imperial College London
### @@@ Dipender Gill – Imperial College London ### 1655602###Co-Author######Imperial College London###
Co-Author: Dipender Gill – Imperial College London
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Co-Author###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Danielle Newby, PhD – University of Oxford ### 1991362###Co-Author###Senior Postdoctoral Researcher in Real World Evidence###University of Oxford###
Co-Author: Danielle Newby, PhD – University of Oxford
###
Role of Real World Data for Regulatory Science when Randomized Clinical Trials are Not ‎Feasible: Lessons Learned from Perinatal Pharmacoepidemiology

Sandra Lopez Leon, MD PhD – Novartis Pharma ### 2326687###Speaker###Director Pharmacoepidemiologist###Novartis Pharma###
Speaker: Sandra Lopez Leon, MD PhD – Novartis Pharma
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Speaker###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Speaker: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Speaker###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Speaker: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway ### 1062980###Speaker###Assistant Professor in Pharmacoepidemiology###Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway###
Speaker: Marleen M.H.J. van Gelder, PhD – Pharmacoepidemiology and Drug Safety research group, Department of Pharmacy, University of Oslo, Norway
###
Polypharmacy among Adolescents and Young Adults Newly Initiating Anti-Anxiety and Anti-Depressive Medications

Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health ### 1655293###Presenting Author###Lead Director -Epidemiology, Safety Surveillance & Collaboration###CVS Health###
Presenting Author: Djeneba Audrey Djibo, PhD (she/her/hers) – CVS Health
### she/her/hers @@@ Jonathan Deshazo, PhD, MPH – CVS Health ### 2325150###Co-Author######CVS Health###
Co-Author: Jonathan Deshazo, PhD, MPH – CVS Health
### @@@ Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health ### 1358102###Co-Author###Executive Director-Safety Surveillance & Collaboration###CVS Health###
Co-Author: Cheryl N. McMahill-Walraven, MSW, PhD – CVS Health
###
Post-acute mortality following COVID-19 infection compared to matched test-negative people in England: findings from the ECHOES national surveillance system

Hester Allen, BSc, MSc, Msc – University of Oxford ### 1994548###Presenting Author###PhD Student in Clinical Epidemiology and Medical statistics###University of Oxford###
Presenting Author: Hester Allen, BSc, MSc, Msc – University of Oxford
### @@@ Katie Hassell – UK Health Security Agency ### 1994549###Co-Author######UK Health Security Agency###
Co-Author: Katie Hassell – UK Health Security Agency
### @@@ Orla Presslie – UK Health Security Agency ### 2325293###Co-Author######UK Health Security Agency###
Co-Author: Orla Presslie – UK Health Security Agency
### @@@ Francesca Bell – UK Health Security Agency ### 2325294###Co-Author######UK Health Security Agency###
Co-Author: Francesca Bell – UK Health Security Agency
### @@@ Martí Català, PhD (he/him/his) – University of Oxford ### 1659148###Co-Author###Senior Data Scientist###University of Oxford###
Co-Author: Martí Català, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Co-Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###
Co-Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Albert Prats-Uribe, MD, MPH, FFPH, DPhil – University of Oxford ### 1360474###Co-Author###Senior Clinical Researcher in Public Health and Epidemiology###University of Oxford###
Co-Author: Albert Prats-Uribe, MD, MPH, FFPH, DPhil – University of Oxford
### @@@ Gavin Dabrera, MBBS – UK Health Security Agency ### 1994552###Co-Author###Consultant Epidemiologist###UK Health Security Agency###
Co-Author: Gavin Dabrera, MBBS – UK Health Security Agency
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Co-Author###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Ines Campos-Matos – UK Health Security Agency ### 2325295###Co-Author######UK Health Security Agency###
Co-Author: Ines Campos-Matos – UK Health Security Agency
###
Poster Session A Set-Up
Poster Session B Set-Up
Poster Session C
Poster Session C Set-Up
Postpartum COVID-19 vaccination and risk of lactational mastitis

Jingran Cao – Pregnancy and Child Health Research Center, HealthPartners Institute ### 2325399###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Jingran Cao – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Kimberly K. Vesco – Kaiser Permanente Center for Health Research ### 2325166###Co-Author######Kaiser Permanente Center for Health Research###
Co-Author: Kimberly K. Vesco – Kaiser Permanente Center for Health Research
### @@@ Yihe G. Daida – Center for Integrated Health Care Research, Kaiser Permanente Hawaii ### 1993452###Co-Author###Research Associate III###Center for Integrated Health Care Research, Kaiser Permanente Hawaii###
Co-Author: Yihe G. Daida – Center for Integrated Health Care Research, Kaiser Permanente Hawaii
### @@@ Gabriela Vazquez-Benitez, PhD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1658758###Co-Author###Senior Research Investigator###Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Gabriela Vazquez-Benitez, PhD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute
### she/her/hers @@@ Malini B. DeSilva – Pregnancy and Child Health Research Center, HealthPartners Institute ### 2325489###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Malini B. DeSilva – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Elisabeth M. Seburg – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1993459###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Elisabeth M. Seburg – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Kirsten Ehresmann – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1993458###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Kirsten Ehresmann – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Elyse O. Kharbanda – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1655768###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Elyse O. Kharbanda – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Abbey Sidebottom – Allina Health ### 2325490###Co-Author######Allina Health###
Co-Author: Abbey Sidebottom – Allina Health
### @@@ Heather S. Lipkind – Weill Cornell-Medicine ### 1993456###Co-Author######Weill Cornell-Medicine###
Co-Author: Heather S. Lipkind – Weill Cornell-Medicine
### @@@ Kristin Palmsten, ScD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1062579###Presenting Author###Senior Research Investigator###Pregnancy and Child Health Research Center, HealthPartners Institute###
Presenting Author: Kristin Palmsten, ScD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute
### she/her/hers
Post-Surgical Opioid Initiation and Diverticulitis Risk: a Multi-jurisdictional Population-Based Cohort Study

Michael Andrew Webster-Clark, PharmD, PhD (he/him/his) – McGill University ### 1062566###Presenting Author###Assistant Professor###McGill University###
Presenting Author: Michael Andrew Webster-Clark, PharmD, PhD (he/him/his) – McGill University
### he/him/his @@@ Matthew Dahl – Manitoba Centre for Health Policy ### 2325542###Co-Author######Manitoba Centre for Health Policy###
Co-Author: Matthew Dahl – Manitoba Centre for Health Policy
### @@@ Amani Hamad – Manitoba Centre for Health Policy ### 2325543###Co-Author######Manitoba Centre for Health Policy###
Co-Author: Amani Hamad – Manitoba Centre for Health Policy
### @@@ Michael Paterson – Institute for Clinical Evaluation Sciences ### 1659108###Co-Author###CORE SCIENTIST (FULL STATUS) PROGRAM LEAD & INTERIM CHIEF SCIENCE OFFICER###Institute for Clinical Evaluation Sciences###
Co-Author: Michael Paterson – Institute for Clinical Evaluation Sciences
### @@@ Fangyun Wu – Institute for Clinical Evaluation Sciences ### 2325544###Co-Author######Institute for Clinical Evaluation Sciences###
Co-Author: Fangyun Wu – Institute for Clinical Evaluation Sciences
### @@@ Carolina Moriello – Lady Davis Institute of the Jewish General Hospital ### 2325545###Co-Author######Lady Davis Institute of the Jewish General Hospital###
Co-Author: Carolina Moriello – Lady Davis Institute of the Jewish General Hospital
### @@@ Audray St-Jean – Lady Davis Institute of the Jewish General Hospital ### 2325546###Co-Author######Lady Davis Institute of the Jewish General Hospital###
Co-Author: Audray St-Jean – Lady Davis Institute of the Jewish General Hospital
### @@@ Samy Suissa, PhD, FRSC, FCAHS – McGill University ### 1302854###Co-Author###Distinguished James McGill Professor###McGill University###
Co-Author: Samy Suissa, PhD, FRSC, FCAHS – McGill University
### @@@ Robert W. Platt, PhD (he/him/his) – McGill University ### 1358167###Co-Author###Professor###McGill University###
Co-Author: Robert W. Platt, PhD (he/him/his) – McGill University
### he/him/his
Potential Benefit of Implantable Cardioverter-Defibrillator Placement During or Early After Acute Hospitalizations in Older Adults with Heart Failure

Nathaniel Kuhrt, BS – Rutgers New Jersey Medical School ### 2331000###Co-Author######Rutgers New Jersey Medical School###
Co-Author: Nathaniel Kuhrt, BS – Rutgers New Jersey Medical School
### @@@ Lynne W. Stevenson, MD – Division of Advanced Heart Failure and Transplant Cardiology, Vanderbilt University Medical Center ### 2331001###Co-Author######Division of Advanced Heart Failure and Transplant Cardiology, Vanderbilt University Medical Center###
Co-Author: Lynne W. Stevenson, MD – Division of Advanced Heart Failure and Transplant Cardiology, Vanderbilt University Medical Center
### @@@ Ehimare Akhabue, MD – Department of Medicine, Rutgers Robert Wood Johnson Medical School ### 2331002###Co-Author######Department of Medicine, Rutgers Robert Wood Johnson Medical School###
Co-Author: Ehimare Akhabue, MD – Department of Medicine, Rutgers Robert Wood Johnson Medical School
### @@@ Aayush Visaria, MD, MPH – Department of Medicine, Rutgers Robert Wood Johnson Medical School ### 2331003###Co-Author######Department of Medicine, Rutgers Robert Wood Johnson Medical School###
Co-Author: Aayush Visaria, MD, MPH – Department of Medicine, Rutgers Robert Wood Johnson Medical School
### @@@ Eileen Lee, BS – Rutgers Robert Wood Johnson Medical School ### 2331004###Co-Author######Rutgers Robert Wood Johnson Medical School###
Co-Author: Eileen Lee, BS – Rutgers Robert Wood Johnson Medical School
### @@@ Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 1063041###Co-Author###Instructor of Medicine###Rutgers Center for Pharmacoepidemiology and Treatment Science###
Co-Author: Benjamin Bates, MD – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Poonam Gandhi, MS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research ### 1359859###Co-Author###Research Project Manager###Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research###
Co-Author: Poonam Gandhi, MS – Center for Pharmacoepidemiology and Treatment Science, Rutgers Institute for Health, Health Care Policy and Aging Research
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Presenting Author###Professor of Medicine and Epidemiology###Rutgers University###
Presenting Author: Soko Setoguchi, MD, DrPH – Rutgers University
###
Practical Skills in Protocol Writing and Statistical Analytic Programming Relevant to Studies Generating Real-World Evidence (RWE)

Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration ### 2015392###Lead Speaker###Master Epidemiologist###U.S. Food and Drug Administration###
Lead Speaker: Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration
### she/her/hers @@@ Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals ### 1360408###Speaker###Sr. Director, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Speaker: Christian Hampp, PhD (he/him/his) – Regeneron Pharmaceuticals
### he/him/his @@@ Jessica J. Jalbert, PhD (she/her/hers) – Regeneron Pharmaceuticals, Inc. ### 1062874###Speaker###Executive Director###Regeneron Pharmaceuticals, Inc.###
Speaker: Jessica J. Jalbert, PhD (she/her/hers) – Regeneron Pharmaceuticals, Inc.
### she/her/hers @@@ Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration ### 1063144###Speaker###Lead Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration###
Speaker: Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
### @@@ Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia ### 1358335###Speaker###Professor###Quality Use of Medicines and Pharmacy Research Centre, University of South Australia###
Speaker: Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
### @@@ Soko Setoguchi, MD, DrPH – Rutgers University ### 1302720###Speaker###Professor of Medicine and Epidemiology###Rutgers University###
Speaker: Soko Setoguchi, MD, DrPH – Rutgers University
###
Predicting Causes of Death from Structured Electronic Health Records Using Machine Learning

Mohammed Al-Garad-, PhD – Vanderbilt University Medical Center ### 1993217###Presenting Author###Research Assistant Professor###Vanderbilt University Medical Center###
Presenting Author: Mohammed Al-Garad-, PhD – Vanderbilt University Medical Center
### @@@ Ruth M. Reeves, PhD – Vanderbilt University Medical Center ### 1993319###Co-Author###Health Services Resesearch Scientist###Vanderbilt University Medical Center###
Co-Author: Ruth M. Reeves, PhD – Vanderbilt University Medical Center
### @@@ Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 1093509###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Rishi J. Desai, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Michele LeNoue-Newton – Vanderbilt University Medical Center ### 2325444###Co-Author######Vanderbilt University Medical Center###
Co-Author: Michele LeNoue-Newton – Vanderbilt University Medical Center
### @@@ Daniel Park – Vanderbilt University Medical Center ### 1658721###Co-Author######Vanderbilt University Medical Center###
Co-Author: Daniel Park – Vanderbilt University Medical Center
### @@@ Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1062580###Co-Author###Associate Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Shirley V. Wang, PhD (she/her/hers) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### she/her/hers @@@ Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Co-Author###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Candace C. Fuller, MPH, PhD – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325235###Co-Author###Research Scientist###Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Candace C. Fuller, MPH, PhD – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1991185###Co-Author###Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Co-Author: José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Aida Kuzucan, PharmD, PhD – US Food and Drug Administration ### 1993317###Co-Author###Epidemiologist###US Food and Drug Administration###
Co-Author: Aida Kuzucan, PharmD, PhD – US Food and Drug Administration
### @@@ Xi Wang – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1993318###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###
Co-Author: Xi Wang – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
### @@@ Haritha Pillai – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA ### 2325446###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA###
Co-Author: Haritha Pillai – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
### @@@ Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 2325347###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Kerry Ngan – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ Jill Whitaker, RN-BC, MSN – Vanderbilt University Medical Center ### 1658722###Co-Author###Nurse Informatics Data Analyst###Vanderbilt University Medical Center###
Co-Author: Jill Whitaker, RN-BC, MSN – Vanderbilt University Medical Center
### @@@ Jessica Deere – Vanderbilt University Medical Center ### 2325445###Co-Author######Vanderbilt University Medical Center###
Co-Author: Jessica Deere – Vanderbilt University Medical Center
### @@@ Michael F. McLemore, RN – Vanderbilt University Medical Center ### 1658723###Co-Author###Nurse Informatics Data Analyst###Vanderbilt University Medical Center###
Co-Author: Michael F. McLemore, RN – Vanderbilt University Medical Center
### @@@ Dax Westerman, MS – Vanderbilt University Medical Center ### 1658725###Co-Author###Principal Application Developer###Vanderbilt University Medical Center###
Co-Author: Dax Westerman, MS – Vanderbilt University Medical Center
### @@@ Michael E. Matheny, MD, MS, MPH – Vanderbilt University Medical Center ### 1655452###Co-Author###Professor of Biomedical Informatics###Vanderbilt University Medical Center###
Co-Author: Michael E. Matheny, MD, MS, MPH – Vanderbilt University Medical Center
###
Pregnancy Potpourri

Jennita Reefhuis, PhD (she/her/hers) – Centers for Disease Control and Prevention ### 1062843###Moderator###Branch Chief###Centers for Disease Control and Prevention###
Moderator: Jennita Reefhuis, PhD (she/her/hers) – Centers for Disease Control and Prevention
### she/her/hers @@@ Elena Rivero-Ferrer, MD, MPH, FISPE (she/her/hers) – RTI Health Solutions, Barcelona, Spain ### 1092305###Moderator###Senior Director, Epidemiology###RTI Health Solutions, Barcelona, Spain###
Moderator: Elena Rivero-Ferrer, MD, MPH, FISPE (she/her/hers) – RTI Health Solutions, Barcelona, Spain
### she/her/hers
Prescribed drug use and aneurysmal subarachnoid haemorrhage incidence: A drug-wide association study

Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1659959###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Presenting Author: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Jos P. Kanning – University Medical Center Utrecht ### 2325252###Co-Author######University Medical Center Utrecht###
Co-Author: Jos P. Kanning – University Medical Center Utrecht
### @@@ Christian Schnier – The University of Edinburgh ### 2325265###Co-Author###Epidemiologist###The University of Edinburgh###
Co-Author: Christian Schnier – The University of Edinburgh
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Co-Author###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Mirjam I. Geerlings, PhD – Amsterdam UMC, department of General Practice ### 2325253###Co-Author######Amsterdam UMC, department of General Practice###
Co-Author: Mirjam I. Geerlings, PhD – Amsterdam UMC, department of General Practice
### @@@ Ynte M. Ruigrok, MD, PhD – UMC Utrecht ### 2325254###Co-Author###Associate Professor###UMC Utrecht###
Co-Author: Ynte M. Ruigrok, MD, PhD – UMC Utrecht
###
Prescribing of Opioids in Menopausal and Postmenopausal Women in the UK: A Population-based Drug Utilization Study

Emma Tillyer, PhD (she/her/hers) – Research Depart of Practice and Policy, School of Pharmacy, University College London (UCL) ### 2325292###Presenting Author###Pharmacoepidemiology PhD Candidate ###Research Depart of Practice and Policy, School of Pharmacy, University College London (UCL)###
Presenting Author: Emma Tillyer, PhD (she/her/hers) – Research Depart of Practice and Policy, School of Pharmacy, University College London (UCL)
### she/her/hers @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
### @@@ Yogini Jani, PhD – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom. ### 1655263###Co-Author###Honorary Associate Professor###Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.###
Co-Author: Yogini Jani, PhD – Research Department of Practice and Policy, UCL School of Pharmacy, University College London, London, United Kingdom.
### @@@ Ruth Brauer, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1062558###Co-Author###Lecturer in Pharmacoepidemiology###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Ruth Brauer, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
###
Prescribing of SSRIs/SNRIs to Menopausal Women and its Associated Risk of Acute Cardiovascular Events: A Cohort Study

Dana Alsugeir, Msc. PharmD. – University college london ### 1657708###Presenting Author###PhD student###University college london###
Presenting Author: Dana Alsugeir, Msc. PharmD. – University college london
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
### @@@ Ruth Brauer, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1062558###Co-Author###Lecturer in Pharmacoepidemiology###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Ruth Brauer, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
###
Prescribing preferences for antidiabetic medications among older Type 2 Diabetes (T2D) patients with Alzheimer’s Disease (ADRD) and multimorbidity, 2013-2019

Julia Liaw, PharmD, MSc – Rutgers University ### 1655381###Presenting Author###MSc###Rutgers University###
Presenting Author: Julia Liaw, PharmD, MSc – Rutgers University
### @@@ Kim M. O'Malley, MS – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 2325460###Co-Author###Research Analyst###Rutgers Center for Pharmacoepidemiology and Treatment Science###
Co-Author: Kim M. O'Malley, MS – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Chintan Dave, PharmD, PhD – Rutgers University ### 1655382###Co-Author###Assistant Professor of Pharmacy and Epidemiology###Rutgers University###
Co-Author: Chintan Dave, PharmD, PhD – Rutgers University
###
Prescription medication use during pregnancy in France between 2010 and 2022: a nationwide study

Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM) ### 1993521###Presenting Author###Epidemiologist###EPI-PHARE (ANSM/CNAM)###
Presenting Author: Sara Miranda, PharmD – EPI-PHARE (ANSM/CNAM)
### @@@ Philippe Herlemont – EPI-PHARE (ANSM/CNAM) ### 1991683###Co-Author######EPI-PHARE (ANSM/CNAM)###
Co-Author: Philippe Herlemont – EPI-PHARE (ANSM/CNAM)
### @@@ Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1360500###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Jérôme Drouin – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1358499###Co-Author###deputy director###EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Alain Weill, MD – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
### @@@ Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France ### 1093512###Co-Author######EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France###
Co-Author: Rosemary Dray-Spira – EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), 143-147 Boulevard Anatole France, 93285, Saint-Denis, France
###
Prevalent New User Designs: State of the Science and Considerations for Complex Clinical Scenarios

Kristian B. Filion, PhD (he/him/his) – McGill University ### 1062622###Lead Speaker###Associate Professor###McGill University###
Lead Speaker: Kristian B. Filion, PhD (he/him/his) – McGill University
### he/him/his @@@ Michael Andrew Webster-Clark, PharmD, PhD (he/him/his) – McGill University ### 1062566###Speaker###Assistant Professor###McGill University###
Speaker: Michael Andrew Webster-Clark, PharmD, PhD (he/him/his) – McGill University
### he/him/his @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Speaker###Assistant Professor###London School of Hygiene and Tropical Medicine###
Speaker: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Andrea Michelle Burden, PhD – Swiss Fenderal Institute of Technology ### 1358409###Speaker###Professor###Swiss Fenderal Institute of Technology###
Speaker: Andrea Michelle Burden, PhD – Swiss Fenderal Institute of Technology
### @@@ Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia ### 1358335###Speaker###Professor###Quality Use of Medicines and Pharmacy Research Centre, University of South Australia###
Speaker: Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
###
Principles of Pharmacoepidemiology

Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research ### 1046831###Lead Speaker###Professor and Director###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research###
Lead Speaker: Tobias Gerhard, PhD (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research
### he/him/his @@@ Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA ### 1358307###Speaker###Professor###University of Kentucky, College of Pharmacy, Lexington, KY, USA###
Speaker: Daniela C. Moga, MD, PhD, FISPE (she/her/hers) – University of Kentucky, College of Pharmacy, Lexington, KY, USA
### she/her/hers @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Speaker###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers
Propensity Scores in Pharmacoepidemiology

John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health ### 1046832###Lead Speaker###Adjunct Faculty###Harvard T.H. Chan School of Public Health###
Lead Speaker: John D. Seeger, PharmD, DrPH, FISPE – Harvard T.H. Chan School of Public Health
### @@@ Jeremy A. Rassen, ScD, FISPE – Aetion ### 1062955###Speaker###Co-founder and President###Aetion###
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
###
PS – There Are Others

John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Moderator###Assistant Professor###London School of Hygiene and Tropical Medicine###
Moderator: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Hisashi Urushihara, DrPH – Keio Univesity ### 1358797###Moderator###Professor###Keio Univesity###
Moderator: Hisashi Urushihara, DrPH – Keio Univesity
###
Psychiatric outcomes and their progression across different diagnoses in children and adolescents following prenatal exposure to antidepressants

Anastasia Giorcelli, MS in Biostatistics (she/her/hers) – Oslo Centre for Biostatistics and Epidemiology - University of Oslo ### 2325290###Presenting Author###PhD fellow###Oslo Centre for Biostatistics and Epidemiology - University of Oslo###
Presenting Author: Anastasia Giorcelli, MS in Biostatistics (she/her/hers) – Oslo Centre for Biostatistics and Epidemiology - University of Oslo
### she/her/hers @@@ Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1655801###Co-Author###Postdoctoral Fellow###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Nhung TH Trinh, PharmD, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
### @@@ Lene Maria Sundbakk, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 2325314###Co-Author######Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Lene Maria Sundbakk, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### @@@ Sina Rostami – Norwegian Institute of Public Health ### 2325363###Co-Author######Norwegian Institute of Public Health###
Co-Author: Sina Rostami – Norwegian Institute of Public Health
### @@@ Shuvasa Thapa, MD, PhD – University Of Oslo ### 2325362###Co-Author######University Of Oslo###
Co-Author: Shuvasa Thapa, MD, PhD – University Of Oslo
### @@@ Anna Cantarutti, PhD – University of Milano-Bicocca ### 1360540###Co-Author###Associate Professor###University of Milano-Bicocca###
Co-Author: Anna Cantarutti, PhD – University of Milano-Bicocca
### @@@ Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Co-Author: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway ### 1063068###Co-Author###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway###
Co-Author: Angela Lupattelli, PhD – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway
###
Psychotropic Medication use before, during, and after the Covid-19 pandemic in Danish Children, Adolescents, and Young Adults – an interrupted time series.

Helene Kildegaard, M – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark ### 1358299###Presenting Author###MD###Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark###
Presenting Author: Helene Kildegaard, M – Clinical Pharmacology, Pharmacy and Environmental Medicine, Dept. of Puiblic Health, University of Southern Denmark
### @@@ Rikke Wesselhoeft, MD – Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark ### 1062690###Co-Author###Associate Professor###Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark###
Co-Author: Rikke Wesselhoeft, MD – Research Unit of Child and Adolescent Psychiatry, Department of Clinical Research, University of Southern Denmark, Denmark
### @@@ Mette Bliddal, PhD (she/her/hers) – Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark ### 1062809###Co-Author###Associate professor###Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark###
Co-Author: Mette Bliddal, PhD (she/her/hers) – Research Unit OPEN, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
### she/her/hers
Psychotropics and Pregnancy: Timing Matters

Elizabeth A. Suarez, PhD – Rutgers Institute for Health ### 1991274###Moderator###Instructor###Rutgers Institute for Health###
Moderator: Elizabeth A. Suarez, PhD – Rutgers Institute for Health
### @@@ Anick Bérard, PhD, FCAHS, FISPE (she/her/hers) – Université de Montréal ### 2326107###Moderator###Professor###Université de Montréal###
Moderator: Anick Bérard, PhD, FCAHS, FISPE (she/her/hers) – Université de Montréal
### she/her/hers
Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions: A cross-sectional study in six EU member states

Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1659959###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Presenting Author: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Caroline Buhl – University of Copenhagen ### 2325661###Co-Author######University of Copenhagen###
Co-Author: Caroline Buhl – University of Copenhagen
### @@@ Ramune Jacobsen, MSc MPH PhD – University of Copenhagen ### 1659682###Co-Author###Assistant Professor###University of Copenhagen###
Co-Author: Ramune Jacobsen, MSc MPH PhD – University of Copenhagen
### @@@ Anna Birna Almarsdóttir – University of Copenhagen ### 2325662###Co-Author######University of Copenhagen###
Co-Author: Anna Birna Almarsdóttir – University of Copenhagen
### @@@ Ella Van Vliet – National Institute for Public Health and the Environment (RIVM) ### 2325663###Co-Author######National Institute for Public Health and the Environment (RIVM)###
Co-Author: Ella Van Vliet – National Institute for Public Health and the Environment (RIVM)
### @@@ Armin Andersen – University of Copenhagen ### 1659701###Co-Author######University of Copenhagen###
Co-Author: Armin Andersen – University of Copenhagen
### @@@ Elena Deligianni – Democritus University of Thrace ### 2325664###Co-Author######Democritus University of Thrace###
Co-Author: Elena Deligianni – Democritus University of Thrace
### @@@ Foteini Dermiki-Gkana, MSc student (she/her/hers) – Democritus University of Thrace ### 1658481###Co-Author###Research assistant###Democritus University of Thrace###
Co-Author: Foteini Dermiki-Gkana, MSc student (she/her/hers) – Democritus University of Thrace
### she/her/hers @@@ Christos Kontogiorgis, PhD (he/him/his) – Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Aexandroupolis, Greece ### 1657664###Co-Author###Assistant Professor###Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Aexandroupolis, Greece###
Co-Author: Christos Kontogiorgis, PhD (he/him/his) – Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Aexandroupolis, Greece
### he/him/his @@@ Chara Oikonomou – Democritus University of Thrace ### 2325665###Co-Author######Democritus University of Thrace###
Co-Author: Chara Oikonomou – Democritus University of Thrace
### @@@ Mirdza Kursite – Riga Stradins University ### 2325666###Co-Author######Riga Stradins University###
Co-Author: Mirdza Kursite – Riga Stradins University
### @@@ Elita Poplavska – Riga Stradins University ### 2325667###Co-Author######Riga Stradins University###
Co-Author: Elita Poplavska – Riga Stradins University
### @@@ Ingrid Hegger – National Institute for Public Health and the Environment (RIVM) ### 2325668###Co-Author######National Institute for Public Health and the Environment (RIVM)###
Co-Author: Ingrid Hegger – National Institute for Public Health and the Environment (RIVM)
### @@@ Marloes Van Der Goot – National Institute for Public Health and the Environment (RIVM) ### 2325669###Co-Author######National Institute for Public Health and the Environment (RIVM)###
Co-Author: Marloes Van Der Goot – National Institute for Public Health and the Environment (RIVM)
### @@@ Paula Barão Sousa Ferreira, PharmD MSc PhD – University of Lisbon ### 1658367###Co-Author###Pharmacovigilance Technician###University of Lisbon###
Co-Author: Paula Barão Sousa Ferreira, PharmD MSc PhD – University of Lisbon
### @@@ Inês Ribeiro-Vaz – University of Porto ### 2325670###Co-Author######University of Porto###
Co-Author: Inês Ribeiro-Vaz – University of Porto
### @@@ Ana Marta Silva – University of Porto ### 2325671###Co-Author######University of Porto###
Co-Author: Ana Marta Silva – University of Porto
### @@@ Mitja Kos – University of Ljubljana ### 1658823###Co-Author######University of Ljubljana###
Co-Author: Mitja Kos – University of Ljubljana
### @@@ Nanča Čebron Lipovec – University of Ljubljana ### 2325672###Co-Author######University of Ljubljana###
Co-Author: Nanča Čebron Lipovec – University of Ljubljana
### @@@ Teresa Leonardo Alves – National Institute for Public Health and the Environment (RIVM) ### 2325673###Co-Author######National Institute for Public Health and the Environment (RIVM)###
Co-Author: Teresa Leonardo Alves – National Institute for Public Health and the Environment (RIVM)
###
Q
Quantifying Problematic Prescribing Cascades Relevant for Clinical Practice with Prescription Sequence Symmetry Analysis

Atiya Mohammad – Pharmacy Department, OLVG, Amsterdam ### 2325197###Co-Author######Pharmacy Department, OLVG, Amsterdam###
Co-Author: Atiya Mohammad – Pharmacy Department, OLVG, Amsterdam
### @@@ Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands ### 1086986###Co-Author###PhD, FISPE###Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands###
Co-Author: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
### @@@ Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands ### 1658657###Co-Author###Associate Professor of Pharmacoepidemiology and Pharmaceutical Care Associate Professor of Pharmacoepidemiology###Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands###
Co-Author: Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands
### she/her/hers @@@ Patricia M.L.A. van den Bemt, PhD, PharmD (she/her/hers) – Department Clinical Pharmacy & Pharmacology, UMCG, Groningen, The Netherlands ### 1358161###Co-Author###Hospital Pharmacist###Department Clinical Pharmacy & Pharmacology, UMCG, Groningen, The Netherlands###
Co-Author: Patricia M.L.A. van den Bemt, PhD, PharmD (she/her/hers) – Department Clinical Pharmacy & Pharmacology, UMCG, Groningen, The Netherlands
### she/her/hers @@@ Fatma Karapinar-Carkit, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands ### 2325176###Presenting Author###Associate professor###Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands###
Presenting Author: Fatma Karapinar-Carkit, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands
### she/her/hers
R
Racial, Ethnic, and Socioeconomic Disparities in P2Y12 Inhibitor Prescribing Following PCI in Medicare Beneficiaries

Sophie Wei – Rutgers University ### 2325551###Co-Author######Rutgers University###
Co-Author: Sophie Wei – Rutgers University
### @@@ Mahmoud Ajaj – Rutgers University ### 2325552###Co-Author######Rutgers University###
Co-Author: Mahmoud Ajaj – Rutgers University
### @@@ Allison Nguyen – Rutgers University ### 2325553###Co-Author######Rutgers University###
Co-Author: Allison Nguyen – Rutgers University
### @@@ Kim M. O'Malley, MS – Rutgers Center for Pharmacoepidemiology and Treatment Science ### 2325460###Co-Author###Research Analyst###Rutgers Center for Pharmacoepidemiology and Treatment Science###
Co-Author: Kim M. O'Malley, MS – Rutgers Center for Pharmacoepidemiology and Treatment Science
### @@@ Farzin Khosrow-Khavar, PhD – Rutgers University ### 2325383###Co-Author###Instructor###Rutgers University###
Co-Author: Farzin Khosrow-Khavar, PhD – Rutgers University
### @@@ Chintan Dave, PharmD, PhD – Rutgers University ### 1655382###Presenting Author###Assistant Professor of Pharmacy and Epidemiology###Rutgers University###
Presenting Author: Chintan Dave, PharmD, PhD – Rutgers University
###
Real ID: Methods and Validation in Pregnancy

Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1063282###Moderator###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Moderator: Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research ### 2329544###Moderator###Senior Director###Carelon Research###
Moderator: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research
### he/him/his
Real-Worl Effectiveness of Maternal Influenza Vaccination During Pregnancy on Risk of Infant Influenza During the First 6 Months of Life

Ousseny Zerbo, PhD – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA ### 1062643###Co-Author###Research Scientist###Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA###
Co-Author: Ousseny Zerbo, PhD – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA
### @@@ Holly Finertie – Division of Research, Kaiser Permanente Northern California, Oakland, California ### 2325537###Co-Author######Division of Research, Kaiser Permanente Northern California, Oakland, California###
Co-Author: Holly Finertie – Division of Research, Kaiser Permanente Northern California, Oakland, California
### @@@ Romain Neugebauer – Kaiser Permanente Division of Research; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA ### 2325459###Co-Author######Kaiser Permanente Division of Research; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA###
Co-Author: Romain Neugebauer – Kaiser Permanente Division of Research; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA
### @@@ Kristin S. Goddard, MPH (she/her/hers) – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California ### 1655534###Co-Author###Research Manager###Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California###
Co-Author: Kristin S. Goddard, MPH (she/her/hers) – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California
### she/her/hers @@@ Nicola P. Klein, MD, PhD – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA ### 1062961###Presenting Author######Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA###
Presenting Author: Nicola P. Klein, MD, PhD – Vaccine Study Center, Kaiser Permanente Northern California, Oakland, California Division of Research, Kaiser Permanente Northern California, Oakland, California Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA
###
Real-world data-based external control for assessing long-term benefit-risk of cell and gene therapies: insights and perspectives

Erwan Muros-Le Rouzic, MPH – F. Hoffmann-La Roche Ltd. ### 1657778###Lead Speaker###Senior Principal Scientist RWD###F. Hoffmann-La Roche Ltd.###
Lead Speaker: Erwan Muros-Le Rouzic, MPH – F. Hoffmann-La Roche Ltd.
### @@@ Seun Osundolire, MD, MPH, PhD – Pfizer Inc. ### 2325479###Speaker###Epidemiologist###Pfizer Inc.###
Speaker: Seun Osundolire, MD, MPH, PhD – Pfizer Inc.
### @@@ Reid D'Amico, PhD – IQVIA ### 2325480###Speaker###Principal###IQVIA###
Speaker: Reid D'Amico, PhD – IQVIA
### @@@ Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1063247###Speaker###Assistant Professor Clinical Therapeutics###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Speaker: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Karla Therese L. Sy, MS, PhD – Pfizer, Inc. ### 1658204###Speaker###Director###Pfizer, Inc.###
Speaker: Karla Therese L. Sy, MS, PhD – Pfizer, Inc.
### @@@ Hannah V. Furby, PhD (she/her/hers) – Roche Product Ltd. ### 1063276###Speaker###Principal Real World Data Scientist###Roche Product Ltd.###
Speaker: Hannah V. Furby, PhD (she/her/hers) – Roche Product Ltd.
### she/her/hers @@@ Carla Y. Vossen, PhD – Syneos Health ### 1359603###Speaker###Senior Director Epidemiology, RWE###Syneos Health###
Speaker: Carla Y. Vossen, PhD – Syneos Health
### @@@ Avery McIntosh, PhD – Pfizer Inc. ### 2325482###Speaker###Director###Pfizer Inc.###
Speaker: Avery McIntosh, PhD – Pfizer Inc.
### @@@ Kate Huang – No affiliation currently ### 2325483### Co-Author######No affiliation currently###
Co-Author: Kate Huang – No affiliation currently
### @@@ Katie Miller – Genentech Inc. ### 2325481### Co-Author######Genentech Inc.###
Co-Author: Katie Miller – Genentech Inc.
###
Real-World Evidence (RWE) Generation for Rare Disease Drug Development and Orphan Drug Approvals

Emily Bratton, MPH, PhD (she/her/hers) – IQVIA ### 2328661###Lead Speaker###Senior Director, Category Lead Safety Evidence for Regulators###IQVIA###
Lead Speaker: Emily Bratton, MPH, PhD (she/her/hers) – IQVIA
### she/her/hers @@@ Daniel Rosenberg, PhD – Johnson & Johnson ### 1993532###Speaker###Cross-Therapy Area Leader, Global Epidemiology###Johnson & Johnson###
Speaker: Daniel Rosenberg, PhD – Johnson & Johnson
### @@@ Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions ### 1062596###Speaker###Director, Epidemiology###RTI Health Solutions###
Speaker: Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions
### @@@ Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA ### 1062564###Speaker###Associate Director RWE###Office of Surveillance and Epidemiology, CDER, US FDA###
Speaker: Jie J. Li, PhD (she/her/hers) – Office of Surveillance and Epidemiology, CDER, US FDA
### she/her/hers
Real-world outcomes: Lung clearance index improvements in Danish children with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.

Esben Herborg Henriksen, MD – Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark ### 2325587###Presenting Author###PhD Student###Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark###
Presenting Author: Esben Herborg Henriksen, MD – Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
### @@@ Rikke Mulvad Sandvik, MD. PhD – Department of Pediatrics and Adolescent Medicine, Rigshospitalet ### 2325612###Co-Author######Department of Pediatrics and Adolescent Medicine, Rigshospitalet###
Co-Author: Rikke Mulvad Sandvik, MD. PhD – Department of Pediatrics and Adolescent Medicine, Rigshospitalet
### @@@ Daniel Faurholt-Jepsen, MD, PhD – Department of Infectious Diseases, University Hospital of Copenhagen – Rigshospitalet, Cystic Fibrosis Centre, DK ### 1992374###Co-Author######Department of Infectious Diseases, University Hospital of Copenhagen – Rigshospitalet, Cystic Fibrosis Centre, DK###
Co-Author: Daniel Faurholt-Jepsen, MD, PhD – Department of Infectious Diseases, University Hospital of Copenhagen – Rigshospitalet, Cystic Fibrosis Centre, DK
### @@@ Mette F. Olsen – Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark ### 2325613###Co-Author###Senior Reseacher###Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark###
Co-Author: Mette F. Olsen – Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark
### @@@ Tacjana Pressler – 3Department of Infectious Diseases, University Hospital of Copenhagen – Rigshospitalet, Cystic Fibrosis Centre, DK ### 2325395###Co-Author######3Department of Infectious Diseases, University Hospital of Copenhagen – Rigshospitalet, Cystic Fibrosis Centre, DK###
Co-Author: Tacjana Pressler – 3Department of Infectious Diseases, University Hospital of Copenhagen – Rigshospitalet, Cystic Fibrosis Centre, DK
### @@@ Thomas Bryrup, MD – 2Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark ### 2325615###Co-Author###PhD Student###2Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark###
Co-Author: Thomas Bryrup, MD – 2Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
### @@@ Frederik F. Buchvald, MD, PhD – Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark ### 2325616###Co-Author###Senior Physician###Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark###
Co-Author: Frederik F. Buchvald, MD, PhD – Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
### @@@ Inger HM Mathiesen, MD, PhD – Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark ### 2325617###Co-Author###Consultant Physician###Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark###
Co-Author: Inger HM Mathiesen, MD, PhD – Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
### @@@ Tavs Qvist, MD, PhD – Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark ### 2325618###Co-Author###Consultant Physician###Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark###
Co-Author: Tavs Qvist, MD, PhD – Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark
### @@@ Hanne V. Olesen, MD, PhD – Danish Center of Pediatric Pulmonology and Allergology, Department of Pediatrics and Adolescents Medicine, University Hospital of Aarhus, Department of Clinical Medicine, Aarhus University, Denmark ### 2325619###Co-Author###Senior Physician###Danish Center of Pediatric Pulmonology and Allergology, Department of Pediatrics and Adolescents Medicine, University Hospital of Aarhus, Department of Clinical Medicine, Aarhus University, Denmark###
Co-Author: Hanne V. Olesen, MD, PhD – Danish Center of Pediatric Pulmonology and Allergology, Department of Pediatrics and Adolescents Medicine, University Hospital of Aarhus, Department of Clinical Medicine, Aarhus University, Denmark
### @@@ Hanne LM Rubak, MD, PhD – Danish Center of Pediatric Pulmonology and Allergology, Department of Pediatrics and Adolescents Medicine, University Hospital of Aarhus, Department of Clinical Medicine, Aarhus University, Denmark ### 2325621###Co-Author###Senior Physician###Danish Center of Pediatric Pulmonology and Allergology, Department of Pediatrics and Adolescents Medicine, University Hospital of Aarhus, Department of Clinical Medicine, Aarhus University, Denmark###
Co-Author: Hanne LM Rubak, MD, PhD – Danish Center of Pediatric Pulmonology and Allergology, Department of Pediatrics and Adolescents Medicine, University Hospital of Aarhus, Department of Clinical Medicine, Aarhus University, Denmark
### @@@ Hanne LM Skov, MD, PhD – Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark ### 2325622###Co-Author###Senior Physician###Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark###
Co-Author: Hanne LM Skov, MD, PhD – Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
### @@@ Camilla Bjørn Jensen, PhD – Copenhagen Phase IV Unit – Phase4CPH Section for Data, Biostatistics and Pharmacoepidemiology, Center for Clinical Research and Prevention ### 1992355###Co-Author###Senior pharmacoepidemiologist###Copenhagen Phase IV Unit – Phase4CPH Section for Data, Biostatistics and Pharmacoepidemiology, Center for Clinical Research and Prevention ###
Co-Author: Camilla Bjørn Jensen, PhD – Copenhagen Phase IV Unit – Phase4CPH Section for Data, Biostatistics and Pharmacoepidemiology, Center for Clinical Research and Prevention
### @@@ Kim Gjerum Nielsen, Prof, Senior Physician – Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark ### 2325623###Co-Author###Professor in Pediatrics###Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark###
Co-Author: Kim Gjerum Nielsen, Prof, Senior Physician – Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
###
Real-world utilization patterns of medications for opioid use disorder among Medicaid-insured adults

Katelin B. Nickel, MPH – Washington University School of Medicine ### 1655835###Co-Author###Sr. programmer analyst###Washington University School of Medicine###
Co-Author: Katelin B. Nickel, MPH – Washington University School of Medicine
### @@@ Payel Jhoom Roy, MD, MSc – University of Pittsburgh ### 2325350###Co-Author######University of Pittsburgh###
Co-Author: Payel Jhoom Roy, MD, MSc – University of Pittsburgh
### @@@ Michael J. Durkin, MD, MPH – Washington University School of Medicine ### 1655836###Co-Author######Washington University School of Medicine###
Co-Author: Michael J. Durkin, MD, MPH – Washington University School of Medicine
### @@@ Ryan Colvin, MPH – Washington University School of Medicine ### 2325351###Co-Author######Washington University School of Medicine###
Co-Author: Ryan Colvin, MPH – Washington University School of Medicine
### @@@ Andrew Atkinson, PhD – Washington University School of Medicine ### 2325352###Co-Author######Washington University School of Medicine###
Co-Author: Andrew Atkinson, PhD – Washington University School of Medicine
### @@@ Katie Suda, PharmD MS (she/her/hers) – University of Pittsburgh School of Medicine, Department of Medicine, Division of General Internal Medicine and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, ### 1360024###Co-Author###Professor###University of Pittsburgh School of Medicine, Department of Medicine, Division of General Internal Medicine and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System,###
Co-Author: Katie Suda, PharmD MS (she/her/hers) – University of Pittsburgh School of Medicine, Department of Medicine, Division of General Internal Medicine and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System,
### she/her/hers @@@ Anne M. Butler, PhD, MS – Washington University School of Medicine ### 1062638###Presenting Author###Assistant Professor###Washington University School of Medicine###
Presenting Author: Anne M. Butler, PhD, MS – Washington University School of Medicine
###
Receipt of glucagon-like peptide 1 receptor agonists is associated with reduced alcohol consumption: A retrospective propensity score-matched cohort study

Mehdi Farokhnia, MD, MPH (he/him/his) – NIH, Johns Hopkins ### 1658915###Presenting Author###Staff Scientist, Assistant Professor###NIH, Johns Hopkins###
Presenting Author: Mehdi Farokhnia, MD, MPH (he/him/his) – NIH, Johns Hopkins
### he/him/his @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-Author: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Joshua Gray – Uniformed Services University ### 2325558###Co-Author######Uniformed Services University###
Co-Author: Joshua Gray – Uniformed Services University
### @@@ Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania ### 1359970###Co-Author###Associate Professor of Medicine and Epidemiology###University of Pennsylvania###
Co-Author: Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania
### he/him/his @@@ David Fiellin – Yale School of Medicine ### 1658923###Co-Author######Yale School of Medicine###
Co-Author: David Fiellin – Yale School of Medicine
### @@@ Henry Kranzler – University of Pennsylvania Perelman School of Medicine ### 2325559###Co-Author######University of Pennsylvania Perelman School of Medicine###
Co-Author: Henry Kranzler – University of Pennsylvania Perelman School of Medicine
### @@@ Amy C. Justice, MD, PhD – Yale School of Medicine ### 1360015###Co-Author######Yale School of Medicine###
Co-Author: Amy C. Justice, MD, PhD – Yale School of Medicine
### @@@ Lorenzo Leggio – National Institutes of Health ### 1658925###Co-Author######National Institutes of Health###
Co-Author: Lorenzo Leggio – National Institutes of Health
### @@@ Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine ### 1062599###Co-Author###Associate Professor###London School of Hygiene and Tropical Medicine / Yale School of Medicine###
Co-Author: Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine
###
Recreational And Medical Cannabis Legalization And Opioid Prescriptions And Mortality

Hai V. Nguyen – School of Pharmacy, Memorial University of Newfoundland, St John’s, Newfoundland & Labrador, Canada ### 1993762###Co-Author######School of Pharmacy, Memorial University of Newfoundland, St John’s, Newfoundland & Labrador, Canada###
Co-Author: Hai V. Nguyen – School of Pharmacy, Memorial University of Newfoundland, St John’s, Newfoundland & Labrador, Canada
### @@@ Emma E. McGinty – Division of Health Policy and Economics, Weill Cornell Medicine, New York, New York ### 1993764###Co-Author######Division of Health Policy and Economics, Weill Cornell Medicine, New York, New York###
Co-Author: Emma E. McGinty – Division of Health Policy and Economics, Weill Cornell Medicine, New York, New York
### @@@ Shweta Mital, PhD – College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada ### 1993767###Co-Author###Assistant Professor###College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada###
Co-Author: Shweta Mital, PhD – College of Pharmacy, University of Manitoba, Winnipeg, Manitoba, Canada
### @@@ G. Caleb Alexander, MD – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ### 1093469###Presenting Author###Professor of Epidemiology and Medicine###Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD###
Presenting Author: G. Caleb Alexander, MD – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
###
Registration
Registration
Registration
Registration
Registration
Registration
Regulatory Pharmacoepidemiology

Danica Marinac-Dabic – FDA ### 1088322###Lead Speaker######FDA###
Lead Speaker: Danica Marinac-Dabic – FDA
### @@@ Katherine Donegan, PhD (she/her/hers) – Medicines and Healthcare products Regulatory Agency ### 1647043###Speaker###Head of Epidemiology###Medicines and Healthcare products Regulatory Agency###
Speaker: Katherine Donegan, PhD (she/her/hers) – Medicines and Healthcare products Regulatory Agency
### she/her/hers
Retention in Buprenorphine versus Methadone Treatment for Opioid Use Disorder in Pregnancy and Postpartum

Chih-Wan Grace Lin, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 2325302###Presenting Author###Postdoctoral Research Fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Presenting Author: Chih-Wan Grace Lin, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Brian T. Bateman, MD, MSc – Stanford University ### 1088175###Co-Author######Stanford University###
Co-Author: Brian T. Bateman, MD, MSc – Stanford University
### @@@ Loreen Straub, MD MS (she/her/hers) – Brigham and Women's Hospital/Harvard Medical School ### 1062604###Co-Author###Instructor in Medicine###Brigham and Women's Hospital/Harvard Medical School###
Co-Author: Loreen Straub, MD MS (she/her/hers) – Brigham and Women's Hospital/Harvard Medical School
### she/her/hers @@@ Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital ### 1397958###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital###
Co-Author: Seanna Vine – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
### @@@ Ayesha C. Sujan, PhD (she/her/hers) – Stanford University ### 1991327###Co-Author###Postdoctoral Fellow###Stanford University###
Co-Author: Ayesha C. Sujan, PhD (she/her/hers) – Stanford University
### she/her/hers @@@ Elizabeth A. Suarez, PhD – Rutgers Institute for Health ### 1991274###Co-Author###Instructor###Rutgers Institute for Health###
Co-Author: Elizabeth A. Suarez, PhD – Rutgers Institute for Health
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Co-Author###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
###
Revolutionising Regulatory Science with Natural Language Processing: a case study on Paediatric Investigation Plans

Saeed Shakibfar – University of Copenhagen ### 2329017###Co-Author######University of Copenhagen###
Co-Author: Saeed Shakibfar – University of Copenhagen
### @@@ Christine E. Hallgreen, PhD – University of Copenhagen ### 2329137###Presenting Author###Associate professor###University of Copenhagen###
Presenting Author: Christine E. Hallgreen, PhD – University of Copenhagen
### @@@ Maurizio Sessa, PharmD – Department of Drug Design and Pharmacology, University of Copenhagen ### 1062857### Co-Author###Associate Professor###Department of Drug Design and Pharmacology, University of Copenhagen###
Co-Author: Maurizio Sessa, PharmD – Department of Drug Design and Pharmacology, University of Copenhagen
###
RIG Meetings
Risk Minimization and Communication: Scientific Approaches and Case Studies for Designing and Evaluating Interventions for the Safe Use of Medicines

Priya Bahri, PhD – European Medicines Agency (EMA) ### 1061402###Lead Speaker###Senior Lead###European Medicines Agency (EMA)###
Lead Speaker: Priya Bahri, PhD – European Medicines Agency (EMA)
### @@@ Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific ### 1088147###Lead Speaker###Senior Director###Evidera. Inc., PPD, a part of Thermo Fisher Scientific###
Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific
### @@@ Peter GM Mol, PhD PharmD (he/him/his) – Dutch Medicines Evaluation Board ### 1659255###Speaker###Professor of drug regulatory science###Dutch Medicines Evaluation Board###
Speaker: Peter GM Mol, PhD PharmD (he/him/his) – Dutch Medicines Evaluation Board
### he/him/his @@@ Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago ### 1046822###Speaker###Professor and Dean###Loyola University of Chicago###
Speaker: Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago
### @@@ Amir Sarayani, PhamrD, MPH, PhD (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 2325185###Speaker###Associate Director###Janssen Research & Development, Johnson & Johnson###
Speaker: Amir Sarayani, PhamrD, MPH, PhD (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Speaker###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers
Risk Minimization Programs for Teratogenic Drugs: How to Move from Art to Science

Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Lead Speaker###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Lead Speaker: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers @@@ Amir Sarayani, PhamrD, MPH, PhD (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 2325185###Speaker###Associate Director###Janssen Research & Development, Johnson & Johnson###
Speaker: Amir Sarayani, PhamrD, MPH, PhD (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Priya Bahri, PhD – European Medicines Agency (EMA) ### 1061402###Speaker###Senior Lead###European Medicines Agency (EMA)###
Speaker: Priya Bahri, PhD – European Medicines Agency (EMA)
### @@@ Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific ### 1088147###Speaker###Senior Director###Evidera. Inc., PPD, a part of Thermo Fisher Scientific###
Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific
### @@@ Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration ### 1360117###Speaker###Associate Director for Research and Strategic Initiatives###US Food and Drug Administration###
Speaker: Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration
###
Risk of acute cardiovascular events in COPD patients after experiencing COVID-19-related vs. non-COVID-19-related exacerbations - a population-based study

Brian K. Kirui, MMedSc – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1655738###Presenting Author###Doctoral student###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Presenting Author: Brian K. Kirui, MMedSc – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Oskar Wallström – COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden ### 2325497###Co-Author###Doctoral student###COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: Oskar Wallström – COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Lowie E.G.W Vanfleteren, MD, PhD – COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden ### 1358948###Co-Author###Assoc. Prof.###COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden###
Co-Author: Lowie E.G.W Vanfleteren, MD, PhD – COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
### @@@ Ailiana Santosa, MD. MMedSc. PhD (she/her/hers) – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358953###Co-Author###Senior researcher###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Ailiana Santosa, MD. MMedSc. PhD (she/her/hers) – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### she/her/hers @@@ Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659121###Co-Author###Assoc. Prof.###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Carl Bonander, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 2325499###Co-Author###Assoc. Prof.###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Carl Bonander, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Caroline Stridsman, PhD – Department of Public Health and Clinical Medicine/The OLIN-unit, Umeå University, Umeå, Sweden. ### 1659663###Co-Author###Assoc. Prof.###Department of Public Health and Clinical Medicine/The OLIN-unit, Umeå University, Umeå, Sweden.###
Co-Author: Caroline Stridsman, PhD – Department of Public Health and Clinical Medicine/The OLIN-unit, Umeå University, Umeå, Sweden.
### @@@ Mats Börjesson – Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden ### 2325188###Co-Author######Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden###
Co-Author: Mats Börjesson – Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden
### @@@ Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358933###Co-Author###Professor of Register Epidemiology###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
###
Risk of aortic aneurysm or dissection following exposure to systemic fluoroquinolone antibiotics – a large-scale distributed network analysis

Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia ### 1358335###Presenting Author###Professor###Quality Use of Medicines and Pharmacy Research Centre, University of South Australia###
Presenting Author: Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
### @@@ Jack Janetski – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia ### 2325578###Co-Author######Quality Use of Medicines and Pharmacy Research Centre, University of South Australia###
Co-Author: Jack Janetski – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
### @@@ Jung Ho Kim – Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea ### 2325579###Co-Author######Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea###
Co-Author: Jung Ho Kim – Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
### @@@ Seng Chan You, MD – Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea ### 1991646###Co-Author######Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea###
Co-Author: Seng Chan You, MD – Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, South Korea
###
Risk of Cardiovascular Adverse Events After COVID-19 Diagnosis in the United States

J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions ### 1062745###Presenting Author###Director, Epidemiology###RTI Health Solutions###
Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Arnstein Lindaas, MA – Acumen, LLC ### 1991272###Co-Author######Acumen, LLC###
Co-Author: Arnstein Lindaas, MA – Acumen, LLC
### @@@ Stella G. Muthuri, PhD – IBM Consulting ### 1660980###Co-Author###Epidemiologist###IBM Consulting###
Co-Author: Stella G. Muthuri, PhD – IBM Consulting
### @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###
Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Morgan M. Richey, Ph.D, MPH – RTI International ### 2325231###Co-Author###Research Pharmacoepidemiologist###RTI International###
Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Co-Author###Epidemiologist###US FDA###
Co-Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###
Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Lisa Kowarski, MPH – IBM Consulting ### 1658849###Co-Author######IBM Consulting###
Co-Author: Lisa Kowarski, MPH – IBM Consulting
### @@@ Mollie McKillop – IBM Consulting ### 2325193###Co-Author######IBM Consulting###
Co-Author: Mollie McKillop – IBM Consulting
### @@@ Shelby Fisher – RTI International ### 2325194###Co-Author######RTI International###
Co-Author: Shelby Fisher – RTI International
### @@@ Hai Lyu – Acumen., LLC ### 2325541###Co-Author###Policy Associate###Acumen., LLC###
Co-Author: Hai Lyu – Acumen., LLC
### @@@ Angela Cheng, MPH – Acumen LLC ### 2325195###Co-Author######Acumen LLC###
Co-Author: Angela Cheng, MPH – Acumen LLC
### @@@ Christine L. Bui, MPH – RTI-HS ### 2325149###Co-Author###Director, Epidemiology###RTI-HS###
Co-Author: Christine L. Bui, MPH – RTI-HS
### @@@ Pablo Freyria Duenas, MA – Acumen LLC ### 2325114###Co-Author######Acumen LLC###
Co-Author: Pablo Freyria Duenas, MA – Acumen LLC
### @@@ Yangping Chen, MPH – Acumen, LLC ### 2325196###Co-Author###Data Policy Analyst###Acumen, LLC###
Co-Author: Yangping Chen, MPH – Acumen, LLC
### @@@ Jeffrey B. Beers, MD – IBM Consulting ### 1658850###Co-Author###Clinical SME###IBM Consulting###
Co-Author: Jeffrey B. Beers, MD – IBM Consulting
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ Timothy Burrell, MD, MBA – IBM Consulting ### 1658852###Co-Author###Associate Partner###IBM Consulting###
Co-Author: Timothy Burrell, MD, MBA – IBM Consulting
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###
Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###
Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###
Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated With JAK inhibitors and TNF inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study

Yongtai Cho, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 2325709###Presenting Author###PhD Student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Yongtai Cho, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Dongwon Yoon, PharmD, PhD (he/him/his) – National Institute on Aging, National Institutes of Health ### 1063238###Co-Author###Post-doctoral researcher###National Institute on Aging, National Institutes of Health###
Co-Author: Dongwon Yoon, PharmD, PhD (he/him/his) – National Institute on Aging, National Institutes of Health
### he/him/his @@@ Farzin Khosrow-Khavar, PhD – Rutgers University ### 2325383###Co-Author###Instructor###Rutgers University###
Co-Author: Farzin Khosrow-Khavar, PhD – Rutgers University
### @@@ Minkyo Song – Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Maryland, United States of America ### 2325710###Co-Author######Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Maryland, United States of America###
Co-Author: Minkyo Song – Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Maryland, United States of America
### @@@ Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302812###Co-Author###Research Assistant Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Risk of Facial Palsy Following COVID-19 Vaccination: A Nationwide Large-Linked Database Study

Dongwon Yoon, PharmD, PhD (he/him/his) – National Institute on Aging, National Institutes of Health ### 1063238###Co-Author###Post-doctoral researcher###National Institute on Aging, National Institutes of Health###
Co-Author: Dongwon Yoon, PharmD, PhD (he/him/his) – National Institute on Aging, National Institutes of Health
### he/him/his @@@ Kyungyeon Jung, PharmD – Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea ### 2325469###Presenting Author###PhD student###Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Kyungyeon Jung, PharmD – Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea
### @@@ Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302812###Co-Author###Research Assistant Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju Hwan Kim, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1991617###Co-Author###PhD student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Byeol-A Yoon, MD – Department of Neurology, Dong-A University College of Medicine, Busan, South Korea ### 2325711###Co-Author######Department of Neurology, Dong-A University College of Medicine, Busan, South Korea###
Co-Author: Byeol-A Yoon, MD – Department of Neurology, Dong-A University College of Medicine, Busan, South Korea
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Risk of Hepatic Events Associated with Use of SGLT-2 Inhibitors Versus GLP-1RA, and Thiazolidinedione Among Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes

Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1991617###Presenting Author###PhD student###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Presenting Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
### @@@ Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts ### 2325186###Co-Author###Postdoctoral fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts###
Co-Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts
### @@@ Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea ### 1991609###Co-Author######Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea###
Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea
### @@@ Jae Hyun Bae, MD, PhD – Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea ### 1991601###Co-Author######Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea###
Co-Author: Jae Hyun Bae, MD, PhD – Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea
### @@@ Yoosoo Chang – Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea ### 1655678###Co-Author######Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea###
Co-Author: Yoosoo Chang – Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea
### @@@ Seungho Ryu – Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea ### 1659464###Co-Author######Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea###
Co-Author: Seungho Ryu – Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine, Seoul, South Korea
### @@@ Christopher D Byrne – National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom ### 2325187###Co-Author######National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom###
Co-Author: Christopher D Byrne – National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, United Kingdom
### @@@ Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea ### 1302813###Co-Author###Associate Professor###School of Pharmacy, Sungkyunkwan University, Suwon, South Korea###
Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
###
Risk of hospitalized pneumonia among patients receiving opioids: Self-Controlled Case Series study

Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1658473###Presenting Author###Master of clinical pharmacy###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Presenting Author: Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1658474###Co-Author###PhD student###School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Daniel Hsiang-Te Tsai, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Risk of kidney stones following SGLT2i- and GLP1-RA initiation among patients with type 2 diabetes in Denmark, Norway, UK, and Taiwan: Population-based active comparator, new user cohort studies and meta-analysis

Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark ### 1062545###Co-Author###Postdoctoral researcher###Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark###
Co-Author: Lars Christian Lund, PhD (he/him/his) – Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark
### he/him/his @@@ Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1659959###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###
Co-Author: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### @@@ Hanne L. Løvdal Gulseth – Norwegian Institute of Public Health ### 1360123###Co-Author######Norwegian Institute of Public Health###
Co-Author: Hanne L. Løvdal Gulseth – Norwegian Institute of Public Health
### @@@ Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1062943###Co-Author###Immediate Past Chair of the ISPE Student Council###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Co-Author: Miyuki Hsing-Chun Hsieh, PhD – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Paz Lopez-Doriga Ruiz – Norwegian Institute of Public Health ### 2325491###Co-Author######Norwegian Institute of Public Health###
Co-Author: Paz Lopez-Doriga Ruiz – Norwegian Institute of Public Health
### @@@ Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1093628###Co-Author###Assistent professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Patrick C. Souverein, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Adrian Martinez de la Torre, PhD – Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich ### 1063022###Co-Author###Postdoctoral Researcher###Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich###
Co-Author: Adrian Martinez de la Torre, PhD – Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich
### @@@ Andrea Michelle Burden, PhD – Swiss Fenderal Institute of Technology ### 1358409###Co-Author###Professor###Swiss Fenderal Institute of Technology###
Co-Author: Andrea Michelle Burden, PhD – Swiss Fenderal Institute of Technology
### @@@ Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1358431###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### @@@ Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1062523###Co-Author###Head of Division###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Presenting Author###Professor###University of Southern Denmark###
Presenting Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United States

J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions ### 1062745###Presenting Author###Director, Epidemiology###RTI Health Solutions###
Presenting Author: J. Bradley Layton, PhD, FISPE (he/him/his) – RTI Health Solutions
### he/him/his @@@ Stella G. Muthuri, PhD – IBM Consulting ### 1660980###Co-Author###Epidemiologist###IBM Consulting###
Co-Author: Stella G. Muthuri, PhD – IBM Consulting
### @@@ Arnstein Lindaas, MA – Acumen, LLC ### 1991272###Co-Author######Acumen, LLC###
Co-Author: Arnstein Lindaas, MA – Acumen, LLC
### @@@ Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration ### 1655306###Co-Author###Health Statistician###U.S Food and Drug Administration###
Co-Author: Patricia C. Lloyd, ScM, PhD – U.S Food and Drug Administration
### @@@ Morgan M. Richey, Ph.D, MPH – RTI International ### 2325231###Co-Author###Research Pharmacoepidemiologist###RTI International###
Co-Author: Morgan M. Richey, Ph.D, MPH – RTI International
### @@@ Joann F. Gruber, PhD, MSPH – US FDA ### 1991147###Co-Author###Epidemiologist###US FDA###
Co-Author: Joann F. Gruber, PhD, MSPH – US FDA
### @@@ Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA ### 1655307###Co-Author###Epidemiologist/Health Statistician###US FDA###
Co-Author: Tainya C. Clarke, PhD, MPH, MSc (she/her/hers) – US FDA
### she/her/hers @@@ Lisa Kowarski, MPH – IBM Consulting ### 1658849###Co-Author######IBM Consulting###
Co-Author: Lisa Kowarski, MPH – IBM Consulting
### @@@ Mollie McKillop – IBM Consulting ### 2325193###Co-Author######IBM Consulting###
Co-Author: Mollie McKillop – IBM Consulting
### @@@ Shelby Fisher – RTI International ### 2325194###Co-Author######RTI International###
Co-Author: Shelby Fisher – RTI International
### @@@ Hai Lyu – Acumen., LLC ### 2325541###Co-Author###Policy Associate###Acumen., LLC###
Co-Author: Hai Lyu – Acumen., LLC
### @@@ Angela Cheng, MPH – Acumen LLC ### 2325195###Co-Author######Acumen LLC###
Co-Author: Angela Cheng, MPH – Acumen LLC
### @@@ Christine L. Bui, MPH – RTI-HS ### 2325149###Co-Author###Director, Epidemiology###RTI-HS###
Co-Author: Christine L. Bui, MPH – RTI-HS
### @@@ Pablo Freyria Duenas, MA – Acumen LLC ### 2325114###Co-Author######Acumen LLC###
Co-Author: Pablo Freyria Duenas, MA – Acumen LLC
### @@@ Yangping Chen, MPH – Acumen, LLC ### 2325196###Co-Author###Data Policy Analyst###Acumen, LLC###
Co-Author: Yangping Chen, MPH – Acumen, LLC
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
### @@@ Jeffrey B. Beers, MD – IBM Consulting ### 1658850###Co-Author###Clinical SME###IBM Consulting###
Co-Author: Jeffrey B. Beers, MD – IBM Consulting
### @@@ Timothy Burrell, MD, MBA – IBM Consulting ### 1658852###Co-Author###Associate Partner###IBM Consulting###
Co-Author: Timothy Burrell, MD, MBA – IBM Consulting
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Mary S. Anthony, PhD – RTI International Health Solutions ### 1095302###Co-Author###Senior Director, Epidemiology###RTI International Health Solutions###
Co-Author: Mary S. Anthony, PhD – RTI International Health Solutions
### @@@ Azadeh Shoaibi, PhD, MHS – FDA ### 1358855###Co-Author###Associate Director Post-market Surveillance###FDA###
Co-Author: Azadeh Shoaibi, PhD, MHS – FDA
###
Risk of Osteoporotic Fractures in Menopausal Women with Common Mental Health Diagnoses Prescribed SSRI/SNRI antidepressants: A Self-controlled Case Series

Dana Alsugeir, Msc. PharmD. – University college london ### 1657708###Presenting Author###PhD student###University college london###
Presenting Author: Dana Alsugeir, Msc. PharmD. – University college london
### @@@ Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1358231###Co-Author###Professor###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Li Wei, MBChB, MSc, MPH, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
### @@@ Ruth Brauer, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom ### 1062558###Co-Author###Lecturer in Pharmacoepidemiology###Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom###
Co-Author: Ruth Brauer, PhD – Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
###
Risk of out-of-hospital cardiac arrest (OHCA) and anticholinergic burden in Taiwan: a case-crossover and case-case-time-control study

Chris Tzu-Ting Su, PharmD – 1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994371###Presenting Author###PhD candidate###1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Chris Tzu-Ting Su, PharmD – 1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Ming-Jen Tsai – 2. Department of Emergency Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City 600, Taiwan. ### 2325461###Co-Author######2. Department of Emergency Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City 600, Taiwan.###
Co-Author: Ming-Jen Tsai – 2. Department of Emergency Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City 600, Taiwan.
###
Risk of Pregnancy Loss after Prenatal Exposure to Doxycycline: A Retrospective Cohort Study

Hung-Kai Chen, MClinPharm – University of Florida ### 2325211###Presenting Author###Graduate student###University of Florida###
Presenting Author: Hung-Kai Chen, MClinPharm – University of Florida
### @@@ Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325434###Co-Author###Research Scientist###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Nicole E. E. Smolinski, PharmD – University of Florida ### 1358688###Co-Author###Graduate Student###University of Florida###
Co-Author: Nicole E. E. Smolinski, PharmD – University of Florida
### @@@ Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy ### 1358834###Co-Author###Graduate Student###University of Florida, Department of Pharmaceutical Outcomes & Policy###
Co-Author: Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy
### @@@ Celeste LY Ewig, PharmD – University of Florida ### 1657495###Co-Author###Graduate Assistant###University of Florida###
Co-Author: Celeste LY Ewig, PharmD – University of Florida
### @@@ Matthew R. Muschett, PharmD (he/him/his) – University of Florida ### 1655771###Co-Author###Graduate Research Assistant###University of Florida###
Co-Author: Matthew R. Muschett, PharmD (he/him/his) – University of Florida
### he/him/his @@@ Priyanka J. Kulkarni, MPH (she/her/hers) – University of Florida ### 2325414###Co-Author###Research Assistant###University of Florida###
Co-Author: Priyanka J. Kulkarni, MPH (she/her/hers) – University of Florida
### she/her/hers @@@ Wen Wen – University of Florida ### 2325415###Co-Author######University of Florida###
Co-Author: Wen Wen – University of Florida
### @@@ Suzanne Gilboa – National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA ### 1991894###Co-Author######National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA###
Co-Author: Suzanne Gilboa – National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
### @@@ Dana Meaney Delman – National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA ### 2325416###Co-Author######National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA###
Co-Author: Dana Meaney Delman – National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
### @@@ Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine ### 1991648###Co-Author######Department of Genetic Medicine, Johns Hopkins School of Medicine###
Co-Author: Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine
### @@@ Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Co-Author: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers
Risk of Prenatal Exposure to Teratogenic Medications: Development of Evidence for the Teratogenic Risk Impact and Mitigation (TRIM) Tool

Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy ### 1358834###Presenting Author###Graduate Student###University of Florida, Department of Pharmaceutical Outcomes & Policy###
Presenting Author: Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy
### @@@ Celeste LY Ewig, PharmD – University of Florida ### 1657495###Co-Author###Graduate Assistant###University of Florida###
Co-Author: Celeste LY Ewig, PharmD – University of Florida
### @@@ Nicole E. E. Smolinski, PharmD – University of Florida ### 1358688###Co-Author###Graduate Student###University of Florida###
Co-Author: Nicole E. E. Smolinski, PharmD – University of Florida
### @@@ Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration ### 1360117###Co-Author###Associate Director for Research and Strategic Initiatives###US Food and Drug Administration###
Co-Author: Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration
### @@@ Cynthia LaCivita, PharmD – US Food and Drug Administration ### 1993690###Co-Author###Director Division of RIsk Managment###US Food and Drug Administration###
Co-Author: Cynthia LaCivita, PharmD – US Food and Drug Administration
### @@@ Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration ### 1062973###Co-Author###Epidemiologist###U.S. Food and Drug Administration###
Co-Author: Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration
### @@@ Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325434###Co-Author###Research Scientist###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Co-Author###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine ### 1991648###Co-Author######Department of Genetic Medicine, Johns Hopkins School of Medicine###
Co-Author: Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine
### @@@ Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Co-Author: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers
Risk of serious infections in psoriasis/psoriatic arthritis biological drug users: a large-scale, propensity score matched cohort study using the Italian VALORE Project distributed database

Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330030###Presenting Author###Post-doc fellowship###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Presenting Author: Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330034###Co-Author######Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Co-Author###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###
Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Massimo Carollo – University of Verona, Verona ### 2330200###Co-Author######University of Verona, Verona###
Co-Author: Massimo Carollo – University of Verona, Verona
### @@@ Federica Soardo – University of Verona, Verona ### 2330992###Co-Author######University of Verona, Verona###
Co-Author: Federica Soardo – University of Verona, Verona
### @@@ Chiara Bellitto, MS (she/her/hers) – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330032###Co-Author###Post-graduate student###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Chiara Bellitto, MS (she/her/hers) – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### she/her/hers @@@ Clèment Mathieu – University of Verona, Verona ### 2330199###Co-Author######University of Verona, Verona###
Co-Author: Clèment Mathieu – University of Verona, Verona
### @@@ Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330031###Co-Author###Researcher###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy ### 2330035###Co-Author######Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy###
Co-Author: Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy
### @@@ Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy ### 2330036###Co-Author######Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy###
Co-Author: Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy
### @@@ Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia ### 2330037###Co-Author######Centro Regionale Farmacovigilanza Regione Puglia###
Co-Author: Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia
### @@@ Paolo Stella – Apulian Regional Health Department, Bari, Italy ### 2330038###Co-Author######Apulian Regional Health Department, Bari, Italy###
Co-Author: Paolo Stella – Apulian Regional Health Department, Bari, Italy
### @@@ Anna Cavazzana – Azienda Zero, Regione Veneto, Italy ### 2330039###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Anna Cavazzana – Azienda Zero, Regione Veneto, Italy
### @@@ Angela Scapin – Azienda Zero, Regione Veneto, Italy ### 2330040###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Angela Scapin – Azienda Zero, Regione Veneto, Italy
### @@@ Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy ### 2330041###Co-Author######Department of Epidemiology, Lazio Regional Health Service, Rome, Italy###
Co-Author: Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy
### @@@ Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service ### 2329370###Co-Author######Department of Epidemiology ASL Roma 1, Lazio Regional Health Service###
Co-Author: Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service
### @@@ Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330042###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330043###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330044###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330045###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330046###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330047###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Rita Francesca Scarpelli – Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy ### 2330201###Co-Author######Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy###
Co-Author: Rita Francesca Scarpelli – Dipartimento Salute e Welfare, Calabria region, Catanzaro, Italy
### @@@ Giovambattista De Sarro – University “Magna Graciae” of Catanzaro, Catanzaro, Italy ### 2330202###Co-Author######University “Magna Graciae” of Catanzaro, Catanzaro, Italy###
Co-Author: Giovambattista De Sarro – University “Magna Graciae” of Catanzaro, Catanzaro, Italy
### @@@ Stefania Spila Alegiani – Italian National Institute of Health ### 2329364###Co-Author######Italian National Institute of Health###
Co-Author: Stefania Spila Alegiani – Italian National Institute of Health
### @@@ Marco Massari – Italian National Institute of Health ### 2329371###Co-Author######Italian National Institute of Health###
Co-Author: Marco Massari – Italian National Institute of Health
### @@@ Claudio Guarneri – claudio.guarneri@unime.it ### 2330993###Co-Author######claudio.guarneri@unime.it###
Co-Author: Claudio Guarneri – claudio.guarneri@unime.it
### @@@ Paolo Gisondi – paolo.gisondi@univr.it ### 2330994###Co-Author######paolo.gisondi@univr.it###
Co-Author: Paolo Gisondi – paolo.gisondi@univr.it
### @@@ Andrea Fontana – Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy ### 2330995###Co-Author######Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy###
Co-Author: Andrea Fontana – Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
### @@@ Gianluca Trifirò, MD, FISPE – Università di Verona ### 1302766###Co-Author###Full Professor of Pharmacology###Università di Verona###
Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona
###
Risk of suicidal attempt and GLP-1RAs in type 2 diabetes population in Taiwan: a case-crossover and case-case-time-control study

Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his @@@ Chris Tzu-Ting Su, PharmD – 1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 1994371###Presenting Author###PhD candidate###1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Chris Tzu-Ting Su, PharmD – 1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1658473###Co-Author###Master of clinical pharmacy###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
###
Risk of Urogenital Infections in Patients with Type 2 Diabetes Initiating SGLT2i versus GLP-1RA: A Danish Emulated Target Trial

Christine Ljungberg, MD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. ### 2325324###Presenting Author###PhD student###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.###
Presenting Author: Christine Ljungberg, MD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.
### @@@ Frederik P.B Kristensen, MD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark. ### 1062972###Co-Author###PhD student###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark.###
Co-Author: Frederik P.B Kristensen, MD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus N, Denmark.
### @@@ Michael Dalager-Pedersen – Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark ### 2325325###Co-Author######Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark###
Co-Author: Michael Dalager-Pedersen – Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark
### @@@ Christina Vandenbroucke-Grauls – Department of Medical Microbiology and Infection Control, Amsterdam University Medical Centers, Amsterdam, The Netherlands ### 2325326###Co-Author######Department of Medical Microbiology and Infection Control, Amsterdam University Medical Centers, Amsterdam, The Netherlands###
Co-Author: Christina Vandenbroucke-Grauls – Department of Medical Microbiology and Infection Control, Amsterdam University Medical Centers, Amsterdam, The Netherlands
### @@@ Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1063034###Co-Author###Chief consultant, professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1063102###Co-Author###Professor and Consultant Physician###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Reimar W W. Thomsen, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###
Risk of Uveitis Following COVID-19 Diagnosis

Ping Shao, M.B.B.S, MS – Regeneron ### 1991789###Presenting Author###Associate Director###Regeneron###
Presenting Author: Ping Shao, M.B.B.S, MS – Regeneron
### @@@ Irene J. Chen, MS – University of Southern California ### 2325207###Co-Author######University of Southern California###
Co-Author: Irene J. Chen, MS – University of Southern California
### @@@ Maggie Hymowitz, MD – Regeneron ### 2325208###Co-Author###Medical Director###Regeneron###
Co-Author: Maggie Hymowitz, MD – Regeneron
### @@@ Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals ### 1991788###Co-Author###Associate Director of Pharmacoepidemiology###Regeneron Pharmaceuticals###
Co-Author: Alexander Breskin, PhD, MPH – Regeneron Pharmaceuticals
### @@@ Daniel Keebler, PhD (he/him/his) – Regeneron ### 1991792###Co-Author###Director, Pharmacoepidemiology###Regeneron###
Co-Author: Daniel Keebler, PhD (he/him/his) – Regeneron
### he/him/his @@@ Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron ### 1991877###Co-Author###VP, Head of Pharmacoepidemiology###Regeneron###
Co-Author: Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron
### she/her/hers @@@ Angelika Manthripragada, PhD – Regeneron ### 2325209###Co-Author###Director, Pharmacoepidemiology###Regeneron###
Co-Author: Angelika Manthripragada, PhD – Regeneron
###
Rotavirus vaccine safety surveillance using a tree‐temporal scan statistic signal-detection method

Na-Young Jeong, PhD – Ewha Womans University ### 1062838###Presenting Author###Postdoctoral researcher###Ewha Womans University###
Presenting Author: Na-Young Jeong, PhD – Ewha Womans University
### @@@ Haerin Cho, MA – Ewha Womans University ### 1660195###Co-Author###PhD student###Ewha Womans University###
Co-Author: Haerin Cho, MA – Ewha Womans University
### @@@ Hee-Jin Kim, MA – Ewha Womans University ### 1063354###Co-Author###PhD student###Ewha Womans University###
Co-Author: Hee-Jin Kim, MA – Ewha Womans University
### @@@ Nam-Kyong Choi – Ewha Womans University ### 1660178###Co-Author######Ewha Womans University###
Co-Author: Nam-Kyong Choi – Ewha Womans University
###
S
Safety of Anti-infectives

Anne M. Butler, PhD, MS – Washington University School of Medicine ### 1062638###Moderator###Assistant Professor###Washington University School of Medicine###
Moderator: Anne M. Butler, PhD, MS – Washington University School of Medicine
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Moderator###Professor###University of Southern Denmark###
Moderator: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
SARS-CoV-2 infection and risk of subsequent demyelinating diseases – a nationwide register-based cohort study in Sweden

Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1358933###Presenting Author###Professor of Register Epidemiology###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Presenting Author: Fredrik Nyberg, MD PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Snieguole Vingeliene – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325167###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Snieguole Vingeliene – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ### 1659121###Co-Author###Assoc. Prof.###School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden###
Co-Author: Huiqi Li, PhD – School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
### @@@ Helena Backman – Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325168###Co-Author######Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Helena Backman – Department of Obstetrics and Gynaecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Ruzan Udumyan, PhD – Clinical Epidemiology and Biostatistics, Department of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. ### 2325169###Co-Author######Clinical Epidemiology and Biostatistics, Department of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.###
Co-Author: Ruzan Udumyan, PhD – Clinical Epidemiology and Biostatistics, Department of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
### @@@ Johan Jendeberg, MD, PhD – Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. ### 2325170###Co-Author###Consultant radiologist###Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.###
Co-Author: Johan Jendeberg, MD, PhD – Department of Radiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
### @@@ Gunlög Rasmussen – Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325171###Co-Author######Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Gunlög Rasmussen – Department of Infectious Diseases, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Martin Sundqvist – Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325172###Co-Author######Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Martin Sundqvist – Department of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Katja Fall – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 1991607###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Katja Fall – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Ayako Hiyoshi, PhD – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325173###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Ayako Hiyoshi, PhD – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
### @@@ Scott Montgomery – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden ### 2325174###Co-Author######Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden###
Co-Author: Scott Montgomery – Clinical Epidemiology and Biostatistics, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
###
Screening of drug-related adverse events by sequence symmetry analysis with spline-based self-controlled case-series design for dose-response relationship: a proof of concept study

Motohiko Adomi, MD, MS – Harvard University ### 2325359###Presenting Author###PhD student###Harvard University###
Presenting Author: Motohiko Adomi, MD, MS – Harvard University
### @@@ Kazuaki Uda – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan ### 2325364###Co-Author######Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan###
Co-Author: Kazuaki Uda – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
### @@@ Ryota Inokuchi – University of Tokyo ### 2325360###Co-Author######University of Tokyo###
Co-Author: Ryota Inokuchi – University of Tokyo
### @@@ Nanako Tamiya – University of Tsukuba ### 2325361###Co-Author######University of Tsukuba###
Co-Author: Nanako Tamiya – University of Tsukuba
### @@@ Masao Iwagami – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan ### 2325365###Co-Author######Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan###
Co-Author: Masao Iwagami – Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan
###
SIG Meetings
SIG Meetings
Skin Cancer Risk Associated With Statin Treatment: A Target Trial Emulation Study

Ping Sheng Chou – School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan ### 2325289###Presenting Author###PharmD student###School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan###
Presenting Author: Ping Sheng Chou – School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, Taiwan
### @@@ Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1658473###Co-Author###Master of clinical pharmacy###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### @@@ Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan ### 1358157###Co-Author###Professor###Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan###
Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
### he/him/his
Social Evening at Spindler & Klatt
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Speaker Ready Room
Specification of Time Zero in Causal Inference Studies Using Real-World Data: Challenges and Solutions.

Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions ### 1062596###Lead Speaker###Director, Epidemiology###RTI Health Solutions###
Lead Speaker: Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions
### @@@ Jaume Aguado, PhD (he/him/his) – RTI Health Solutions ### 1063271###Speaker###Director, Biostatistics###RTI Health Solutions###
Speaker: Jaume Aguado, PhD (he/him/his) – RTI Health Solutions
### he/him/his @@@ Ellen Caniglia, ScD – University of Pennsylvania School of Medicine ### 1655294###Speaker###Assistant Professor###University of Pennsylvania School of Medicine###
Speaker: Ellen Caniglia, ScD – University of Pennsylvania School of Medicine
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Speaker###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Speaker: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Camille Maringe, PhD – London Scholl of Hygiene & Tropical Medicine ### 1655676###Speaker###Assistant Professor###London Scholl of Hygiene & Tropical Medicine###
Speaker: Camille Maringe, PhD – London Scholl of Hygiene & Tropical Medicine
### @@@ Jonathan Sterne, MSc PhD (he/him/his) – University of Bristol ### 2325178###Speaker###Professor of Medical Statistics and Epidemiology###University of Bristol###
Speaker: Jonathan Sterne, MSc PhD (he/him/his) – University of Bristol
### he/him/his
Spotlight Poster Session A
Spotlight Poster Session B
Spotlight Poster Session C
Stroke Risk Following Receipt of COVID-19 Bivalent Vaccines Among U.S. Adults Aged ≥65 Years

Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration ### 1659299###Presenting Author###Mathematical Statistician###Center for Biologics Evaluation and Research, Food and Drug Administration###
Presenting Author: Yun Lu, PhD – Center for Biologics Evaluation and Research, Food and Drug Administration
### @@@ Kathryn Matuska, BA – Acumen, LLC ### 1659336###Co-Author###Policy Lead###Acumen, LLC###
Co-Author: Kathryn Matuska, BA – Acumen, LLC
### @@@ Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC ### 2325538###Co-Author###Senior Policy Assoicate###Acumen, LLC###
Co-Author: Gita Nadimpalli, MD, MPH, PhD – Acumen, LLC
### @@@ Yuxin Ma – Acumen LLC ### 2325286###Co-Author######Acumen LLC###
Co-Author: Yuxin Ma – Acumen LLC
### @@@ Nathan N. Duma, PhD – Acumen LLC ### 2325539###Co-Author######Acumen LLC###
Co-Author: Nathan N. Duma, PhD – Acumen LLC
### @@@ Henry Zhang – Food and Drug Administration ### 2325540###Co-Author######Food and Drug Administration###
Co-Author: Henry Zhang – Food and Drug Administration
### @@@ Yiyun Chiang, MPH – Acumen LLC ### 2325287###Co-Author###Data and Policy Analyst - Statistical Programmer###Acumen LLC###
Co-Author: Yiyun Chiang, MPH – Acumen LLC
### @@@ Hai Lyu – Acumen., LLC ### 2325541###Co-Author###Policy Associate###Acumen., LLC###
Co-Author: Hai Lyu – Acumen., LLC
### @@@ Yoganand Chillarige, MPA – Acumen LLC ### 1655508###Co-Author###Research Manager###Acumen LLC###
Co-Author: Yoganand Chillarige, MPA – Acumen LLC
### @@@ Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA ### 1358531###Co-Author######Centers for Medicare & Medicaid Services, Washington, DC, USA###
Co-Author: Jeffrey A. Kelman, MD, MMSc – Centers for Medicare & Medicaid Services, Washington, DC, USA
### @@@ Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA ### 1358508###Co-Author###Deputy Director###Office of Biostatistics and Pharmacovigilance, CBER, US FDA###
Co-Author: Richard A. Forshee, PhD – Office of Biostatistics and Pharmacovigilance, CBER, US FDA
### @@@ Steven A. Anderson, PhD, MPP – Food and Drug Administration ### 1358532###Co-Author######Food and Drug Administration###
Co-Author: Steven A. Anderson, PhD, MPP – Food and Drug Administration
###
Students/Early Career Professionals Meet & Greet
Surprising Benefits of Diabetes Drugs

Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School ### 1655331###Moderator###Instructor in Medicine###Brigham and Women's Hospital and Harvard Medical School###
Moderator: Phyo T. Htoo, MD, PhD – Brigham and Women's Hospital and Harvard Medical School
### @@@ Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany ### 2328243###Moderator###Associate Professor###Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany###
Moderator: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany
### he/him/his
Switching from warfarin to direct oral anticoagulants in older adults with atrial fibrillation: a US nationwide cohort study

Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA ### 1360618###Co-Author###Professor of Medicine, Harvard Medical School###Massachusetts General Hospital, Boston, MA###
Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA
### @@@ Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School ### 2325571###Co-Author######Hebrew Rehabilitation Center, Harvard Medical School###
Co-Author: Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1991377###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Julianna Mastrorilli – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325572###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Julianna Mastrorilli – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
###
Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the Italian multi-regional VALORE distributed database network

Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330031###Presenting Author###Researcher###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Presenting Author: Giorgia Pellegrini, MS – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330030###Co-Author###Post-doc fellowship###Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Andrea Spini, PharmD PhD – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona ### 1993969###Co-Author###Assistant Professor###Department of Diagnostics and Public Health, University of Verona, Verona###
Co-Author: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
### @@@ Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy ### 2330034###Co-Author######Department of Diagnostics and Public Health, University of Verona, Verona, Italy###
Co-Author: Luca L’Abbate – Department of Diagnostics and Public Health, University of Verona, Verona, Italy
### @@@ Massimo Carollo – University of Verona, Verona ### 2330200###Co-Author######University of Verona, Verona###
Co-Author: Massimo Carollo – University of Verona, Verona
### @@@ Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy ### 2330035###Co-Author######Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy###
Co-Author: Olivia Leoni – Lombardy Regional Centre of Pharmacovigilance and Regional Epidemiologic Observatory, Milan, Italy
### @@@ Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy ### 2330036###Co-Author######Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy###
Co-Author: Arianna Mazzone – Azienda Regionale per l’Innovazione e gli Acquisti, S.p.A, Milan, Italy
### @@@ Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia ### 2330037###Co-Author######Centro Regionale Farmacovigilanza Regione Puglia###
Co-Author: Domenica Ancona – Centro Regionale Farmacovigilanza Regione Puglia
### @@@ Paolo Stella – Apulian Regional Health Department, Bari, Italy ### 2330038###Co-Author######Apulian Regional Health Department, Bari, Italy###
Co-Author: Paolo Stella – Apulian Regional Health Department, Bari, Italy
### @@@ Anna Cavazzana – Azienda Zero, Regione Veneto, Italy ### 2330039###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Anna Cavazzana – Azienda Zero, Regione Veneto, Italy
### @@@ Angela Scapin – Azienda Zero, Regione Veneto, Italy ### 2330040###Co-Author######Azienda Zero, Regione Veneto, Italy###
Co-Author: Angela Scapin – Azienda Zero, Regione Veneto, Italy
### @@@ Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy ### 2330041###Co-Author######Department of Epidemiology, Lazio Regional Health Service, Rome, Italy###
Co-Author: Sara Lopes – Department of Epidemiology, Lazio Regional Health Service, Rome, Italy
### @@@ Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service ### 2329370###Co-Author######Department of Epidemiology ASL Roma 1, Lazio Regional Health Service###
Co-Author: Valeria Belleudi – Department of Epidemiology ASL Roma 1, Lazio Regional Health Service
### @@@ Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330042###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Stefano Ledda – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy ### 2330043###Co-Author######Regione Autonoma della Sardegna, Cagliari, Italy###
Co-Author: Paolo Carta – Regione Autonoma della Sardegna, Cagliari, Italy
### @@@ Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330044###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Paola Rossi – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy ### 2330045###Co-Author######Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy###
Co-Author: Lucian Ejlli – Friuli-Venezia Giulia Regional Center of Pharmacovigilance, Trieste, Italy
### @@@ Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330046###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Ester Sapigni – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy ### 2330047###Co-Author######Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy###
Co-Author: Aurora Puccini – Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy
### @@@ Claudio Guarneri – claudio.guarneri@unime.it ### 2330993###Co-Author######claudio.guarneri@unime.it###
Co-Author: Claudio Guarneri – claudio.guarneri@unime.it
### @@@ Paolo Gisondi – paolo.gisondi@univr.it ### 2330994###Co-Author######paolo.gisondi@univr.it###
Co-Author: Paolo Gisondi – paolo.gisondi@univr.it
### @@@ Stefania Spila Alegiani – Italian National Institute of Health ### 2329364###Co-Author######Italian National Institute of Health###
Co-Author: Stefania Spila Alegiani – Italian National Institute of Health
### @@@ Marco Massari – Italian National Institute of Health ### 2329371###Co-Author######Italian National Institute of Health###
Co-Author: Marco Massari – Italian National Institute of Health
### @@@ Gianluca Trifirò, MD, FISPE – Università di Verona ### 1302766###Co-Author###Full Professor of Pharmacology###Università di Verona###
Co-Author: Gianluca Trifirò, MD, FISPE – Università di Verona
###
T
Target Trial Emulation with Real World Evidence: Regulatory Grade Pharmacoepidemiology in the SIGMA consortium

Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062658###Lead Speaker###Prof. Dr. sc. hum.###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Lead Speaker: Ulrike Haug, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### @@@ Juan Jose Abellan, MSc, PhD – European Medicines Agency ### 1991548###Speaker###Biostatistics and RWE Senior Specialist###European Medicines Agency###
Speaker: Juan Jose Abellan, MSc, PhD – European Medicines Agency
### @@@ Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1062544###Speaker###Professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Speaker: Vera Ehrenstein, MPH, DSc – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Buket Öztürk Esen, MSc, PhD (she/her/hers) – Aarhus University, Aarhus, Denmark ### 1062595###Speaker###Postdoctoral Researcher###Aarhus University, Aarhus, Denmark###
Speaker: Buket Öztürk Esen, MSc, PhD (she/her/hers) – Aarhus University, Aarhus, Denmark
### she/her/hers @@@ Vanessa Didelez, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 2325330###Speaker###Professor of Statistics and Causal Inference###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Vanessa Didelez, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Wiebke Schäfer, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062894###Speaker###Post-doctoral researcher###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Wiebke Schäfer, PhD – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### @@@ Jonas Reinold, MSC, PhD (he/him/his) – Department Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062999###Speaker###Head of Unit###Department Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Speaker: Jonas Reinold, MSC, PhD (he/him/his) – Department Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS
### he/him/his @@@ David Martinez, MSc – RTI Health Solutions ### 1658516###Speaker###Senior Statistician###RTI Health Solutions###
Speaker: David Martinez, MSc – RTI Health Solutions
### @@@ Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions ### 1062596###Speaker###Director, Epidemiology###RTI Health Solutions###
Speaker: Xabier Garcia de Albeniz Martinez, MD, PhD – RTI Health Solutions
### @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Oisin Ryan, PhD – University Medical Center Utrecht, Utrecht, the Netherlands ### 2325279###Speaker###Assistant Professor###University Medical Center Utrecht, Utrecht, the Netherlands###
Speaker: Oisin Ryan, PhD – University Medical Center Utrecht, Utrecht, the Netherlands
### @@@ Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet ### 1932107###Speaker###Postdoctoral Researcher###CAUSALab at IMM, Karolinska Institutet###
Speaker: Jessica C. Young, PhD (she/her/hers) – CAUSALab at IMM, Karolinska Institutet
### she/her/hers
The association between exposure to GLP-1 receptor agonists and risk of suicide-related and self-harm-related events in diabetic patients from the UK general practice IQVIA Medical Research Data (IMRD) database

Andrei Barbulescu, PhD (he/him/his) – European Medicines Agency ### 2325485###Presenting Author###pharmacoepidemiologist###European Medicines Agency###
Presenting Author: Andrei Barbulescu, PhD (he/him/his) – European Medicines Agency
### he/him/his @@@ María Clara Restrepo-Méndez, PhD – European Medicines Agency ### 1992322###Co-Author###Pharmacoepidemiologist###European Medicines Agency###
Co-Author: María Clara Restrepo-Méndez, PhD – European Medicines Agency
### @@@ Daniel R. Morales, PhD – European Medicines Agency ### 1062632###Co-Author###pharmacoepidemiologist###European Medicines Agency###
Co-Author: Daniel R. Morales, PhD – European Medicines Agency
### @@@ Robert Flynn, PhD – European Medicines Agency, University of Dundee ### 1658035###Co-Author###pharmacoepidemiologist###European Medicines Agency, University of Dundee###
Co-Author: Robert Flynn, PhD – European Medicines Agency, University of Dundee
###
The Association between Oral Antibiotic Use and Asthma Exacerbation in Children seen in an Ambulatory Care Setting

Carmen Canete Ramirez, PharmD (she/her/hers) – University of Montreal ### 2325334###Presenting Author###MSc Student###University of Montreal###
Presenting Author: Carmen Canete Ramirez, PharmD (she/her/hers) – University of Montreal
### she/her/hers @@@ Ana C Blanchard, MD, MSc – University of Montreal ### 2325386###Co-Author######University of Montreal###
Co-Author: Ana C Blanchard, MD, MSc – University of Montreal
### @@@ Amélie Forget, MSc – University of Montreal ### 2325387###Co-Author######University of Montreal###
Co-Author: Amélie Forget, MSc – University of Montreal
### @@@ Marie-Élaine Métras, PharmD, MSc – University of Montreal ### 2325388###Co-Author######University of Montreal###
Co-Author: Marie-Élaine Métras, PharmD, MSc – University of Montreal
### @@@ Tibor Schuster, PhD – McGill University ### 1093618###Co-Author######McGill University###
Co-Author: Tibor Schuster, PhD – McGill University
### @@@ Lucie Blais, PhD – University of Montreal ### 2325389###Co-Author######University of Montreal###
Co-Author: Lucie Blais, PhD – University of Montreal
### @@@ Cristina Longo, PhD – University of Montreal ### 2325390###Co-Author######University of Montreal###
Co-Author: Cristina Longo, PhD – University of Montreal
###
The Comparative Risk of Urinary Tract Infections with Degarelix and Gonadotropin-Releasing Hormone Agonists among Patients Diagnosed with Prostate Cancer: A Population-Based Cohort Study

Farzin Khosrow-Khavar, PhD – Rutgers University ### 2325383###Presenting Author###Instructor###Rutgers University###
Presenting Author: Farzin Khosrow-Khavar, PhD – Rutgers University
### @@@ Elisa Bandera, MD, PhD – Rutgers Cancer Institute of New Jersey ### 2325384###Co-Author######Rutgers Cancer Institute of New Jersey###
Co-Author: Elisa Bandera, MD, PhD – Rutgers Cancer Institute of New Jersey
### @@@ Chintan Dave, PharmD, PhD – Rutgers University ### 1655382###Co-Author###Assistant Professor of Pharmacy and Epidemiology###Rutgers University###
Co-Author: Chintan Dave, PharmD, PhD – Rutgers University
###
The effect of influenza vaccination on risk of myocardial infarction (MI) in patients taking statins: a self-controlled case series study

William E. Henley – University of Exeter ### 1660061###Presenting Author######University of Exeter###
Presenting Author: William E. Henley – University of Exeter
### @@@ Adam Streeter – Universität Münster ### 1991740###Co-Author######Universität Münster###
Co-Author: Adam Streeter – Universität Münster
###
The effectiveness of adalimumab biosimilars and originator for the treatment of Psoriasis: A target trial emulation study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

Duc Binh Phan, MSc – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom. ### 2326723###Presenting Author###PhD Student###Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.###
Presenting Author: Duc Binh Phan, MSc – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
### @@@ Anthony Bewley – Barts Health NHS Trust and Queen Mary University of London Medical School, London, United Kingdom. ### 2330952###Co-Author######Barts Health NHS Trust and Queen Mary University of London Medical School, London, United Kingdom.###
Co-Author: Anthony Bewley – Barts Health NHS Trust and Queen Mary University of London Medical School, London, United Kingdom.
### @@@ Philip Laws – Department of Dermatology, University of Leeds, Leeds, United Kingdom. ### 2330953###Co-Author######Department of Dermatology, University of Leeds, Leeds, United Kingdom.###
Co-Author: Philip Laws – Department of Dermatology, University of Leeds, Leeds, United Kingdom.
### @@@ Teena Mackenzie – Royal Berkshire NHS Foundation Trust, Reading, United Kingdom. ### 2330954###Co-Author######Royal Berkshire NHS Foundation Trust, Reading, United Kingdom.###
Co-Author: Teena Mackenzie – Royal Berkshire NHS Foundation Trust, Reading, United Kingdom.
### @@@ Catherine Smith – St Johns Institute of Dermatology, Guys & St Thomas NHS Foundation Trust, Kings College London, London, United Kingdom. ### 2328472###Co-Author######St Johns Institute of Dermatology, Guys & St Thomas NHS Foundation Trust, Kings College London, London, United Kingdom.###
Co-Author: Catherine Smith – St Johns Institute of Dermatology, Guys & St Thomas NHS Foundation Trust, Kings College London, London, United Kingdom.
### @@@ Christopher Griffiths – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, Department of Dermatology, King’s College Hospital, King’s College London, London, United Kingdom. ### 2330955###Co-Author######Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, Department of Dermatology, King’s College Hospital, King’s College London, London, United Kingdom.###
Co-Author: Christopher Griffiths – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, Department of Dermatology, King’s College Hospital, King’s College London, London, United Kingdom.
### @@@ Mark Lunt – Versus Arthritis Epidemiology Unit, The University of Manchester, Manchester, United Kingdom ### 2326729###Co-Author######Versus Arthritis Epidemiology Unit, The University of Manchester, Manchester, United Kingdom###
Co-Author: Mark Lunt – Versus Arthritis Epidemiology Unit, The University of Manchester, Manchester, United Kingdom
### @@@ Richard B Warren – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom. ### 2326732###Co-Author######Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.###
Co-Author: Richard B Warren – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
### @@@ Zenas Zee Ngai Yiu – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom. ### 2326733###Co-Author######Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.###
Co-Author: Zenas Zee Ngai Yiu – Dermatology Centre, Northern Care Alliance NHS Foundation Trust, National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom.
###
The Evolving Landscape of Drug Safety: Research, Reporting, and Real-World Outcomes

Amir Sarayani, PhamrD, MPH, PhD (he/him/his) – Janssen Research & Development, Johnson & Johnson ### 2325185###Moderator###Associate Director###Janssen Research & Development, Johnson & Johnson###
Moderator: Amir Sarayani, PhamrD, MPH, PhD (he/him/his) – Janssen Research & Development, Johnson & Johnson
### he/him/his @@@ Peter GM Mol, PhD PharmD (he/him/his) – Dutch Medicines Evaluation Board ### 1659255###Moderator###Professor of drug regulatory science###Dutch Medicines Evaluation Board###
Moderator: Peter GM Mol, PhD PharmD (he/him/his) – Dutch Medicines Evaluation Board
### he/him/his
The extent and magnitude of bias in case-crossover studies of real-world non-transient medications patterns: a simulation study with real-world examples

Hsiao-Ching Huang, MPH, PhD – Reagan-Udall Foundation for the FDA ### 2325458###Presenting Author###Research Scientist###Reagan-Udall Foundation for the FDA###
Presenting Author: Hsiao-Ching Huang, MPH, PhD – Reagan-Udall Foundation for the FDA
### @@@ Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1062862###Co-Author###Assistant Professor###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Saria Awadalla – University of Illinois Chicago, School of Public Health ### 1994592###Co-Author######University of Illinois Chicago, School of Public Health###
Co-Author: Saria Awadalla – University of Illinois Chicago, School of Public Health
### @@@ Daniel R. Touchette, PharmD, MA – University of Illinois Chicago, College of Pharmacy ### 1658080###Co-Author######University of Illinois Chicago, College of Pharmacy###
Co-Author: Daniel R. Touchette, PharmD, MA – University of Illinois Chicago, College of Pharmacy
### @@@ Glen T. Schumock – University of Illinois Chicago, College of Pharmacy ### 1994591###Co-Author######University of Illinois Chicago, College of Pharmacy###
Co-Author: Glen T. Schumock – University of Illinois Chicago, College of Pharmacy
### @@@ Todd A. Lee, PharmD, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago ### 1657993###Co-Author######Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago###
Co-Author: Todd A. Lee, PharmD, PhD – Department of Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago
###
The Final Word
The growing global problem of drug shortages: Understanding their impact on research, patients and healthcare systems

Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1062862###Lead Speaker###Assistant Professor###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Lead Speaker: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Katie Suda, PharmD MS (she/her/hers) – University of Pittsburgh School of Medicine, Department of Medicine, Division of General Internal Medicine and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, ### 1360024###Speaker###Professor###University of Pittsburgh School of Medicine, Department of Medicine, Division of General Internal Medicine and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System,###
Speaker: Katie Suda, PharmD MS (she/her/hers) – University of Pittsburgh School of Medicine, Department of Medicine, Division of General Internal Medicine and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System,
### she/her/hers @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Speaker###Professor###University of Southern Denmark###
Speaker: Anton Pottegård, PhD, DMSc – University of Southern Denmark
###
The Hidden Role Of AI In Treatment Selection: Friend Or Foe To The Study And Practice Of Pharmacoepidemiology?

Harriet Dickinson, MPhil, PhD – Gilead ### 1991252###Lead Speaker###RWE Director###Gilead###
Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead
### @@@ Enriqueta Vallejo-Yagüe, PhD, Pharm – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland ### 2325322###Speaker###Advanced Postdoc and Team Lead###Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland###
Speaker: Enriqueta Vallejo-Yagüe, PhD, Pharm – Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
### @@@ Katoo Muylle, MSc, PhD (she/her/hers) – AstraZeneca ### 2325323###Speaker###Real World Evidence Manager###AstraZeneca###
Speaker: Katoo Muylle, MSc, PhD (she/her/hers) – AstraZeneca
### she/her/hers @@@ Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1655344###Speaker###Assistant Professor###University of North Carolina at Chapel Hill###
Speaker: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his @@@ Danica Marinac-Dabic – FDA ### 1088322###Speaker######FDA###
Speaker: Danica Marinac-Dabic – FDA
###
The Masking Phenomenon: Evaluating COVID-19 Vaccine Reports and Their Impact on AE Reporting in KAERS

Suvin Park – Ewha Womans University ### 1659876###Presenting Author###Seoul, Korea###Ewha Womans University###
Presenting Author: Suvin Park – Ewha Womans University
### @@@ Na-Young Jeong, PhD – Ewha Womans University ### 1062838###Co-Author###Postdoctoral researcher###Ewha Womans University###
Co-Author: Na-Young Jeong, PhD – Ewha Womans University
### @@@ Hui-Eon Lee – Ewha Womans University ### 1660185###Co-Author######Ewha Womans University###
Co-Author: Hui-Eon Lee – Ewha Womans University
### @@@ Hee-Jin Kim, MA – Ewha Womans University ### 1063354###Co-Author###PhD student###Ewha Womans University###
Co-Author: Hee-Jin Kim, MA – Ewha Womans University
### @@@ Eunsun Lim, MS – Ewha Womans University ### 1063363###Co-Author###PhD Student###Ewha Womans University###
Co-Author: Eunsun Lim, MS – Ewha Womans University
### @@@ Nam-Kyong Choi – Ewha Womans University ### 1660178###Co-Author######Ewha Womans University###
Co-Author: Nam-Kyong Choi – Ewha Womans University
###
The nature of uncertainties on the benefit-risk balance of anticancer medicines at initial marketing authorisation in the European Union

Anne Taams, MSc – Dutch Medicines Evaluation Board ### 2325534###Presenting Author###Assessor and researcher###Dutch Medicines Evaluation Board###
Presenting Author: Anne Taams, MSc – Dutch Medicines Evaluation Board
### @@@ Carla Herberts – Department Regulatory affairs, uniQure, Amsterdam, The Netherlands ### 2325535###Co-Author######Department Regulatory affairs, uniQure, Amsterdam, The Netherlands###
Co-Author: Carla Herberts – Department Regulatory affairs, uniQure, Amsterdam, The Netherlands
### @@@ Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University ### 1063247### Co-Author###Assistant Professor Clinical Therapeutics###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University###
Co-Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University
### he/him/his @@@ Toine Egberts – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands ### 1302793###Co-Author######Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands###
Co-Author: Toine Egberts – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands
### @@@ Francesco Pignatti, MD – European Medicines Agency ### 1659375###Co-Author######European Medicines Agency###
Co-Author: Francesco Pignatti, MD – European Medicines Agency
### @@@ Nikolaos Zafiropoulos – European Medicines Agency, Amsterdam, the Netherlands ### 2325536###Co-Author######European Medicines Agency, Amsterdam, the Netherlands###
Co-Author: Nikolaos Zafiropoulos – European Medicines Agency, Amsterdam, the Netherlands
###
The Pharmacoepidemiologist's Toolbox for Professional Empowerment

Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals ### 1360272###Lead Speaker###Sr Dir, Pharmacoepidemiology###Regeneron Pharmaceuticals###
Lead Speaker: Caitlin Knox, PhD MPH FISPE (she/her/hers) – Regeneron Pharmaceuticals
### she/her/hers @@@ Hope Mueller, Masters of Business – Currax Pharmaceuticals LLC ### 2344857###Speaker###Senior Vice President, Corporate Development and Strategy###Currax Pharmaceuticals LLC ###
Speaker: Hope Mueller, Masters of Business – Currax Pharmaceuticals LLC
### @@@ Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania ### 1359970###Speaker###Associate Professor of Medicine and Epidemiology###University of Pennsylvania###
Speaker: Vin Lo Re, III, MD, MSCE (he/him/his) – University of Pennsylvania
### he/him/his @@@ Lisa G. Pont, PhD, FISPE – University of Technology Sydney ### 1655255###Speaker###Professor of Pharmacy###University of Technology Sydney###
Speaker: Lisa G. Pont, PhD, FISPE – University of Technology Sydney
### @@@ Mary E. Ritchey, PhD, FISPE – CERobs Consulting ### 1994002###Speaker###Chief Scientific Officer###CERobs Consulting###
Speaker: Mary E. Ritchey, PhD, FISPE – CERobs Consulting
### @@@ Robert W. Platt, PhD (he/him/his) – McGill University ### 1358167###Speaker###Professor###McGill University###
Speaker: Robert W. Platt, PhD (he/him/his) – McGill University
### he/him/his @@@ Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1655344###Speaker###Assistant Professor###University of North Carolina at Chapel Hill###
Speaker: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his
The Pill-osophy of Making Medicines Safe

Hubert G. Leufkens, PhD, FISPE – University of Utrecht ### 1061394###Moderator###Emeritus Professor ###University of Utrecht###
Moderator: Hubert G. Leufkens, PhD, FISPE – University of Utrecht
### @@@ Jieni Li, MPH, PhD – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy ### 1991698###Moderator###Postdoctoral Fellow###University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy###
Moderator: Jieni Li, MPH, PhD – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy
###
The risk of cardiovascular (CV) events after initiation of SGLT2i, GLP-1RA, DPP4i, or SUs in patients with T2D and low-to-moderate CV risk

Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School ### 1655578###Presenting Author###Senior Research Specialist ###Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School###
Presenting Author: Helen Tesfaye, PharmD, MSc – Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School
### @@@ Julie M. Paik, MD, ScD – Brigham and Women's Hospital ### 1655332###Co-Author######Brigham and Women's Hospital###
Co-Author: Julie M. Paik, MD, ScD – Brigham and Women's Hospital
### @@@ Caroline Alix, BA – Brigham and Women's Hospital ### 2325341###Co-Author######Brigham and Women's Hospital###
Co-Author: Caroline Alix, BA – Brigham and Women's Hospital
### @@@ Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School ### 1991353###Co-Author###Research Assistant###Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School###
Co-Author: Elyse C. DiCesare, BA – Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School
### @@@ Sara J. Cromer, MD – Massachusetts General Hospital ### 1993958###Co-Author######Massachusetts General Hospital###
Co-Author: Sara J. Cromer, MD – Massachusetts General Hospital
### @@@ Brendan M. Everett, MD, MPH – Brigham and Women’s Hospital ### 1360564###Co-Author######Brigham and Women’s Hospital###
Co-Author: Brendan M. Everett, MD, MPH – Brigham and Women’s Hospital
### @@@ Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital ### 1302713###Co-Author###Professor###Brigham and Women's Hospital###
Co-Author: Robert J. Glynn, PhD, ScD – Brigham and Women's Hospital
### @@@ Deborah J. Wexler, MD, MSc – Massachusetts General Hospital ### 1360566###Co-Author######Massachusetts General Hospital###
Co-Author: Deborah J. Wexler, MD, MSc – Massachusetts General Hospital
### @@@ Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and ### 1360380###Co-Author###Associate Professor of Medicine###Brigham and Women's Hospital and###
Co-Author: Elisabetta Patorno, MD, DrPH (she/her/hers) – Brigham and Women's Hospital and
### she/her/hers
The Risk of Cardiovascular Disease in Postmenopausal Oestrogen Receptor-Positive Breast Cancer Patients Treated with Aromatase Inhibitors: A UK Population-based Study

Lauren McVicker, PhD (she/her/hers) – Centre for Public Health, Queen's University Belfast ### 1302879###Presenting Author###Postdoctoral Research Fellow###Centre for Public Health, Queen's University Belfast###
Presenting Author: Lauren McVicker, PhD (she/her/hers) – Centre for Public Health, Queen's University Belfast
### she/her/hers @@@ Christopher Cardwell, PhD – Centre for Public Health, Queen's University Belfast ### 1302789###Co-Author###Professor###Centre for Public Health, Queen's University Belfast###
Co-Author: Christopher Cardwell, PhD – Centre for Public Health, Queen's University Belfast
### @@@ Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland ### 1093536###Co-Author###Senior Lecturer###Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland###
Co-Author: Blanaid Hicks, PhD – Centre for Public Health, Queen’s University Belfast, Belfast, Northern Ireland
### @@@ Anton Pottegård, PhD, DMSc – University of Southern Denmark ### 1062518###Co-Author###Professor###University of Southern Denmark###
Co-Author: Anton Pottegård, PhD, DMSc – University of Southern Denmark
### @@@ Úna McMenamin, PhD – Centre for Public Health, Queen's University Belfast ### 1302881###Co-Author###UKRI Future Leaders Fellow and Lecturer in Population Cancer Research###Centre for Public Health, Queen's University Belfast###
Co-Author: Úna McMenamin, PhD – Centre for Public Health, Queen's University Belfast
###
The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of explicit criteria for teratogenicity risk mitigation programs

Celeste LY Ewig, PharmD – University of Florida ### 1657495###Presenting Author###Graduate Assistant###University of Florida###
Presenting Author: Celeste LY Ewig, PharmD – University of Florida
### @@@ Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy ### 1358834###Co-Author###Graduate Student###University of Florida, Department of Pharmaceutical Outcomes & Policy###
Co-Author: Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy
### @@@ Nicole E. E. Smolinski, PharmD – University of Florida ### 1358688###Co-Author###Graduate Student###University of Florida###
Co-Author: Nicole E. E. Smolinski, PharmD – University of Florida
### @@@ Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration ### 1360117###Co-Author###Associate Director for Research and Strategic Initiatives###US Food and Drug Administration###
Co-Author: Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration
### @@@ Cynthia LaCivita, PharmD – US Food and Drug Administration ### 1993690###Co-Author###Director Division of RIsk Managment###US Food and Drug Administration###
Co-Author: Cynthia LaCivita, PharmD – US Food and Drug Administration
### @@@ Leila Lackey – Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 2325575###Co-Author######Center for Drug Evaluation and Research, U.S. Food and Drug Administration###
Co-Author: Leila Lackey – Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### @@@ Sara Eggers – Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 2325576###Co-Author######Center for Drug Evaluation and Research, U.S. Food and Drug Administration###
Co-Author: Sara Eggers – Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### @@@ Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325434###Co-Author###Research Scientist###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Co-Author###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine ### 1991648###Co-Author######Department of Genetic Medicine, Johns Hopkins School of Medicine###
Co-Author: Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine
### @@@ Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Co-Author: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers
The Teratogenic Risk Impact and Mitigation (TRIM) Tool: Development of Scoring Weights to Prioritize Medications for Risk Management Beyond Labelling

Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325113###Presenting Author###Associate Professor###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Presenting Author: Judith C. Maro, PhD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### @@@ Celeste LY Ewig, PharmD – University of Florida ### 1657495###Co-Author###Graduate Assistant###University of Florida###
Co-Author: Celeste LY Ewig, PharmD – University of Florida
### @@@ Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy ### 1358834###Co-Author###Graduate Student###University of Florida, Department of Pharmaceutical Outcomes & Policy###
Co-Author: Yanning Wang, MS – University of Florida, Department of Pharmaceutical Outcomes & Policy
### @@@ Nicole E. E. Smolinski, PharmD – University of Florida ### 1358688###Co-Author###Graduate Student###University of Florida###
Co-Author: Nicole E. E. Smolinski, PharmD – University of Florida
### @@@ Gita Toyerskani – Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 2325574###Co-Author######Center for Drug Evaluation and Research, U.S. Food and Drug Administration###
Co-Author: Gita Toyerskani – Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### @@@ Cynthia LaCivita, PharmD – US Food and Drug Administration ### 1993690###Co-Author###Director Division of RIsk Managment###US Food and Drug Administration###
Co-Author: Cynthia LaCivita, PharmD – US Food and Drug Administration
### @@@ Leila Lackey – Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 2325575###Co-Author######Center for Drug Evaluation and Research, U.S. Food and Drug Administration###
Co-Author: Leila Lackey – Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### @@@ Sara Eggers – Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 2325576###Co-Author######Center for Drug Evaluation and Research, U.S. Food and Drug Administration###
Co-Author: Sara Eggers – Center for Drug Evaluation and Research, U.S. Food and Drug Administration
### @@@ Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration ### 1062973###Co-Author###Epidemiologist###U.S. Food and Drug Administration###
Co-Author: Esther H. Zhou, MD, PhD – U.S. Food and Drug Administration
### @@@ Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 2325434###Co-Author###Research Scientist###Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###
Co-Author: Thuy N. Thai, MPH, PhD (she/her/hers) – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
### she/her/hers @@@ Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine ### 1991648###Co-Author######Department of Genetic Medicine, Johns Hopkins School of Medicine###
Co-Author: Sonja A. Rasmussen, MD – Department of Genetic Medicine, Johns Hopkins School of Medicine
### @@@ Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety ### 1061393###Co-Author###Distinguished Professor###University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety###
Co-Author: Almut G. Winterstein, PharmD, PhD, FISPE (she/her/hers) – University of Florida, Pharmaceutical Outcomes & Policy and Center for Drug Evaluation and Safety
### she/her/hers
The Treatment and Prevention of Pregnancy-related Infections

Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway ### 1358057###Moderator###Professor###Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway###
Moderator: Hedvig M.E Nordeng, PhD (she/her/hers) – Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
### she/her/hers @@@ Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1063219###Moderator###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Moderator: Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### she/her/hers
The use of brain-penetrant calcium channel blockers (BP-CCBs) and risk of suicidality and hospitalization among patients with neuropsychiatric disorders: a retrospective comparative cohort study

Azza Shoaibi, PhD, MPH – Johnson & Johnson ### 1360292###Co-Author###Director###Johnson & Johnson###
Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson
### @@@ Justin Bohn, ScD – Johnson & Johnson ### 1991161###Presenting Author###Associate Director, Epidemiology###Johnson & Johnson###
Presenting Author: Justin Bohn, ScD – Johnson & Johnson
### @@@ David M. Kern, PhD, MS (he/him/his) – Johnson & Johnson ### 1062834###Co-Author###Sr. Director, Epidemiology###Johnson & Johnson###
Co-Author: David M. Kern, PhD, MS (he/him/his) – Johnson & Johnson
### he/him/his @@@ Michael Maher – Johnson & Johnson ### 2325320###Co-Author######Johnson & Johnson###
Co-Author: Michael Maher – Johnson & Johnson
### @@@ Amin Yakubu – Johnson & Johnson ### 2325321###Co-Author######Johnson & Johnson###
Co-Author: Amin Yakubu – Johnson & Johnson
### @@@ Dmytro Dymshyts – Johnson & Johnson ### 1994088###Co-Author######Johnson & Johnson###
Co-Author: Dmytro Dymshyts – Johnson & Johnson
###
Time Intervals between Milestones of Studies Evaluating the Effectiveness of Risk Minimisation Measures Assessed by PRAC

Sharon C.M Essink, MSc (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. ### 2327878###Presenting Author###PhD student###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.###
Presenting Author: Sharon C.M Essink, MSc (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
### she/her/hers @@@ Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. ### 2327879###Co-Author######Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.###
Co-Author: Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
### @@@ Thomas Goedecke – European Medicines Agency, Amsterdam, The Netherlands. ### 2330964###Co-Author######European Medicines Agency, Amsterdam, The Netherlands.###
Co-Author: Thomas Goedecke – European Medicines Agency, Amsterdam, The Netherlands.
### @@@ Sabine M.J.M. Straus – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. ### 2327880###Co-Author######Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.###
Co-Author: Sabine M.J.M. Straus – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
### @@@ Helga Gardarsdottir, PharmD, PhD, FISPE (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands ### 1061395###Co-Author###Professor RWD for decision making on medicines###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands###
Co-Author: Helga Gardarsdottir, PharmD, PhD, FISPE (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
### she/her/hers @@@ Marie L. De Bruin – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. ### 2327881###Co-Author######Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.###
Co-Author: Marie L. De Bruin – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
###
Time to cystoscopy after low- or high-dose aspirin initiation: A Danish nationwide cohort study

Malene Andersen, MD (she/her/hers) – Aarhus University and Aarhus University Hospital ### 2325512###Presenting Author###PhD student###Aarhus University and Aarhus University Hospital###
Presenting Author: Malene Andersen, MD (she/her/hers) – Aarhus University and Aarhus University Hospital
### she/her/hers @@@ Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1063034###Co-Author###Chief consultant, professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Co-Author: Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
### @@@ Jørgen Bjerggaard Jensen – Aarhus University and Aarhus university hospital ### 2325513###Co-Author###Professor###Aarhus University and Aarhus university hospital###
Co-Author: Jørgen Bjerggaard Jensen – Aarhus University and Aarhus university hospital
### @@@ Lars Dyrskjøt – Aarhus University and Aarhus University Hospital ### 2325514###Co-Author###Professor###Aarhus University and Aarhus University Hospital###
Co-Author: Lars Dyrskjøt – Aarhus University and Aarhus University Hospital
###
Time, Time and Time Again: Disentangling Time Trends in Prescribing with Age Period Cohort Analysis, An Exemplar on the Annual Prevalence of Statin Prescribing for Males and Females in the United States (2000-2019)

Nicholas Bakewell, MSc (he/him/his) – Institute of Health Policy, Management and Evaluation ### 1992486###Presenting Author###PhD Student###Institute of Health Policy, Management and Evaluation###
Presenting Author: Nicholas Bakewell, MSc (he/him/his) – Institute of Health Policy, Management and Evaluation
### he/him/his
Time-travelling Trends

Claudia Bruno, PhD BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway ### 1062978###Moderator###Post doctoral researcher###School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway###
Moderator: Claudia Bruno, PhD BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
### she/her/hers @@@ Christos Kontogiorgis, PhD (he/him/his) – Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Aexandroupolis, Greece ### 1657664###Moderator###Assistant Professor###Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Aexandroupolis, Greece###
Moderator: Christos Kontogiorgis, PhD (he/him/his) – Laboratory of Hygiene and Environmental Protection, School of Medicine, Democritus University of Thrace, Aexandroupolis, Greece
### he/him/his
Timing and Duration of ADHD Medication Use in Pregnancy and Risk of Preterm Birth

Chaitra Srinivas, PharmD, MMSc (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1659381###Presenting Author###PhD Candidate###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Presenting Author: Chaitra Srinivas, PharmD, MMSc (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### she/her/hers @@@ Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1358431###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Co-Author: Øystein Karlstad, MscPharm, PhD – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### @@@ Hein Stigum – Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway. ### 1991298###Co-Author######Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway.###
Co-Author: Hein Stigum – Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway.
### @@@ Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway. ### 1063219###Co-Author###Senior researcher###Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.###
Co-Author: Kari Furu, MPH, PhD (she/her/hers) – Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway.
### she/her/hers @@@ Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. ### 1062759###Co-Author###Assistant Professor###Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.###
Co-Author: Carolyn E. Cesta, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
### @@@ Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden. ### 1358377###Co-Author###Associate professor###Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.###
Co-Author: Johan Reutfors, MD, PhD – Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
### @@@ Jennifer Hutcheon – Division of Maternal Fetal Medicine, The University of British Columbia, Vancouver, Canada. ### 1991299###Co-Author######Division of Maternal Fetal Medicine, The University of British Columbia, Vancouver, Canada.###
Co-Author: Jennifer Hutcheon – Division of Maternal Fetal Medicine, The University of British Columbia, Vancouver, Canada.
### @@@ Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health ### 1360547###Co-Author###Senior researcher###Norwegian Institute of Public Health###
Co-Author: Jacqueline M. Cohen, PhD (she/her/hers) – Norwegian Institute of Public Health
### she/her/hers
Treatment Patterns and Effectiveness and Safety of Anticoagulant Therapy

Tianze Jiao, PhD (he/him/his) – University of Florida College of Pharmacy ### 2328547###Moderator###Assistant Professor###University of Florida College of Pharmacy###
Moderator: Tianze Jiao, PhD (he/him/his) – University of Florida College of Pharmacy
### he/him/his @@@ Fawaz Alharbi, MSc, PhD – Saudi Food and Drug Authority ### 2329951###Moderator###Director of Drug Safety and Risk management ###Saudi Food and Drug Authority ###
Moderator: Fawaz Alharbi, MSc, PhD – Saudi Food and Drug Authority
###
Treatment strategies and their comparative effectiveness in relapse prevention after the first relapse in persons with first-episode schizophrenia

Heidi Taipale, PharmD – Niuvanniemi Hospital ### 1062908###Presenting Author###Senior Researcher###Niuvanniemi Hospital###
Presenting Author: Heidi Taipale, PharmD – Niuvanniemi Hospital
### @@@ Antti Tanskanen – Niuvanniemi Hospital ### 1658414###Co-Author######Niuvanniemi Hospital###
Co-Author: Antti Tanskanen – Niuvanniemi Hospital
### @@@ Jari Tiihonen – Karolinska Institutet ### 1659052###Co-Author###Professor###Karolinska Institutet###
Co-Author: Jari Tiihonen – Karolinska Institutet
###
Trends in Fentanyl Containing Drug Seizures and Fentanyl Related Deaths across Canada between 2020 and 2023

Ria Garg, PharmD (she/her/hers) – Leslie Dan Faculty of Pharmacy, University of Toronto ### 1992447### Co-Author###PhD Student###Leslie Dan Faculty of Pharmacy, University of Toronto###
Co-Author: Ria Garg, PharmD (she/her/hers) – Leslie Dan Faculty of Pharmacy, University of Toronto
### she/her/hers @@@ Shaleesa Ledlie, MPH (she/her/hers) – Leslie Dan Faculty of Pharmacy, University of Toronto ### 1991951###Presenting Author###PhD Candidate###Leslie Dan Faculty of Pharmacy, University of Toronto###
Presenting Author: Shaleesa Ledlie, MPH (she/her/hers) – Leslie Dan Faculty of Pharmacy, University of Toronto
### she/her/hers @@@ Pamela Leece, MD – Public Health Ontario ### 1991952###Co-Author######Public Health Ontario###
Co-Author: Pamela Leece, MD – Public Health Ontario
### @@@ Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1359899###Co-Author###Scientist###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
###
Trends in Mifepristone Dispensing in the United States: 2016–2023

Laura E. Dodge, ScD, MPH (she/her/hers) – Optum Epidemiology ### 2330509###Presenting Author###Senior Epidemiologist###Optum Epidemiology###
Presenting Author: Laura E. Dodge, ScD, MPH (she/her/hers) – Optum Epidemiology
### she/her/hers @@@ Hannah Katcoff – Optum Epidemiology ### 2330508###Co-Author######Optum Epidemiology###
Co-Author: Hannah Katcoff – Optum Epidemiology
### @@@ Laura Yochum – Optum Epidemiology ### 2327396###Co-Author######Optum Epidemiology###
Co-Author: Laura Yochum – Optum Epidemiology
### @@@ Andrea Chomistek, MPH, ScD – Optum Epidemiology ### 2327115###Co-Author######Optum Epidemiology###
Co-Author: Andrea Chomistek, MPH, ScD – Optum Epidemiology
###
Trends in the Cost and Utilization of Publicly Dispensed Respiratory Inhalers in Ontario, Canada: A Repeated Cross-Sectional Study

Ria Garg, PharmD (she/her/hers) – Leslie Dan Faculty of Pharmacy, University of Toronto ### 1992447###Presenting Author###PhD Student###Leslie Dan Faculty of Pharmacy, University of Toronto###
Presenting Author: Ria Garg, PharmD (she/her/hers) – Leslie Dan Faculty of Pharmacy, University of Toronto
### she/her/hers @@@ Tianru Wang – ICES, Toronto, Ontario, Canada ### 2325531###Co-Author######ICES, Toronto, Ontario, Canada###
Co-Author: Tianru Wang – ICES, Toronto, Ontario, Canada
### @@@ Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1062862###Co-Author###Assistant Professor###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Mina Tadrous, PharmD PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
### @@@ Tony Antoniou – Li Ka Shing Knowledge Institute, St. Michael’s Hospital ### 1660981###Co-Author###Scientist###Li Ka Shing Knowledge Institute, St. Michael’s Hospital###
Co-Author: Tony Antoniou – Li Ka Shing Knowledge Institute, St. Michael’s Hospital
### @@@ Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada ### 1359899###Co-Author###Scientist###Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada###
Co-Author: Tara Gomes, PhD – Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
###
U
Unravelling Sex Disparities in Statin Dose Titration Patterns in Primary Care.

Pauline Kiss, MSc – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands ### 2325315###Presenting Author###PhD candidate###Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands###
Presenting Author: Pauline Kiss, MSc – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
### @@@ Alicia Uijl, PhD – Department of Cardiology, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands ### 2325136###Co-Author###Assistant professor###Department of Cardiology, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands###
Co-Author: Alicia Uijl, PhD – Department of Cardiology, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands
### @@@ Tessa Duk, MSc – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands ### 2325316###Co-Author###PhD Candidate###Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands###
Co-Author: Tessa Duk, MSc – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
### @@@ Diederick E. Grobbee, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands ### 1993358###Co-Author###Professor of Clinical Epidemiology###Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands###
Co-Author: Diederick E. Grobbee, PhD – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
### @@@ Monika Hollander – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands ### 2325317###Co-Author######Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands###
Co-Author: Monika Hollander – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
### @@@ Elisabeth Smits – PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands. ### 1358326###Co-Author######PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.###
Co-Author: Elisabeth Smits – PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.
### @@@ Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands ### 1359696###Co-Author###Professor###Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands###
Co-Author: Miriam C.J.M. Sturkenboom, PhD – Department of Data Science & Biostatistics, Julius Global Health, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands
### @@@ Sanne Peters – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands ### 2325318###Co-Author######Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands###
Co-Author: Sanne Peters – Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, The Netherlands
###
Ursodeoxycholic acid and severe COVID-19 outcomes in people with liver disease: a cohort study using the OpenSAFELY platform

Ruth E. Costello, PhD – London School of Hygiene and Tropical Medicine ### 1993505###Presenting Author###Research Fellow###London School of Hygiene and Tropical Medicine###
Presenting Author: Ruth E. Costello, PhD – London School of Hygiene and Tropical Medicine
### @@@ Karen Waller – University of Sydney ### 2325226###Co-Author######University of Sydney###
Co-Author: Karen Waller – University of Sydney
### @@@ Rachel Smith – Cambridge University Hospitals NHS Foundation Trust ### 2325227###Co-Author######Cambridge University Hospitals NHS Foundation Trust###
Co-Author: Rachel Smith – Cambridge University Hospitals NHS Foundation Trust
### @@@ George Mells – University of Cambridge ### 2325228###Co-Author######University of Cambridge###
Co-Author: George Mells – University of Cambridge
### @@@ Angel Wong – London School of Hygiene and Tropical Medicine ### 1062549###Co-Author###BSc PhD###London School of Hygiene and Tropical Medicine###
Co-Author: Angel Wong – London School of Hygiene and Tropical Medicine
### @@@ Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine ### 1360173###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
### @@@ Viyaasan Mahalingasivam – London School of Hygiene and Tropical Medicine ### 2325229###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Viyaasan Mahalingasivam – London School of Hygiene and Tropical Medicine
### @@@ Emily Herrett, PhD – London School of Hygiene and Tropical Medicine ### 1991300###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-Author: Emily Herrett, PhD – London School of Hygiene and Tropical Medicine
### @@@ Bang Zheng – London School of Hygiene and Tropical Medicine ### 1723607###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Bang Zheng – London School of Hygiene and Tropical Medicine
### @@@ Liang-Lu Lin – London School of Hygiene and Tropical Medicine ### 2325230###Co-Author######London School of Hygiene and Tropical Medicine###
Co-Author: Liang-Lu Lin – London School of Hygiene and Tropical Medicine
### @@@ Amir Mehrkar – University of Oxford ### 1360181###Co-Author######University of Oxford###
Co-Author: Amir Mehrkar – University of Oxford
### @@@ Sebastian Bacon – University of Oxford ### 1360177###Co-Author######University of Oxford###
Co-Author: Sebastian Bacon – University of Oxford
### @@@ Ben Goldacre – University of Oxford ### 1360189###Co-Author######University of Oxford###
Co-Author: Ben Goldacre – University of Oxford
### @@@ Laurie Tomlinson, PhD – London School of Hygiene and Tropical Medicine ### 1360000###Co-Author###NIHR Research Professor###London School of Hygiene and Tropical Medicine###
Co-Author: Laurie Tomlinson, PhD – London School of Hygiene and Tropical Medicine
### @@@ John R. Tazare, PhD – London School of Hygiene and Tropical Medicine ### 1062669###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-Author: John R. Tazare, PhD – London School of Hygiene and Tropical Medicine
### @@@ Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine ### 1062599###Co-Author###Associate Professor###London School of Hygiene and Tropical Medicine / Yale School of Medicine###
Co-Author: Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine
###
Use of Gabapentinoids and Risk of Hip Fractures: A Population-based Case-crossover and Case-case-time-control Study

Miriam T Y Leung, MClinPharm – Centre for Medicine Use and Safety, Monash University ### 1655954###Presenting Author###PhD student###Centre for Medicine Use and Safety, Monash University###
Presenting Author: Miriam T Y Leung, MClinPharm – Centre for Medicine Use and Safety, Monash University
### @@@ Justin P Turner, PhD – Centre for Medicine Use and Safety, Monash University ### 1992790###Co-Author######Centre for Medicine Use and Safety, Monash University###
Co-Author: Justin P Turner, PhD – Centre for Medicine Use and Safety, Monash University
### @@@ Clara Marquina, PhD – Centre for Medicine Use and Safety, Monash University ### 2325611###Co-Author######Centre for Medicine Use and Safety, Monash University###
Co-Author: Clara Marquina, PhD – Centre for Medicine Use and Safety, Monash University
### @@@ Jenni Ilomäki, PhD – Centre for Medicine Use and Safety, Monash University ### 1655256###Co-Author###Senior Lecturer###Centre for Medicine Use and Safety, Monash University###
Co-Author: Jenni Ilomäki, PhD – Centre for Medicine Use and Safety, Monash University
### @@@ Tim Tran, PhD – Austin Health ### 1992793###Co-Author######Austin Health###
Co-Author: Tim Tran, PhD – Austin Health
### @@@ J Simon Bell, PhD – Centre for Medicine Use and Safety, Monash University ### 1655335###Co-Author######Centre for Medicine Use and Safety, Monash University###
Co-Author: J Simon Bell, PhD – Centre for Medicine Use and Safety, Monash University
###
Use of HIV medication during pregnancy in Germany

Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1062583###Presenting Author###Senior scientist###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Presenting Author: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers @@@ Nadine Wentzell, Msc – Leibniz Institute for Prevention Research and Epidemiology – BIPS ### 1062940### Co-Author###Research Associate###Leibniz Institute for Prevention Research and Epidemiology – BIPS###
Co-Author: Nadine Wentzell, Msc – Leibniz Institute for Prevention Research and Epidemiology – BIPS
### @@@ Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS ### 1397900###Co-Author###Statistician, postdoctoral research fellow###Leibniz Institute for Prevention Research and Epidemiology - BIPS###
Co-Author: Bianca Kollhorst, PhD (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
### she/her/hers
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk

Cheng Chen, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA ### 2325645###Co-Author###Epidemiologist Reviewer###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA###
Co-Author: Cheng Chen, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
### @@@ Efe Eworuke – Epidemiology and Drug Safety, Real World Solutions, IQVIA, Washington DC, USA ### 1991833###Co-Author######Epidemiology and Drug Safety, Real World Solutions, IQVIA, Washington DC, USA###
Co-Author: Efe Eworuke – Epidemiology and Drug Safety, Real World Solutions, IQVIA, Washington DC, USA
### @@@ Ashish Rai, PhD, MSPH, MBBS (he/him/his) – Department of Population Medicine, Harvard Pilgrim Health Care Institute ### 2325557###Co-Author###Research Scientist###Department of Population Medicine, Harvard Pilgrim Health Care Institute###
Co-Author: Ashish Rai, PhD, MSPH, MBBS (he/him/his) – Department of Population Medicine, Harvard Pilgrim Health Care Institute
### he/him/his @@@ Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 2325646###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA###
Co-Author: Laura Hou – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA
### @@@ Jenice S. Ko – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA ### 2325647###Co-Author######Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA###
Co-Author: Jenice S. Ko – Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA
### @@@ Mary Ross Southworth – Division of Cardiology and Nephrology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA ### 2325648###Co-Author######Division of Cardiology and Nephrology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA###
Co-Author: Mary Ross Southworth – Division of Cardiology and Nephrology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
### @@@ José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1991185###Co-Author###Pharmacoepidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Co-Author: José J. Hernández-Muñoz, RPh, MPH, MSc, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration ### 1063144###Presenting Author###Lead Epidemiologist###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration###
Presenting Author: Mingfeng Zhang, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration
###
Use of Target Trial Emulation for VHA Drug Safety Evaluations: A Case Study with Bivalent COVID-19 Vaccination and Hospitalizations for Ischemic Stroke

Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration ### 1302728###Presenting Author###Investigator###Veterans Health Administration###
Presenting Author: Kevin W. Mcconeghy, PharmD, PhD – Veterans Health Administration
### @@@ Kwan Hur, PhD – Veterans Health Administration ### 1657376###Co-Author###Biostatistician###Veterans Health Administration###
Co-Author: Kwan Hur, PhD – Veterans Health Administration
### @@@ Rong Jiang, MS – Veterans Health Administration ### 1991597###Co-Author###Management and Program Analyst###Veterans Health Administration###
Co-Author: Rong Jiang, MS – Veterans Health Administration
### @@@ Lucy Pandey, MS – Veterans Health Administration ### 1657535###Co-Author######Veterans Health Administration###
Co-Author: Lucy Pandey, MS – Veterans Health Administration
### @@@ Walid Gellad, MD – VA Pittsburgh Healthcare System ### 1992664###Co-Author######VA Pittsburgh Healthcare System###
Co-Author: Walid Gellad, MD – VA Pittsburgh Healthcare System
### @@@ Peter Glassman, MBBS, MSc – Veterans Health Administration ### 1657543###Co-Author######Veterans Health Administration###
Co-Author: Peter Glassman, MBBS, MSc – Veterans Health Administration
### @@@ Chester B. Good, MD, MPH – Veterans Health Administration ### 1359135###Co-Author######Veterans Health Administration###
Co-Author: Chester B. Good, MD, MPH – Veterans Health Administration
### @@@ Donald R. Miller, ScD – Veterans Health Administration ### 1991692###Co-Author###Professor and Health Scientist###Veterans Health Administration###
Co-Author: Donald R. Miller, ScD – Veterans Health Administration
### @@@ Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA ### 1659630###Co-Author###Director, Clinical Epidemiology Program###Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA###
Co-Author: Yinong Young-Xu, ScD, MA, MS – Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA
### @@@ Fran E. Cunningham, PharmD – Veterans Health Administration ### 1655509###Co-Author###Director, Center for Medication Safety###Veterans Health Administration###
Co-Author: Fran E. Cunningham, PharmD – Veterans Health Administration
###
Use of trazodone and quetiapine for delirium in older adults after hospital discharge and risks of adverse clinical outcomes

Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 2325401###Presenting Author###Research fellow###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Presenting Author: Chun-Ting Yang, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ James Wilkins – McLean Hospital ### 2325404###Co-Author######McLean Hospital###
Co-Author: James Wilkins – McLean Hospital
### @@@ Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital ### 2325379###Co-Author###Research Fellow###Brigham and Women's Hospital###
Co-Author: Kevin Pritchard, OT, PhD, OTR – Brigham and Women's Hospital
### @@@ Qiaoxi Chen, phD – Brigham and Women's Hospital ### 2325400###Co-Author###Postdoctoral Research Fellow###Brigham and Women's Hospital###
Co-Author: Qiaoxi Chen, phD – Brigham and Women's Hospital
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
### @@@ Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Co-Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
###
Using External Validity Methods to Improve the Precision of Effect Estimates in Subgroups

Michael Andrew Webster-Clark, PharmD, PhD (he/him/his) – McGill University ### 1062566###Presenting Author###Assistant Professor###McGill University###
Presenting Author: Michael Andrew Webster-Clark, PharmD, PhD (he/him/his) – McGill University
### he/him/his @@@ Alan R. Ellis, PhD, MSW – North Carolina State University ### 1659730###Co-Author###Associate Professor###North Carolina State University###
Co-Author: Alan R. Ellis, PhD, MSW – North Carolina State University
### @@@ Alan C. Kinlaw, PhD – Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill ### 1358525###Co-Author###Assistant Professor###Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill###
Co-Author: Alan C. Kinlaw, PhD – Division of Pharmaceutical Outcomes and Policy, School of Pharmacy, University of North Carolina at Chapel Hill
### @@@ Robert W. Platt, PhD (he/him/his) – McGill University ### 1358167###Co-Author###Professor###McGill University###
Co-Author: Robert W. Platt, PhD (he/him/his) – McGill University
### he/him/his
Using generative AI to more efficiently conduct systematic reviews, solve coding problems, and communicate research findings: a student-led workshop

Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill ### 1046824###Lead Speaker###Associate Professor###University of North Carolina at Chapel Hill###
Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – University of North Carolina at Chapel Hill
### she/her/hers @@@ Jeanny H. Wang, MPH – University of North Carolina at Chapel Hill ### 2325251###Speaker###Graduate Research Assistant###University of North Carolina at Chapel Hill###
Speaker: Jeanny H. Wang, MPH – University of North Carolina at Chapel Hill
### @@@ Clement Acheampong, B.Pharm, MPH – University of North Carolina at Chapel Hill ### 2325331###Speaker###PhD Student###University of North Carolina at Chapel Hill###
Speaker: Clement Acheampong, B.Pharm, MPH – University of North Carolina at Chapel Hill
### @@@ Bria Carmichael, MPH – University of North Carolina at Chapel Hill ### 2325332###Speaker###Doctoral Student###University of North Carolina at Chapel Hill###
Speaker: Bria Carmichael, MPH – University of North Carolina at Chapel Hill
### @@@ Catherine Wiener, MS – Department of Epidemiology, University of North Carolina at Chapel Hill ### 1991528###Speaker###PhD Student###Department of Epidemiology, University of North Carolina at Chapel Hill###
Speaker: Catherine Wiener, MS – Department of Epidemiology, University of North Carolina at Chapel Hill
###
Using High Dimensional Iterative Causal Forest (hdiCF) to Identify Subgroups with Heterogeneous Treatment Effects: Glucagon-like Peptide 1 Receptor Agonists (GLP1RA) vs Sulfonylurea (SU) on Asthma Exacerbations

Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill ### 1062647###Presenting Author###postdoc###University of North Carolina at Chapel Hill###
Presenting Author: Tiansheng Wang, PharmD, PhD – University of North Carolina at Chapel Hill
### @@@ Virginia Pate, MS – University of North Carolina at Chapel Hill ### 1358426###Co-Author###Analyst###University of North Carolina at Chapel Hill###
Co-Author: Virginia Pate, MS – University of North Carolina at Chapel Hill
### @@@ Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA ### 1360328###Co-Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA###
Co-Author: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
### @@@ John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism ### 1991568###Co-Author######University of North Carolina School of Medicine Division of Endocrinology and Metabolism###
Co-Author: John Buse, MD, PhD – University of North Carolina School of Medicine Division of Endocrinology and Metabolism
### @@@ Michael Kosorok – University of North Carolina Gillings School of Global Public Health Department of Biostatistics ### 1359686###Co-Author######University of North Carolina Gillings School of Global Public Health Department of Biostatistics###
Co-Author: Michael Kosorok – University of North Carolina Gillings School of Global Public Health Department of Biostatistics
### @@@ Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill ### 1062525###Co-Author###Professor###University of North Carolina at Chapel Hill###
Co-Author: Til Stürmer, MD, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/his
Using Multiple Medications with Similar Adverse Drug Reactions Can Increase the Likelihood of a Prescribing Cascade: Results from a Cohort Study

Atiya Mohammad – Pharmacy Department, OLVG, Amsterdam ### 2325197###Co-Author######Pharmacy Department, OLVG, Amsterdam###
Co-Author: Atiya Mohammad – Pharmacy Department, OLVG, Amsterdam
### @@@ Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands ### 1658657###Co-Author###Associate Professor of Pharmacoepidemiology and Pharmaceutical Care Associate Professor of Pharmacoepidemiology###Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands###
Co-Author: Jacqueline G. Hugtenburg, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands
### she/her/hers @@@ Patricia M.L.A. van den Bemt, PhD, PharmD (she/her/hers) – Department Clinical Pharmacy & Pharmacology, UMCG, Groningen, The Netherlands ### 1358161###Co-Author###Hospital Pharmacist###Department Clinical Pharmacy & Pharmacology, UMCG, Groningen, The Netherlands###
Co-Author: Patricia M.L.A. van den Bemt, PhD, PharmD (she/her/hers) – Department Clinical Pharmacy & Pharmacology, UMCG, Groningen, The Netherlands
### she/her/hers @@@ Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands ### 1086986###Presenting Author###PhD, FISPE###Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands###
Presenting Author: Petra Denig, PharmD, PhD, FISPE – Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
### @@@ Fatma Karapinar-Carkit, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands ### 2325176###Co-Author###Associate professor###Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands###
Co-Author: Fatma Karapinar-Carkit, PhD, PharmD (she/her/hers) – Department of Clinical Pharmacy & Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands
### she/her/hers
Using Pharmacoepidemiology Database Resources to Address Drug Safety Research

Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine ### 1046837###Lead Speaker###Associate Director of Epidemiology###Johnson and Johnson Innovative Medicine###
Lead Speaker: Kevin Haynes, PharmD, MSCE (he/him/his) – Johnson and Johnson Innovative Medicine
### he/him/his @@@ Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy ### 1302758###Speaker###Head of Unit at ARS Toscana, Florence, Italy###ARS Toscana, Florence, Italy###
Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
### she/her/hers @@@ Matthew W. Reynolds, PhD, FISPE – Azimuth Research Group ### 1659421###Speaker###Senior Vice President, Scientific Affairs###Azimuth Research Group###
Speaker: Matthew W. Reynolds, PhD, FISPE – Azimuth Research Group
### @@@ Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research ### 2329544###Speaker###Senior Director###Carelon Research###
Speaker: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research
### he/him/his @@@ Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC ### 1088164###Speaker###Assistant Professor###Department of Population Health Sciences, Duke University School of Medicine, Durham, NC###
Speaker: Sudha R. R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
### she/her/hers
Using Prescription Symmetry Sequence Analysis in the context of Antiparkinsonian Treatments in the United Kingdom

Xihang Chen, MMath (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford ### 1992095###Presenting Author###Research Assistant in Health Data Science###Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford###
Presenting Author: Xihang Chen, MMath (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford
### he/him/his @@@ Berta Raventós, PhD – Erasmus Medical Center ### 1992204###Co-Author###Postdoctoral researcher###Erasmus Medical Center###
Co-Author: Berta Raventós, PhD – Erasmus Medical Center
### @@@ Ty Stanford – NHMRC Medicines Intelligence Centre of Research Excellence ### 1358336###Co-Author######NHMRC Medicines Intelligence Centre of Research Excellence###
Co-Author: Ty Stanford – NHMRC Medicines Intelligence Centre of Research Excellence
### @@@ Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford ### 1062615###Co-Author###Professor of Pharmaco-and Device Epidemiology###University of Oxford###
Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Edward Burn, PhD – University of Oxford ### 1358374###Co-Author###Senior Researcher in Epidemiology and Health Economics###University of Oxford###
Co-Author: Edward Burn, PhD – University of Oxford
### @@@ Martí Català, PhD (he/him/his) – University of Oxford ### 1659148###Co-Author###Senior Data Scientist###University of Oxford###
Co-Author: Martí Català, PhD (he/him/his) – University of Oxford
### he/him/his @@@ Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia ### 1358335###Co-Author###Professor###Quality Use of Medicines and Pharmacy Research Centre, University of South Australia###
Co-Author: Nicole L. Pratt, FISPE – Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
### @@@ Laura Molina Porce – Neurological Tissue Bank of the Biobanc-Hospital Clinic-Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) ### 2325313###Co-Author######Neurological Tissue Bank of the Biobanc-Hospital Clinic-Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS)###
Co-Author: Laura Molina Porce – Neurological Tissue Bank of the Biobanc-Hospital Clinic-Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS)
### @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Co-Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###
Co-Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Danielle Newby, PhD – University of Oxford ### 1991362###Co-Author###Senior Postdoctoral Researcher in Real World Evidence###University of Oxford###
Co-Author: Danielle Newby, PhD – University of Oxford
###
Using probabilistic bias analysis to account for outcome misclassification of COVID-19 death in pharmacoepidemiologic studies

Marleen Bokern, MSc – London School of Hygiene and Tropical Medicine ### 1659494###Presenting Author###PhD candidate###London School of Hygiene and Tropical Medicine###
Presenting Author: Marleen Bokern, MSc – London School of Hygiene and Tropical Medicine
### @@@ Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine ### 1062599###Co-Author###Associate Professor###London School of Hygiene and Tropical Medicine / Yale School of Medicine###
Co-Author: Christopher T. Rentsch, PhD, FISPE – London School of Hygiene and Tropical Medicine / Yale School of Medicine
### @@@ Jennifer K. Quint, PhD, FRCP – National Heart & Lung Institute, Imperial College London ### 1359146###Co-Author###Professor of Respiratory Epidemiology###National Heart & Lung Institute, Imperial College London###
Co-Author: Jennifer K. Quint, PhD, FRCP – National Heart & Lung Institute, Imperial College London
### @@@ Jacob Hunnicutt – Boehringer Ingelheim ### 2325417###Co-Author###Director, Epidemiology###Boehringer Ingelheim###
Co-Author: Jacob Hunnicutt – Boehringer Ingelheim
### @@@ Kieran J. Rothnie, PhD – GSK ### 1062865###Co-Author###Director Epidemiology###GSK###
Co-Author: Kieran J. Rothnie, PhD – GSK
### @@@ Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine ### 1358165###Co-Author###Professor###London School of Hygiene & Tropical Medicine###
Co-Author: Ian Douglas, PhD, MSc, BSc – London School of Hygiene & Tropical Medicine
### @@@ Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine ### 1360173###Co-Author###Assistant Professor###London School of Hygiene and Tropical Medicine###
Co-Author: Anna Schultze, PhD, MSc – London School of Hygiene and Tropical Medicine
###
Using QBA in the Selection of Computable Operational Definitions to Minimize Misclassification & Underpower in RWE Studies

Aaron Kamauu, MD MS MPH – Navidence ### 2325689###Presenting Author###CEO, Co-Founder###Navidence###
Presenting Author: Aaron Kamauu, MD MS MPH – Navidence
### @@@ Christen M. Gray – BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK ### 1360359###Co-Author######BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK###
Co-Author: Christen M. Gray – BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK
### @@@ Carla A. Talarico, PhD – AstraZeneca ### 1991256###Co-Author######AstraZeneca###
Co-Author: Carla A. Talarico, PhD – AstraZeneca
### @@@ Craig Parker, MD MS – Navidence ### 1994009###Co-Author######Navidence###
Co-Author: Craig Parker, MD MS – Navidence
### @@@ Jared Kamauu – Navidence ### 2325691###Co-Author######Navidence###
Co-Author: Jared Kamauu – Navidence
### @@@ Amanda Shields – Navidence ### 2325692###Co-Author######Navidence###
Co-Author: Amanda Shields – Navidence
### @@@ Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca ### 1658805###Co-Author###Senior Director, Epidemiology###Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca###
Co-Author: Sylvia Taylor, PhD, MPH, MBA – Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca
### @@@ Sudhir Venkatesan, PhD, MPH – BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca ### 1658797###Co-Author###Director###BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca###
Co-Author: Sudhir Venkatesan, PhD, MPH – BPM Evidence Statistics, BioPharmaceuticals Medical, AstraZeneca
###
Using simulations to evaluate characteristics of negative control outcomes and their impact on bias detection

Zafar Zafari, MSc, PhD – University of Maryland School of Pharmacy ### 1659618###Presenting Author###Associate Professor of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy###
Presenting Author: Zafar Zafari, MSc, PhD – University of Maryland School of Pharmacy
### @@@ Susan dosReis, PhD – University of Maryland School of Pharmacy ### 1359191###Co-Author###Professor, Department of Practice, Sciences, and Health Outcomes Research###University of Maryland School of Pharmacy###
Co-Author: Susan dosReis, PhD – University of Maryland School of Pharmacy
### @@@ Jeong-eun Park, AB, MPH, RPh – University of Maryland School of Pharmacy ### 1659619###Co-Author######University of Maryland School of Pharmacy###
Co-Author: Jeong-eun Park, AB, MPH, RPh – University of Maryland School of Pharmacy
### @@@ Wei Hua, MSc, MHS, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA ### 1358275###Co-Author###Deputy Division Director###Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA###
Co-Author: Wei Hua, MSc, MHS, MD, PhD – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, USA
### @@@ Yong Ma, Ph.D – Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research, FDA ### 1359916###Co-Author###Lead Mathematical Statistician###Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research, FDA###
Co-Author: Yong Ma, Ph.D – Office of Biostatistics, Office of Translational Sciences, Center of Drug Evaluation and Research, FDA
### @@@ Fang Tian – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD ### 1659617###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD###
Co-Author: Fang Tian – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
###
Utilization Trends of Antiretroviral Therapy in Manitoba, Canada: A Population-based Study Between 2007 and 2022

Laila Aboulatta, PharmD – University of Manitoba ### 1655316###Presenting Author###PhD student###University of Manitoba###
Presenting Author: Laila Aboulatta, PharmD – University of Manitoba
### @@@ Georgia Booth – Aberystwyth University ### 2325705###Co-Author######Aberystwyth University###
Co-Author: Georgia Booth – Aberystwyth University
### @@@ Lara Haidar, PharmD MSc (she/her/hers) – University of Manitoba ### 1655756###Co-Author###PhD student###University of Manitoba###
Co-Author: Lara Haidar, PharmD MSc (she/her/hers) – University of Manitoba
### she/her/hers @@@ Basem Elmatary – University of Manitoba ### 2325706###Co-Author######University of Manitoba###
Co-Author: Basem Elmatary – University of Manitoba
### @@@ Qier Tan – University of Manitoba ### 1992382###Co-Author###Analyst###University of Manitoba###
Co-Author: Qier Tan – University of Manitoba
### @@@ Sherif Eltonsy, PhD – University of Manitoba ### 1357974###Co-Author###Assistant Professor###University of Manitoba###
Co-Author: Sherif Eltonsy, PhD – University of Manitoba
###
V
Vaccine Effectiveness - Beyond COVID-19

Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1655839###Moderator###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Moderator: Katsiaryna Bykov, PharmD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
### @@@ Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute ### 1659086###Moderator###Senior Research Scientist###Harvard Pilgrim Health Care Institute###
Moderator: Elizabeth J. Bell, PhD, MPH (she/her/hers) – Harvard Pilgrim Health Care Institute
### she/her/hers
Vaccine Safety Across Ages & Platforms

Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency ### 1655442###Moderator###Pharmacoepidemiology/RWE Senior Specialist###RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency###
Moderator: Catherine Cohet, PhD (she/her/hers) – RWE Workstream, Data Analytics & Methods Task Force, European Medicines Agency
### she/her/hers @@@ Amie Goodin, PhD, MPP – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States ### 1659995###Moderator###Assistant Professor###Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States###
Moderator: Amie Goodin, PhD, MPP – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, United States
###
Vaccine Safety Potpourri

Wilhelmine Meeraus, PhD – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK ### 1655385###Moderator###Epidemiology Director###Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK###
Moderator: Wilhelmine Meeraus, PhD – Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK
### @@@ Deborah Layton, PhD, FISPE – PEPI Consultancy Limited ### 1656012###Moderator###Director###PEPI Consultancy Limited###
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
###
Validation of lactational mastitis diagnosis codes in electronic health care data

Malini B. DeSilva – Pregnancy and Child Health Research Center, HealthPartners Institute ### 2325489###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Malini B. DeSilva – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Elisabeth M. Seburg – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1993459###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Elisabeth M. Seburg – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Kirsten Ehresmann – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1993458###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Kirsten Ehresmann – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Gabriela Vazquez-Benitez, PhD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1658758###Co-Author###Senior Research Investigator###Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Gabriela Vazquez-Benitez, PhD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute
### she/her/hers @@@ Yihe G. Daida – Center for Integrated Health Care Research, Kaiser Permanente Hawaii ### 1993452###Co-Author###Research Associate III###Center for Integrated Health Care Research, Kaiser Permanente Hawaii###
Co-Author: Yihe G. Daida – Center for Integrated Health Care Research, Kaiser Permanente Hawaii
### @@@ Kimberly K. Vesco – Kaiser Permanente Center for Health Research ### 2325166###Co-Author######Kaiser Permanente Center for Health Research###
Co-Author: Kimberly K. Vesco – Kaiser Permanente Center for Health Research
### @@@ Elyse O. Kharbanda – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1655768###Co-Author######Pregnancy and Child Health Research Center, HealthPartners Institute###
Co-Author: Elyse O. Kharbanda – Pregnancy and Child Health Research Center, HealthPartners Institute
### @@@ Kristin Palmsten, ScD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute ### 1062579###Presenting Author###Senior Research Investigator###Pregnancy and Child Health Research Center, HealthPartners Institute###
Presenting Author: Kristin Palmsten, ScD (she/her/hers) – Pregnancy and Child Health Research Center, HealthPartners Institute
### she/her/hers
Validity of pharmaceutical claims data for determining medication exposure in long-term care facilities

Emma K. Pearce, BPharm(Hons), BPharmSci – University of South Australia, UniSA Clinical & Health Sciences, Adelaide, South Australia, Australia ### 2330943###Co-Author######University of South Australia, UniSA Clinical & Health Sciences, Adelaide, South Australia, Australia###
Co-Author: Emma K. Pearce, BPharm(Hons), BPharmSci – University of South Australia, UniSA Clinical & Health Sciences, Adelaide, South Australia, Australia
### @@@ Geraint Rogers, PhD – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2330944###Co-Author######South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Co-Author: Geraint Rogers, PhD – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Lucy Carpenter, PhD – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2330945###Co-Author######South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Co-Author: Lucy Carpenter, PhD – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Maria C. Inacio, MS, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2326852###Co-Author######Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Co-Author: Maria C. Inacio, MS, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2326851###Co-Author###Professor###Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Co-Author: Gillian E. Caughey, PhD – Registry of Senior Australians (ROSA), South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Andrew Shoubridge, PhD – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2330946###Co-Author######South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Co-Author: Andrew Shoubridge, PhD – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Lito Papanicolas – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia ### 2330947###Co-Author######South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia###
Co-Author: Lito Papanicolas – South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia
### @@@ Janet K. Sluggett, PhD, BPharm(Hons), GDip ClinEpid, FANZCAP, FSHP (she/her/hers) – University of South Australia ### 2326857###Presenting Author###Associate Professor in Pharmacy and Pharmacoepidemiology###University of South Australia###
Presenting Author: Janet K. Sluggett, PhD, BPharm(Hons), GDip ClinEpid, FANZCAP, FSHP (she/her/hers) – University of South Australia
### she/her/hers
Vancomycin-Induced Acute Kidney Injury in Critically Ill Adult Patients: a Multicenter Target Trial Emulation Study

Joanna E. Klopotowska, PharmD, PhD (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325203###Presenting Author###Assistant Professor, Principal Investigator###Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Presenting Author: Joanna E. Klopotowska, PharmD, PhD (she/her/hers) – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### she/her/hers @@@ Izak A.R. Yasrebi-de Kom – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325601###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Izak A.R. Yasrebi-de Kom – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Kitty J. Jager – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325475###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Kitty J. Jager – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Vianda S. Stel – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325606###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Vianda S. Stel – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Nicholas C. Chesnaye – ERA Registry, Amsterdam UMC, Department of Medical Informatics, Amsterdam, the Netherlands ### 2325607###Co-Author######ERA Registry, Amsterdam UMC, Department of Medical Informatics, Amsterdam, the Netherlands###
Co-Author: Nicholas C. Chesnaye – ERA Registry, Amsterdam UMC, Department of Medical Informatics, Amsterdam, the Netherlands
### @@@ Ameen Abu-Hanna – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325476###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Ameen Abu-Hanna – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Nicolette F. de Keizer – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325472###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Nicolette F. de Keizer – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Dave A. Dongelmans – Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325471###Co-Author######Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Dave A. Dongelmans – Department of Intensive Care Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
### @@@ Giovanni Cinà – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands ### 2325610###Co-Author######Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands###
Co-Author: Giovanni Cinà – Department of Medical Informatics, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands
###
W
Welcome and Keynote Session: The future of pharmacoepidemiology, powered by technology

William G. Dixon, MD PhD – University of Manchester ### 1062521###Keynote Speaker###Professor of Digital Epidemiology###University of Manchester###
Keynote Speaker: William G. Dixon, MD PhD – University of Manchester
### @@@ Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA ### 1653783###Speaker###Associate Director of Epidemiology###IQVIA###
Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
### she/her/hers @@@ Paul Strijbos, PhD (he/him/his) – F. Hoffmann-La Roche ### 2412788###Speaker###Senior Principal Neurotech Innovation Leader###F. Hoffmann-La Roche###
Speaker: Paul Strijbos, PhD (he/him/his) – F. Hoffmann-La Roche
### he/him/his @@@ Martin Seneviratne, MBBS MS (he/him/his) – Phare Health ### 2412789###Speaker###Co-Founder###Phare Health###
Speaker: Martin Seneviratne, MBBS MS (he/him/his) – Phare Health
### he/him/his @@@ Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC ### 1046833###Chairperson###Chief Scientific Officer, IQVIA Real-World Solutions, Retired###Dreyer Strategies LLC###
Chairperson: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
### she/her/hers @@@ Daniel A. Caños, PhD, MPH ### 2406272###Chairperson#########
Chairperson: Daniel A. Caños, PhD, MPH
###
Welcome Reception & Academic Showcase
Welcome to ISPE 2024
Why Real World Evidence (RWE) Studies Need Implementation Research: The Value Proposition

Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific ### 1088147###Lead Speaker###Senior Director###Evidera. Inc., PPD, a part of Thermo Fisher Scientific###
Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera. Inc., PPD, a part of Thermo Fisher Scientific
### @@@ Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States ### 1088178###Speaker###Sr. Director###Merck & Co., Inc., Rahway, NJ, United States###
Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
### he/him/his @@@ Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration ### 1360117###Speaker###Associate Director for Research and Strategic Initiatives###US Food and Drug Administration###
Speaker: Gita A. Toyserkani, PharmD, MBA – US Food and Drug Administration
### @@@ Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago ### 1046822###Speaker###Professor and Dean###Loyola University of Chicago###
Speaker: Elaine H. Morrato, DrPH FISPE – Loyola University of Chicago
###
Withholding of oral anticoagulants in patients with dementia and atrial fibrillation by frailty status

Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ### 1082840###Presenting Author###Assistant Professor###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School###
Presenting Author: Kueiyu Joshua Lin, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School
### @@@ Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA ### 1360618###Co-Author###Professor of Medicine, Harvard Medical School###Massachusetts General Hospital, Boston, MA###
Co-Author: Daniel E. Singer, MD – Massachusetts General Hospital, Boston, MA
### @@@ Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School ### 2325571###Co-Author######Hebrew Rehabilitation Center, Harvard Medical School###
Co-Author: Darae Ko – Hebrew Rehabilitation Center, Harvard Medical School
### @@@ Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1658130###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Yichi Zhang – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School ### 1991377###Co-Author######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School###
Co-Author: Alexander Cervone – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
### @@@ Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research ### 1655334###Co-Author###Associate Professor of Medicine, Harvard Medical School###Hebrew SeniorLife Marcus Institute for Aging Research###
Co-Author: Dae Hyun Kim, MD, ScD – Hebrew SeniorLife Marcus Institute for Aging Research
###
Y
Your Brain on CVD and Diabetes Drugs

G. Caleb Alexander, MD – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD ### 1093469###Moderator###Professor of Epidemiology and Medicine###Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD###
Moderator: G. Caleb Alexander, MD – Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
### @@@ Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital ### 1063034###Moderator###Chief consultant, professor###Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital###
Moderator: Mette Nørgaard, MD, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
###
Z
Z-drug use in the first trimester and risk of congenital malformations in the U.S.

Kelly Fung, MS – Brigham and Women's Hospital and Harvard Medical School ### 2325301###Presenting Author###Research Specialist###Brigham and Women's Hospital and Harvard Medical School###
Presenting Author: Kelly Fung, MS – Brigham and Women's Hospital and Harvard Medical School
### @@@ Loreen Straub, MD MS (she/her/hers) – Brigham and Women's Hospital/Harvard Medical School ### 1062604###Co-Author###Instructor in Medicine###Brigham and Women's Hospital/Harvard Medical School###
Co-Author: Loreen Straub, MD MS (she/her/hers) – Brigham and Women's Hospital/Harvard Medical School
### she/her/hers @@@ Brian T. Bateman, MD, MSc – Stanford University ### 1088175###Co-Author######Stanford University###
Co-Author: Brian T. Bateman, MD, MSc – Stanford University
### @@@ Ayesha C. Sujan, PhD (she/her/hers) – Stanford University ### 1991327###Co-Author###Postdoctoral Fellow###Stanford University###
Co-Author: Ayesha C. Sujan, PhD (she/her/hers) – Stanford University
### she/her/hers @@@ Gregory Brill – Brigham and Women's Hospital ### 1655926###Co-Author###Programmer###Brigham and Women's Hospital###
Co-Author: Gregory Brill – Brigham and Women's Hospital
### @@@ Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health ### 1093997###Co-Author###Professor of Epidemiology###Harvard T.H. Chan School of Public Health###
Co-Author: Sonia Hernandez-Diaz, MD, DrPH – Harvard T.H. Chan School of Public Health
### @@@ Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ### 1359931###Co-Author###Associate Professor of Medicine###Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School###
Co-Author: Krista F. Huybrechts, PhD, MS – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
###